Table of Contents
Index to Financial Statements

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 10-K

 

(Mark One)

 

x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the fiscal year ended December 31, 2004

 

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission File Number 1-10989

 


 

VENTAS, INC.

(Exact Name of Registrant as Specified in Its Charter)

 

Delaware

  61-1055020
(State or Other Jurisdiction of Incorporation or Organization)   (IRS Employer Identification No.)

 

10350 Ormsby Park Place, Suite 300, Louisville, Kentucky 40223

(Address of Principal Executive Offices) (Zip Code)

 

(502) 357-9000

(Registrant’s Telephone Number, Including Area Code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class

 

Name of Each Exchange on Which Registered


Common Stock, par value $0.25 per share

  New York Stock Exchange

 

Securities registered pursuant to Section 12(g) of the Act: None

 


 

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes x     No ¨

 

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of Registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment of this Form 10-K.     x

 

Indicate by check mark whether the Registrant is an accelerated filer (as defined in Rule 12b-2 of the Act). Yes x     No ¨

 

The aggregate market value of shares of the Registrant’s common stock, par value $0.25 per share (“Common Stock”), held by non-affiliates of the Registrant as of June 30, 2004 was approximately $1.9 billion. For purposes of the foregoing calculation only, all directors and executive officers of the Registrant have been deemed affiliates.

 

As of February 25, 2005, 84,789,533 shares of the Registrant’s Common Stock were outstanding.

 

Portions of the Registrant’s definitive Proxy Statement for the Annual Meeting of Stockholders to be held on May 24, 2005 are incorporated by reference into Part III, Items 10 through 14 of this Annual Report on Form 10-K.

 



Table of Contents
Index to Financial Statements

CAUTIONARY STATEMENTS

 

Unless otherwise indicated, the terms “we,” “us” and “our” and other similar terms in this Annual Report on Form 10-K refer to Ventas, Inc. and its consolidated subsidiaries.

 

Forward-Looking Statements

 

This Annual Report on Form 10-K includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, funds from operations, dividends and dividend plans, financing plans, business strategy, budgets, projected costs, capital expenditures, competitive positions, growth opportunities, expected lease income, continued qualification as a real estate investment trust (“REIT”), plans and objectives of management for future operations and statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will” and other similar expressions are forward-looking statements. These forward-looking statements are inherently uncertain, and security holders must recognize that actual results may differ from our expectations. We do not undertake a duty to update these forward-looking statements.

 

Our actual future results and trends may differ materially depending on a variety of factors discussed in our filings with the Securities and Exchange Commission (the “Commission”). Factors that may affect our plans or results include without limitation: (a) the ability and willingness of Kindred Healthcare, Inc. and certain of its affiliates (collectively, “Kindred”) to continue to meet and/or perform their obligations under their contractual arrangements with us, including without limitation the lease agreements and various agreements entered into by us and Kindred at the time of our spin off of Kindred on May 1, 1998 (the “1998 Spin Off”), as such agreements may have been amended and restated in connection with Kindred’s emergence from bankruptcy on April 20, 2001; (b) the ability and willingness of Kindred to continue to meet and/or perform its obligation to indemnify and defend us for all litigation and other claims relating to the healthcare operations and other assets and liabilities transferred to Kindred in the 1998 Spin Off; (c) the ability of Kindred and our other operators, tenants and borrowers to maintain the financial strength and liquidity necessary to satisfy their respective obligations and duties under the leases and other agreements with us and their existing credit agreements; (d) our success in implementing our business strategy and our ability to identify, underwrite, consummate and integrate diversifying acquisitions or investments; (e) the nature and extent of future competition; (f) the extent of future healthcare reform and regulation, including cost containment measures and changes in reimbursement policies, procedures and rates; (g) increases in our cost of borrowing; (h) the ability of our operators to deliver high quality care and to attract patients; (i) the results of litigation affecting us; (j) changes in general economic conditions and/or economic conditions in the markets in which we may, from time to time, compete; (k) our ability to pay down, refinance, restructure and/or extend our indebtedness as it becomes due; (l) the movement of interest rates and the resulting impact on the value of and the accounting for our interest rate swap agreement; (m) our ability and willingness to maintain our qualification as a REIT due to economic, market, legal, tax or other considerations; (n) final determination of our taxable net income for the year ended December 31, 2004 and for the year ending December 31, 2005; (o) the ability and willingness of our tenants to renew their leases with us upon expiration of the leases and our ability to relet our properties on the same or better terms in the event such leases expire and are not renewed by the existing tenants; and (p) the impact on the liquidity, financial condition and results of operations of Kindred and our other operators resulting from increased operating costs and uninsured liabilities for professional liability claims, and the ability of Kindred and our other operators to accurately estimate the magnitude of these liabilities. Many of these factors are beyond the control of our management.

 

Kindred Information

 

Kindred is subject to the reporting requirements of the Commission and is required to file with the Commission annual reports containing audited financial information and quarterly reports containing unaudited financial information. The information related to Kindred provided in this Annual Report on Form 10-K is derived from filings made by Kindred with the Commission or other publicly available information, or has been provided by Kindred. We have not verified this information either through an independent investigation or by reviewing Kindred’s public filings. We have no reason to believe that this information is inaccurate in any material respect, but we cannot assure you that all of this information is accurate. Kindred’s filings with the Commission can be found at the Commission’s website at www.sec.gov. We are providing this data for informational purposes only, and you are encouraged to obtain Kindred’s publicly available filings from the Commission.

 

2


Table of Contents
Index to Financial Statements

TABLE OF CONTENTS

 

PART I     

Item 1.      Business

  

4

Item 2.      Properties

  

32

Item 3.      Legal Proceedings

  

34

Item 4.      Submission of Matters to a Vote of Security Holders

  

34

PART II     

Item 5.      Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

  

34

Item 6.      Selected Financial Data

  

36

Item 7.      Management’s Discussion and Analysis of Financial Condition and Results of Operations

  

37

Item 7A.  Quantitative and Qualitative Disclosures About Market Risk

  

50

Item 8.      Financial Statements and Supplementary Data

  

51

Item 9.      Changes in and Disagreements With Accountants on Accounting and Financial Disclosure

  

117

Item 9A.  Controls and Procedures

  

117

Item 9B.  Other Information

  

117

PART III     

Item 10.   Directors and Executive Officers of the Registrant

  

118

Item 11.   Executive Compensation

  

118

Item 12.   Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

  

118

Item 13.   Certain Relationships and Related Transactions

  

118

Item 14.   Principal Accountant Fees and Services

  

118

PART IV     

Item 15.   Exhibits, Financial Statement Schedules and Reports on Form 8-K

  

119

 

3


Table of Contents
Index to Financial Statements

PART I

 

ITEM 1.     Business

 

BUSINESS

 

Overview

 

We are a healthcare REIT incorporated in Delaware in 1985. We own a geographically diverse portfolio of healthcare and senior housing facilities which, as of December 31, 2004, consisted of 201 skilled nursing facilities, 40 hospitals, 30 senior housing facilities, and 16 other facilities in 39 states. Except with respect to our medical office buildings, we lease these facilities to healthcare operating companies under “triple-net” or “absolute-net” leases. As of December 31, 2004, Kindred leased 225 of our facilities. As of December 31, 2004, we also had real estate loan investments relating to 25 healthcare and senior housing facilities.

 

We operate through one segment, which consists of financing, owning and leasing healthcare-related and senior housing facilities. See our Consolidated Financial Statements and notes thereto, including “Note 2—Summary of Significant Accounting Policies,” included in Part II, Item 8 of this Annual Report on Form 10-K.

 

Our business strategy is comprised of two primary objectives: diversifying our portfolio of properties and increasing our earnings. We intend to continue to diversify our real estate portfolio by operator, facility type and reimbursement source. We intend to invest in or acquire additional healthcare-related and/or senior housing assets across a wide spectrum.

 

Portfolio of Properties

 

As of December 31, 2004, we conducted substantially all of our business through Ventas Realty, Limited Partnership, a wholly owned operating partnership (“Ventas Realty”), Ventas Finance I, LLC, a wholly owned limited liability company (“Ventas Finance”), and ElderTrust Operating Limited Partnership, an operating partnership in which we own 99.6% of the partnership units (“ETOP”). As of December 31, 2004: Ventas Realty owned 38 of our hospitals, 157 of our skilled nursing facilities and 26 of our senior housing and other facilities; Ventas Finance owned 39 of our skilled nursing facilities; and ETOP owned five of our skilled nursing facilities, 10 of our senior housing facilities and three other facilities. We and certain of our other subsidiaries owned the remaining nine facilities.

 

The following table provides an overview of our portfolio of healthcare properties and investments as of and for the year ended December 31, 2004:

 

    As of and For the Year Ended December 31, 2004

Portfolio by Type


  # of
Properties


  # of
Beds/Units


  Revenue (a)

    Percent of
Total
Revenues


    Original
Investment


  Percent of
Original
Investment


   

Original
Investment
Per

Bed/Unit


  Number
of
States (b)


    (dollars in thousands)

Healthcare Properties

                                           

Skilled nursing facilities

  201   25,532   $ 135,854     57.4 %   $ 833,088   55.1 %   $ 32.6   31

Hospitals

  40   3,557     70,517     29.8 %     319,298   21.1 %     89.8   19

Senior housing facilities

  30   3,684     22,364     9.4 %     319,386   21.1 %     86.7   13

Other facilities

  16   122     4,176     1.7 %     40,439   2.7 %     nm   4
   
 
 


 

 

 

         

Total healthcare properties

  287   32,895     232,911     98.3 %   $ 1,512,211   100.0 %         39
                         

 

         

Other Real Estate Investments

                                           

Loan receivable

  25   1,983     2,958 (c)   1.3 %                      
   
 
 


 

                     

Total

  312   34,878   $ 235,869     99.6 %(d)                      
   
 
 


 

                     

 

4


Table of Contents
Index to Financial Statements

(a) Includes (i) revenue of $2.3 million related to the amortization of deferred revenue recorded as a result of our receipt of Kindred common stock in connection with Kindred’s emergence from bankruptcy on April 20, 2001 and the amortization of the deferred revenue recorded from the receipt of $4.5 million of additional future rent under our leases with Kindred and (ii) $0.1 million from subleases under our leases with Kindred.
(b) As of December 31, 2004, we owned healthcare properties located in 39 states operated by 11 different operators.
(c) Interest income from our mezzanine loan made to Trans Healthcare, Inc. (“THI”) on November 4, 2002 (the “THI Mezzanine Loan”).
(d) The remainder of our total revenues is interest and other income.
nm Not meaningful.

 

Healthcare Facilities

 

Skilled Nursing Facilities .    Our skilled nursing facilities typically provide nursing care services to the elderly and rehabilitation and restoration services, including physical, occupational and speech therapies, and other medical treatment for patients and residents who do not require the high technology, care-intensive setting of an acute care or rehabilitation hospital.

 

Hospitals .    Our hospitals generally are long-term acute care hospitals that serve medically complex, chronically ill patients who require a high level of monitoring and specialized care, but whose conditions do not necessitate the continued services of an intensive care unit. The operator of these hospitals has the capability to treat patients who suffer from multiple systemic failures or conditions such as neurological disorders, head injuries, brain stem and spinal cord trauma, cerebral vascular accidents, chemical brain injuries, central nervous system disorders, developmental anomalies and cardiopulmonary disorders. Chronic patients are often dependent on technology for continued life support, such as mechanical ventilators, total parenteral nutrition, respiration or cardiac monitors and dialysis machines, and, therefore, due to their severe medical conditions, these patients generally are not clinically appropriate for admission to a nursing facility or rehabilitation hospital. Our one 29-bed rehabilitation hospital provides high intensity physical, respiratory, neurological, orthopedic and other treatment protocols for patients during recovery.

 

Senior Housing Facilities .    Our assisted and independent living facilities offer residential units on a month-to-month basis primarily to elderly individuals with various levels of assistance requirements. Residents of these facilities are provided meals in a central dining area and engage in group activities organized by the staff. Assisted living residents may also be provided personal supervision and daily assistance with eating, bathing, grooming and administering medication that make it possible for them to live independently.

 

Other Facilities .    Our other facilities consist of medical office buildings, which offer office space primarily to physicians and other healthcare-related businesses, and personal care facilities, which provide specialized care, including supported living services, neurorehabilitation, neurobehavioral management and vocational programs, for persons with acquired or traumatic brain injury.

 

Other Real Estate Investments

 

Our THI Mezzanine Loan is secured by equity pledges in entities that own and operate 17 healthcare properties plus liens on four other healthcare properties and interests in three additional properties and a physical therapy business. See “Note 6—Mergers and Acquisitions” of the Notes to Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K.

 

5


Table of Contents
Index to Financial Statements

Geographic Diversification .    Our portfolio is broadly diversified by geographic location, with facilities in one state comprising more than 10% percent of our 2004 total revenues. The following table shows our rental income derived by geographic location for the year ended December 31, 2004:

 

    

For the Year Ended

December 31, 2004


 
     Rental
Income (a)


   Percent of
Total Revenues


 
     (dollars in thousands)  

State

             

California

   $ 24,079    10.2 %

Massachusetts

     23,390    9.9 %

Indiana

     15,762    6.7 %

Florida

     14,453    6.1 %

Kentucky

     13,857    5.9 %

Ohio

     13,837    5.8 %

North Carolina

     12,420    5.2 %

Illinois

     11,180    4.7 %

Texas

     10,682    4.5 %

Wisconsin

     8,882    3.7 %

Other (29 states)

     84,369    35.6 %
    

  

Total

   $ 232,911    98.3 %(b)
    

  


(a) Includes (i) revenue of $2.3 million related to the amortization of deferred revenue recorded as a result of our receipt of Kindred common stock and the amortization of the deferred revenue recorded from the receipt of $4.5 million of additional future rent under our leases with Kindred and (ii) $0.1 million from subleases under our leases with Kindred.
(b) The remainder of our total revenues is interest from a loan receivable and interest and other income.

 

Certificates of Need

 

As a result of the geographic diversification of our portfolio, a majority of our skilled nursing facilities and hospitals are located in states that have certificate of need (“CON”) requirements. A CON, which is issued by governmental agencies with jurisdiction over healthcare facilities, is at times required for expansion of existing facilities, construction of new facilities, addition of beds, acquisition of major items of equipment or introduction of new services. The CON rules and regulations may restrict an operator’s ability to expand our properties in certain circumstances.

 

The following table shows the percentage of our revenues derived by skilled nursing facilities and hospitals in states with and without CON requirements for the year ended December 31, 2004:

 

    

For the Year Ended

December 31, 2004


 
     Skilled
Nursing
Facilities


    Hospitals

    Total

 

States with CON requirements

   68.8 %   53.7 %   63.6 %

States without CON requirements

   31.2 %   46.3 %   36.4 %
    

 

 

Total

   100.0 %   100.0 %   100.0 %
    

 

 

 

Dependence on Kindred

 

For the years ended December 31, 2004 and 2003, Kindred accounted for approximately 81.2% and 93.5%, respectively, of our total revenues. Our reliance on Kindred is a result of the 1998 Spin Off, in which we

 

6


Table of Contents
Index to Financial Statements

transferred to Kindred our previous hospital, nursing facility and ancillary services businesses and we retained substantially all of the real property which we leased to Kindred.

 

Kindred Master Leases

 

As of December 31, 2004, we leased 225 of our facilities to Kindred pursuant to our master lease agreements with Kindred (collectively, the “Kindred Master Leases”). Ventas Realty is the lessor under each Kindred Master Lease, except for the Kindred Master Lease entered into with Ventas Finance (the “Kindred CMBS Master Lease”).

 

Each Kindred Master Lease is a “triple-net lease” pursuant to which Kindred is required to pay all insurance, taxes, utilities, maintenance and repairs related to the properties.

 

Under each Kindred Master Lease, the aggregate annual rent is referred to as Base Rent (as defined in the applicable Kindred Master Lease). Base Rent escalates on May 1 of each year at an annual rate of 3.5% over the Prior Period Base Rent (as defined in the applicable Kindred Master Lease) if certain Kindred revenue parameters are met. Assuming such Kindred revenue parameters are met, Base Rent due under the Kindred Master Leases will be $198.9 million from May 1, 2005 to April 30, 2006. See “Note 3—Revenues from Properties” of the Notes to Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K.

 

The properties leased to Kindred pursuant to each Kindred Master Lease are grouped into bundles, with each bundle containing a varying number of properties. All properties within a bundle have primary terms ranging from 10 to 15 years, commencing May 1, 1998, plus renewal options totaling 15 years. Properties are renewable only in bundles.

 

We have a one-time right under each Kindred Master Lease (the “Reset Right”), exercisable by notice given on or after January 20, 2006 and on or before July 19, 2007, to increase the rent to a then fair market rental rate, commencing as early as July 19, 2006, for a total fee of $4.6 million payable on a pro-rata basis at the time of exercise under the applicable Kindred Master Lease. The Reset Right generally applies on a lease-by-lease basis, except that the Reset Rights under Master Lease No. 1, Master Lease No. 1A and the Kindred CMBS Master Lease can only be exercised together. If the Reset Right is exercised for any Kindred Master Lease, the annual escalations currently applicable to that lease may be altered or reduced, depending on market conditions at the time. We believe that, based on information currently available to us and current market conditions, if we were entitled to and did exercise the Reset Right, the rent under the Kindred Master Leases would increase, perhaps materially. However, the value of the Reset Right is dependent on a variety of factors and is highly speculative and there can be no assurances regarding the value of the Reset Right. See “Risk Factors—Risks Arising from Our Business—We are dependent on Kindred; Kindred’s inability or unwillingness to satisfy its obligations under its agreements with us could significantly harm us and our ability to service our indebtedness and other obligations and to make distributions to our stockholders as required to continue to qualify as a REIT.”

 

Recent Developments

 

From January 1, 2005 through February 28, 2005, we have invested an additional $49.0 million in healthcare and senior housing assets. The initial cash yield on these investments exceeds 9.0%. The investments consist of an acute care hospital, one assisted living facility, three medical office buildings and a first mortgage loan.

 

Competition

 

We compete for real property investments with healthcare providers, other healthcare-related REITs, healthcare lenders, real estate partnerships, banks, insurance companies and other investors. Some of our competitors are significantly larger and have greater financial resources and lower cost of capital than we do. Our

 

7


Table of Contents
Index to Financial Statements

ability to continue to compete successfully for real property investments will be determined by numerous factors, including our ability to identify suitable acquisition or investment targets, our ability to negotiate acceptable terms for any such acquisition and the availability and cost of capital to us. See “Risk Factors—Risks Arising from Our Business—We may encounter certain risks when implementing our business strategy to pursue investments in, and/or acquisitions or development of, additional healthcare-related and/or senior housing assets” and “Note 7—Borrowing Arrangements” of the Notes to Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K.

 

The operators of our properties compete on a local and regional basis with other healthcare operators. Their ability to compete successfully for patients at our facilities depends upon several factors, including the quality of care at the facility, the scope of services provided, the operational reputation of the operator, physician referral patterns, physical appearance of the facilities, other competitive systems of healthcare delivery within the community, population and demographics, and the financial condition of the operator. Private, federal and state reimbursement programs and the effect of other laws and regulations also may have a significant impact on our operators’ ability to compete successfully for patients at the properties. See “Risk Factors—Risks Arising from Our Business—Changes in the reimbursement rates or methods of payment from third-party payors, including the Medicare and Medicaid programs, could have a material adverse effect on our tenants.”

 

Employees

 

As of December 31, 2004, we had 24 full-time employees and one part-time employee. We consider the relationship with our employees to be good.

 

Insurance

 

We maintain and/or require in our existing leases that our tenants maintain liability and casualty insurance on the properties and their operations. Under the Kindred Master Leases, Kindred is required to maintain, at its expense, certain insurance coverage related to the properties under the Kindred Master Leases and Kindred’s operations at the related facilities. See “—Dependence on Kindred—Kindred Master Leases.” However, we cannot assure you that Kindred and our other tenants will maintain such insurance, and any failure by Kindred or our other tenants to do so could have a material adverse effect on our business, financial condition, results of operation and liquidity, on our ability to service our indebtedness and on our ability to make distributions to our stockholders as required to continue to qualify as a REIT (a “Material Adverse Effect”). We believe that Kindred and our other tenants are in substantial compliance with the insurance requirements contained in their respective leases with us.

 

We believe that the amount and scope of insurance coverage provided by our own and our tenants’ policies is customary for similarly situated companies in our industry. We cannot assure you that in the future such insurance will be available at a reasonable price or that we will be able to maintain adequate levels of insurance coverage.

 

Due to the increase in the number and severity of professional liability claims against healthcare providers, the availability of professional liability insurance has been severely restricted and the premiums for such insurance coverage has increased dramatically. As a result, many healthcare providers may incur large funded and unfunded professional liability expense, which could have a material adverse effect on their liquidity, financial condition and results of operations. In addition, many healthcare providers are pursuing different organizational and corporate structures coupled with insurance programs that provide less insurance coverage. Therefore, we cannot assure you that our tenants will continue to carry the insurance coverage required under the terms of their leases with us or that we will continue to require the same levels of insurance under our leases.

 

Additional Information

 

We maintain a website at www.ventasreit.com. The information on our website is not incorporated by reference in this Annual Report on Form 10-K, and our web address is included as an inactive textual reference only.

 

8


Table of Contents
Index to Financial Statements

We make available, free of charge, through our website our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) as soon as reasonably practicable after we electronically file such material with, or furnish it to, the Commission. In addition, our Guidelines on Governance, the charters for each of our Audit and Compliance, Nominating and Governance and Executive Compensation Committees and our Code of Ethics and Business Conduct are available on our website, and we will mail copies of the foregoing documents to stockholders, free of charge, upon request to Corporate Secretary, Ventas, Inc., 10350 Ormsby Park Place, Suite 300, Louisville, KY 40223.

 

GOVERNMENTAL REGULATION

 

Healthcare Regulation

 

General

 

The operators of our properties derive a substantial portion of their revenues from third party payors, including the Medicare and Medicaid programs. Medicare is a federal program that provides certain hospital and medical insurance benefits to persons age 65 and over, certain disabled persons and persons with end-stage renal disease. Medicaid is a medical assistance program jointly funded by federal and state governments and administered by each state pursuant to which benefits are available to certain indigent patients. The Medicare and Medicaid statutory framework is subject to administrative rulings, interpretations and discretion that affect the amount and timing of reimbursement made under Medicare and Medicaid. The amounts of program payments received by our operators and tenants can be changed by legislative or regulatory actions and by determinations by agents for the programs. See “—Healthcare Reform.” In addition, private payors, including managed care payors, increasingly are demanding discounted fee structures and the assumption by healthcare providers of all or a portion of the financial risk. Efforts to impose greater discounts and more stringent cost controls upon operators by private payors are expected to continue. We cannot assure you that adequate reimbursement levels will continue to be available for services to be provided by the operators of our properties which currently are being reimbursed by Medicare, Medicaid and private payors. Significant limits on the scope of services reimbursed and on reimbursement rates and fees could have a material adverse effect on these operators’ liquidity, financial condition and results of operations, which could affect adversely their ability to make rental payments to us.

 

The operators of our properties are subject to other extensive federal, state and local laws and regulations including, but not limited to, laws and regulations relating to licensure, conduct of operations, ownership of facilities, addition of facilities, services, prices for services, billing for services, and the confidentiality and security of health-related information. These laws authorize periodic inspections and investigations, and identification of deficiencies that, if not corrected, can result in sanctions that include loss of licensure to operate and loss of rights to participate in the Medicare and Medicaid programs. Regulatory agencies have substantial powers to affect the actions of operators of our properties if the agencies believe that there is an imminent threat to patient welfare, and in some states these powers can include assumption of interim control over facilities through receiverships.

 

Certificates of Need

 

Some states require state approval for development and expansion of healthcare facilities and services, including findings of need for additional or expanded healthcare facilities or services. A CON is issued by governmental agencies with jurisdiction over healthcare facilities and is at times required for expansion of existing facilities, construction of new facilities, addition of beds, and acquisition of major items of equipment or introduction of new services. The CON rules and regulations may restrict an operator’s ability to expand our properties in certain circumstances.

 

In the last several years, in response to mounting Medicaid budget deficits, many states have begun to tighten CON controls, including the imposition of moratoriums on new nursing facilities and hospitals. Some states have also increased controls over licensing and change-of-ownership rules.

 

9


Table of Contents
Index to Financial Statements

In the event that any operator of our properties fails to make rental payments to us or to comply with the applicable healthcare regulations, and, in either case, the operator or its lenders fail to cure the default prior to the expiration of the applicable cure period, our ability to evict that operator and substitute another operator or operators may be materially delayed or limited by various state licensing, receivership, CON or other laws, as well as by Medicare and Medicaid change-of-ownership rules. Such delays and limitations could have a material adverse effect on our ability to collect rent, to obtain possession of leased properties, or otherwise to exercise remedies for tenant default. In addition, we may also incur substantial additional expenses in connection with any such licensing, receivership or change-of-ownership proceedings.

 

Fraud and Abuse

 

There are extensive federal and state laws and regulations prohibiting fraud and abuse in the healthcare industry that can result in significant criminal and civil penalties that can materially affect the operators of our properties. The federal laws include:

 

    The anti-kickback statute (Section 1128B(b) of the Social Security Act), which prohibits certain business practices and relationships that might affect the provision and cost of healthcare services reimbursable under Medicare, Medicaid and other federal healthcare programs, including the payment or receipt of remuneration for the referral of patients whose care will be paid by Medicare or other governmental programs.

 

    The physician self-referral prohibition (Ethics in Patient Referral Act of 1989, commonly referred to as the “Stark Law”), which prohibits referrals by physicians of Medicare patients to providers of a broad range of designated healthcare services with which the physicians (or their immediate family members) or Medicaid have ownership interests or certain other financial arrangements.

 

    The False Claims Act, which prohibits any person from knowingly presenting false or fraudulent claims for payment to the federal government (including the Medicare and Medicaid programs).

 

    The Civil Monetary Penalties Law, which authorizes the United States Department of Health and Human Services (“HHS”) to impose civil penalties administratively for fraudulent acts.

 

    The Health Insurance Portability and Accountability Act of 1996 (commonly referred to as “HIPAA”), which among other things, protects the privacy and security of individually identifiable health information by limiting its use and disclosure.

 

Sanctions for violating these federal laws include criminal and civil penalties that range from punitive sanctions, damage assessments, money penalties, imprisonment, denial of Medicare and Medicaid payments, and/or exclusion from the Medicare and Medicaid programs. These laws also impose an affirmative duty on operators to ensure that they do not employ or contract with persons excluded from the Medicare and other government programs.

 

Many states have adopted or are considering legislative proposals similar to the federal fraud and abuse laws, some of which extend beyond the Medicare and Medicaid programs to prohibit the payment or receipt of remuneration for the referral of patients and physician self-referrals regardless of whether the service was reimbursed by Medicare or Medicaid. Many states have also adopted or are considering legislative proposals to increase patient protections, such as minimum staffing levels, criminal background checks, and limiting the use and disclosure of patient specific health information. These state laws also impose criminal and civil penalties similar to the federal laws.

 

In the ordinary course of their business, the operators of our properties have been and are subject regularly to inquiries, investigations and audits by federal and state agencies that oversee these laws and regulations. Recent federal and state legislation has greatly increased funding for investigations and enforcement actions which have increased dramatically over the past several years. This trend is expected to continue. Private enforcement of healthcare fraud also has increased due in large part to amendments to the civil False Claims Act

 

10


Table of Contents
Index to Financial Statements

in 1986 that were designed to encourage private individuals to sue on behalf of the government. These whistleblower suits by private individuals, known as qui tam relators, may be filed by almost anyone, including present and former patients or nurses and other employees. HIPAA also created a series of new healthcare related crimes.

 

As federal and state budget pressures continue, federal and state administrative agencies may also continue to escalate investigation and enforcement efforts to root out waste and to control fraud and abuse in governmental healthcare programs. A violation of any of these federal and state fraud and abuse laws and regulations could have a material adverse effect on our operators’ liquidity, financial condition and results of operations, which could affect adversely their ability to make rental payments to us.

 

Long-Term Acute Care Hospitals

 

Substantially all of our hospitals are operated as long-term acute care hospitals (“LTACs”), which are hospitals that have a Medicare average length of stay greater than 25 days. Our hospitals are freestanding facilities and we do not own any “hospitals within hospitals.” In order to receive Medicare and Medicaid reimbursement, each hospital must meet the applicable conditions of participation set forth by HHS relating to the type of hospital, its equipment, personnel and standard of medical care, as well as comply with state and local laws and regulations. Hospitals undergo periodic on-site licensure surveys, which generally are limited if the hospital is accredited by the Joint Commission on Accreditation of Healthcare Organizations (“JCAHO”) or other recognized accreditation organizations. A loss of licensure or certification could adversely affect a hospital’s ability to receive payments from the Medicare and Medicaid programs, which could in turn adversely impact the operator’s ability to make rental payments under its leases with us.

 

Skilled Nursing Facilities

 

The operators of our skilled nursing facilities (“SNFs”) generally are licensed on an annual or bi-annual basis and certified annually for participation in the Medicare and Medicaid programs through various regulatory agencies which determine compliance with federal, state and local laws. These legal requirements relate to the quality of the nursing care provided, qualifications of the administrative personnel and nursing staff, the adequacy of the physical plant and equipment and continuing compliance with the laws and regulations governing the operation of nursing facilities. A loss of licensure or certification could adversely affect a nursing facility’s ability to receive payments from the Medicare and Medicaid programs, which could in turn adversely impact the operator’s ability to make rental payments under its leases with us.

 

Assisted Living Facilities

 

Assisted living facilities (“ALFs”) provide services to aid in activities of daily living, such as bathing, meals, security, transportation, recreation, medication supervision and limited therapeutic programs. More intensive medical needs of the resident are often met within ALFs by home health providers, close coordination with the resident’s physician and skilled nursing facilities. ALFs are subject to relatively few federal regulations. Instead, they are regulated mainly by state and local laws which govern the licensing of beds, the provision of services, staffing requirements and other operational matters. However, these state laws vary greatly from one state to another.

 

The recent increase in the number of ALFs around the country has attracted the attention of various federal agencies which believe there should be more federal regulation of ALFs. So far Congress has deferred to state regulation of ALFs. As a result of the increased federal scrutiny along with the rapid increase in the number of ALFs, some states have revised and strengthened their regulation of ALFs. More states are expected to do the same in the future.

 

11


Table of Contents
Index to Financial Statements

Any significant expansion in the number or type of, or a violation of any of, these federal, state or local laws and regulations could have a material adverse effect on our operators’ liquidity, financial condition and results of operations, which could affect adversely their ability to make rental payments to us.

 

Healthcare Reform

 

Healthcare is one of the largest industries in the United States and continues to attract much legislative interest and public attention. In an effort to reduce federal spending on healthcare, in 1997 the federal government enacted the Balanced Budget Act (“BBA”), which contained extensive changes to the Medicare and Medicaid programs, including substantial reimbursement reductions for healthcare operations. For certain healthcare providers, including hospitals and SNFs, implementation of the BBA resulted in more drastic reimbursement reductions than had been anticipated. In addition to its impact on Medicare, the BBA also afforded states more flexibility in administering their Medicaid plans, including the ability to shift most Medicaid enrollees into managed care plans without first obtaining a federal waiver.

 

The following key legislative and regulatory changes have been made to the BBA to provide some relief from the drastic reductions in Medicare and Medicaid reimbursement resulting from implementation of the BBA:

 

    The Balanced Budget Refinement Act of 1999 (“BBRA”);

 

    The Medicare, Medicaid, and State Child Health Insurance Program Benefits Improvement and Protection Act of 2000 (“BIPA”);

 

    Beginning on October 1, 2003, the Center for Medicare & Medicaid Services (“CMS”) instituted a one-time “administrative fix” to increase SNF payment rates by 3.26%; and

 

    The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (“Medicare Modernization Act”, sometimes referred to as the “Drug Bill”).

 

For the last several years, many states have announced actual or potential budget shortfalls. As a result of these budget shortfalls, many states have announced that they are implementing or considering implementing “freezes” or cuts in Medicaid rates paid to providers, including hospitals and nursing homes.

 

The Medicare and Medicaid programs, including payment levels and methods, are in a state of change and are less predictable following the enactment of BBA and the subsequent reform activities. We cannot assure you that future healthcare legislation or changes in the administration or implementation of governmental healthcare reimbursement programs will not have a material adverse effect on the liquidity, financial condition or results of operations of our operators and tenants, which could have a material adverse effect on their ability to make rental payments and which, in turn, could have a Material Adverse Effect on us.

 

Medicare Reimbursement; Long-Term Acute Care Hospitals

 

The BBA mandated the creation of a prospective payment system for LTACs (“LTAC PPS”), which became effective on October 1, 2002 for LTAC cost report periods commencing on or after October 1, 2002. LTACs have transitioned or are currently transitioning to LTAC PPS, which classifies patients into distinct diagnostic groups based on clinical characteristics and expected resource needs.

 

Under LTAC PPS, LTACs are no longer reimbursed on a reasonable cost basis that reflects costs incurred, but rather on a predetermined rate. LTAC PPS requires payment for a Medicare beneficiary at a predetermined, per discharge amount for each defined patient category (called “Long Term Care—Diagnosis Related Groups” or “LTC-DRGs”), adjusted for differences in area wage levels.

 

For LTACs that have filed cost reports before October 1, 2002, a five-year phase-in period has been implemented to gradually transition such LTACs from cost-based reimbursement to 100% federal prospective

 

12


Table of Contents
Index to Financial Statements

payment under LTAC PPS. At the beginning of any cost reporting period during the phase-in, such LTACs may exercise a one-time, non-revocable election to transition fully to LTAC PPS rate. Kindred has stated that it has fully transitioned 62 of its 64 LTACs to the LTAC PPS rates.

 

According to CMS, LTAC PPS is required by law to be “budget neutral,” which means that total payments under LTAC PPS must equal the amount that would have been paid if the system had not been implemented. As such, budget neutrality adjustments will continue to reduce total Medicare payments made under the system until all facilities have been fully phased-in to the new system.

 

Updates to the LTAC PPS payment rates are published annually for the LTAC rate year (July 1 through June 30). However, annual updates to the LTAC PPS classification system and its relative weighting system (LTC-DRGs) will continue to coincide with the federal fiscal year (October 1 to September 30) as with the prospective payment system for short-term acute care hospitals (DRGs).

 

On May 7, 2004, CMS published a final rule updating the LTAC PPS payment rates for the 2005 rate year (July 1, 2004 through June 30, 2005). Under this final rule, LTACs received a 3.1% increase in Medicare payments starting July 1, 2004. In the final rule, CMS further increased LTAC PPS rates by reducing the negative budget neutrality adjustment to 0.5% from 6.0%. The final rule also reduced the threshold for cases to qualify for additional outlier payments, expanded the interrupted stay policy to include all readmissions within three days to result in only one payment to the LTAC instead of the two payments the LTAC would have received prior to the final rule, and set forth the requirements for satellites and remote locations of long-term care hospitals to qualify for separate hospital certification.

 

On August 2, 2004, CMS published a final rule updating the LTC-DRG categorization system for LTAC PPS for the 2005 federal fiscal year (October 1, 2004 through September 30, 2005). The final rule revised the relative weights for each LTC-DRG used to estimate the resource needs of patients classified in each LTC-DRG. The final rule also revised the minimum average length of stay requirements for each LTC-DRG necessary to receive full payment under the system.

 

On January 28, 2005, CMS issued a proposed rule to update LTAC PPS payment rates for the 2006 rate year (July 1, 2005 through June 30, 2006). Under this proposed rule, LTACs will receive a 3.1% increase in Medicare payments starting July 1, 2005. CMS further proposed reducing the negative budget neutrality adjustment resulting in a 0.3% increase in LTAC PPS rates starting July 1, 2005. The proposed rule further reduces the threshold for cases to qualify for additional outlier payments. If this rule becomes final, the combined effective increase in fiscal year 2006 Medicare rates for LTACs would be 5.5%.

 

The proposed rule also indicates that research is to be conducted to determine the feasibility of implementing the recommendations of the Medicare Payment Advisory Commission to more clearly define the role of LTACs in the inpatient continuum of care by establishing facility and patient criteria and for Medicare’s Quality Improvement Organizations to play a larger role in reviewing LTAC admissions for medical necessity and for compliance with any facility and patient criteria. Comments on this rule will be accepted until March 29, 2005 and a final rule is expected to be published later in the second quarter of 2005.

 

We cannot assure you that future updates to the LTAC PPS system or Medicare reimbursement for LTACs will not materially and adversely impact our LTAC operators which, in turn, could have a Material Adverse Effect on us. See “Risk Factors—Risks Arising from Our Business—Changes in the reimbursement rates or methods of payment from third-party payors, including the Medicare and Medicaid programs, could have a material adverse effect on our tenants.”

 

Medicare Reimbursement; Skilled Nursing Facilities

 

BBA established a prospective payment system for skilled nursing facilities (“SNF PPS”) offering Part A covered services. Under the SNF PPS, payment amounts are based upon classifications determined through

 

13


Table of Contents
Index to Financial Statements

assessments of individual Medicare patients in the skilled nursing facility, rather than on the facility’s reasonable costs. The payments received under the SNF PPS are intended generally to cover all inpatient services for Medicare patients, including routine nursing care, most capital-related costs associated with the inpatient stay, and ancillary services, such as respiratory therapy, occupational therapy, speech therapy and certain covered drugs. Under the SNF PPS, per diem payments are made to nursing home facilities for each resident.

 

As a result of SNF PPS, Medicare payments to SNFs dropped by 12.5% in 1999. Although there has been some payment relief (as described below), certain of the payment relief provisions have expired, and we cannot assure you that the current reimbursement levels under the SNF PPS will continue or be sufficient to permit our operators to satisfy their obligations, including payment of rent under their leases with us.

 

In response to widespread healthcare industry concern about the effects of BBA, the federal government enacted BBRA on November 29, 1999. BBRA increased the per diem reimbursement rates for certain high acuity patients by 20% starting April 1, 2000 and continuing until such time as case-mix refinements are implemented by CMS. As explained below, CMS has yet to implement case-mix refinements and, therefore, this 20% temporary per diem add-on has been extended and remains in effect. Under BBRA, outpatient rehabilitation therapy providers received a two-year moratorium on the annual cap on the amount of physical, occupational and speech therapy provided to a patient, which moratorium was subsequently extended until December 31, 2005.

 

Passed in December 2000, BIPA provided additional relief from the projected impact of the BBA. BIPA revised the annual market basket update factor upward from “market basket minus 1%” to (a) “market basket” in federal fiscal year 2001, and (b) “market basket minus 0.5%” in federal fiscal years 2002 and 2003. BIPA also increased the per diem reimbursement rates for the rehabilitation-related patient categories by 6.7%, from April 1, 2001 until such time as case-mix refinements are implemented by CMS. As explained below, CMS has yet to implement case-mix refinement and, therefore, this 6.7% temporary payment increase remains in effect.

 

In August 2003, CMS administratively corrected the market basket inflation adjustment it used in the implementation of SNF PPS as mandated by the BBA. A one-time 3.26% increase to the market basket inflation adjustment was made for all SNF PPS payment rates beginning on October 1, 2003. In addition, in December 2003, the Medicare Modernization Act provided that no reductions should be made to the market basket increases for the SNF PPS rates; therefore 2004 funding was increased by the full market basket of 3%.

 

During 2003, financial limitations on therapy services went into effect. For Part B nursing facility residents, a $1,500 limit was placed on the reimbursement level for physical therapy/speech language pathology services combined and a separate $1,500 limit for occupational therapy. As a result of administrative delays and litigation, this limitation was only effective from September 1, 2003 through December 8, 2003, the effective date of the Medicare Modernization Act, which included a two-year moratorium on the application of therapy caps until December 31, 2005.

 

On July 29, 2004, CMS announced an update to SNF PPS for the 2005 federal fiscal year (October 1, 2004 through September 30, 2005). Starting October 1, 2004, SNFs received a 2.8% increase in Medicare payments. CMS also announced that the two temporary payment increases—the 20% temporary per diem add-on for certain payment categories and the 6.7% temporary payment increase for other categories, both discussed above—will remain in effect until CMS implements a refined case mix classification system to better account for medically complex patients. Although CMS is actively developing a refined case mix classification system, at this time it cannot be predicted when such system will be announced and implemented, or what the impact of such system will be on the liquidity or profitability of our tenants.

 

On February 7, 2005, President Bush released his Fiscal Year 2006 Budget to Congress. The 2006 budget projects that CMS will refine SNF PPS in 2006 to ensure appropriate payments for certain high-cost cases, sometimes referred to as “RUGS Refinement,” which is assumed under President Bush’s proposed budget to reduce Medicare payments to SNFs by approximately $1.5 billion dollars in FY 2006 and by $10 billion over the

 

14


Table of Contents
Index to Financial Statements

next five years. There can be no assurance when RUGS Refinement may be implemented, or if implemented, what impact RUGS Refinement may have on the liquidity or profitability of our tenants.

 

There can be no assurances that updates or proposed changes to the SNF PPS or Medicare reimbursement for SNFs will not materially adversely impact our SNF operators which, and in turn, could have a Material Adverse Effect on us. See “Risk Factors—Risks Arising from Our Business—Changes in the reimbursement rates or methods of payment from third-party payors, including the Medicare and Medicaid programs, could have a material adverse effect on our tenants.”

 

Medicaid Reimbursement; Skilled Nursing Facilities

 

Approximately two-thirds of all nursing home residents are dependent on Medicaid. Medicaid reimbursement rates, however, typically are less than the amounts charged by the operators of our properties. BBA repealed the “Boren Amendment” federal payment standard for Medicaid payments to hospitals and nursing facilities effective October 1, 1997, giving states greater latitude in setting payment rates for these providers. Furthermore, federal legislation restricts a nursing facility operator’s ability to withdraw from the Medicaid Program by restricting the eviction or transfer of Medicaid residents.

 

For the last several years, many states have announced actual or potential budget shortfalls. As a result of these budget shortfalls, many states have announced that they are implementing or considering implementing “freezes” or cuts in Medicaid rates paid to SNF providers.

 

In an effort to mitigate the state Medicaid budget crisis, the federal Jobs and Growth Tax Relief Reconciliation Act (“Tax Relief Act”) was enacted on May 28, 2003, which included a $10 billion increase in Medicaid federal funding through federal fiscal year 2004. In addition, the Tax Relief Act provides an additional $10 billion in state fiscal relief for federal fiscal years 2003 and 2004 to assist states with funding shortfalls. These temporary federal funding provisions were successful in mitigating state Medicaid funding reductions through mid-calendar year 2004. However, state budget shortfalls continue, fueled in large part by continuing rapid increases in Medicaid spending.

 

President Bush’s 2006 Budget recommends Congress make changes to the Medicaid program that are estimated to result in $60 billion in savings to the federal government primarily through the accounting practices some states use to calculate their matched payments. At this time, it is not possible to predict whether significant Medicaid rate freezes or cuts or other program changes will be adopted and if so, by how many states or whether the United States Government will revoke, reduce or stop approving “provider taxes” that have the effect of increasing Medicaid payments to the states, or the impact of such actions on our operators. However, severe and widespread Medicaid rate cuts or freezes could have a material adverse effect on our SNF operators and, in turn, could have a Material Adverse Effect on us.

 

Nursing Home Quality Initiative

 

In 2002 HHS launched the Nursing Home Quality Initiative program. This program, which is designed to provide consumers with comparative information about nursing home quality measures, rates nursing homes on various quality of care indicators. Since 2002, investigative and enforcement activities regarding nursing home quality compliance has intensified both on the federal and state administrative levels.

 

If the operators of our properties are unable to achieve quality of care ratings that are comparable or superior to those of their competitors, patients may choose alternate facilities, which could cause operating revenues to decline. In the event the financial condition or operating revenues of these operators are adversely affected, the operators’ ability to make rental payments to us could be adversely affected, which, in turn, could have a Material Adverse Effect on us.

 

15


Table of Contents
Index to Financial Statements

Environmental Regulation

 

As an owner of real property, we are subject to various federal, state and local laws and regulations regarding environmental, health and safety matters. These laws and regulations address, among other things, asbestos, polychlorinated biphenyls, fuel oil management, wastewater discharges, air emissions, radioactive materials, medical wastes, and hazardous wastes. In certain cases, the costs of complying with these laws and regulations and the penalties for non-compliance can be substantial. For example, although we do not generally operate our properties, we may be held jointly and severally liable for costs relating to the investigation and cleanup of any property from which there is or has been a release or threatened release of a hazardous or toxic substance and any other affected properties, regardless of whether we knew of or caused the release. In addition to these costs, which are typically not limited by law or regulation and could exceed the property’s value, we could be liable for certain other costs, including governmental fines and injuries to persons or property. See “Risk Factors—Risks Arising from Our Business—If any of our properties are found to be contaminated, or if we become involved in any environmental disputes, we could incur substantial liabilities and costs.”

 

We are generally indemnified by the current operators of our properties for contamination caused by those operators. Under the Kindred Master Leases, Kindred has agreed to indemnify us against any environmental claims (including penalties and clean-up costs) resulting from any condition arising in, on or under, or relating to, the leased properties at any time on or after the lease commencement date for the applicable leased property and from any condition permitted to deteriorate on or after such date (including as a result of migration from adjacent properties not owned or operated by us or any of our affiliates other than Kindred and its direct affiliates). However, we cannot assure you that Kindred or another operator will have the financial capability or the willingness to satisfy any such environmental claims, and in the event Kindred or another operator is unable or unwilling to do so, we may be required to satisfy the claims. See “Risk Factors—Risks Arising from Our Business—We are dependent on Kindred; Kindred’s inability or unwillingness to satisfy its obligations under its agreements with us could significantly harm us and our ability to service our indebtedness and other obligations and to make distributions to our stockholders as required to continue to qualify as a REIT.” We have also agreed to indemnify Kindred and certain of our other operators against any environmental claims (including penalties and clean-up costs) resulting from any condition arising on or under, or relating to, the leased properties at any time before the lease commencement date for the applicable leased property.

 

We did not make any material capital expenditures in connection with such environmental, health, and safety laws, ordinances and regulations in 2004 and do not expect that we will have to make any such material capital expenditures during 2005.

 

16


Table of Contents
Index to Financial Statements

FEDERAL INCOME TAX CONSIDERATIONS

 

The following discussion of “Federal Income Tax Considerations” is not exhaustive of all possible tax considerations and is not tax advice. Moreover, this summary does not deal with all tax aspects that might be relevant to a particular stockholder in light of such stockholder’s circumstances, nor does it deal with particular types of stockholders that are subject to special treatment under the Internal Revenue Code of 1986, as amended (the “Code”), such as insurance companies, financial institutions and broker-dealers. The Code provisions governing the federal income tax treatment of REITs are highly technical and complex, and this summary is qualified in its entirety by the applicable Code provisions, rules and Treasury regulations promulgated thereunder, and administrative and judicial interpretations thereof. The following discussion is based on current law, which could be changed at any time, possibly retroactively.

 

Federal Income Taxation of Ventas

 

We elected REIT status beginning with the year ended December 31, 1999. Beginning with the 1999 tax year, we believe that we have satisfied the requirements to qualify as a REIT. We intend to continue to qualify as a REIT for federal income tax purposes. If we continue to qualify for taxation as a REIT, we generally will not be subject to federal corporate income tax on net income that we currently distribute to stockholders. This treatment substantially eliminates the “double taxation” (i.e., taxation at both the corporate and stockholder levels) that generally results from investment in a corporation.

 

Notwithstanding our qualification as a REIT, we will be subject to federal income tax on any undistributed taxable income, including undistributed net capital gains at regular corporate rates. In addition, we will be subject to a 4% excise tax if we do not satisfy specific REIT distribution requirements. See “—Requirements for Qualification as a REIT—Annual Distribution Requirements.” We may be subject to the “alternative minimum tax” on our undistributed items of tax preference. If we have (i) net income from the sale or other disposition of “foreclosure property” (see below) that is held primarily for sale to customers in the ordinary course of business or (ii) other non-qualifying income from foreclosure property, we will be subject to tax at the highest corporate rate on such income. See “—Requirements for Qualification as a REIT—Asset Tests.” In addition, if we have net income from “prohibited transactions” (which are, in general, certain sales or other dispositions of property (other than foreclosure property) held primarily for sale to customers in the ordinary course of business), such income will be subject to a 100% tax.

 

We may also be subject to “Built-in Gains Tax” on any appreciated asset that we own or acquire that was previously owned by a C corporation (i.e., a corporation generally subject to full corporate level tax). We own appreciated assets that we held on January 1, 1999, the effective date of our REIT election. These assets are subject to the Built-in Gains Tax rules because we were a taxable C corporation prior to January 1, 1999. If we dispose of any of these assets and recognize gain on the disposition of such asset during the 10-year period following January 1, 1999, then we generally will be subject to regular corporate income tax on the gain equal to the lower of (a) the recognized gain at the time of the disposition or (b) the built-in gain in that asset as of January 1, 1999. The total amount of gain on which we can be taxed under the Built-in Gains Tax rules is limited to our net built-in gain at the time we became a REIT, i.e., the excess of the aggregate fair market value of our assets at the time we became a REIT over the adjusted tax bases of those assets at that time. In connection with the sale of any assets, all or a portion of such gain could be treated as ordinary income instead of capital gain and be subject to taxation and/or the minimum REIT distribution requirements.

 

See “—Requirements for Qualification as a REIT” below for other circumstances in which we may be required to pay federal taxes.

 

17


Table of Contents
Index to Financial Statements

Requirements for Qualification as a REIT

 

To continue to qualify as a REIT, we must continue to meet the requirements discussed below, relating to our organization, sources of income, nature of assets and distributions of income to stockholders.

 

Organizational Requirements

 

The Code defines a REIT as a corporation, trust or association (i) that is managed by one or more directors or trustees; (ii) the beneficial ownership of which is evidenced by transferable shares or by transferable certificates of beneficial interest; (iii) that would be taxable as a domestic corporation, but for Sections 856 through 859 of the Code; (iv) that is neither a financial institution nor an insurance company subject to certain provisions of the Code; (v) the beneficial ownership of which is held by 100 or more persons during at least 335 days of a taxable year of 12 months, or during a proportionate part of a shorter taxable year (the “100 Shareholder Rule”); (vi) not more than 50% in value of the outstanding stock of which is owned, directly or indirectly, by five or fewer individuals (as defined in the Code to include certain entities) during the last half of each taxable year (the “5/50 Rule”); (vii) that makes an election to be a REIT (or has made such election for a previous taxable year) and satisfies all relevant filing and other administrative requirements established by the Internal Revenue Service (“IRS”) that must be met in order to elect and to maintain REIT status; (viii) that uses a calendar year for federal income tax purposes; and (ix) that meets certain other tests, described below, regarding the nature of its income and assets.

 

We believe that we have satisfied the organizational requirements and believe we will continue to do so in the future. In order to prevent a concentration of ownership of our stock that would cause us to fail the 5/50 Rule or the 100 Shareholder Rule, we have placed certain restrictions on the transfer of our shares that are intended to prevent further concentration of share ownership. However, such restrictions may not prevent us from failing to meet these requirements, and thereby failing to qualify as a REIT.

 

In addition, to qualify as a REIT, a corporation may not have (as of the end of the taxable year) any earnings and profits that were accumulated in periods before it elected REIT status. We believe that at December 31, 1999 we did not have any accumulated earnings and profits that are attributable to periods during which we were not a REIT, although the IRS would be entitled to challenge that determination.

 

Gross Income Tests

 

To continue to qualify as a REIT, we must satisfy two annual gross income requirements. First, at least 75% of our gross income (excluding gross income from prohibited transactions) for each taxable year must consist of defined types of income derived directly or indirectly from investments relating to real property or mortgages on real property (including pledges of equity interest in certain entities holding real property and also including “rents from real property” (defined below)) and, in certain circumstances, interest on certain types of temporary investment income. Second, at least 95% of our gross income (excluding gross income from prohibited transactions) for each taxable year must be derived from such real property or temporary investments, dividends, interest and gain from the sale or disposition of stock or securities, or from any combination of the foregoing. To qualify as rents from real property for the purpose of satisfying the gross income tests, rental payments must generally be received from unrelated persons and not be based on the net income of the tenant. Also, the rent attributable to personal property must not exceed 15% of the total rent. Further, we generally must not operate or manage the property or furnish or render services to the tenants of such property, other than through an “independent contractor” who is adequately compensated and from whom we derive no income (a de minimis exception is allowed for noncustomary services provided by us if the annual value of does not exceed 1% of the gross income derived from the property).

 

Amounts received from a tenant will not qualify as “rents from real property” if we, or an owner of 10% or more of our shares, directly or constructively is deemed to own 10% or more of the ownership interests in the tenant (a “Related Party Tenant”).

 

18


Table of Contents
Index to Financial Statements

We do not believe that we have, nor do we anticipate that we will in the future, (i) charged/charge rent that is based in whole or in part on the income or profits of any person (except by reason of being based on a fixed percentage or percentages of receipts or sales consistent with the rule described above), (ii) derived/derive rent attributable to personal property leased in connection with real property that exceeds 15% of the total rents, (iii) derived/derive rent attributable to a Related Party Tenant, or (iv) provided/provide any noncustomary services to tenants other than through qualifying independent contractors, except as permitted by the 1% de minimis exception or to the extent that the amount of resulting nonqualifying income would not cause us to fail to satisfy the 95% and 75% gross income tests. We believe that we have been and will continue to be in compliance with the gross income tests. However, we cannot assure you that we are or will continue to be in compliance with the gross income tests.

 

If we fail to satisfy one or both of the 75% or 95% gross income tests for any taxable year, we may nevertheless continue to qualify as a REIT for such year if we are entitled to relief under certain provisions of the Code. These relief provisions generally will be available if our failure to meet such tests was due to reasonable cause and not due to willful neglect, we attach a schedule of the sources of our income to our return and any incorrect information on the schedules was not due to fraud with intent to evade tax. It is not possible, however, to state whether in all circumstances we would be entitled to the benefit of these relief provisions. Even if these relief provisions were to apply, a 100% tax would be imposed with respect to the excess net income.

 

Asset Tests

 

At the close of each quarter of our taxable year, we must satisfy two tests relating to the nature of our assets. First, at least 75% of the value of our total assets must be represented by cash or cash items (including certain receivables), government securities, “real estate assets” or, in cases where we raise new capital through stock or long-term (maturity of at least five years) debt offerings, temporary investments in stock or debt instruments during the one-year period following our receipt of such capital (the “75% asset test”). The term “real estate asset” includes interests in real property, interests in mortgages on real property to the extent the mortgage balance does not exceed the value of the associated real property, and shares of other REITs. For purposes of the 75% asset test, the term “interest in real property” includes an interest in land and improvements thereon, such as buildings or other inherently permanent structures (including items that are structural components of such buildings or structures), a leasehold in real property and an option to acquire real property (or a leasehold in real property). Second, of the investments not included in the 75% asset class, the value of any one issuer’s debt and equity securities owned by us (other than our interest in any entity classified as a partnership for federal income tax purposes, the stock of a taxable REIT subsidiary (as defined below) or the stock of a qualified REIT subsidiary) may not exceed 5% of the value of our total assets (the “5% asset test”), and we may not own more than 10% of any one issuer’s outstanding voting securities or 10% of the value of any one issuer’s outstanding securities, subject to limited “safe harbor” exceptions for certain straight debt obligations (except for our ownership interest in an entity that is disregarded for federal income tax purposes, that is classified as a partnership for federal income tax purposes or that is the stock of a qualified REIT subsidiary) (the “10% securities test”). In addition, no more than 20% of the value of our assets can be represented by securities of taxable REIT subsidiaries.

 

If we should fail to satisfy the asset tests at the end of a calendar quarter except for our first calendar quarter, such a failure would not cause us to fail to qualify as a REIT or to lose our REIT status if (i) we satisfied all of the asset tests at the close of the preceding calendar quarter and (ii) the discrepancy between the value of our assets and the asset test requirements arose from changes in the market values of our assets and was not wholly or partly caused by an acquisition of nonqualifying assets. As a result of the enactment of the America Jobs Creation Act of 2004, if the conditions as described in clauses (i) and (ii) above were not satisfied, we still could avoid disqualification by eliminating any discrepancy within six months after the last day of the quarter in which we identify the asset test failure. A penalty up to $50,000 may be assessed for such failure. We intend to maintain adequate records of the value of our assets to ensure compliance with the asset tests and to take such other actions as may be required to comply with those tests.

 

19


Table of Contents
Index to Financial Statements

We believe that we have been and will continue to be in compliance with the 10% securities test and the 5% asset test. However, we cannot assure you that we are or will continue to be in compliance with either of these tests. If we failed to satisfy either of these tests, we would lose our REIT status. If we lost our status as a REIT, it would have a Material Adverse Effect on us.

 

Foreclosure Property

 

The foreclosure property rules permit us (by our election) to foreclose or repossess properties without being disqualified as a result of receiving income that does not qualify under the gross income tests; however, a corporate tax is imposed upon net income from “foreclosure property” that is not otherwise “good REIT” income. Detailed rules specify the calculation of the tax. The after-tax amount increases the amount the REIT must distribute each year.

 

“Foreclosure property” includes any real property and any personal property incident to such real property acquired by bid at foreclosure or by agreement or process of law after there was a default or a default was imminent on the leased property. However, for qualified healthcare properties, we are permitted to terminate leases other than by reason of default or imminent default. During a 90-day grace period, we may operate the foreclosed property without an “independent contractor” or qualifying lessee. The 90-day grace period will begin on the date we acquire possession of the property.

 

To maintain foreclosure property treatment after the 90-day grace period, we must cause the property to be managed by an “independent contractor” (from whom we derive or receive no income) or lease the property pursuant to a lease qualifying as a true lease for income tax purposes to an unrelated third party. Ownership of the tenant must not be attributed to us in violation of the related tenant rule of Section 856(d)(2)(B) (relating to 10% or more owned tenants). If the property is leased to a third party under a true lease, the foreclosure property rules are not then relevant.

 

Foreclosure property treatment will end on the first day on which the REIT enters into a lease of the property that will give rise to income that is not good rental income under Section 856(c)(3). In addition, foreclosure property treatment will end if any construction takes place on the property (other than completion of a building, or other improvement more than 10% complete before default became imminent). Foreclosure property treatment is available for an initial period of three years and may be extended up to six years. Foreclosure property treatment for qualified healthcare property is available for an initial period of two years and may be extended up to six years.

 

Taxable REIT Subsidiaries

 

We are permitted to own up to 100% of a “taxable REIT subsidiary” or a “TRS.” Tax legislation implemented TRS rules to allow REITs to have greater flexibility in engaging in activities, which previously had been prohibited by REIT rules. TRSs are corporations subject to tax as a regular “C” corporation. Generally, a TRS can own assets that cannot be owned by a REIT and can perform otherwise impermissible tenant services (excluding the direct or indirect operation or management of a lodging or healthcare facility) which would otherwise disqualify the REIT’s rental income under the REIT income tests. In enacting the TRS rules, Congress intended that the arrangements between a REIT and its TRSs be structured to ensure that a TRS will be subject to an appropriate level of federal income taxation. As a result, there are certain limits on the ability of a TRS to deduct interest payments made to us. In addition, we will be obligated to pay a 100% penalty tax on some payments that we receive or on certain expenses deducted by the TRS if the economic arrangements between the REIT, the REIT’s tenants and the TRS are not comparable to similar arrangements among unrelated parties.

 

On March 26, 2002, we formed a TRS, Ventas Capital Corporation, a Delaware corporation. On November 8, 2002, we formed another TRS, Ventas TRS, LLC, a Delaware limited liability company. Both companies are owned 100% by Ventas Realty. As of December 31, 2004, neither Ventas Capital Corporation nor Ventas TRS, LLC owned any of our assets.

 

20


Table of Contents
Index to Financial Statements

Due to the acquisition of ElderTrust, on February 5, 2004, we also own substantially all of ET Capital Corporation. ET Capital Corporation is a TRS 100% owned by ETOP. As of December 31, 2004, ET Capital Corporation’s only assets were intercompany loans.

 

Annual Distribution Requirements

 

In order to be taxed as a REIT, we are required to distribute dividends (other than capital gain dividends) to our stockholders in an amount at least equal to (i) the sum of (A) 90% of our “REIT taxable income” (computed without regard to the dividends paid deduction and our net capital gain) and (B) 90% of the net income (after tax), if any, from foreclosure property, minus (ii) the sum of certain items of non-cash income. Such distributions must be paid in the taxable year to which they relate, or in the following taxable year if declared before we timely file our tax return for such year and if paid on or before the first regular dividend payment after such declaration. To the extent that we do not distribute all of our net capital gain or distribute at least 90%, but less than 100%, of our “REIT taxable income,” as adjusted, we will be subject to tax on the undistributed amount at regular capital gains and ordinary corporate tax rates except to the extent of net operating loss or capital loss carryforwards. If any taxes are paid in connection with the Built-in Gains Tax rules, these taxes will be deductible in computing REIT taxable income. Furthermore, if we fail to distribute during each calendar year at least the sum of (i) 85% of our REIT ordinary income for such year, (ii) 95% of our REIT capital gain net income for such year (other than long-term capital gain we elect to retain and treat as having been distributed to stockholders), and (iii) any undistributed taxable income from prior periods, we will be subject to a 4% nondeductible excise tax on the excess of such required distribution over the amounts actually distributed.

 

We believe that we have satisfied the annual distribution requirements for the year of our REIT election and each year thereafter. However, we cannot assure you that we have satisfied the distribution requirements for the year of our REIT election and subsequent years. Although we intend to continue meeting the annual distribution requirements to qualify as a REIT for federal income tax purposes for the year ended December 31, 2004 and subsequent years, it is possible that economic, market, legal, tax or other considerations may limit our ability to meet such requirements. As a result, if we were not able to meet the annual distribution requirement, we would fail to qualify as a REIT.

 

Failure to Continue to Qualify

 

If our election to be taxed as a REIT is revoked or terminated (e.g., due to a failure to meet the REIT qualification tests), we will be subject to tax (including any applicable alternative minimum tax) on our taxable income at regular corporate rates except to the extent of net operating loss and capital loss carryforwards. Distributions to stockholders will not be deductible by us, nor will they be required to be made. To the extent of current and accumulated earnings and profits, all distributions to stockholders will be taxable as ordinary income, and, subject to certain limitations in the Code, corporate stockholders may be eligible for the dividends received deduction. In addition, we would be prohibited from re-electing REIT status for the four taxable years following the year during which we ceased to qualify as a REIT, unless certain relief provisions of the Code applied. It is impossible to predict whether we would be entitled to such statutory relief.

 

Federal Income Taxation of U.S. Stockholders

 

As used herein, the term “U.S. Stockholder” means a holder of our common stock that for U.S. federal income tax purposes is (i) a citizen or resident of the United States, (ii) a corporation, partnership or other entity created or organized in or under the laws of the United States or of any political subdivision thereof, (iii) an estate whose income from sources without the United States is includible in gross income for U.S. federal income tax purposes regardless of its connection with the conduct of a trade or business within the United States or (iv) any trust with respect to which (A) a U.S. court is able to exercise primary supervision over the administration of such trust and (B) one or more U.S. persons have the authority to control all substantial decisions of the trust.

 

21


Table of Contents
Index to Financial Statements

As long as we qualify as a REIT, distributions made to our taxable U.S. Stockholders out of current or accumulated earnings and profits (and not designated as capital gain dividends) will be taken into account by such U.S. Stockholders as ordinary income and will not be eligible for the capital gains tax rate (i.e., qualified dividends rate) generally available to individuals or for the dividends received deduction generally available to corporations. Distributions that are designated as capital gain dividends will be taxed as a capital gain (to the extent such distributions do not exceed our actual net capital gain for the taxable year) without regard to the period for which the stockholder has held its shares. The tax rates applicable to such capital gains are discussed below. Distributions in excess of current and accumulated earnings and profits will not be taxable to a stockholder to the extent that they do not exceed the adjusted basis of the stockholder’s shares, but rather will reduce the adjusted basis of such shares. To the extent that distributions in excess of current and accumulated earnings and profits exceed the adjusted basis of a stockholder’s shares, such distributions will be included in income as capital gains assuming the shares are capital assets in the hands of the stockholder. The tax rate applicable to such capital gain will depend on the stockholder’s holding period for the shares. In addition, any distribution declared by us in October, November or December of any year and payable to a stockholder of record on a specified date in any such month shall be treated as both paid by us and received by the stockholder on December 31 of such year, provided that the distribution is actually paid by us during January of the following calendar year.

 

We may elect to treat all or a part of our undistributed net capital gain as if it had been distributed to our stockholders (including for purposes of the 4% excise tax discussed above under “—Requirements for Qualification as a REIT—Annual Distribution Requirements”). If we make such an election, our stockholders would be required to include in their income as long-term capital gain their proportionate share of our undistributed net capital gain, as designated by us. Each such stockholder would be deemed to have paid its proportionate share of the income tax imposed on us with respect to such undistributed net capital gain, and this amount would be credited or refunded to the stockholder. In addition, the tax basis of the stockholder’s shares would be increased by its proportionate share of undistributed net capital gains included in its income, less its proportionate share of the income tax imposed on us with respect to such gains.

 

Stockholders may not include in their individual income tax returns any of our net operating losses or capital losses. Instead, such losses would be carried over by us for potential offset against our future income (subject to certain limitations). Taxable distributions from us and gain from the disposition of our common stock will not be treated as passive activity income and, therefore, stockholders generally will not be able to apply any “passive activity losses” (such as losses from certain types of limited partnerships in which the stockholder is a limited partner) against such income. In addition, taxable distributions from us generally will be treated as investment income for purposes of the investment interest limitations. Capital gains from the disposition of the shares (or distributions treated as such) will be treated as investment income only if the stockholder so elects, in which case such capital gains will be taxed at ordinary income rates. We will notify stockholders after the close of our taxable year as to the portions of the distributions attributable to that year that constitute ordinary income, return of capital and capital gain.

 

In general, any gain or loss realized upon a taxable disposition of our common stock by a stockholder who is not a dealer in securities will be treated as capital gain or loss. Lower marginal tax rates for individuals may apply in the case of capital gains, depending on the holding period of the shares that are sold. However, any loss upon a sale or exchange of shares by a stockholder who has held such shares for six months or less (after applying certain holding period rules) will be treated as a long-term capital loss to the extent of distributions from us required to be treated by such stockholder as long-term capital gain. All or a portion of any loss realized upon a taxable disposition of shares may be disallowed if other shares are purchased within 30 days before or after the disposition.

 

For non-corporate taxpayers, the tax rate differential between capital gain and ordinary income may be significant. The highest marginal individual income tax rate applicable to ordinary income is currently 35%. Any capital gain generally will be currently taxed to a non-corporate taxpayer at a maximum rate of 15% with respect

 

22


Table of Contents
Index to Financial Statements

to capital assets held for more than one year. The tax rates applicable to ordinary income apply to gain attributable to the sale or exchange of capital assets held for one year or less. In the case of capital gain attributable to the sale or exchange of certain real property held for more than one year, an amount of such gain equal to the amount of all prior depreciation deductions not otherwise required to be taxed as ordinary depreciation recapture income will be taxed at a maximum rate of 25%. With respect to distributions designated by a REIT as capital gain dividends (including deemed distributions of retained capital gains), the REIT also may designate (subject to certain limits) whether the dividend is taxable to non-corporate stockholders as a 15% rate gain distribution or an unrecaptured depreciation distribution taxed at a 25% rate.

 

The characterization of income as capital or ordinary may affect the deductibility of capital losses. Capital losses not offset by capital gains generally may be deducted against a non-corporate taxpayer’s ordinary income only up to a maximum annual amount of $3,000. Non-corporate taxpayers may carry forward their unused capital losses. All net capital gain of a corporate taxpayer is subject to tax at ordinary corporate rates. A corporate taxpayer can deduct capital losses only to the extent of capital gains, with unused losses being carried back three years and forward five years.

 

Treatment of Tax-Exempt Stockholders

 

Tax-exempt organizations, including qualified employee pension and profit sharing trusts and individual retirement accounts (collectively, “Exempt Organizations”), generally are exempt from federal income taxation. However, they are subject to taxation on their unrelated business taxable income (“UBTI”). While many investments in real estate generate UBTI, the IRS has issued a published ruling that dividend distributions by a REIT to an exempt employee pension trust do not constitute UBTI, provided that the shares of the REIT are not otherwise used in an unrelated trade or business of the exempt employee pension trust. Based on that ruling, and subject to the exceptions discussed below, amounts distributed by us to Exempt Organizations generally should not constitute UBTI. However, if an Exempt Organization finances its acquisition of our common stock with debt, a portion of its income from us will constitute UBTI pursuant to the “debt-financed property” rules. Furthermore, social clubs, voluntary employee benefit associations, supplemental unemployment benefit trusts and qualified group legal services plans that are exempt from taxation under paragraphs (7), (9), (17) and (20), respectively, of Section 501(c) of the Code are subject to different UBTI rules, which generally will require them to characterize distributions from us as UBTI. In addition, in certain circumstances, a pension trust that owns more than 10% of our stock is required to treat a percentage of the dividends from us as UBTI (the “UBTI Percentage”). The UBTI Percentage is the gross income, less related direct expenses, derived by us from an unrelated trade or business (determined as if we were a pension trust) divided by our gross income, less related direct expenses, for the year in which the dividends are paid. The UBTI rule applies to a pension trust holding more than 10% of our stock only if (i) the UBTI Percentage is at least 5%, (ii) we qualify as a REIT by reason of the modification of the 5/50 Rule that allows the beneficiaries of the pension trust to be treated as holding our shares in proportion to their actuarial interests in the pension trust and (iii) either (A) one pension trust owns more than 25% of the value of our stock or (B) a group of pension trusts individually holding more than 10% of the value of our stock collectively own more than 50% of the value of our stock.

 

Special Tax Considerations for Non-U.S. Stockholders

 

The rules governing U.S. federal income taxation of nonresident alien individuals, foreign corporations, foreign partnerships and other foreign stockholders (collectively, “Non-U.S. Stockholders”) are complex, and no attempt will be made herein to provide more than a summary of such rules. Non-U.S. stockholders should consult with their own tax advisors to determine the impact of federal, state and local income tax laws with regard to their ownership of our common stock, including any reporting requirements.

 

For purposes of this discussion, the term “Non-U.S. Stockholder” does not include any foreign stockholder whose investment in our stock is “effectively connected” with the conduct of a trade or business in the United States. Such a foreign stockholder, in general, will be subject to U.S. federal income tax with respect to its

 

23


Table of Contents
Index to Financial Statements

investment in our stock in the same manner as a U.S. Stockholder is taxed (subject to applicable alternative minimum tax and a special alternative minimum tax in the case of nonresident alien individuals). In addition, a foreign corporation receiving income that is treated as effectively connected with a U.S. trade or business also may be subject to an additional 30% “branch profits tax,” unless an applicable tax treaty provides a lower rate or an exemption. Certain certification requirements must be satisfied in order for effectively connected income to be exempt from withholding.

 

Distributions to Non-U.S. Stockholders that are not attributable to gain from sales or exchanges by us of U.S. real property interests and are not designated by us as capital gain dividends (or deemed distributions of retained capital gains) will be treated as dividends of ordinary income to the extent that they are made out of our current or accumulated earnings and profits. Such distributions ordinarily will be subject to a withholding tax equal to 30% of the gross amount of the distribution unless an applicable tax treaty reduces or eliminates that tax. Distributions in excess of our current and accumulated earnings and profits will not be taxable to a stockholder to the extent that such distributions do not exceed the adjusted basis of the stockholder’s shares, but rather will reduce the adjusted basis of such shares. To the extent that distributions in excess of current and accumulated earnings and profits exceed the adjusted basis of a Non-U.S. Stockholder’s shares, such distributions will give rise to tax liability if the Non-U.S. Stockholder would otherwise be subject to tax on any gain from the sale or disposition of its shares, as described below.

 

For any year in which we qualify as a REIT, distributions that are attributable to gain from sales or exchanges by us of U.S. real property interests will be taxed to a Non-U.S. Stockholder under the provisions of the Foreign Investment in Real Property Tax Act of 1980 (“FIRPTA”). Under FIRPTA, distributions attributable to gain from sales of U.S. real property interests are taxed to a Non-U.S. Stockholder as if such gain were effectively connected with a U.S. business. Non-U.S. Stockholders thus would be taxed at the normal capital gain rates applicable to U.S. Stockholders (subject to applicable alternative minimum tax and a special alternative minimum tax in the case of nonresident alien individuals). Distributions subject to FIRPTA also may be subject to 30% branch profits tax in the hands of a foreign corporate stockholder not entitled to treaty relief or exemption.

 

We expect to withhold U.S. tax at the rate of 30% on the gross amount of any dividends, other than dividends treated as attributable to gain from sales or exchanges of U.S. real property interests and capital gain dividends, paid to a Non-U.S. Stockholder, unless (i) a lower treaty rate applies and the required form evidencing eligibility for that reduced rate is filed with us or the appropriate withholding agent or (ii) the Non-U.S. Stockholder files an IRS Form W-8 ECI or a successor form with us or the appropriate withholding agent claiming that the distributions are effectively connected with the Non-U.S. Stockholder’s conduct of a U.S. trade or business.

 

Under FIRPTA, we are required to withhold 35% of any distribution that is designated as a capital gain dividend or which could be designated as a capital gain dividend. Thus, if we designate previously made distributions as capital gain dividends, subsequent distributions (up to the amount of such prior distributions) will be treated as capital gain dividends for purposes of FIRPTA withholding.

 

For so long as our common stock continues to be regularly traded on an established securities market, the sale of such stock by any Non-U.S. Stockholder who is not a Five Percent Non-U.S. Stockholder (as defined below) generally will not be subject to U.S. federal income tax (unless the Non-U.S. Stockholder is a nonresident alien individual who was present in the United States for more than 182 days during the taxable year of the sale and certain other conditions apply, in which case such gain will be subject to a 30% tax on a gross basis). A “Five Percent Non-U.S. Stockholder” is a Non-U.S. Stockholder who, at some time during the five-year period preceding such sale or disposition, beneficially owned (including under certain attribution rules) more than 5% of the total fair market value of our common stock (as outstanding from time to time) or owned shares of another class of our stock that represented value greater than 5% of our common stock (measured at the time such shares were acquired).

 

24


Table of Contents
Index to Financial Statements

In general, the sale or other taxable disposition of our common stock by a Five Percent Non-U.S. Stockholder also will not be subject to U.S. federal income tax if we are a “domestically controlled REIT.” A REIT is a “domestically controlled REIT” if, at all times during the five-year period preceding the relevant testing date, less than 50% in value of its shares is held directly or indirectly by Non-U.S. Stockholders (taking into account those persons required to include the REIT’s dividends in income for U.S. federal income tax purposes). Although we believe that we currently qualify as a domestically controlled REIT because our common stock is publicly traded, we cannot assure you that we will qualify as a domestically controlled REIT at any time in the future. If we do not constitute a domestically controlled REIT, a Five Percent Non-U.S. Stockholder will be taxable in the same manner as a U.S. Stockholder with respect to gain on the sale of our common stock (subject to applicable alternative minimum tax and a special alternative minimum tax in the case of nonresident alien individuals).

 

Information Reporting Requirements and Backup Withholding Tax

 

We will report to our U.S. Stockholders and to the IRS the amount of distributions paid during each calendar year and distributions required to be treated as so paid during a calendar year, and the amount of tax withheld, if any. Under the backup withholding rules, a stockholder may be subject to backup withholding at the applicable rate (currently 28%) with respect to distributions paid unless such holder (i) is a corporation or comes within certain other exempt categories and, when required, demonstrates this fact or (ii) provides a taxpayer identification number, certifies as to no loss of exemption from backup withholding and otherwise complies with the applicable requirements of the backup withholding rules. A stockholder who does not provide us with its correct taxpayer identification number also may be subject to penalties imposed by the IRS. In addition, we may be required to withhold a portion of capital gain distributions to any stockholders who fail to certify their non-foreign status to us.

 

U.S. Stockholders should consult their own tax advisors regarding their qualifications for an exemption from backup withholding and the procedure for obtaining such an exemption. Backup withholding is not an additional tax. Rather, the amount of any backup withholding with respect to a payment to a U.S. Stockholder will be allowed as a credit against the U.S. Stockholder’s U.S. federal income tax liability and may entitle the U.S. Stockholder to a refund, provided that the required information is furnished to the IRS.

 

Backup withholding tax and information reporting generally will not apply to distributions paid to Non-U.S. Stockholders outside the United States that are treated as (i) dividends subject to the 30% (or lower treaty rate) withholding tax discussed above, (ii) capital gain dividends or (iii) distributions attributable to gain from the sale or exchange by us of U.S. real property interests. As a general matter, backup withholding and information reporting will not apply to a payment of the proceeds of a sale of our common stock by or through a foreign office of a foreign broker. Information reporting (but not backup withholding) will apply, however, to a payment of the proceeds of a sale of our common stock by a foreign office of a broker that (i) is a United States person, (ii) derives 50% or more of its gross income for certain periods from the conduct of a trade or business in the United States, or (iii) is a “controlled foreign corporation” for United States tax purposes, unless the broker has documentary evidence in its records that the holder is a Non-U.S. Stockholder and certain other conditions are satisfied, or the stockholder otherwise establishes an exemption. Payment to or through a United States office of a broker of the proceeds of a sale of our common stock is subject to both backup withholding and information reporting unless the stockholder certifies under penalties of perjury that the stockholder is a Non-U.S. Stockholder or otherwise establishes an exemption. A Non-U.S. Stockholder may obtain a refund of any amounts withheld under the backup withholding rules by filing the appropriate claim for a refund with the IRS.

 

Other Tax Considerations

 

We and our stockholders may be subject to state and local tax in states and localities in which we do business or own property. The tax treatment of us and our stockholders in such jurisdictions may differ from the federal income tax treatment described above. Consequently, stockholders should consult their own tax advisors regarding the effect of state and local tax laws on their ownership of shares of our common stock.

 

25


Table of Contents
Index to Financial Statements

RISK FACTORS

 

Our business, operations and financial condition are subject to various risks. Some of these risks are described below; however, this section does not describe all risks applicable to us, our industry or our business, and it is intended only as a summary of certain material factors. If any of the following risks actually occur, we could be materially and adversely affected.

 

We have grouped these risk factors into three general categories:

 

  risks arising from our business;

 

  risks arising from our capital structure; and

 

  risks arising from our status as a REIT.

 

Risks Arising from Our Business

 

We are dependent on Kindred; Kindred’s inability or unwillingness to satisfy its obligations under its agreements with us could significantly harm us and our ability to service our indebtedness and other obligations and to make distributions to our stockholders as required to continue to qualify as a REIT.

 

We are dependent on Kindred in a number of ways:

 

    We lease a substantial portion of our properties to Kindred under the Kindred Master Leases, and therefore:

 

    Kindred was the primary source of our total revenues in 2004 and 2003; and

 

    since the Kindred Master Leases are triple-net leases, we depend on Kindred to pay insurance, taxes, utilities and maintenance and repair expenses required in connection with the leased properties.

 

    In connection with the 1998 Spin Off, Kindred assumed, and agreed to indemnify us for, the following:

 

    all obligations under third-party leases and third-party contracts, except for those contracts relating to the ownership of our properties;

 

    all losses, including costs and expenses, resulting from future claims and all liabilities that may arise out of the ownership or operation of the healthcare operations either before or after the date of the spin-off; and

 

    any claims that were pending at the time of the spin-off and that arose out of the ownership or operation of the healthcare operations or were asserted after the spin-off and that arise out of the ownership or operation of the healthcare operations or any of the assets or liabilities transferred to Kindred in connection with the spin-off.

 

We cannot assure you that Kindred will have sufficient assets, income and access to financing and insurance coverage to enable it to satisfy its obligations under its agreements with us. In addition, any failure by Kindred to effectively conduct its operations could have a material adverse effect on its business reputation or on its ability to enlist and maintain patients in its facilities. Any inability or unwillingness on the part of Kindred to satisfy its obligations under its agreements with us could have a Material Adverse Effect on us. See “Business—Dependence on Kindred.”

 

We may be unable to find another lessee/operator for our properties if we have to replace Kindred or our other operators.

 

We may have to find another lessee/operator for the properties covered by one or more of the Kindred Master Leases or the leases with our other operators upon the expiration of the terms of the applicable lease or upon a default by Kindred or our other operators. During any period that we are attempting to locate one or more

 

26


Table of Contents
Index to Financial Statements

lessees/operators there could be a decrease or cessation of rental payments by Kindred or our other operators. We cannot assure you that we will be able to locate another suitable lessee/operator or, if we are successful in locating such an operator, that the rental payments from the new operator would not be significantly less than the existing rental payments. Our ability to locate another suitable lessee/operator may be significantly delayed or limited by various state licensing, receivership, CON or other laws, as well as by Medicare and Medicaid change-of-ownership rules. In addition, we may also incur substantial additional expenses in connection with any such licensing, receivership or change-of-ownership proceedings. Such delays, limitations and expenses could have a Material Adverse Effect on us and/or materially delay or impact our ability to collect rent, to obtain possession of leased properties or otherwise to exercise remedies for tenant default.

 

We may encounter certain risks when implementing our business strategy to pursue investments in, and/or acquisitions or development of, additional healthcare-related and/or senior housing assets.

 

We intend to continue to pursue investments in, and/or acquisitions or development of, additional healthcare-related and/or senior housing assets, subject to the contractual restrictions contained in our revolving credit facility and the indentures governing our outstanding senior notes. Acquisitions of and investments in such properties entail general investment risks associated with any real estate investment, including risks that the investment will fail to perform in accordance with expectations, the estimates of the cost of improvements necessary for acquired properties will prove inaccurate and the lessee/operator will fail to meet performance expectations. If we pursue new development projects, such projects would be subject to numerous risks, including risks of construction delays or cost overruns that may increase project costs, new project commencement risks such as receipt of zoning, occupancy and other required governmental approvals and permits and the incurrence of development costs in connection with projects that are not pursued to completion. In addition, we may borrow to finance investments in, and/or acquisition or development of, healthcare-related or other properties, which would increase our leverage.

 

We compete for acquisition or investment opportunities with entities that have substantially greater financial resources than we have. Our ability to compete successfully for such opportunities is affected by many factors, including our cost of obtaining debt and equity capital at rates comparable to or better than our competitors. Competition generally may reduce the number of suitable acquisition or investment opportunities available to us and increase the bargaining power of property owners seeking to sell, thereby impeding our acquisitions, investment or development activities. See “Business—Competition.”

 

Even if we are successful at identifying and competing for acquisition or investment opportunities, such opportunities involve a number of risks. These risks include diversion of management’s attention, the risk that the value of the properties or businesses we acquire or invest in could decrease substantially after such acquisition or investment and the risk that we will not be able to accurately assess the value of properties or businesses that are not of the type we currently own, some or all of which could have a Material Adverse Effect on us.

 

Additionally, if we are successful in continuing to implement our business strategy to pursue investments in, and/or acquisitions or development of, additional, healthcare-related and/or senior housing assets or businesses, we intend to increase the number of operators of our properties and our business segments. We cannot assure you that we will have the capabilities to successfully monitor and manage a portfolio of properties with a growing number of operators and/or manage such businesses.

 

We are subject to the risks associated with investment in a single industry, the heavily regulated healthcare industry.

 

All of our investments are in properties used in the healthcare industry; therefore we are exposed to risks associated with the healthcare industry in particular. The healthcare industry is highly regulated and changes in government regulation have in the past had material adverse consequences on the industry in general, which may not even have been contemplated by lawmakers and regulators. We cannot assure you that future changes in government regulation of healthcare will not have a material adverse effect on the healthcare industry, including

 

27


Table of Contents
Index to Financial Statements

our lessees/operators. Moreover, our ability to invest in non-healthcare, non-healthcare-related or non-senior housing properties is restricted by the terms of our revolving credit facility. See “Governmental Regulation—Healthcare Regulation.”

 

Our tenants, including Kindred, may be adversely affected by increasing healthcare regulation and enforcement.

 

We believe that the regulatory environment surrounding the long-term care industry has intensified both in the amount and type of regulations and in the efforts to enforce those regulations. This is particularly true for large for-profit, multi-facility providers like Kindred.

 

The extensive federal, state and local laws and regulations affecting the healthcare industry include, but are not limited to, laws and regulations relating to licensure, conduct of operations, ownership of facilities, addition of facilities and equipment, allowable costs, services, prices for services, quality of care, patient rights, fraudulent or abusive behavior, and financial and other arrangements which may be entered into by healthcare providers. Federal and state governments have intensified enforcement policies, resulting in a significant increase in the number of inspections, citations of regulatory deficiencies and other regulatory sanctions, including terminations from the Medicare and Medicaid programs, bars on Medicare and Medicaid payments for new admissions, civil monetary penalties and even criminal penalties. See “Governmental Regulation—Healthcare Regulation.” If Kindred or our other tenants and operators fail to comply with the extensive laws, regulations and other requirements applicable to their businesses, they could become ineligible to receive reimbursement from governmental and private third-party payor programs, suffer civil and/or criminal penalties and/or be required to make significant changes to their operations. Kindred and our other tenants also could be forced to expend considerable resources responding to an investigation or other enforcement action under applicable laws or regulations. In addition, as part of the settlement agreement Kindred entered into with the federal government, it agreed to comply with the terms of a corporate integrity agreement. Kindred could incur additional expenses in complying with the corporate integrity agreement, and its failure to comply with the corporate integrity agreement could have a material adverse effect on Kindred’s results of operations, financial condition and its ability to make rental payments to us, which, in turn, could have a Material Adverse Effect on us.

 

We are unable to predict the future course of federal, state and local regulation or legislation, including the Medicare and Medicaid statutes and regulations. Changes in the regulatory framework could have a material adverse effect on Kindred and our other operators, which, in turn, could have a Material Adverse Effect on us.

 

Changes in the reimbursement rates or methods of payment from third-party payors, including the Medicare and Medicaid programs, could have a material adverse effect on our tenants.

 

Kindred and certain of our other tenants and operators rely on reimbursement from third-party payors, including the Medicare and Medicaid programs, for substantially all of their revenues. See “Governmental Regulation—Healthcare Regulation.” There continue to be various federal and state legislative and regulatory proposals to implement cost-containment measures that limit payments to healthcare providers. In addition, private third-party payors have continued their efforts to control healthcare costs. We cannot assure you that adequate reimbursement levels will be available for services to be provided by Kindred and other tenants which are currently being reimbursed by Medicare, Medicaid or private payors. Significant limits by governmental and private third-party payors on the scope of services reimbursed and on reimbursement rates and fees could have a material adverse effect on the liquidity, financial condition and results of operations of Kindred and certain of our other operators and tenants, which, in turn, could have a Material Adverse Effect on us.

 

Significant legal actions could subject Kindred and our other operators to increased operating costs and substantial uninsured liabilities, which could materially and adversely affect Kindred’s and our other operators’ liquidity, financial condition and results of operation.

 

Although claims and costs of professional liability insurance seem to be growing at a slower pace, over the past few years, Kindred and our other skilled nursing facility operators have experienced substantial increases in

 

28


Table of Contents
Index to Financial Statements

both the number and size of professional liability claims in recent years. In addition to large compensatory claims, plaintiffs’ attorneys continue to seek significant punitive damages and attorneys’ fees.

 

Due to the high level in the number and severity of professional liability claims against healthcare providers, the availability of professional liability insurance has been severely restricted and the premiums on such insurance coverage have increased dramatically. As a result, Kindred’s and our other operators’ insurance coverage might not cover all claims against them or continue to be available to them at a reasonable cost. If Kindred or our other operators are unable to maintain adequate insurance coverage or are required to pay punitive damages, they may be exposed to substantial liabilities.

 

Kindred insures its professional liability risks in part through a wholly-owned, limited purpose insurance company. The limited purpose insurance company insures initial losses up to specified coverage levels per occurrence with no aggregate coverage limit. Coverage for losses in excess of those per occurrence levels is maintained through unaffiliated commercial insurance carriers up to an aggregate limit. The limited purpose insurance company then insures all claims in excess of the aggregate limit for the unaffiliated commercial insurance carriers. Kindred maintains general liability insurance and professional malpractice liability insurance in amounts and with deductibles which Kindred management has indicated that it believes are sufficient for its operations.

 

Operators that insure their professional liability risks through their own captive limited purpose entities generally estimate the future cost of professional liability through actuarial studies which rely primarily on historical data. However, due to the increase in the number and severity of professional claims against healthcare providers, these actuarial studies may underestimate the future cost of claims and we cannot assure you that such operators’ reserves for future claims will be adequate to cover the actual cost of such claims. If the actual cost of such claims is significantly higher than the operators’ reserves, it could have a material adverse effect on the liquidity, financial condition and results of operation of our operators and their ability to make rental payments to us, which in turn, could have a Material Adverse Effect on us.

 

Kindred and our other operators may be sued under a federal whistleblower statute.

 

Kindred and our other operators may be sued under a federal whistleblower statute designed to combat fraud and abuse in the healthcare industry. See “Government Regulation—Healthcare Regulation.” These lawsuits can involve significant monetary damages and award bounties to private plaintiffs who successfully bring these suits. If any such lawsuits were to be brought against Kindred or our other operators, such suits combined with increased operating costs and substantial uninsured liabilities could have a material adverse effect on the liquidity, financial condition and results of operation of Kindred and our other operators and their ability to make rental payments to us, which, in turn, could have a Material Adverse Effect on us.

 

If any of our properties are found to be contaminated, or if we become involved in any environmental disputes, we could incur substantial liabilities and costs.

 

Under federal and state environmental laws and regulations, a current or former owner of real property may be liable for costs related to the investigation, removal and remediation of hazardous or toxic substances or petroleum that are released from or are present at or under, or that are disposed of in connection with such property. Owners of real property may also face other environmental liabilities, including government fines and penalties imposed by regulatory authorities and damages for injuries to persons, property or natural resources. Environmental laws and regulations often impose liability without regard to whether the owner was aware of, or was responsible for, the presence, release or disposal of hazardous or toxic substances or petroleum. In certain circumstances, environmental liability may result from the activities of a current or former operator of the property. While we are generally indemnified by the current operators of our properties for contamination caused by such operators, such indemnities may not adequately cover all environmental costs. See “Government Regulation—Environmental Regulation.”

 

29


Table of Contents
Index to Financial Statements

Risks Arising from Our Capital Structure

 

We may become more leveraged.

 

As of December 31, 2004, we had approximately $843.2 million of indebtedness. Our revolving credit facility and the indentures governing our outstanding senior notes permit us to incur substantial additional debt, and we may borrow additional funds, which may include secured borrowings. A high level of indebtedness may have the following consequences:

 

    a substantial portion of our cash flow from operations must be dedicated to the payment of debt service, thus reducing the funds available for our business strategy and for distributions to stockholders;

 

    potential limits on our ability to adjust rapidly to changing market conditions and vulnerability in the event of a downturn in general economic conditions or in the real estate and/or healthcare sectors;

 

    a potential impairment of our ability to obtain additional financing for our business strategy; and

 

    a potential downgrade in the rating of our debt securities by one or more rating agencies which could have the effect of, among other things, increasing the cost of our borrowing.

 

We may be unable to raise additional capital necessary to continue to implement our business plan and to meet our debt payments.

 

In order to continue to implement our business plan and to meet our debt payments, we may need to raise additional capital. Our ability to incur additional indebtedness is restricted by the terms of our revolving credit facility and the indentures governing our outstanding senior notes. In addition, adverse economic conditions could cause the terms on which we can obtain additional borrowings to become unfavorable. In such circumstances, we may be required to raise additional equity in the capital markets or liquidate one or more investments in properties at times that may not permit realization of the maximum return on the investments and that could result in adverse tax consequences to us. In addition, certain healthcare regulations may constrain our ability to sell assets. We cannot assure you that we will be able to meet our debt service obligations, and the failure to do so could have a Material Adverse Effect on us.

 

We hedge our floating-rate debt with an interest rate swap and may record charges and incur costs associated with the termination or change in value of our interest rate swap.

 

We have an interest rate swap agreement to hedge all or a portion of our existing floating-rate debt through June 30, 2008. We periodically assess our interest rate swap in relation to our outstanding balances of floating-rate debt, and based on such assessments may terminate portions of our swap or enter into additional swaps. Termination of swaps with accrued losses, or changes in the value of swaps as a result of falling interest rates, would require the payment of costs and/or result in charges to our earnings and net worth.

 

Risks Arising from Our Status as a REIT

 

Loss of our status as a REIT would have significant adverse consequences to us and the value of our common stock.

 

If we lose our status as a REIT, we will face serious tax consequences that will substantially reduce the funds available for distribution to our stockholders for each of the years involved because:

 

    we would not be allowed a deduction for distributions to stockholders in computing our taxable income and would be subject to federal income tax at regular corporate rates;

 

    we also could be subject to the federal alternative minimum tax and possibly increased state and local taxes; and

 

    unless we are entitled to relief under statutory provisions, we could not elect to be subject to tax as a REIT for four taxable years following the year during which we were disqualified.

 

30


Table of Contents
Index to Financial Statements

In addition, if we fail to qualify as a REIT, all distributions to stockholders would continue to be treated as dividends to the extent of our current and accumulated earning and profits, although corporate stockholders may be eligible for the dividends received deduction and individual stockholders may be eligible for taxation at the rates generally applicable to long-term capital gains (currently at a maximum rate of 15%) with respect to distributions. We would no longer be required to pay dividends to maintain REIT status.

 

As a result of all these factors, our failure to qualify as a REIT also could impair our ability to implement our business strategy and would adversely affect the value of our common stock.

 

Qualification as a REIT involves the application of highly technical and complex Code provisions for which there are only limited judicial and administrative interpretations. The determination of various factual matters and circumstances not entirely within our control may affect our ability to remain qualified as a REIT. In addition, new legislation, regulations, administrative interpretations or court decisions may adversely affect our investors or our ability to remain qualified as a REIT for tax purposes. Although we believe that we qualify as a REIT, we cannot assure you that we will continue to qualify or remain qualified as a REIT for tax purposes.

 

See “Federal Income Tax Considerations—Federal Income Taxation of Ventas” and “—Requirements for Qualification as a REIT.”

 

The 90% distribution requirement will decrease our liquidity and may limit our ability to engage in otherwise beneficial transactions.

 

To comply with the 90% distribution requirement applicable to REITs and to avoid the nondeductible excise tax, we must make distributions to our stockholders. See “Federal Income Tax Considerations—Requirements for Qualification as a REIT—Annual Distribution Requirements.” The indentures governing our outstanding senior notes permit us to make annual distributions to our stockholders in an amount equal to the minimum amount necessary to maintain our REIT status so long as the ratio of our Debt to Adjusted Total Assets (as each term is defined in the indentures) does not exceed 60% and to make additional distributions if we pass certain other financial tests. However, distributions may limit our ability to rely upon rental payments from our properties or subsequently acquired properties to finance investments, acquisitions or new developments.

 

Although we anticipate that we generally will have sufficient cash or liquid assets to enable us to satisfy the REIT distribution requirement, it is possible that from time to time we may not have sufficient cash or other liquid assets to meet the 90% distribution requirement or we may decide to retain cash or distribute such greater amount as may be necessary to avoid income and excise taxation. This may be due to the timing differences between the actual receipt of income and actual payment of deductible expenses, on the one hand, and the inclusion of that income and deduction of those expenses in arriving at our taxable income, on the other hand. In addition, nondeductible expenses such as principal amortization or repayments or capital expenditures in excess of non-cash deductions may also cause us to fail to have sufficient cash or liquid assets to enable us to satisfy the 90% distribution requirement.

 

In the event that timing differences occur or we deem it appropriate to retain cash, we may borrow funds, issue additional equity securities (although we cannot assure you that we will be able to do so), pay taxable stock dividends, if possible, distribute other property or securities or engage in a transaction intended to enable us to meet the REIT distribution requirements. This may require us to raise additional capital to meet our obligations; however, see “—Risks Arising from Our Capital Structure—We may be unable to raise additional capital necessary to continue to implement our business plan and to meet our debt payments.” The terms of our revolving credit facility and the indentures governing our outstanding senior notes restrict our ability to engage in some of these transactions.

 

31


Table of Contents
Index to Financial Statements

We may still be subject to corporate level taxes.

 

Following our REIT election, we are considered to be a former C corporation for income tax purposes. Therefore, potentially, we remain subject to corporate level taxes for any asset dispositions occurring on or before December 31, 2008.

 

ITEM 2.     Properties

 

Healthcare and Senior Housing Facilities

 

As of December 31, 2004, we owned 201 skilled nursing facilities, 40 hospitals, 30 senior housing facilities and 16 other facilities in 39 states. We believe that the geographic diversity of the properties makes our portfolio less susceptible to adverse changes in state reimbursement and regulation and regional economic downturns.

 

Ventas Realty has granted mortgage liens on certain of its properties to secure borrowings under our revolving credit facility, and Ventas Finance has granted mortgage liens on all of the properties covered by the Kindred CMBS Master Lease to secure a loan in the original principal amount of $225.0 million from Merrill Lynch Mortgage Lending, Inc. In addition, certain subsidiaries of Ventas have mortgage debt secured by that subsidiary’s facility.

 

32


Table of Contents
Index to Financial Statements

The following table sets forth certain information regarding the facilities owned by us as of December 31, 2004 for each state in which we own property:

 

     Skilled Nursing Facilities

   Hospitals

   Senior Housing
Facilities


   Other
Facilities


State


  

Number

of
Facilities


   Licensed
Beds


  

Number
of

Facilities


   Licensed
Beds


  

Number

of

Facilities


   Units

  

Alabama

   3    443    —      —      —      —      —  

Arizona

   5    723    2    109    —      —      —  

California

   11    1,341    5    417    —      —      —  

Colorado

   4    515    1    68    —      —      —  

Connecticut

   6    736    —      —      1    81    —  

Florida

   —      —      6    491    2    279    4

Georgia

   5    685    —      —      —      —      —  

Idaho

   8    791    —      —      —      —      —  

Illinois

   —      —      4    431    2    297    —  

Indiana

   15    2,313    1    59    —      —      —  

Kansas

   —      —      —      —      1    276    —  

Kentucky

   11    1,375    1    374    —      —      —  

Louisiana

   —      —      1    168    —      —      —  

Maine

   10    801    —      —      —      —      —  

Maryland

   3    462    —      —      —      —      —  

Massachusetts

   27    2,934    2    109    6    736    —  

Michigan

   1    —      1    160    2    267    —  

Minnesota

   1    140    —      —      —      —      —  

Missouri

   —      —      2    227    1    173    —  

Montana

   2    331    —      —      —      —      —  

Nebraska

   1    163    —      —      —      —      —  

Nevada

   2    180    1    52    1    152    —  

New Hampshire

   3    512    —      —      —      —      —  

New Jersey

   1    153    —      —      —      —      1

New Mexico

   —      —      1    61    1    200    —  

North Carolina

   19    2,339    1    124    —      —      —  

Ohio

   16    2,127    1    29    5    479    —  

Oklahoma

   —      —      1    59    —      —      —  

Oregon

   2    254    —      —      —      —      —  

Pennsylvania

   5    731    2    115    6    508    2

Rhode Island

   2    201    —      —      —      —      —  

Tennessee

   4    681    1    49    —      —      —  

Texas

   —      —      6    455    1    138    9

Utah

   5    620    —      —      —      —      —  

Vermont

   1    160    —      —      —      —      —  

Virginia

   4    629    —      —      1    98    —  

Washington

   9    885    —      —      —      —      —  

Wisconsin

   11    1,856    —      —      —      —      —  

Wyoming

   4    451    —      —      —      —      —  
    
  
  
  
  
  
  

Total

   201    25,532    40    3,557    30    3,684    16
    
  
  
  
  
  
  

 

Other Real Estate Investments

 

Our THI Mezzanine Loan is secured by equity pledges in entities that own and operate 17 healthcare properties, plus liens on four other healthcare properties and interests in three additional properties and a physical therapy business. See “Note 6—Mergers and Acquisitions” of the Notes to Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K.

 

33


Table of Contents
Index to Financial Statements

Corporate Offices

 

We lease our corporate offices in Louisville, Kentucky and Chicago, Illinois.

 

ITEM 3.     Legal Proceedings

 

The information contained in “Note 13—Litigation” of the Notes to Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K is incorporated by reference into this Item 3. Except as set forth therein, we are not a party to, nor is any of our property the subject of, any material pending legal proceedings.

 

ITEM 4.     Submission of Matters to a Vote of Security Holders

 

Not applicable.

 

PART II

 

ITEM 5.     Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

 

Market Information

 

Our common stock, $0.25 par value, is listed and traded on the New York Stock Exchange (the “NYSE”) under the symbol “VTR.” The following table sets forth, for the periods indicated, the high and low sales prices of our common stock as reported on the NYSE and the dividends declared per share.

 

     Sales Price of
Common Stock


    
     High

   Low

   Dividends Declared

2003

                    

First Quarter

   $ 12.24    $ 11.08    $ 0.2675

Second Quarter

     15.33      11.67      0.2675

Third Quarter

     18.33      14.83      0.2675

Fourth Quarter

     22.98      17.05      0.2675

2004

                    

First Quarter

   $ 27.55    $ 21.88    $ 0.3250

Second Quarter

     27.98      20.56      0.3250

Third Quarter

     27.84      23.06      0.3250

Fourth Quarter

     29.48      24.40      0.3250

 

As of February 25, 2005, there were 84,789,533 shares of our common stock outstanding and approximately 3,709 stockholders of record.

 

Dividend Policy

 

On February 24, 2005, we declared the first quarterly installment of our 2005 dividend in an amount of $0.36 per share payable on April 5, 2005 to stockholders of record on March 24, 2005. We expect to distribute 100% or more of our taxable net income to our stockholders for 2005.

 

A number of factors are considered by our Board of Directors when making the final determination regarding the frequency and amount of our dividends. These decisions regarding dividends are normally made quarterly. Therefore, we cannot assure you that we will maintain the policy stated above. Please see “Cautionary Statements” and “Risk Factors” for a description of other factors that may affect our distribution policy.

 

34


Table of Contents
Index to Financial Statements

Our stockholders may reinvest all or a portion of any cash distribution on their shares of our common stock by participating in our Distribution Reinvestment and Stock Purchase Plan, subject to the terms of the plan. See “Note 14—Capital Stock” of the Notes to Consolidated Financial Statements.

 

Director and Employee Stock Sales

 

Certain of our directors, executive officers and other employees may, from time to time, adopt non-discretionary, written trading plans that comply with Rule 10b5-1 under the Exchange Act, or otherwise monetize their equity-based compensation.

 

Stock Repurchases

 

During the fourth quarter ended December 31, 2004, no purchases of our common stock were made by or on behalf of us or any “affiliated purchaser” (as defined in Rule 10b-18(a)(3) under the Exchange Act).

 

35


Table of Contents
Index to Financial Statements

ITEM 6.     Selected Financial Data

 

You should read the following selected financial data in conjunction with our Consolidated Financial Statements and the notes thereto included in Item 8 of this Annual Report on Form 10-K.

 

     As of and For the Year Ended December 31,

 
     2004

    2003

    2002

    2001

    2000

 
     (in thousands, except per share data)  

Operating Data

                                        

Rental income

   $ 232,911     $ 189,987     $ 174,822     $ 169,392     $ 212,038  

Gain on sale of Kindred common stock

     —         9,039       5,014       15,425       —    

General, administrative and professional fees

     16,917       15,158       12,913       14,902       20,781  

United States Settlement

     —         —         —         —         96,493  

Loss on extinguishment of debt

     1,370       84       11,077       1,322       4,207  

Interest expense

     66,817       61,660       72,384       79,595       86,803  

Interest on United States Settlement

     —         4,943       5,461       4,592       —    

Loss on uncollectible amounts due from tenants

     —         —         —         —         43,888  

Income (loss) before discontinued operations

     100,173       96,135       36,949       46,496       (69,179 )

Discontinued operations

     20,727       66,618       28,757       4,070       3,727  

Net income (loss)

     120,900       162,753       65,706       50,566       (65,452 )

Per Share Data

                                        

Income (loss) per common share before discontinued operations, basic

   $ 1.20     $ 1.21     $ 0.53     $ 0.68     $ (1.02 )

Net income (loss) per common share, basic

   $ 1.45     $ 2.05     $ 0.95     $ 0.74     $ (0.96 )

Income (loss) per common share before discontinued operations, diluted

   $ 1.19     $ 1.20     $ 0.53     $ 0.67     $ (1.02 )

Net income (loss) per common share, diluted

   $ 1.43     $ 2.03     $ 0.93     $ 0.73     $ (0.96 )

Dividends declared per common share

   $ 1.30     $ 1.07     $ 0.95     $ 0.92     $ 0.91  

Other Data

                                        

Net cash provided by operating activities

   $ 149,958     $ 137,366     $ 116,385     $ 79,893     $ 85,338  

Net cash (used in) provided by investing activities

     (298,695 )     159,701       (34,140 )     2,760       5,359  

Net cash provided by (used in) financing activities

     69,998       (217,418 )     (98,386 )     (151,458 )     (142,890 )

FFO (1)

     150,322       152,631       84,083       92,180       (24,221 )

Weighted average shares outstanding, basic

     83,491       79,340       69,336       68,409       68,010  

Weighted average shares outstanding, diluted

     84,352       80,094       70,290       69,363       68,131  

Balance Sheet Data

                                        

Real estate investments, at cost

   $ 1,512,211     $ 1,090,181     $ 1,221,406     $ 1,175,838     $ 1,176,143  

Cash and cash equivalents

     3,365       82,104       2,455       18,596       87,401  

Kindred common stock

     —         —         16,713       55,118       —    

Total assets

     1,126,935       812,850       895,780       941,859       981,145  

Senior notes payable and other debt

     843,178       640,562       707,709       848,368       886,385  

United States Settlement

     —         —         43,992       54,747       96,493  

 

36


Table of Contents
Index to Financial Statements

(1) We consider funds from operations (“FFO”) an appropriate measure of performance of an equity REIT, and we use the National Association of Real Estate Investment Trusts’ (“NAREIT”) definition of FFO. NAREIT defines FFO as net income (computed in accordance with accounting principles generally accepted in the United States (“GAAP”)), excluding gains or losses from sales of real estate property, plus real estate depreciation and amortization, and after adjustments for unconsolidated partnerships and joint ventures. FFO presented herein is not necessarily comparable to FFO presented by other real estate companies due to the fact that not all real estate companies use the same definition. FFO should not be considered as an alternative to net income (determined in accordance with GAAP) as an indicator of our financial performance or as an alternative to cash flow from operating activities (determined in accordance with GAAP) as a measure of our liquidity, nor is FFO indicative of sufficient cash flow to fund all of our needs. See “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Results of Operations—Funds from Operations” included in Item 7 of this Annual Report on Form 10-K.

 

ITEM 7.     Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

The following discussion and analysis provides information which management believes is relevant to an assessment and understanding of our consolidated results of operations and financial condition of Ventas, Inc. (together with its subsidiaries, except where the context otherwise requires, “we,” “us” or “our”). You should read this discussion in conjunction with our Consolidated Financial Statements and the notes thereto included in Item 8 of this Annual Report on Form 10-K. This Management’s Discussion and Analysis will help you understand:

 

    Key transactions that we completed in 2004;

 

    Our critical accounting policies and estimates;

 

    Accounting policies that we adopted in 2004, 2003 and 2002;

 

    Our results of operations for the last three years;

 

    Our liquidity and capital resources; and

 

    Our funds from operations.

 

Key Transactions in 2004

 

During 2004, we completed the following key transactions:

 

    We acquired all of the outstanding common shares of ElderTrust in a cash transaction valued at $184.0 million, inclusive of $33.5 million in unrestricted and restricted cash;

 

    We acquired 15 facilities now leased by affiliates of Brookdale Living Communities, Inc. for a purchase price of $157.4 million;

 

    We acquired an additional 11 facilities from various sellers for an aggregate purchase price of $109.2 million;

 

    We issued $125 million of 6  5 / 8 % unsecured senior notes, maturing on October 15, 2014;

 

    We obtained a new $300 million secured revolving credit facility initially priced at 125 basis points over LIBOR, an improvement over our previous revolving credit facility which was initially priced at 275 basis points over LIBOR; and

 

    We raised $51.1 million of equity with the public sale of two million shares of our common stock.

 

Critical Accounting Policies and Estimates

 

Our Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”), which requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and the related disclosures. We believe that the following critical accounting policies, among others, affect our more significant estimates and judgments used in the preparation of our financial statements.

 

37


Table of Contents
Index to Financial Statements

Long-Lived Assets

 

Investments in real estate properties are recorded at cost. We account for acquisitions using the purchase method. The cost of the properties acquired is allocated among tangible land, buildings and equipment and recognized intangibles based upon estimated fair values in accordance with the provisions of Statement of Financial Accounting Standards (“SFAS”) No. 141, “Business Combinations.” We estimate fair values of the components of assets acquired as of the acquisition date or engage a third party appraiser as necessary. Recognized intangibles, if any, include the value of acquired lease contracts and related customer relationships.

 

Our method for determining fair value varies with the categorization of the asset acquired. We estimate the fair value of buildings on an as-if-vacant basis, and amortize the building value over the estimated remaining life of the building. We determine the allocated value of other fixed assets based upon the replacement cost and amortize such value over their estimated remaining useful lives. We determine the value of land either based on real estate tax assessed values in relation to the total value of the asset, internal analyses of recently acquired and existing comparable properties within our portfolio or third party appraisals. The fair value of in-place leases, if any, reflects (i) above and below market leases, if any, determined by discounting the difference between the estimated current market rent and the in-place rentals, the resulting intangible asset of which is amortized to rental revenue over the remaining life of the associated lease plus any fixed rate renewal periods, if applicable, (ii) the estimated value of the cost to obtain tenants, including tenant allowances, tenant improvements and leasing commissions, which is amortized over the remaining life of the associated lease, and (iii) an estimated value of the absorption period to reflect the value of the rents and recovery costs foregone during a reasonable lease-up period, as if the acquired space was vacant, which is amortized over the remaining life of the associated lease. We also estimate the value of tenant or other customer relationships acquired by considering the nature and extent of existing business relationships with the tenant, growth prospects for developing new business with such tenant, such tenant’s credit quality, expectations of lease renewals with such tenant, and the potential for significant, additional future leasing arrangements with such tenant. We amortize such value, if any, over the expected term of the associated arrangements or leases, which would include the remaining lives of the related leases and any expected renewal periods.

 

Impairment of Long-Lived Assets

 

We periodically evaluate our long-lived assets, primarily consisting of our investments in real estate, for impairment indicators. If indicators of impairment are present, we evaluate the carrying value of the related real estate investments in relation to the future undiscounted cash flows of the underlying operations and adjust the net book value of leased properties and other long-lived assets to fair value if the sum of the expected future cash flow or sales proceeds is less than book value. An impairment loss is recognized at the time we make any such adjustment. Future events could occur which would cause us to conclude that impairment indicators exist and an impairment loss is warranted.

 

Revenue Recognition

 

Certain of our leases, excluding our master lease agreements (the “Kindred Master Leases”) with Kindred Healthcare, Inc. and certain of its affiliates (collectively, “Kindred”), provide for periodic and determinable increases in base rent. Base rental revenues under these leases are recognized on a straight-line basis over the term of the applicable lease. Certain of our other leases, including the Kindred Master Leases, provide for an annual increase in rental payments only if certain revenue parameters or other contingencies are met. We recognize the increased rental revenue under these leases only if the revenue parameters or other contingencies are met rather than on a straight-line basis over the term of the applicable lease. We recognize income from rent, lease termination fees and other income once all of the following criteria are met in accordance with SEC Staff Accounting Bulletin 104: (i) the agreement has been fully executed and delivered; (ii) services have been rendered; (iii) the amount is fixed or determinable; and (iv) the collectibility is reasonably assured.

 

38


Table of Contents
Index to Financial Statements

Legal Contingencies

 

We are involved in litigation as described in “Note 13—Litigation” of the Notes to Consolidated Financial Statements. We evaluate such matters by (i) ascertaining the probability that such litigation could result in a loss for us and (ii) determining an estimate of any possible loss. In accordance with SFAS No. 5, “Accounting for Contingencies,” we accrue for any probable losses that are estimable and disclose any loss contingencies that are possible. If management’s assessment of our liability with respect to these actions is incorrect, such matters could have a material adverse effect on us.

 

Fair Value of Derivative Instruments

 

The valuation of derivative instruments requires us to make estimates and judgments that affect the fair value of the instruments. Fair values for our derivatives are verified with a third party consultant which utilizes pricing models that consider forward yield curves and discount rates. Such amounts and the recognition of such amounts in the financial statements are subject to significant estimates which may change in the future.

 

Adoption of Accounting Policies

 

In December 2004, the Financial Accounting Standards Board (the “FASB”) issued SFAS No. 123(R), “Share-Based Payment” (“SFAS No. 123(R)”), which is a revision to SFAS No. 123, “Accounting for Stock-Based Compensation” (“SFAS No. 123”). SFAS No. 123(R) supersedes Accounting Principles Board Opinion No. 25, “Accounting for Stock Issued to Employees” (“APB Opinion No. 25”). Generally, the approach in SFAS No. 123(R) is similar to the approach described in SFAS No. 123, except that SFAS No. 123(R) requires all share-based payments to employees, including grants of employee stock options, be recognized in the income statement based on their fair values. Pro forma disclosure is no longer an alternative under SFAS No. 123(R).

 

As required under SFAS No. 123(R), we expect to adopt the provisions of this accounting standard on July 1, 2005. We expect to apply the modified prospective method of adoption in which compensation cost is recognized beginning on the date we adopt the accounting standard for all share-based payments granted after the adoption date and for all awards granted to employees prior to the adoption date that remain unvested on the adoption date. As permitted by SFAS No. 123(R), we currently account for share-based payments to employees using the intrinsic value method under APB Opinion No. 25 and, as such, generally recognize no compensation cost for employee stock options. The adoption of SFAS No. 123(R) is expected to result in an immaterial increase in expense during the second half of 2005 based on unvested options outstanding as of December 31, 2004 and current compensation plans. While the effect of adoption depends on the level of share-based payments granted in the future and unvested grants on the date we adopt SFAS No. 123(R), the effect of this accounting standard on our prior operating results would approximate the effect of SFAS No. 123 as described in the disclosure of pro forma net income and earnings per share. See “Note 9—Stockholders’ Equity and Stock Options” of the Notes to Consolidated Financial Statements.

 

In April 2002, FASB issued SFAS No. 145, “Rescission of FASB Statements No. 4, 44, and 64, Amendment of FASB Statement No. 13, and Technical Correction” (“SFAS 145”). SFAS No. 4, “Reporting Gains and Losses from Extinguishment of Debt” (“SFAS 4”), required that gains and losses from the extinguishment of debt that were included in the determination of net income be aggregated and, if material, classified as an extraordinary item. The provisions of SFAS 145 that relate to the rescission of SFAS 4 required us to reclassify certain prior period items that no longer meet the extraordinary classification into continuing operations. Additionally, future gains and losses related to debt extinguishment may be required to be classified as income from continuing operations. The provisions of SFAS 145 relating to the rescission of SFAS 4 became effective in fiscal years beginning after May 15, 2002. As required, on January 1, 2003 we adopted SFAS 145. In accordance with SFAS 145, our prior year financial statements have been reclassified to include gains and losses from extinguishment of debt in continuing operations. This reclassification has no effect on our net income.

 

39


Table of Contents
Index to Financial Statements

Effective January 1, 2002, we adopted the provisions of SFAS No. 144, “Accounting for the Impairment or Disposal of Long-Lived Assets” (“SFAS 144”), SFAS 144 addresses the financial accounting and reporting for the impairment or disposal of long-lived assets. SFAS 144 extends the reporting requirements of discontinued operations to include components of an entity that have either been disposed or are classified as held for sale. The operating results of properties that were disposed of subsequent to January 1, 2002 have been reclassified as discontinued operations in the Consolidated Statements of Income for each of the three years ended December 31, 2004 included herein. See “Note 5—Dispositions” of the Notes to Consolidated Financial Statements.

 

Results of Operations

 

The tables below show our results of operations for each year and the absolute and percentage change in those results from year to year.

 

Years Ended December 31, 2004 and 2003

 

     Year Ended
December 31,


    Change

 
     2004

   2003

    $

    %

 
     (dollars in thousands)  

Revenues:

                             

Rental income

   $ 232,911    $ 189,987     $ 42,924     22.6 %

Interest income from loan receivable

     2,958      3,036       (78 )   (2.6 )

Interest and other income

     987      1,696       (709 )   (41.8 )
    

  


 


     

Total revenues

     236,856      194,719       42,137     21.6  

Expenses:

                             

Property-level operating expenses

     1,337      —         1,337     —    

General, administrative and professional fees

     16,917      15,158       1,759     11.6  

Reversal of contingent liability

     —        (20,164 )     20,164     100.0  

Amortization of restricted stock grants

     1,207      1,274       (67 )   (5.3 )

Depreciation

     49,035      39,500       9,535     24.1  

Net loss on swap breakage

     —        5,168       (5,168 )   (100.0 )

Interest

     66,817      61,660       5,157     8.4  

Loss on extinguishment of debt

     1,370      84       1,286     1531.0  

Interest on United States Settlement

     —        4,943       (4,943 )   (100.0 )
    

  


 


     

Total expenses

     136,683      107,623       29,060     27.0  
    

  


 


     

Operating income

     100,173      87,096       13,077     15.0  

Gain on sale of Kindred common stock

     —        9,039       (9,039 )   (100.0 )
    

  


 


     

Income before discontinued operations

     100,173      96,135       4,038     4.2  

Discontinued operations

     20,727      66,618       (45,891 )   (68.9 )
    

  


 


     

Net income

   $ 120,900    $ 162,753     $ (41,853 )   (25.7 )%
    

  


 


     

 

Revenues

 

The increase in our 2004 rental income reflects (i) a $10.4 million increase resulting from the 3.5% annual increase in the rent paid under Kindred Master Leases effective May 1, 2004, and the rent increase from the July 1, 2003 amendment to the Kindred Master Leases, and (ii) the recognition of $32.1 million in additional rent relating to the properties acquired during 2004. See “Note 6—Mergers and Acquisitions” of the Notes to Consolidated Financial Statements. The rental income from Kindred includes $2.3 million related to the

 

40


Table of Contents
Index to Financial Statements

amortization of deferred revenue recorded as a result of our receipt of Kindred common stock in connection with Kindred’s emergence from bankruptcy on April 20, 2001 and the receipt of $4.5 million of additional future rent under the Kindred Master Leases.

 

Interest income from loan receivable represents interest income received in connection with a $17.0 million mezzanine loan made to Trans Healthcare, Inc. (“THI”) on November 4, 2002. As of February 15, 2005, the mezzanine loan amount outstanding was $12.4 million.

 

The decrease in interest and other income is primarily attributable to the recovery in 2003 of a previously written-off receivable.

 

Expenses

 

The increase in general, administrative and professional fees is primarily attributable to costs associated with our initiative to develop and market our strategic diversification program, engage in comprehensive asset management, comply with regulatory requirements such as the Sarbanes-Oxley Act of 2002, and to attract and retain appropriate personnel to achieve our business objectives.

 

During the year ended December 31, 2003, we reported an increase of approximately $20.2 million to our operating results, reflecting the reversal of a previously recorded contingent liability. See “Note 10—Income Taxes” of the Notes to Consolidated Financial Statements.

 

Depreciation expense increased primarily due to the properties acquired during 2004. See “Note 6—Mergers and Acquisitions” of the Notes to Consolidated Financial Statements.

 

As a result of anticipated lower variable rate debt balances due to the sale of 10 facilities on December 11, 2003, we entered into an agreement with the counterparty to our interest rate swap to break $120.0 million of the $450.0 million notional amount in exchange for a payment to the counterparty of approximately $8.6 million. In addition, we recognized $3.4 million of a previously deferred gain recorded in connection with the 1999 transaction to shorten the maturity of a separate interest rate swap. The $5.2 million net expense, which was previously reported in accumulated other comprehensive income on the Consolidated Balance Sheet, was recognized as a net expense in the Consolidated Statement of Income for the year ended December 31, 2003.

 

Interest expense includes $3.9 million and $4.1 million of amortized deferred financing costs for the years ended December 31, 2004 and 2003, respectively. Interest expense included in discontinued operations was $0.4 million and $3.5 million for the years ended December 31, 2004 and 2003, respectively. Total interest expense, excluding interest on the United States settlement but including interest allocated to discontinued operations, increased $2.0 million in 2004 over 2003. The increase in interest expense from continuing and discontinued operations was due primarily to (i) a $6.6 million increase related to the assumed debt for the ElderTrust merger and Brookdale transactions partially offset by, (ii) a $3.2 million decrease from lower effective interest rates, (iii) a $0.8 million decrease from the amortization of a deferred gain recorded in connection with the 1999 transaction to shorten the maturity of our previous $800.0 million notional amount interest rate swap (the “1998 Swap”), (iv) a $0.3 million decrease from reduced principal balances of our existing debt and (v) a $0.3 million decrease in amortization of deferred financing costs.

 

In September 2004, we refinanced indebtedness under our prior credit agreement at lower interest rates and incurred a loss from extinguishment of debt of $1.4 million related to the write-off of unamortized deferred financing costs.

 

Interest expense on our settlement with the United States Department of Justice declined to zero in 2004 from $4.9 million in 2003 due to full prepayment in 2003. On June 30, 2003, we incurred a $2.7 million non-cash expense relating to the early repayment of the settlement that is reflected as interest on United States settlement on our Consolidated Statement of Income for the year ended December 31, 2003. There was no prepayment penalty or other cash expense upon early repayment of the United States settlement. See “Note 11—Commitments and Contingencies” of the Notes to Consolidated Financial Statements.

 

41


Table of Contents
Index to Financial Statements

Gain On Sale of Kindred Common Stock

 

During the year ended December 31, 2003, we disposed of 920,814 shares of Kindred common stock and recognized a gain of $9.0 million. Since the sale, we have not owned any shares of Kindred common stock.

 

Discontinued Operations

 

The decrease in discontinued operations is a result of a lower net gain on the sale of properties in 2004. Discontinued operations in 2003 includes the net income of 27 properties sold in 2003 and in 2004, whereas the discontinued operations in 2004 only includes the net income of two properties sold in 2004.

 

In 2004, we completed the sale of two facilities for $21.1 million in net cash proceeds and recognized a net gain on the sale of $19.4 million. In addition, the tenant paid us lease termination fees approximating $0.5 million. In 2003, we completed the sale of 27 facilities for $139.2 million in net cash proceeds and recognized a net gain on the sale of $51.8 million. In addition, the tenants paid us lease termination fees approximating $10.1 million. The net gains and lease termination fees are included in discontinued operations for the respective years in which the dispositions occurred.

 

See “Note 5—Dispositions” of the Notes to Consolidated Financial Statements.

 

Years Ended December 31, 2003 and 2002

 

    

Year Ended

December 31,


    Change

 
     2003

    2002

    $

    %

 
     (dollars in thousands)  

Revenues:

                              

Rental income

   $ 189,987     $ 174,822     $ 15,165     8.7 %

Interest income from loan receivable

     3,036       995       2,041     205.1  

Interest and other income

     1,696       1,178       518     44.0  
    


 


 


     

Total revenues

     194,719       176,995       17,724     10.0  

Expenses:

                              

General, administrative and professional fees

     15,158       12,913       2,245     17.4  

Reversal of contingent liability

     (20,164 )     —         (20,164 )   —    

Amortization of restricted stock grants

     1,274       1,853       (579 )   (31.2 )

Depreciation

     39,500       38,229       1,271     3.3  

Net loss on swap breakage

     5,168       5,407       (239 )   (4.4 )

Interest

     61,660       72,384       (10,724 )   (14.8 )

Loss on extinguishment of debt

     84       11,077       (10,993 )   (99.2 )

Interest on United States Settlement

     4,943       5,461       (518 )   (9.5 )
    


 


 


     

Total expenses

     107,623       147,324       (39,701 )   (26.9 )
    


 


 


     

Operating income

     87,096       29,671       57,425     193.5  

Gain on sale of Kindred common stock

     9,039       5,014       4,025     80.3  
    


 


 


     

Income before provision (benefit) for income taxes, net gain real estate disposals and discontinued operations

     96,135       34,685       61,450     177.2  

Provision (benefit) for income taxes

     —         (2,200 )     2,200     100.0  
    


 


 


     

Income before net gain on real estate disposals and discontinued operations

     96,135       36,885       59,250     160.6  

Net gain on real estate disposals

     —         64       (64 )   (100.0 )
    


 


 


     

Income before discontinued operations

     96,135       36,949       59,186     160.2  

Discontinued operations

     66,618       28,757       37,861     131.7  
    


 


 


     

Net income

   $ 162,753     $ 65,706     $ 97,047     147.7 %
    


 


 


     

 

42


Table of Contents
Index to Financial Statements

Revenues

 

The increase in 2003 rental income reflects (i) the 3.5% increase in the rent paid under the Kindred Master Leases effective May 1, 2003, (ii) the $8.6 million increase in annualized rent on certain Kindred facilities effective July 1, 2003 and (iii) $6.0 million in additional rent earned during the year ended December 31, 2003 under our master lease with THI.

 

The rental income from Kindred includes $2.3 million related to the amortization of deferred revenue recorded as a result of our receipt of Kindred common stock on April 20, 2001 and the receipt of $4.5 million of additional future rent under the Kindred Master Leases.

 

Interest income from loan receivable represents interest income received in connection with the THI mezzanine loan.

 

The increase in interest and other income is primarily attributable to the recovery in 2003 of a previously written-off receivable. In addition, interest income increased due to higher cash balances on hand to invest during 2003, which was partially offset by reduced interest rates.

 

Expenses

 

The increase in general, administrative and professional fees is primarily attributable to costs associated with our initiative to develop and market our strategic diversification program, to improve our overall asset management system, and to attract and retain appropriate personnel to achieve our business objectives.

 

During the year ended December 31, 2003, we reported an increase of approximately $20.2 million to our operating results, reflecting the reversal of a previously recorded contingent liability. See “Note 10—Income Taxes” of the Notes to Consolidated Financial Statements.

 

For the year ended December 31, 2003, we recorded an expense of $5.2 million related to the loss on a $120 million notional swap breakage. For the year ended December 31, 2002, we recorded an expense of $5.4 million related to the loss on a $350 million notional swap breakage. See “Note 7—Borrowing Arrangements” of the Notes to Consolidated Financial Statements.

 

Interest expense includes $4.1 million and $3.7 million of amortized deferred financing costs for the years ended December 31, 2003 and 2002, respectively. Interest expense included in discontinued operations was $3.5 million and $6.2 million for the years ended December 31, 2003 and 2002, respectively. Total interest expense, excluding interest on the United States settlement but including interest allocated to discontinued operations, decreased $13.4 million in 2003 over 2002. The decrease in interest expense from continuing and discontinued operations was due primarily to (i) a $9.9 million decrease as a result of reduced debt balances, (ii) a $0.4 million decrease from reduced interest rates, (iii) a $1.6 million decrease in swap ineffectiveness (See “Note 7—Borrowing Arrangements” of the Notes to Consolidated Financial Statements), and (iv) a $1.5 million decrease from the amortization of a deferred gain recorded in connection with a 1999 transaction to shorten the maturity of the 1998 Swap. We recorded swap ineffectiveness in the Consolidated Statement of Income of $0.3 million and $1.9 million for the years ended December 31, 2003 and 2002, respectively, to reflect the value of the excess of the notional amount of the 1998 Swap and 2003-2008 Swap (as defined below) over our future anticipated variable rate debt balance.

 

In April 2002, we refinanced indebtedness under our prior credit agreement and incurred a loss from extinguishment of debt of $6.9 million related to the write-off of unamortized deferred financing costs associated with our previous revolving credit facility. In December 2002, we incurred an additional $4.2 loss related to the repurchase of $34.0 million principal amount of our outstanding senior notes consisting of the write-off of unamortized deferred financing costs and premiums paid to repurchase.

 

43


Table of Contents
Index to Financial Statements

On June 30, 2003, we incurred a $2.7 million expense relating to the early repayment of our United States settlement that is reflected as interest on United States Settlement on the Consolidated Statement of Income for the year ended December 31, 2003.

 

Gain on Sale of Kindred Common Stock

 

During the year ended December 31, 2003, we disposed of 920,814 shares of Kindred common stock and recognized a gain of $9.0 million. During the year ended December 31, 2002, we disposed of 159,500 shares of Kindred common stock and recognized a gain of $5.0 million.

 

Discontinued Operations

 

The increase in discontinued operations is a result of a higher net gain on the sale of properties in 2003, offset by the loss of net income due to the sales. Discontinued operations in 2002 includes the net income of properties sold in 2002 and in 2003, whereas the discontinued operations in 2003 only includes the net income of properties sold in 2003.

 

In the second quarter ended June 30, 2002, we sold a skilled nursing facility for $1.5 million in net cash proceeds to an unrelated third party and recognized a gain of $1.1 million which was included as a component of discontinued operations and we sold a hospital facility for $27.1 million in net cash proceeds to an unrelated third party and recognized a gain of $22.4 million which was also included as a component of discontinued operations.

 

Funds from Operations

 

Our funds from operations (“FFO”) for the five years ended December 31, 2004 are summarized in the following table:

 

     For the Year Ended December 31,

 
     2004

    2003

    2002

    2001

    2000

 
     (in thousands)  

Net income (loss)

   $ 120,900     $ 162,753     $ 65,706     $ 50,566     $ (65,452 )

Adjustments:

                                        

Depreciation on real estate assets

     48,647       39,216       38,012       37,855       38,068  

Realized gain on sale of real estate assets

     —         —         (64 )     (290 )     (957 )

Other items:

                                        

Discontinued operations

                                        

Real estate depreciation—discontinued

     203       2,443       3,879       4,049       4,120  

Gain on sale of real estate

     (19,428 )     (51,781 )     (23,450 )     —         —    
    


 


 


 


 


Funds from operations

   $ 150,322     $ 152,631     $ 84,083     $ 92,180     $ (24,221 )
    


 


 


 


 


 

Historical cost accounting for real estate assets implicitly assumes that the value of real estate assets diminishes predictably over time. Since real estate values instead have historically risen or fallen with market conditions, many industry investors have considered presentations of operating results for real estate companies that use historical cost accounting to be insufficient by themselves. To overcome this problem, we consider FFO an appropriate measure of performance of an equity REIT, and we use the National Association of Real Estate Investment Trusts (“NAREIT”) definition of FFO. NAREIT defines FFO as net income (computed in accordance with GAAP), excluding gains (or losses) from sales of real estate property, plus real estate depreciation and amortization, and after adjustments for unconsolidated partnerships and joint ventures.

 

FFO presented herein is not necessarily comparable to FFO presented by other real estate companies due to the fact that not all real estate companies use the same definition. FFO should not be considered as an alternative

 

44


Table of Contents
Index to Financial Statements

to net income (determined in accordance with GAAP) as an indicator of our financial performance or as an alternative to cash flow from operating activities (determined in accordance with GAAP) as a measure of our liquidity, nor is FFO necessarily indicative of sufficient cash flow to fund all of our needs. We believe that in order to facilitate a clear understanding of our consolidated historical operating results, FFO should be examined in conjunction with net income as presented in the Consolidated Financial Statements and data included elsewhere in this Annual Report on Form 10-K.

 

Asset/Liability Management

 

Asset/liability management is a key element of our overall risk management program. The objective of asset/liability management is to support the achievement of business strategies while maintaining appropriate risk levels. The asset/liability management process focuses on a variety of risks, including market risk (primarily interest rate risk) and credit risk. Effective management of these risks is an important determinant of the absolute levels and variability of FFO and net worth. The following discussion addresses our integrated management of assets and liabilities, including the use of derivative financial instruments. We do not use derivative financial instruments for speculative purposes.

 

Market Risk

 

We receive revenue primarily by leasing our assets under leases that are long-term triple net-leases in which the rental rate is generally fixed with annual escalators, subject to certain limitations. We also earn revenue from the THI mezzanine loan. Our obligations under our revolving credit facility are floating rate obligations whose interest rate and related monthly interest payments vary with the movement in LIBOR. The general fixed nature of our assets and the variable nature of our obligations create interest rate risk. If interest rates were to rise significantly, our lease and other revenue might not be sufficient to meet our debt obligations. In order to mitigate this risk, on September 28, 2001, we entered into an interest rate swap agreement in the notional amount of $450 million to hedge floating rate debt for the period between July 1, 2003 and June 30, 2008 (the “2003-2008 Swap”). The swap is treated as a cash flow hedge for accounting purposes and is with a highly rated counterparty on which we pay a fixed rate of 5.385% and receive LIBOR from the counterparty. On December 11, 2003, due to our lower expected future variable debt balances, we reduced the notional amount of the swap for the period from December 11, 2003 through June 29, 2006 from $450 million to $330 million. See “Note 7—Borrowing Arrangements” of the Notes to Consolidated Financial Statements. There are no collateral requirements under the swap. The notional amount of the swap is scheduled to decline from $330.0 million as follows:

 

Notional Amount


 

Date


$300,000,000

  June 30, 2006

  150,000,000

  June 30, 2007

               —  

  June 30, 2008

 

To highlight the sensitivity of the interest rate swap and fixed rate debt to changes in interest rates, the following summary shows the effects of a hypothetical instantaneous change of 100 basis points (BPS) in interest rates as of December 31, 2004 and 2003 (in thousands):

 

     As of December 31,

 
     2004

    2003

 
     Swap

    Fixed Rate Debt

    Swap

    Fixed Rate Debt

 

Notional amount

   $ 330,000       N/A     $ 330,000       N/A  

Book value

     N/A     $ (582,251 )     N/A     $ (366,038 )

Fair value (a)

     (16,550 )     (635,990 )     (27,868 )     (405,563 )

Fair value reflecting change in interest rates: (a)

                                

-100 BPS

     (25,489 )     (672,024 )     (40,364 )     (427,663 )

+100 BPS

     (7,917 )     (602,641 )     (15,906 )     (384,922 )

 

45


Table of Contents
Index to Financial Statements

(a) The change in fair value of the swap was due to the general increase in interest rates. The change in fair value of fixed rate debt was due to (i) the assumption of approximately $96.3 million in fixed rate debt as a result of our ElderTrust merger and acquisitions during 2004, the fair value of which approximated book value at December 31, 2004, (ii) the issuance of $125.0 million in Senior Notes (as defined below) in October 2004, the fair value of which was approximately $127.5 million at December 31, 2004, and (iii) general increase in interest rates.
N/A Not applicable.

 

We paid $13.3 million under the swap during the year ended December 31, 2004. Assuming that interest rates do not change, we estimate that we will pay approximately $7.7 million on the swap during the year ending December 31, 2005.

 

The carrying value of our variable rate debt approximates fair value. There is no cash flow impact from the fluctuation of interest rates because we currently hedge 100% of our variable rate debt. The fair value of our fixed rate debt is $636.0 million, which is based on open market trading activity provided by a third party for our Senior Notes and based on rates offered for similar arrangements for our mortgage indebtedness.

 

Credit Risk

 

As a result of our spin off of Kindred in 1998, we have a significant concentration of credit risk with Kindred under the Kindred Master Leases. For the years ended December 31, 2004 and 2003, Kindred accounted for $192.4 million, or 81.2% of our total revenues, and $182.0, or 93.5% of our total revenues, respectively. Accordingly, Kindred’s financial condition and ability to meet our rent obligations will largely determine our rental revenues and our ability to make distributions to our stockholders. In addition, any failure by Kindred to effectively conduct its operations could have a material adverse effect on its business reputation or on its ability to enlist and maintain patients in its facilities. See “Risk Factors—Risks Arising from Our Business—We are dependent on Kindred; Kindred’s inability or unwillingness to satisfy its obligations under its agreements with us could significantly harm us and our ability to service our indebtedness and other obligations and to make distributions to our stockholders as required to continue to qualify as a REIT” included in Part I, Item 1 of this Annual Report on Form 10-K and “Note 4—Concentration of Credit Risk” of the Notes to Consolidated Financial Statements. We monitor our credit risk under our lease agreements with our tenants by, among other things, (i) reviewing and analyzing information regarding the healthcare industry generally, publicly available information regarding tenants, and information provided by the tenants and borrowers under our lease and other agreements, and (ii) having periodic discussions with tenants, borrowers and their representatives.

 

Liquidity and Capital Resources

 

During 2004, our principal sources of liquidity were proceeds from equity and debt issuances, cash flow from operations, borrowings under revolving credit facilities and disposition of real estate assets, proceeds from stock option exercises, and proceeds from the Distribution Reinvestment and Stock Purchase Plan. We anticipate that cash flow from operations over the next twelve months will be adequate to fund our business operations, dividends to shareholders and debt amortization. Capital requirements for acquisitions may require funding from borrowings, assumption of debt from the seller, issuance of secured or unsecured long-term debt or other securities or equity offerings.

 

We intend to continue to fund future investments through cash flow from operations, borrowings under our revolving credit facility, disposition of assets and issuance of secured or unsecured long-term debt or other securities. As of December 31, 2004, we had cash and cash equivalents of $3.4 million, escrow deposits and restricted cash of $25.7 million (comprised of $5.0 million of reserves under the CMBS Loan (as defined below), $11.2 million that we paid into escrow as required under our mortgage agreements, a deposit of $9.5 million in connection with an IRS Section 1031 Exchange), and unused revolving credit availability of $251.3 million under our revolving credit facility.

 

46


Table of Contents
Index to Financial Statements

CMBS Transaction

 

On December 12, 2001, we raised $225.0 million in gross proceeds from the completion of a commercial mortgage backed securitization transaction (the “CMBS Loan”). As of December 31, 2004, the CMBS Loan bears interest at a weighted average of LIBOR plus 1.4935%, with principal and interest payable monthly. The CMBS Loan matures on December 9, 2006, at which time a principal balloon payment of approximately $206.4 million will be due, assuming all scheduled amortization payments are made and no prepayments are made. The CMBS Loan may be prepaid in whole or in part at any time and from time to time without penalty or premium.

 

The CMBS Loan is secured by liens on 39 skilled nursing facilities transferred by Ventas Realty to Ventas Finance I, LLC (“Ventas Finance”) and leased to Kindred under a Kindred Master Lease (the “Kindred CMBS Master Lease”). Except for certain customary exceptions, the CMBS Loan is non-recourse to Ventas Finance and us. See “Note 7—Borrowing Arrangements” of the Notes to Consolidated Financial Statements.

 

Revolving Credit Facility

 

We obtained a new $300.0 million revolving credit facility in September 2004 that replaced our previous revolving credit facility. The revolving credit facility bears interest at LIBOR plus a percentage ranging 1.05% to 1.75%, depending on our consolidated leverage ratio. As of December 31, 2004, borrowings under the revolving credit facility were bearing interest at LIBOR plus 1.25%. We also incur an annual facility fee of 25 basis points payable in quarterly installments. The borrowing rate on the revolving credit facility at December 31, 2004 was approximately 3.65%. Initial borrowings under the revolving credit facility were used to refinance all of the amounts outstanding under our previous revolving credit facility and pay off the $60.0 million term loan under our previous revolving credit facility (the “Tranche B Term Loan”). Our current revolving credit facility matures in September 2007, subject to a one-year extension.

 

The outstanding aggregate principal balance of the revolving credit facility may not exceed either (a) the borrowing base (as described below) or (b) $300.0 million. As of December 31, 2004, the outstanding principal balance under the revolving credit facility (excluding outstanding letters of credit of $0.5 million) was $39.0 million and there was no term loan. Subject to the terms of the revolving credit facility, we have the option to increase our borrowing capacity to an amount not to exceed $450.0 million.

 

As of December 31, 2004, the borrowing base under the revolving credit facility was $290.8 million. The borrowing base is the sum of (i) sixty-five percent (65%) of the aggregate appraised property value of the borrowing base properties, plus (ii) 100% of amounts on deposit in certain cash collateral or pledged accounts. The borrowing base properties are currently comprised of 44 owned or leased real properties, which are also mortgaged to secure the revolving credit facility. As of December 31, 2004, the borrowing base properties had a net book value of $113.5 million and were leased to Kindred pursuant to Master Lease No. 1.

 

The agreement relating to the revolving credit facility contains a number of restrictive covenants. See “Note 7—Borrowing Arrangements” of the Notes to Consolidated Financial Statements.

 

Senior Notes Offering

 

In October 2004, we completed the offering of 6  5 / 8 % Senior Notes due October 15, 2014 of our subsidiaries, Ventas Realty and Ventas Capital Corporation (“the Issuers”), in the aggregate principal amount of $125.0 million (the “2014 Senior Notes”). In April 2002, we completed the offering of 8  3 / 4 % Senior Notes due May 1, 2009 of the Issuers in the aggregate principal amount of $175.0 million (the “2009 Senior Notes”) and 9% Senior Notes due May 1, 2012 of the Issuers, in the aggregate principal amount of $225.0 million (the “2012 Senior Notes” and, together with the 2009 Senior Notes and the 2014 Senior Notes, the “Senior Notes”). On December 31, 2002, we purchased $0.8 million principal amount of 2009 Senior Notes and $33.2 million principal amount of 2012 Senior Notes in open market transactions. As of December 31, 2004, $125.0 million principal amount of 2014 Senior Notes, $174.2 million principal amount of 2009 Senior Notes and $191.8 million principal amount of 2012 Senior Notes were outstanding. We and certain of our subsidiaries have fully and unconditionally guaranteed the Senior Notes.

 

47


Table of Contents
Index to Financial Statements

Pursuant to the registration rights agreement entered into in connection with the 2014 Senior Notes offering, on January 28, 2005, we completed an offer to exchange the 2014 Senior Notes with a new series of notes that are registered under the Securities Act of 1933, as amended, and are otherwise substantially identical to the outstanding 2014 Senior Notes, except that certain transfer restrictions, registration rights and liquidated damages do not apply to the new notes. We did not receive any additional proceeds in connection with the exchange offer.

 

The Senior Notes are subject to a number of restrictive covenants. See “Note 7—Borrowing Arrangements” of the Notes to Consolidated Financial Statements.

 

Dividends

 

In order to continue to qualify as a REIT, we must make annual distributions to our stockholders of at least 90% of REIT taxable income (excluding net capital gain). We declared dividends greater than 100% of estimated taxable income for 2004 and intend to pay a dividend greater than 100% of taxable income for 2005.

 

We expect that REIT taxable income will be less than cash flow due to the allowance of depreciation and other non-cash deductions in computing REIT taxable income. Although we anticipate that we generally will have sufficient cash or liquid assets to enable us to satisfy the 90% distribution requirement, it is possible that from time to time we may not have sufficient cash or other liquid assets to meet the 90% distribution requirement or we may decide to retain cash or distribute such greater amount as may be necessary to avoid income and excise taxation. If we do not have sufficient cash or liquid assets to enable us to satisfy the 90% distribution requirement, or if we desire to retain cash, we may borrow funds, issue additional equity securities, pay taxable stock dividends, if possible, distribute other property or securities or engage in a transaction intended to enable us to meet the REIT distribution requirements.

 

Capital Expenditures and Property Acquisitions

 

Except with respect to our medical office buildings, capital expenditures to maintain and improve the leased properties generally will be incurred by our tenants. Accordingly, we do not believe that we will incur any major expenditures in connection with the leased properties. After the expiration of the leases, or in the event that the tenants are unable or unwilling to meet their obligations under the leases, we anticipate that any expenditures relating to the maintenance of leased properties for which we may become responsible will be funded by cash flows from operations or through additional borrowings. To the extent that unanticipated expenditures or significant borrowings are required, our liquidity may be affected adversely. Our ability to make expenditures and borrow funds is restricted by the terms of our revolving credit facility and the Senior Notes.

 

Shelf Registration Statement and Equity Offering

 

On June 19, 2002, we filed a universal shelf registration statement on Form S-3 with the Securities and Exchange Commission relating to $750.0 million of common stock, preferred stock, debt securities, depository shares and warrants. The registration statement became effective on July 8, 2002.

 

On March 15, 2004, we completed the sale of 2,000,000 shares of our common stock in an underwritten public offering under the shelf registration statement. We received $51.1 million in net proceeds from the sale, which we used to repay indebtedness under our revolving credit facility and for general corporate purposes, including the funding of acquisitions. As of December 31, 2004, $599.1 million of securities remained available for offering under the shelf registration statement.

 

During the fourth quarter ended December 31, 2002, we completed the sale of 9,000,000 shares of our common stock in a joint equity offering with Tenet Healthcare Corporation (“Tenet”). In the offering, Tenet sold all 8,301,067 shares of our common stock that it held. Our net proceeds from the sale were $93.6 million, which we used to repay outstanding indebtedness, including the indebtedness incurred by us to invest in transactions with THI.

 

48


Table of Contents
Index to Financial Statements

Other

 

In 2004, we assumed facility level mortgage debt in connection with acquisitions of certain facilities and the ElderTrust merger. Outstanding facility level mortgage debt was approximately $100.5 million as of December 31, 2004. See “Note 6—Mergers and Acquisitions” of the Notes to Consolidated Financial Statements.

 

In 2000, we recorded a $96.5 million charge related to the United States settlement. Under the United States settlement, we were required to pay $103.6 million to the federal government, of which $34.0 million was paid on April 20, 2001, the date of Kindred’s emergence from bankruptcy. The balance of $69.6 million bore interest at 6% per annum and was payable in equal quarterly installments over a five-year term commencing on June 30, 2001. The charge in the fourth quarter of 2000 was discounted for accounting purposes based on an imputed borrowing rate of 10.75%. We were required to pay $16.2 million in principal and interest in 2003 under the United States settlement. On June 30, 2003, we prepaid in full the principal amount owed on the United States settlement. There was no prepayment penalty or other charges payable on account of the early repayment.

 

We received proceeds on the exercises of stock options in the amounts of $17.7 million and $22.6 million for the years ended December 31, 2004 and 2003, respectively. Future proceeds on the exercises of stock options are primarily affected by the future performance of our stock price and the number of options outstanding. Options outstanding have decreased to 1.6 million as of December 31, 2004, from 2.6 million and 4.2 million as of December 31, 2003 and 2002, respectively.

 

We generated net proceeds from our Distribution Reinvestment and Stock Purchase Plan of $5.3 million during the fourth quarter of 2004 and $13.1 million for the year ended December 31 2004. Beginning in March 2005, we are offering a 1% discount on the purchase price of our stock to shareholders who reinvest their dividends and/or make optional cash purchases of common stock through the plan. During 2004 we offered a 2% discount. Each month or quarter, as applicable, we may lower or eliminate the discount without prior notice, thereby affecting the future proceeds that we receive from this plan.

 

We have outstanding loans to certain current and former executive officers in the aggregate principal amount of approximately $3.2 million as of December 31, 2004, down from $3.8 million at December 31, 2003. The loans are payable over ten years beginning, in each case, on the date such loan was made. See “Note 15—Related Party Transactions” of the Notes to Consolidated Financial Statements.

 

Cash Flows

 

Net cash provided by operating activities totaled $150.0 million and $137.4 million for the years ended December 31, 2004 and 2003, respectively. The increase in 2004 cash flows is primarily a result of increases due to rent escalators and additional rent net of interest expense relating to the properties acquired during 2004.

 

Net cash used in investing activities for the year ended December 31, 2004 was $298.7 million. We invested $323.7 million in real property which was financed through borrowings under the revolving credit facility and cash on hand and sold two facilities for proceeds of $21.1 million. Net cash provided by investing activities for the year ended December 31, 2003 was $159.7 million. We received $139.2 million in proceeds from the disposal of real estate properties and $20.2 million in proceeds from the sale of the Kindred common stock. Net cash used in investing activities for the year ended December 31, 2002 was $34.1 million. We made a net investment in transactions with THI of $68.9 million, received $28.6 million in proceeds from the disposal of real estate properties, and received $7.0 million in proceeds from the sale of the Kindred common stock.

 

Net cash provided by financing activities totaled $70.0 million for the year ended December 31, 2004. The proceeds included (i) $125.0 million from the issuance of the 2014 Senior Notes, (ii) $64.2 million from the issuance of common stock; (iii) $39.0 million from net borrowings on the revolving credit facility and (iv) $17.7 million from the issuance of common stock upon exercise of stock options. The uses included (i) an aggregate principal payment of $67.0 million on our Tranche B Term Loan, CMBS Loan and other mortgage loans, and (ii) $103.5 million of cash dividend payments.

 

49


Table of Contents
Index to Financial Statements

Net cash used in financing activities totaled $217.4 million for the year ended December 31, 2003. The uses included (i) an aggregate principal payment of $67.1 million on our revolving credit facility and the CMBS Loan, (ii) $37.4 million payment in 2003 for the settlement of the repurchase of the Senior Notes that occurred on December 31, 2002, (iii) $8.6 million in swap breakage fees, (iv) full repayment on the United States settlement of $46.6 million and (v) $80.2 million of cash dividend payments. The uses were offset by $22.6 million of proceeds from the issuance of common stock upon of exercise of stock options.

 

Net cash used in financing totaled $98.4 million for the year ended December 31, 2002. The uses include (i) a net of $106.7 million payment of principal on our revolving credit facility and the CMBS Loan, (ii) $15.1 million in financing fees, (iii) $12.8 million in swap breakage costs, (iv) $50.1 million of cash dividend payments, and (v) $10.8 million of principal payments on the United States settlement. The uses were offset by net proceeds of $97.2 million from the issuance of common stock including the net proceeds of $93.6 million from the issuance of nine million shares and $3.6 million from the exercise of stock options.

 

On December 31, 2002, we repurchased through open market purchases $0.8 million principal amount of 2009 Senior Notes and $33.2 million principal amount of 2012 Senior Notes. The total purchase price aggregated $37.4 million. As a result of these purchases, we reported a loss from the extinguishment of debt of $4.2 million in the fourth quarter ended December 31, 2002.

 

Contractual Obligations

 

The following table summarizes the effect that minimum debt (which includes principal and interest payments) and other material noncancelable commitments are expected to have on our cash flow in the future periods (in thousands).

 

     Total

   Less than 1
year


   1-3 years

    3-5 years

    More than 5
years


 

Long-term debt obligations (1)(2)

   $ 1,226,443    $ 64,014    $ 366,277 (3)   $ 293,750 (4)   $ 502,402 (5)

Obligations under interest rate swap(2)

     16,550      7,723      8,061       766       —    

Operating lease obligations

     1,364      379      771       214       —    
    

  

  


 


 


Total

   $ 1,244,357    $ 72,116    $ 375,109     $ 294,730     $ 502,402  
    

  

  


 


 



(1) Amounts represent contractual amounts due, including interest.
(2) Interest on variable rate debt and obligations under the interest rate swap were based on forward rates obtained as of December 31, 2004.
(3) Includes a $206.4 million balloon payment due December 2006 on the CMBS Loan.
(4) Includes $174.2 million outstanding principal amount of the 2009 Senior Notes.
(5) Includes $191.8 million outstanding principal amount of the 2012 Senior Notes, and $125.0 million of the 2014 Senior Notes.

 

In connection with the Kindred spin off, we assigned our former third-party lease obligations and third-party guarantee agreements to Kindred. As of December 31, 2004, we believe that the aggregate exposure under our third-party lease obligations was approximately $26.0 million and that we have no material exposure under the third-party guarantee agreements. Kindred has agreed to indemnify and hold us harmless from and against all claims against us arising out of the third-party leases, and we do not expect to incur any liability under those leases. However, we cannot assure you that Kindred will have sufficient assets, income and access to financing to enable it to satisfy, or that it will continue to honor its obligations under the indemnity agreement relating to the third-party leases. See “Note 11—Commitments and Contingencies” of the Notes to Consolidated Financial Statements.

 

ITEM 7A.     Quantitative and Qualitative Disclosures About Market Risk

 

The information set forth in Item 7 of this Annual Report on Form 10-K under “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Asset/Liability Management” is incorporated by reference into this Item 7A.

 

50


Table of Contents
Index to Financial Statements

ITEM 8.     Financial Statements and Supplementary Data

 

Ventas, Inc.

 

Index to Consolidated Financial Statements and Financial Statement Schedule

 

Management Report on Internal Control over Financial Reporting

  52

Report of Independent Registered Public Accounting Firm

  53

Report of Independent Registered Public Accounting Firm on Internal Control over Financial Reporting

  54

Consolidated Balance Sheets as of December 31, 2004 and 2003

  55

Consolidated Statements of Income for the years ended December 31, 2004, 2003 and 2002

  56

Consolidated Statements of Stockholders Equity (Deficit) for the years ended December 31, 2004, 2003 and 2002

  57

Consolidated Statements of Cash Flows for the years ended December 31, 2004, 2003 and 2002

  58

Notes to Consolidated Financial Statements

  59

Consolidated Financial Statement Schedule

   

Schedule III—Real Estate and Accumulated Depreciation

  106

 

51


Table of Contents
Index to Financial Statements

MANAGEMENT REPORT ON INTERNAL CONTROL OVER FINANCIAL REPORTING

 

Management of Ventas, Inc. (the “Company”) is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Rule 13a-15(f) under the Securities Exchange Act of 1934, as amended. The Company’s internal control system was designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation and fair presentation of financial statements for external reporting purposes in accordance with generally accepted accounting principles in the United States.

 

Management, under the supervision of the Company’s Chief Executive Officer, Chief Financial Officer and Chief Accounting Officer, assessed the effectiveness of the Company’s internal control over financial reporting based on the framework established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Based on this assessment, management has determined that the Company’s internal control over financial reporting as of December 31, 2004 was effective. All internal control systems, no matter how well designed, have inherent limitations. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. Therefore, the Company’s internal control over financial reporting can provide only reasonable assurance with respect to financial statement preparation and presentation and may not prevent or detect misstatements.

 

Management’s assessment of the effectiveness of the Company’s internal control over financial reporting as of December 31, 2004, has been audited by Ernst & Young LLP, an independent registered public accounting firm, as stated in their report included herein, which expresses an unqualified opinion on management’s assessment and on the effectiveness of the Company’s internal control over financial reporting as of December 31, 2004.

 

52


Table of Contents
Index to Financial Statements

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

Stockholders and Board of Directors

Ventas, Inc.

 

We have audited the accompanying consolidated balance sheets of Ventas, Inc. as of December 31, 2004 and 2003, and the related consolidated statements of income, stockholders’ equity (deficit) and cash flows for each of the three years in the period ended December 31, 2004. Our audits also included the financial statement schedule listed in the Index. These financial statements and schedule are the responsibility of our management. Our responsibility is to express an opinion on these financial statements and schedule based on our audits.

 

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

 

In our opinion, the financial statements referred to above present fairly, in all material respects, the consolidated financial position of Ventas, Inc. at December 31, 2004 and 2003, and the consolidated results of its operations and its cash flows for each of the three years in the period ended December 31, 2004, in conformity with accounting principles generally accepted in the United States. Also, in our opinion, the related financial statement schedule, when considered in relation to the basic financial statements taken as a whole, presents fairly in all material respects the information set forth therein.

 

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the effectiveness of Ventas, Inc.’s internal control over financial reporting as of December 31, 2004, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated February 22, 2005, expressed an unqualified opinion thereon.

 

As discussed in Notes 2 and 5 to the consolidated financial statements, the Company changed its method of accounting for gains and losses on extinguishment of debt in 2003 and changed its method of accounting for disposal of long-lived assets in 2002.

 

/s/ Ernst & Young LLP

 

Chicago, Illinois

February 22, 2005

 

53


Table of Contents
Index to Financial Statements

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

ON INTERNAL CONTROL OVER FINANCIAL REPORTING

 

Stockholders and Board of Directors

Ventas, Inc.

 

We have audited management’s assessment, included in the accompanying Management Report on Internal Control Over Financial Reporting, that Ventas, Inc. maintained effective internal control over financial reporting as of December 31, 2004, based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (the COSO criteria). Ventas, Inc.’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting. Our responsibility is to express an opinion on management’s assessment and an opinion on the effectiveness of the company’s internal control over financial reporting based on our audit.

 

We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, evaluating management’s assessment, testing and evaluating the design and operating effectiveness of internal control, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

 

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

In our opinion, management’s assessment that Ventas, Inc. maintained effective internal control over financial reporting as of December 31, 2004, is fairly stated, in all material respects, based on the COSO criteria. Also, in our opinion, Ventas, Inc. maintained, in all material respects, effective internal control over financial reporting as of December 31, 2004, based on the COSO criteria.

 

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheets as of December 31, 2004 and 2003, and the related consolidated statements of income, stockholders’ equity (deficit) and cash flows for each of the three years in the period ended December 31, 2004, and the financial statement schedule listed in the index of Ventas, Inc. and our report dated February 22, 2005, expressed an unqualified opinion thereon.

 

/s/ Ernst & Young LLP

 

Chicago, Illinois

February 22, 2005

 

54


Table of Contents
Index to Financial Statements

VENTAS, INC.

 

CONSOLIDATED BALANCE SHEETS

 

December 31, 2004 and 2003

(In thousands, except per share amounts)

 

     2004

    2003

 

Assets

                

Real estate investments:

                

Land

   $ 147,327     $ 104,300  

Building and improvements

     1,364,884       985,881  
    


 


       1,512,211       1,090,181  

Accumulated depreciation

     (454,110 )     (408,891 )
    


 


Net real estate property

     1,058,101       681,290  

Loan receivable, net

     13,031       16,455  
    


 


Net real estate investments

     1,071,132       697,745  

Cash and cash equivalents

     3,365       82,104  

Escrow deposits and restricted cash

     25,710       7,575  

Deferred financing costs, net

     13,550       13,465  

Notes receivable from employees

     3,216       3,772  

Other

     9,962       8,189  
    


 


Total assets

   $ 1,126,935     $ 812,850  
    


 


Liabilities and stockholders’ equity

                

Liabilities:

                

Senior Notes payable and other debt

   $ 843,178     $ 640,562  

Deferred revenue

     12,887       15,308  

Interest rate swap agreements

     16,550       27,868  

Accrued dividend

     27,498       21,614  

Accrued interest

     8,743       5,821  

Accounts payable and other accrued liabilities

     27,461       14,968  

Deferred income taxes

     30,394       30,394  
    


 


Total liabilities

     966,711       756,535  
    


 


Commitments and contingencies

                

Stockholders’ equity:

                

Preferred stock, 10,000 shares authorized, unissued

     —         —    

Common stock, $0.25 par value; authorized 180,000 shares; 85,131 and 82,608 shares issued at December 31, 2004 and 2003, respectively

     21,283       20,652  

Capital in excess of par value

     208,903       162,466  

Unearned compensation on restricted stock

     (633 )     (748 )

Accumulated other comprehensive loss

     (9,114 )     (18,294 )

Retained earnings (deficit)

     (45,297 )     (56,790 )
    


 


       175,142       107,286  

Treasury stock, 532 and 1,817 shares at December 31, 2004 and 2003, respectively

     (14,918 )     (50,971 )
    


 


Total stockholders’ equity

     160,224       56,315  
    


 


Total liabilities and stockholders’ equity

   $ 1,126,935     $ 812,850  
    


 


 

See accompanying notes.

 

55


Table of Contents
Index to Financial Statements

VENTAS, INC.

 

CONSOLIDATED STATEMENTS OF INCOME

 

For the Years Ended December 31, 2004, 2003 and 2002

(In thousands, except per share amounts)

 

     2004

   2003

    2002

 

Revenues:

                       

Rental income

   $ 232,911    $ 189,987     $ 174,822  

Interest income from loan receivable

     2,958      3,036       995  

Interest and other income

     987      1,696       1,178  
    

  


 


Total revenues

     236,856      194,719       176,995  

Expenses:

                       

Property-level operating expenses

     1,337      —         —    

General, administrative and professional fees

     16,917      15,158       12,913  

Reversal of contingent liability

     —        (20,164 )     —    

Amortization of restricted stock grants

     1,207      1,274       1,853  

Depreciation

     49,035      39,500       38,229  

Net loss on swap breakage

     —        5,168       5,407  

Interest

     66,817      61,660       72,384  

Loss on extinguishment of debt

     1,370      84       11,077  

Interest on United States Settlement

     —        4,943       5,461  
    

  


 


Total expenses

     136,683      107,623       147,324  
    

  


 


Operating income

     100,173      87,096       29,671  

Gain on sale of Kindred common stock

     —        9,039       5,014  
    

  


 


Income before provision (benefit) for income taxes, net gain on real estate disposals and discontinued operations

     100,173      96,135       34,685  

Provision (benefit) for income taxes

     —        —         (2,200 )
    

  


 


Income before net gain on real estate disposals and discontinued operations

     100,173      96,135       36,885  

Net gain on real estate disposals

     —        —         64  
    

  


 


Income before discontinued operations

     100,173      96,135       36,949  

Discontinued operations

     20,727      66,618       28,757  
    

  


 


Net income

   $ 120,900    $ 162,753     $ 65,706  
    

  


 


Earnings per common share:

                       

Basic:

                       

Income before discontinued operations

   $ 1.20    $ 1.21     $ 0.53  

Net income

   $ 1.45    $ 2.05     $ 0.95  

Diluted:

                       

Income before discontinued operations

   $ 1.19    $ 1.20     $ 0.53  

Net income

   $ 1.43    $ 2.03     $ 0.93  

Shares used in computing earnings per common share:

                       

Basic

     83,491      79,340       69,336  

Diluted

     84,352      80,094       70,290  

 

 

See accompanying notes.

 

56


Table of Contents
Index to Financial Statements

VENTAS, INC.

 

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT)

 

For the Years Ended December 31, 2004, 2003, and 2002

(In thousands, except per share amounts)

 

   

Common

Stock Par

Value


 

Capital in

Excess of

Par Value


   

Unearned

Compensation

On Restricted

Stock


   

Accumulated

Other

Comprehensive

Income (Loss)


   

Retained

Earnings

(Deficit)


   

Treasury

Stock


    Total

 

Balance at January 1, 2002

  $ 18,402   $ 122,468     $ (1,000 )   $ 36,174     $ (134,088 )   $ (133,030 )   $ (91,074 )

Comprehensive income:

                                                     

Net income

    —       —         —         —         65,706       —         65,706  

Unrealized loss on interest rate swaps

    —       —         —         (55,957 )     —         —         (55,957 )

Reclassification adjustment for realized loss on interest rate swaps included in net income during the year

    —       —         —         30,137       —         —         30,137  

Unrealized loss on Kindred common stock

    —       —         —         (31,456 )     —         —         (31,456 )

Reclassification adjustment for realized gain on Kindred common stock included in net income during the year

    —       —         —         (5,014 )     —         —         (5,014 )
                                                 


Comprehensive income

                                                  3,416  

Dividends to common stockholders—$0.95 per share

    —       —         —         —         (65,897 )     —         (65,897 )

Proceeds from issuance of shares for offering, net

    2,250     91,363       —         —         —         —         93,613  

Proceeds from issuance of shares for stock plans, net

    —       (18,627 )     —         —         —         22,344       3,717  

Grant of restricted stock, net of forfeitures

    —       (3,425 )     (1,646 )     —         —         5,816       745  

Amortization of restricted stock grants

    —       —         1,853       —         —         —         1,853  
   

 


 


 


 


 


 


Balance at December 31, 2002

    20,652     191,779       (793 )     (26,116 )     (134,279 )     (104,870 )     (53,627 )

Comprehensive income:

                                                     

Net income

    —       —         —         —         162,753       —         162,753  

Unrealized loss on interest rate swaps

    —       —         —         (8,226 )     —         —         (8,226 )

Reclassification adjustment for realized loss on interest rate swaps included in net income during the year

    —       —         —         21,577       —         —         21,577  

Unrealized gain on Kindred common stock

    —       —         —         3,510       —         —         3,510  

Reclassification adjustment for realized gain on Kindred common stock included in net income during the year

    —       —         —         (9,039 )     —         —         (9,039 )
                                                 


Comprehensive income

                                                  170,575  

Dividends to common stockholders—$1.07 per share

    —       —         —         —         (85,264 )     —         (85,264 )

Proceeds from issuance of shares for stock plans, net

    —       (26,636 )     —         —         —         49,420       22,784  

Grant of restricted stock, net of forfeitures

    —       (2,677 )     (1,229 )     —         —         4,479       573  

Amortization of restricted stock grants

    —       —         1,274       —         —         —         1,274  
   

 


 


 


 


 


 


Balance at December 31, 2003

    20,652     162,466       (748 )     (18,294 )     (56,790 )     (50,971 )     56,315  

Comprehensive income:

                                                     

Net income

    —       —         —         —         120,900       —         120,900  

Unrealized loss on interest rate swaps

    —       —         —         (1,965 )     —         —         (1,965 )

Reclassification adjustment for realized loss on interest rate swaps included in net income during the year

    —       —         —         11,145       —         —         11,145  
                                                 


Comprehensive income

                                                  130,080  

Dividends to common stockholders—$1.30 per share

    —       —         —         —         (109,407 )     —         (109,407 )

Proceeds from issuance of shares for offering, net

    631     63,575       —         —         —         —         64,206  

Proceeds from issuance of shares for stock plans, net

    —       (16,854 )     —         —         —         34,653       17,799  

Grant of restricted stock, net of forfeitures

    —       (284 )     (1,092 )     —         —         1,400       24  

Amortization of restricted stock grants

    —       —         1,207       —         —         —         1,207  
   

 


 


 


 


 


 


Balance at December 31, 2004

  $ 21,283   $ 208,903     $ (633 )   $ (9,114 )   $ (45,297 )   $ (14,918 )   $ 160,224  
   

 


 


 


 


 


 


 

See accompanying notes.

 

57


Table of Contents
Index to Financial Statements

VENTAS, INC.

 

CONSOLIDATED STATEMENTS OF CASH FLOWS

 

For the Years Ended December 31, 2004, 2003 and 2002

(In thousands)

 

    2004

    2003

    2002

 

Cash flows from operating activities:

                       

Net income

  $ 120,900     $ 162,753     $ 65,706  

Adjustments to reconcile net income to net cash provided by operating activities:

                       

Depreciation (including amounts in discontinued operations)

    49,238       41,943       42,108  

Amortization of deferred financing costs

    3,895       4,095       3,706  

Amortization of restricted stock grants

    1,207       1,274       1,853  

Reversal of contingent liability

          (20,164 )      

Straight-lining of rental income

    (2,462 )     (108 )     (188 )

Gain on sale of Kindred common stock

          (9,039 )     (5,014 )

Gain on sale of assets (including amounts in discontinued operations)

    (19,428 )     (51,781 )     (23,514 )

Loss on impairment of asset (included in discontinued operations)

          845        

Loss on extinguishment of debt

    1,370       84       11,077  

Amortization of deferred revenue

    (2,577 )     (3,707 )     (2,711 )

Net loss on swap breakage

          5,168       5,407  

Other

    (2,016 )     (212 )     2,023  

Changes in operating assets and liabilities:

                       

(Increase) decrease in escrow deposits and restricted cash

    (8,965 )     12,378       820  

Increase in other assets

    (102 )     (1,892 )     (1,338 )

Increase (decrease) in accrued interest

    2,922       (1,416 )     6,646  

Increase (decrease) in accounts payable and accrued and other liabilities

    5,976       (2,855 )     9,804  
   


 


 


Net cash provided by operating activities

    149,958       137,366       116,385  

Cash flows from investing activities:

                       

Purchase of furniture and equipment

    (202 )     (258 )     (308 )

Net investment in real estate property

    (323,729 )           (53,000 )

Investment in loan receivable

                (64,931 )

Proceeds from sale of loan receivable, net

                49,033  

Sale of real estate properties

    21,100       139,164       28,620  

Proceeds from sale of Kindred common stock

          20,223       6,950  

Proceeds from loan receivable

    3,580       205        

Repayment (issuance) of notes receivable from employees

    556       367       (504 )
   


 


 


Net cash (used in) provided by investing activities

    (298,695 )     159,701       (34,140 )

Cash flows from financing activities:

                       

Net change in borrowings under revolving credit facility

    39,000       (59,900 )     (101,301 )

Proceeds from debt

    125,000             620,300  

Purchase of Senior Notes

          (37,366 )      

Repayment of debt

    (67,011 )     (7,247 )     (18,590 )

Repayment of debt through refinancing

                (607,106 )

Payment of swap breakage fee

          (8,575 )     (12,837 )

Payment of deferred financing costs

    (5,350 )     (40 )     (15,127 )

Payment on the United States Settlement

          (46,647 )     (10,755 )

Issuance of common stock

    64,206             93,560  

Proceeds from stock option exercises

    17,676       22,604       3,595  

Cash distribution to stockholders

    (103,523 )     (80,247 )     (50,125 )
   


 


 


Net cash provided by (used in) financing activities

    69,998       (217,418 )     (98,386 )
   


 


 


Net (decrease) increase in cash and cash equivalents

    (78,739 )     79,649       (16,141 )

Cash and cash equivalents at beginning of year

    82,104       2,455       18,596  
   


 


 


Cash and cash equivalents at end of year

  $ 3,365     $ 82,104     $ 2,455  
   


 


 


Supplemental disclosure of cash flow information:

                       

Interest paid including swap payments and receipts

  $ 62,530     $ 70,342     $ 60,790  

Supplemental schedule of non-cash activities:

                       

Dividend distribution of Kindred common stock

  $     $     $ 17,086  

Assets and liabilities assumed from acquisition:

                       

Real estate investments

  $ 103,603     $     $  

Escrow deposits and restricted cash

  $ 9,170     $     $  

Other assets acquired

  $ 206     $     $  

Debt

  $ 105,627     $     $  

Other liabilities

  $ 7,352     $     $  

 

See accompanying notes.

 

58


Table of Contents
Index to Financial Statements

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Note 1—Description of Business

 

Ventas, Inc. (together with its subsidiaries, except where the context otherwise requires, “we,” “us” or “our”) is a healthcare real estate investment trust (“REIT”) with a geographically diverse portfolio of healthcare and senior housing facilities. As of December 31, 2004, this portfolio consisted of 201 skilled nursing facilities, 40 hospitals, 30 senior housing facilities and 16 other facilities in 39 states. Except with respect to our medical office buildings, we lease these facilities to healthcare operating companies under “triple-net” or “absolute net” leases. Kindred Healthcare, Inc. and its subsidiaries (collectively, “Kindred”) leased 225 of our facilities as of December 31, 2004. We also have real estate loan investments relating to 25 healthcare and senior housing facilities as of December 31, 2004.

 

We conduct substantially all of our business through a wholly owned operating partnership, Ventas Realty, Limited Partnership (“Ventas Realty”), a wholly owned limited liability company, Ventas Finance I, LLC (“Ventas Finance”), and an operating partnership, ElderTrust Operating Partnership (“ETOP”), in which we own 99.6% of the partnership units.

 

Note 2—Summary of Significant Accounting Policies

 

Impact of Recently Issued Accounting Standards

 

In December 2004, the Financial Accounting Standards Board (the “FASB”) issued Statement of Financial Accounting Standards (“SFAS”) No. 123(R), “Share-Based Payment” (“SFAS No. 123(R)”), which is a revision to SFAS No. 123, “Accounting for Stock-Based Compensation” (“SFAS No. 123”). SFAS No. 123(R) supersedes Accounting Principles Board Opinion No. 25, “Accounting for Stock Issued to Employees” (“APB Opinion No. 25”). Generally, the approach in SFAS No. 123(R) is similar to the approach described in SFAS No. 123, except that SFAS No. 123(R) requires all share-based payments to employees, including grants of employee stock options, be recognized in the income statement based on their fair values. Pro forma disclosure is no longer an alternative under SFAS No. 123(R).

 

As required under SFAS No. 123(R), we expect to adopt the provisions of this accounting standard on July 1, 2005. We expect to apply the modified prospective method of adoption in which compensation cost is recognized beginning on the date we adopt the accounting standard for all share-based payments granted after the adoption date and for all awards granted to employees prior to the adoption date that remain unvested on the adoption date. As permitted by SFAS No. 123(R), we currently account for share-based payments to employees using the intrinsic value method under APB Opinion No. 25 and, as such, generally recognize no compensation cost for employee stock options. The adoption of SFAS No. 123(R) is expected to result in an immaterial increase in expense during the second half of 2005 based on unvested options outstanding as of December 31, 2004 and current compensation plans. While the effect of adoption depends on the level of share-based payments granted in the future and unvested grants on the date we adopt SFAS No. 123(R), the effect of this accounting standard on our prior operating results would approximate the effect of SFAS No. 123 as described in the disclosure of pro forma net income and earnings per share. See “Note 9—Stockholders’ Equity and Stock Options”.

 

In April 2002, FASB issued SFAS No. 145, “Rescission of FASB Statements No. 4, 44, and 64, Amendment of FASB Statement No. 13, and Technical Correction” (“SFAS No. 145”). SFAS No. 4, “Reporting Gains and Losses from Extinguishment of Debt” (“SFAS No. 4”), required that gains and losses from the extinguishment of debt that were included in the determination of net income be aggregated and, if material, classified as an extraordinary item. The provisions of SFAS No. 145 that related to the rescission of SFAS No. 4 required us to reclassify certain prior period items that no longer meet the extraordinary classification into continuing operations. Additionally, future gains and losses related to debt extinguishment may be required to be classified as income from continuing operations. The provisions of SFAS No. 145 related to the rescission of

 

59


Table of Contents
Index to Financial Statements

VENTAS, INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

SFAS No. 4 became effective in fiscal years beginning after May 15, 2002. As required, on January 1, 2003 we adopted SFAS No. 145. In accordance with SFAS No. 145, our prior year financial statements have been reclassified to include gains and losses from extinguishment of debt in continuing operations. This reclassification has no effect on our net income.

 

Basis of Presentation

 

The consolidated financial statements include the accounts of Ventas, Inc. and all of its direct and indirect wholly owned subsidiaries and ETOP. All significant intercompany accounts and transactions have been eliminated in consolidation.

 

Accounting Estimates

 

The preparation of financial statements in accordance with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of rental revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

Reclassifications

 

Certain prior year amounts have been reclassified to conform to the current year presentation.

 

Segment Reporting

 

We have one primary reportable segment, which consists of investment in real estate. Our primary business is financing, owning and leasing healthcare-related and senior housing facilities and leasing or subleasing such facilities to third parties, primarily Kindred. See “Note 4—Concentration of Credit Risk.” Substantially all of our leases are triple-net leases, which require the tenants to pay all property-related expenses. With the exception of our medical office buildings, we do not operate our facilities nor do we allocate capital to maintain the properties. Substantially all depreciation and interest expenses, except for interest expense relating to the United States Settlement (as defined in “Note 11—Commitments and Contingencies—Settlement of United States Claims”), reflected in the Consolidated Statements of Income relate to the ownership of our investment in real estate.

 

Discontinued Operations

 

The results of operations and gain/(loss) on real estate properties sold or held for sale are reflected in the Consolidated Statements of Income as “discontinued operations” for all periods presented. Interest expense allocated to discontinued operations has been estimated based on a proportional allocation of rental income among all of our facilities.

 

Long-Lived Assets

 

Investments in real estate properties are recorded at cost. We account for acquisitions using the purchase method. The cost of the properties acquired is allocated among tangible land, buildings and equipment and recognized intangibles based upon estimated fair values in accordance with the provisions of SFAS No. 141, “Business Combinations.” We estimate fair values of the components of assets acquired as of the acquisition date or engage a third party appraiser as necessary. Recognized intangibles, if any, include the value of acquired lease contracts and related customer relationships.

 

60


Table of Contents
Index to Financial Statements

VENTAS, INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

Our method for determining fair value varies with the categorization of the asset acquired. We estimate the fair value of our buildings on an as-if-vacant basis, and amortize the building value over the estimated remaining life of the building. We determine the allocated value of other fixed assets based upon the replacement cost and amortize such value over their estimated remaining useful lives. We determine the value of land either based on real estate tax assessed values in relation to the total value of the asset, internal analyses of recently acquired and existing comparable properties within our portfolio or third party appraisals. The fair value of in-place leases, if any, reflects (i) above and below market leases, if any, determined by discounting the difference between the estimated current market rent and the in-place rentals, the resulting intangible asset of which is amortized to rental revenue over the remaining life of the associated lease plus any fixed rate renewal periods, if applicable, (ii) the estimated value of the cost to obtain tenants, including tenant allowances, tenant improvements and leasing commissions, which is amortized over the remaining life of the associated lease, and (iii) an estimated value of the absorption period to reflect the value of the rents and recovery costs foregone during a reasonable lease-up period, as if the acquired space was vacant, which is amortized over the remaining life of the associated lease. We also estimate the value of tenant or other customer relationships acquired by considering the nature and extent of existing business relationships with the tenant, growth prospects for developing new business with such tenant, such tenant’s credit quality, expectations of lease renewals with such tenant, and the potential for significant, additional future leasing arrangements with such tenant. We amortize such value, if any, over the expected term of the associated arrangements or leases, which would include the remaining lives of the related leases and any expected renewal periods.

 

Depreciation for buildings is recorded on the straight-line basis, using estimated useful lives ranging from 20 to 50 years.

 

Impairment of Long-Lived Assets

 

We periodically evaluate our long-lived assets, primarily consisting of our investments in real estate, for impairment indicators. If indicators of impairment are present, we evaluate the carrying value of the related real estate investments in relation to the future undiscounted cash flows of the underlying operations. We adjust the net book value of leased properties and other long-lived assets to fair value, if the sum of the expected future cash flow or sales proceeds is less than book value. An impairment loss is recognized at the time we make any such adjustment. Future events could occur which would cause us to conclude that impairment indicators exist and an impairment loss is warranted.

 

During the year ended December 31, 2003, we recorded a $0.8 million impairment on one non-operating skilled nursing facility. During the years ended December 31, 2004 and 2002, we did not recognize an impairment loss.

 

Loan Receivable

 

The loan receivable is stated at the unpaid principal balance net of deferred origination fees. Net deferred origination fees are comprised of loan fees collected from the borrower net of certain direct costs. Net deferred origination fees are amortized over the contractual life of the loan using the level yield method. Interest income on the loans receivable is recorded as earned. We evaluate the collectibility of the loan receivable based on, among other things (i) corporate and facility level financial and operational reports, (ii) compliance with the financial covenants set forth in the applicable loan documents and (iii) the financial stability of the applicable borrower and any guarantor.

 

Cash Equivalents

 

Cash equivalents consist of highly liquid investments with a maturity date of three months or less when purchased. These investments are stated at cost which approximates fair value.

 

61


Table of Contents
Index to Financial Statements

VENTAS, INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

Escrow Deposits and Restricted Cash

 

Escrow deposits primarily consist of amounts held by lenders to provide for future real estate tax and insurance expenditures and tenant improvements, earnest money deposits on acquisitions and net proceeds from property sales that were executed as a tax-deferred disposition. Restricted cash represents amounts committed for various utility deposits and security deposits paid to us by third parties.

 

Deferred Financing Costs

 

Deferred financing costs are amortized as a component of interest expense over the terms of the related borrowings using a method that approximates a level yield, and are net of accumulated amortization of approximately $7.3 million and $7.4 million at December 31, 2004 and 2003, respectively.

 

Derivative Instruments

 

As discussed in “Note 7—Borrowing Arrangements,” we use derivative instruments to protect against the risk of interest rate movements on future cash flows under our variable rate debt agreements. Derivative instruments are reported at fair value on the Consolidated Balance Sheets. Changes in the fair value of derivatives deemed to be eligible for hedge accounting are reported in accumulated other comprehensive income exclusive of ineffectiveness amounts which are reported in interest expense. As of December 31, 2004, a $9.1 million net unrealized loss on the derivatives is included in accumulated other comprehensive income. Changes in fair value of derivative instruments that are not eligible for hedge accounting are reported in the Consolidated Statements of Income. See “Note 8—Fair Values of Financial Instruments.” Fair values of derivative instruments are verified with a third party consultant.

 

Fair Values of Financial Instruments

 

The following methods and assumptions were used in estimating fair value disclosures for financial instruments.

 

    Cash and cash equivalents: The carrying amount of cash and cash equivalents reported in the Consolidated Balance Sheets approximates fair value because of the short maturity of these instruments.

 

    Real estate loan receivable: The fair value of loans receivable approximates net carrying value, based on rates offered for similar arrangements.

 

    Notes receivable from employees: The fair values of the notes receivable from employees are estimated using a discounted cash flow analysis, using interest rates being offered for similar loans to borrowers with similar credit ratings.

 

    Interest rate swap agreement: The fair value of the interest rate swap agreement is based on rates being offered for similar arrangements which consider forward yield curves and discount rates.

 

    Revolving credit facilities and CMBS Loan: The fair values of borrowings under variable rate agreements approximate their carrying value.

 

    Senior Notes payable: The fair values of borrowings under fixed rate agreements are estimated based on open market trading activity provided by a third party.

 

    Other mortgages: The fair value of other mortgage loans approximates net carrying value, based on rates offered for similar arrangements.

 

62


Table of Contents
Index to Financial Statements

VENTAS, INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

Comprehensive Income

 

SFAS No. 130, “Reporting Comprehensive Income,” establishes guidelines for the reporting and display of comprehensive income and its components in financial statements. Comprehensive income includes net income and all other non-owner changes in stockholders’ equity during a period including unrealized gains and losses on equity securities classified as available-for-sale and unrealized fair value adjustments on certain derivative instruments.

 

Revenue Recognition

 

Certain of our leases, excluding the Kindred Master Leases (as defined below), provide for periodic and determinable increases in base rent. Base rental revenues under these leases are recognized on a straight-line basis over the terms of the applicable lease. Certain of our other leases, including the Kindred Master Leases, provide for an annual increase in rental payments only if certain revenue parameters or other contingencies are met. We recognize the increased rental revenue under these leases only if the revenue parameters or other contingencies are met rather than on a straight-line basis over the term of the applicable lease. We recognize income from rent, lease termination fees and other income once all of the following criteria are met in accordance with SEC Staff Accounting Bulletin 104: (i) the agreement has been fully executed and delivered; (ii) services have been rendered; (iii) the amount is fixed or determinable; and (iv) the collectibility is reasonably assured.

 

Note 3—Revenues from Properties

 

Approximately 81.2% of our total revenues for the year ended December 31, 2004 was derived from our master lease agreements with Kindred (the “Kindred Master Leases”). Each Kindred Master Lease is a “triple-net lease” pursuant to which Kindred is required to pay all insurance, taxes, utilities, maintenance and repairs related to the properties. There are several renewal bundles of properties under each Kindred Master Lease, with each bundle containing a varying number of properties. All properties within a bundle have primary terms ranging from 10 to 15 years from May 1, 1998, subject to certain exceptions, and are subject to three five-year renewal terms.

 

Kindred is subject to the reporting requirements of the Securities and Exchange Commission (the “Commission”) and is required to file with the Commission annual reports containing audited financial information and quarterly reports containing unaudited financial information. The information related to Kindred provided in this Annual Report on Form 10-K is derived from filings made with the Commission or other publicly available information, or has been provided to us by Kindred. We have not verified this information either through an independent investigation or by reviewing Kindred’s public filings. We have no reason to believe that such information is inaccurate in any material respect, but we cannot assure you that all of this information is accurate. Kindred’s filings with the Commission can be found at the Commission’s website at www.sec.gov. We are providing this data for informational purposes only, and you are encouraged to obtain Kindred’s publicly available filings from the Commission.

 

Under each Kindred Master Lease, the aggregate annual rent is referred to as Base Rent (as defined in each Kindred Master Lease). Base Rent escalates on May 1 of each year at an annual rate of 3.5% over the prior period Base Rent if certain Kindred revenue parameters are met. Assuming such Kindred revenue parameters are met, annual Base Rent under the Kindred Master Leases will be $198.9 million from May 1, 2005 to April 30, 2006.

 

On July 1, 2003, we amended the Kindred Master Leases to increase rent on certain facilities leased to Kindred by $8.6 million per year on an annualized basis (May 1, 2003-April 30, 2004), for approximately seven years. This amount will escalate 3.5% annually in accordance with the Kindred Master Leases.

 

63


Table of Contents
Index to Financial Statements

VENTAS, INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

The future contracted minimum rentals, excluding rent escalations and excluding the amortization of the value of the Kindred common stock and the $4.5 million in cash received on April 20, 2001, the date on which Kindred emerged from bankruptcy, but with straight-line rents where applicable, for all our leases are as follows:

 

     Kindred

   Other

   Total

     (in thousands)

2005

   $ 192,187    $ 50,155    $ 242,342

2006

     192,187      50,254      242,441

2007

     192,187      50,240      242,427

2008

     157,144      49,473      206,617

2009

     139,622      48,708      188,330

Thereafter

     168,714      323,525      492,239
    

  

  

Total

   $ 1,042,041    $ 572,355    $ 1,614,396
    

  

  

 

We have a one-time right under each Kindred Master Lease (the “Reset Right”), exercisable by notice given on or after January 20, 2006 and on or before July 19, 2007, to increase the rent to a then fair market rental rate, commencing as early as July 19, 2006, for a total fee of $4.6 million payable on a pro-rata basis at the time of exercise under the applicable Kindred Master Lease. The Reset Right generally applies on a lease-by-lease basis, except that the Reset Rights under Master Lease No. 1, Master Lease No. 1A and the Kindred CMBS Master Lease (defined in “Note 7—Borrowing Arrangements—CMBS Transaction”) can only be exercised together. If the Reset Right is exercised for any Kindred Master Lease, the annual escalations currently applicable to that lease may be altered or reduced, depending on market conditions at the time. We believe that, based on information currently available to us and current market conditions, if we were entitled to and did exercise the Reset Right, the rent under the Kindred Master Leases would increase, perhaps materially. However, the value of the Reset Right is dependent on a variety of factors and is highly speculative and there can be no assurances regarding the value of the Reset Right.

 

Note 4—Concentration of Credit Risk

 

As of December 31, 2004, approximately 67.3% of our properties, based on their original cost, were operated by Kindred and approximately 55.1% of our properties, based on their original cost, were skilled nursing facilities. Our remaining properties consist of hospitals, senior housing facilities and other facilities. Our facilities are located in 39 states, with facilities in one state accounting for more than 10% of total revenues during the years ended December 31, 2004, 2003 and 2002.

 

Because we lease a substantial portion of our properties to Kindred and Kindred is the primary source of our total revenues, Kindred’s financial condition and ability and willingness to satisfy its obligations under the Kindred Master Leases and certain other agreements with us will significantly impact our revenues and our ability to service our indebtedness and to make distributions to our stockholders. On September 13, 1999, Kindred filed for protection under the federal bankruptcy laws with the United States Bankruptcy Court for the District of Delaware, and Kindred emerged from bankruptcy on April 20, 2001. Despite Kindred’s emergence from bankruptcy, we cannot assure you that Kindred will have sufficient assets, income and access to financing to enable it to satisfy its obligations under the Kindred Master Leases or that Kindred will perform its obligations under the Kindred Master Leases. The inability or unwillingness of Kindred to satisfy its obligations under the Kindred Master Leases would have a material adverse effect on our business, financial condition, results of operation and liquidity, on our ability to service our indebtedness and on our ability to make distributions to our stockholders as required to maintain our status as a REIT.

 

64


Table of Contents
Index to Financial Statements

VENTAS, INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

Note 5—Dispositions

 

In 2004, we completed the sale of two facilities for $21.1 million in net cash proceeds and recognized a net gain on the sale of $19.4 million. In addition, the tenant paid us lease termination fees approximating $0.5 million. In 2003, we completed the sale of 27 facilities for $139.2 million in net cash proceeds and recognized a net gain on the sale of $51.8 million. In addition, the tenants paid us lease termination fees approximating $10.1 million. In 2002, we completed the sale of two facilities for $28.6 million in net cash proceeds and recognized a net gain on the sale of $23.5 million. The net gains and lease termination fees are included in discontinued operations for the respective years in which the dispositions occurred.

 

As of December 31, 2003, 2002 and 2001, the net book value of the facilities sold and held for sale during 2004, 2003 and 2002 was $3.2 million, $91.7 million and $5.3 million, respectively.

 

Set forth below is a summary of the results of operations of the sold and held for sale facilities during the years ended December 31, 2004, 2003 and 2002:

 

     For the Years Ended December 31,

     2004

   2003

   2002

     (in thousands)

Revenues:

                    

Rental income

   $ 1,392    $ 11,510    $ 15,410

Interest and other income

     500      10,116      —  

Expenses:

                    

Interest

     390      3,501      6,224

Depreciation

     203      2,443      3,879

Loss on impairment of asset held for sale

     —        845      —  
    

  

  

Income before gain on sale of real estate

     1,299      14,837      5,307

Gain on sale of real estate

     19,428      51,781      23,450
    

  

  

Discontinued operations

   $ 20,727    $ 66,618    $ 28,757
    

  

  

 

Note 6—Mergers and Acquisitions

 

During the year ended December 31, 2004, we completed the acquisitions described below. The primary reason for these acquisitions was to invest in healthcare and senior housing properties with an expected yield on investment, as well as to diversify our properties and revenue base and reduce our dependence on Kindred for rental revenue.

 

ElderTrust Merger

 

On February 5, 2004, we acquired all of the outstanding common shares of ElderTrust, in an all cash transaction valued at $184.0 million. At the close of the ElderTrust transaction, ElderTrust had approximately $33.5 million in unrestricted and restricted cash. After transaction costs, the net investment of the ElderTrust transaction was approximately $160.0 million. The ElderTrust transaction added 18 facilities to our portfolio. The ElderTrust properties are leased to various operators under leases having remaining terms primarily ranging from four to 11 years and initially providing for aggregate, annual cash base rent of approximately $16.4 million, subject to escalation as provided in the leases. Concurrent with the consummation of the ElderTrust transaction, we also purchased all of the limited partnership units in ETOP, then held by third parties at $12.50 per unit, other than 31,455 Class C Units in ETOP (which remain outstanding). ETOP owns directly or indirectly all of the ElderTrust properties. Our ownership of the ElderTrust properties is subject to approximately $77.7 million of property-level debt as of December 31, 2004.

 

65


Table of Contents
Index to Financial Statements

VENTAS, INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

Brookdale Transactions

 

During the period from January 1, 2004 through May 12, 2004, we acquired 15 independent living or assisted living facilities for an aggregate purchase price of $157.4 million. These facilities are leased by us to affiliates of Brookdale Living Communities, Inc. (“Brookdale”) pursuant to a master lease containing 10 properties and five separate single facility leases, all of which are triple-net leases guaranteed by Brookdale having an initial term of 15 years and initially providing for aggregate, annual cash base rent of approximately $14.5 million, subject to annual escalation of the greater of (i) 2% or (ii) 75% of the annual increase in the consumer price index.

 

Other 2004 Acquisitions

 

During 2004, we acquired four senior housing facilities and two skilled nursing facilities, for an aggregate purchase price of $93.3 million. The facilities are leased under triple-net leases, having initial terms of 10 to 15 years and providing aggregate, annual cash base rent of approximately $8.9 million, subject to escalation as provided in the leases. We also acquired five medical office buildings, for an aggregate purchase price of $15.9 million. These buildings are leased to various tenants under leases having remaining terms ranging from four to six years and initially providing for aggregate, annual cash base rent of approximately $1.9 million, subject to escalation as provided in the leases. We have engaged managers to manage the operations at the medical office buildings.

 

Estimated Fair Value

 

The 2004 acquisitions were accounted for under the purchase method. The following table summarizes the preliminary estimated fair values of the assets acquired and liabilities assumed at the date of acquisition. Such estimates are subject to refinement as additional valuation information is received. We are in the process of computing fair values; thus, the allocation of the purchase price is subject to refinement.

 

    

ElderTrust

Merger


   

Brookdale

Transactions


  

Other 2004

Acquisitions


   Total

 
     (in millions)  

Land

   $ 17     $ 14    $ 12    $ 43  

Buildings and improvements

     144       144      96      384  

Cash and cash equivalents

     28       —        —        28  

Other assets

     5       2      3      10  
    


 

  

  


Total assets acquired

     194       160      111      465  
    


 

  

  


Notes payable and other debt

     83       20      3      106  

Other liabilities

     2       3      2      7  
    


 

  

  


Total liabilities acquired

     85       23      5      113  
    


 

  

  


Net assets acquired

     109       137      106      352  

Less cash acquired

     (28 )     —        —        (28 )
    


 

  

  


Net cash paid

   $ 81     $ 137    $ 106    $ 324  
    


 

  

  


 

The buildings are being depreciated over their estimated useful lives, which were determined to be 30 years for those acquired in the ElderTrust merger and 35 years for all other 2004 acquisitions.

 

66


Table of Contents
Index to Financial Statements

VENTAS, INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

Unaudited Pro Forma

 

The following table illustrates the effect on net income and earnings per share as if we had consummated our 2004 acquisitions and merger and the 2004 equity offering as of the beginning of each of the three years ended December 31, 2004:

 

     For the Years Ended December 31,

     2004

   2003

   2002

     (in thousands, except per share amounts)

Revenues

   $ 249,372    $ 239,380    $ 221,656

Expenses

     143,922      135,946      175,647

Net income from continuing operations

     105,450      112,473      53,287

Net income

     126,177      179,091      82,044

Earnings per common share:

                    

Basic:

                    

Net income from continuing operations

   $ 1.26    $ 1.38    $ 0.75

Net income

   $ 1.51    $ 2.20    $ 1.15

Diluted:

                    

Net income from continuing operations

   $ 1.25    $ 1.37    $ 0.74

Net income

   $ 1.49    $ 2.18    $ 1.13

Shares used in computing earnings per common share:

                    

Basic

     83,824      81,340      71,336

Diluted

     84,685      82,094      72,290

 

Transactions with Trans Healthcare, Inc.

 

On November 4, 2002, we, through Ventas Realty completed a $120.0 million transaction with Trans Healthcare, Inc. (“THI”), a privately owned long-term care and hospital company. The transaction was structured as a $53.0 million sale-leaseback transaction and a $67.0 million loan, comprised of a first mortgage loan and a mezzanine loan. Following a sale of the $50 million THI first mortgage loan in December 2002, our investment in THI was $70.0 million.

 

As part of the THI sale leaseback, Ventas Realty purchased five properties and is leasing them back to THI under a triple-net master lease. The properties subject to the sale leaseback are four skilled nursing facilities and one continuing care retirement community. The THI master lease, which has an initial term of 10 years, provides for initial annual base rent of $5.9 million. The THI master lease provides that if THI meets specified revenue parameters, annual base rent will escalate each year by the greater of (i) 3% or (ii) 50% of the consumer price index.

 

THI remains current on all of its payment obligations to us, although we have entered into several forbearance agreements with THI regarding certain non-financial terms of its agreements with us. As of February 15, 2005, the balance of the mezzanine loan was $12.4 million. The THI mezzanine loan bears interest, inclusive of upfront fees, at 18% per annum and is secured by equity pledges in entities that own and operate the 17 healthcare facilities that also collateralize the THI first mortgage loan, plus liens on four other healthcare properties, and interests in three additional properties and a physical therapy business.

 

67


Table of Contents
Index to Financial Statements

VENTAS, INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

Note 7—Borrowing Arrangements

 

The following is a summary of our long-term debt and certain interest rate and maturity information as of December 31, 2004 and 2003:

 

     As of December 31,

     2004

   2003

     (in thousands)

Revolving credit facility

   $ 39,000    $ —  

Tranche B Term Loan

     —        59,100

8.75% Senior Notes due 2009

     174,217      174,217

9.00% Senior Notes due 2012

     191,821      191,821

6.625% Senior Notes due 2014

     125,000      —  

CMBS Loan

     212,612      215,424

Other mortgage loans

     100,528      —  
    

  

     $ 843,178    $ 640,562
    

  

 

CMBS Loan

 

On December 12, 2001, we raised $225.0 million in gross proceeds from the completion of a commercial mortgage backed securitization transaction (the “CMBS Transaction”). Under a Loan and Security Agreement dated as of December 12, 2001 (the “CMBS Loan Agreement”), Ventas Finance obtained a loan in the principal amount of $225.0 million (the “CMBS Loan”) from Merrill Lynch Mortgage Lending, Inc., as lender (the “CMBS Lender”). The CMBS Loan is comprised of six components (i) a component in the original principal amount of $125,230,000 which bears interest at LIBOR plus 0.8665%; (ii) a component in the original principal amount of $17,970,000 which bears interest at LIBOR plus 1.1665%; (iii) a component in the original principal amount of $8,860,000 which bears interest at LIBOR plus 1.5165%; (iv) a component in the original principal amount of $26,830,000 which bears interest at LIBOR plus 1.9665%; (v) a component in the original principal amount of $26,830,000 which bears interest at LIBOR plus 2.6665%; and (vi) a component in the original principal amount of $19,280,000 which bears interest at LIBOR plus 3.1665%. Principal of and interest on the CMBS Loan is payable monthly. Principal payments on the CMBS Loan were calculated based upon a 25-year amortization schedule using an assumed interest rate of 9.46% per annum. The CMBS Loan matures on December 9, 2006, at which time a principal balloon payment of approximately $206.4 million will be due, assuming all scheduled amortization payments are made and no prepayments are made on the CMBS Loan. The CMBS Loan may be prepaid in whole or in part at any time and from time to time without penalty or premium.

 

The CMBS Loan is secured by liens on 39 skilled nursing facilities transferred by Ventas Realty to Ventas Finance and leased to Kindred under a Kindred Master Lease (the “Kindred CMBS Master Lease”). Except for certain customary exceptions, the CMBS Loan is non-recourse to Ventas Finance and us.

 

Ventas Finance is required to maintain or cause to be maintained various reserve accounts under the CMBS Loan Agreement including a debt service reserve, an imposition and insurance reserve and a replacement reserve account. The impositions and insurance reserve and the replacement reserve under the CMBS Loan Agreement are being funded and/or maintained by Kindred as required under and in accordance with the terms of the Kindred CMBS Master Lease. If Kindred should be unwilling or unable to fund these reserves under the CMBS Loan Agreement, Ventas Finance will be required to fund and/or maintain such reserves. Restricted cash at December 31, 2004 included $5.0 million related to the debt service reserve account for the CMBS Loan.

 

68


Table of Contents
Index to Financial Statements

VENTAS, INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

Monthly rental amounts under the Kindred CMBS Master Lease are deposited directly by Kindred into a central account for the benefit of the CMBS Lender. After application to monthly principal and interest payments and the reserve accounts, the central account is swept on a daily basis to Ventas Finance. However, during the continuance of an event of default or a Cash Flow Sweep Event, as defined in the CMBS Loan Agreement, all amounts in the central account in excess of the current month’s principal and interest payment and the required reserve payments will be deposited into an account and applied as a prepayment of the CMBS Loan on the next monthly payment date.

 

Revolving Credit Facility

 

On September 8, 2004, we entered into a three-year revolving credit facility totaling $300 million which replaced our previous revolving credit facility. Subject to certain conditions, we may extend the revolving credit facility for one year and increase our borrowing capacity to an amount not to exceed $450.0 million. Generally, borrowings outstanding under the revolving credit facility bears interest at a fluctuating LIBOR-based rate per annum plus an applicable percentage ranging from 1.05% to 1.75% depending on our consolidated leverage ratio. The applicable percentage was 1.25% at December 31, 2004. The previous revolving credit facility included borrowings bearing interest at a fluctuating LIBOR-based rate and the Tranche B Term Loan. The Tranche B Term Loan bore interest at LIBOR plus 2.50% and was due April 2007. Ventas Realty is the borrower and we are guarantors under the revolving credit facility.

 

Obligations under the revolving credit facility are secured by liens on certain of Ventas Realty’s real property assets and any related leases, rents and personal property, and, at Ventas Realty’s option, may be secured by certain cash collateral. Currently, 44 real properties owned or leased by Ventas Realty are mortgaged to secure the revolving credit facility. As of December 31, 2004, the net book value of these properties was $113.5 million. As of December 31, 2004, the borrowing base under the revolving credit facility was $290.8 million, the aggregate principal balance of outstanding obligations (excluding outstanding letters of credit of $0.5 million) was $39.0 million and the remaining availability was $251.3 million.

 

We incurred losses on extinguishment of debt in the amounts of $1.4 million and $6.9 million for the years ended December 31, 2004 and 2002, respectively, representing the write-off of unamortized deferred financing costs related to previous revolving credit facilities and early extinguishment premium on the 2009 Senior Notes and 2012 Senior Notes (as each term is defined below).

 

The revolving credit facility contains a number of restrictive covenants, including, without limitation, covenants pertaining to (i) the incurrence of additional indebtedness; (ii) limitations on liens; (iii) customary restrictions on certain dividends, distributions and other payments (the sum of all restricted payments made by us after April 17, 2002 cannot exceed 95% of our aggregate cumulative funds from operations (“FFO”)); (iv) mergers, sales of assets and other transactions; (v) requirements regarding the maintenance of certain (a) consolidated leverage ratios, (b) consolidated fixed charge coverage ratios and (c) consolidated adjusted net worth; (vi) transactions with affiliates; (vii) permitted business and development activities and uses of loan proceeds; and (viii) changes to material agreements. The revolving credit facility contains various potential events of default and is, among other things, cross-defaulted with certain other indebtedness and obligations of Ventas Realty.

 

Senior Notes

 

On April 17, 2002, Ventas Realty and Ventas Capital Corporation, a wholly owned subsidiary of Ventas Realty (collectively, the “Issuers”), completed the offering of 8  3 / 4 % Senior Notes due 2009 in the aggregate principal amount of $175.0 million (the “2009 Senior Notes”) and 9% Senior Notes due 2012 in the aggregate

 

69


Table of Contents
Index to Financial Statements

VENTAS, INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

principal amount of $225.0 million (the “2012 Senior Notes”). On October 15, 2004, the Issuers completed the offering of 6  5 / 8 % Senior Notes due 2014 in the aggregate principal amount of $125.0 million (the “2014 Senior Notes” and together with the 2009 Senior Notes and the 2012 Senior Notes, the “Senior Notes”). The Senior Notes were issued under separate indentures, and mature on May 1, 2009, May 1, 2012, and October 15, 2014, respectively.

 

The Senior Notes are unconditionally guaranteed, jointly and severally, on a senior unsecured basis by us and by certain of our current and future subsidiaries as described in the indentures (collectively, the “Guarantors”). The Senior Notes are part of our general unsecured obligations, rank equal in right of payment with all of our existing and future senior obligations and rank senior to all of our existing and future subordinated indebtedness. However, the Senior Notes are effectively subordinated to all borrowings under our revolving credit facility with respect to the assets securing obligations under the facility. In addition, the Senior Notes are structurally subordinated to the CMBS Loan.

 

The Issuers may redeem the 2009 Senior Notes and the 2012 Senior Notes in whole at any time, or in part from time to time, at a redemption price equal to 100% of the principal amount thereof, plus accrued and unpaid interest thereon to the redemption date and a make-whole premium described in the applicable indenture. The Issuers may redeem the 2014 Senior Notes in whole at any time, or in part from time to time, (i) prior to October 15, 2009 at a redemption price equal to 100% of the principal amount thereof plus a make-whole premium described in the applicable indenture and (ii) on or after October 15, 2009 at varying redemption prices set forth in the applicable indenture, plus, in each case, accrued and unpaid interest thereon to the redemption date. In addition, the Issuers may redeem up to 35% of the 2014 Senior Notes prior to October 15, 2007 with the net cash proceeds from certain equity offerings at a redemption price equal to 106.625% of the principal amount thereof plus accrued and unpaid interest thereon to the redemption date.

 

If we experience certain kinds of changes of control, the Issuers must make an offer to repurchase the Senior Notes, in whole or in part, at a purchase price in cash equal to 101% of the principal amount of the Senior Notes, plus any accrued and unpaid interest to the date of purchase; provided, however, that in the event Moody’s and S&P have confirmed their ratings at Ba3 or higher and BB- or higher on the Senior Notes and certain other conditions are met, this repurchase obligation will not apply.

 

The indentures governing the Senior Notes contain covenants that limit our ability and the ability of certain of our subsidiaries (collectively, the “Restricted Group”) to, among other things: (i) incur debt; (ii) incur secured debt; (iii) make certain dividends, distributions and investments (the sum of all restricted payments made by us cannot exceed 95% of our aggregate cumulative FFO from April 2002); (iv) enter into certain transactions, including transactions with affiliates; (v) subject our subsidiaries to restrictions on dividends or other payments to us; (vi) merge, consolidate or transfer all or substantially all of the Restricted Group’s assets; and (vii) sell assets. The Restricted Group is also required to maintain total unencumbered assets of at least 150% of the Restricted Group’s unsecured debt.

 

On December 31, 2002, we purchased $0.8 million principal amount of 2009 Senior Notes and $33.2 million principal amount of 2012 Senior Notes in open market transactions. The total purchase price aggregated $37.4 million. As a result of these purchases, we reported a loss on extinguishment of debt of $4.2 million in the fourth quarter ended December 31, 2002.

 

Other Mortgages

 

We have outstanding 16 other mortgage loans that we assumed in connection with the acquisition of properties or the ElderTrust merger. Outstanding principal balances on these loans ranges from $0.2 million to

 

70


Table of Contents
Index to Financial Statements

VENTAS, INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

$13.0 million as of December 31, 2004. The loans bear interest at fixed rates ranging 6.2% to 8.5%, except with respect to one loan with an outstanding principal balance of $8.9 million, which bears interest at the lender’s variable rate 2.0% as of December 31, 2004. The fixed rate debt bears interest at a weighted average rate of 7.5% as of December 31, 2004. The loans have a weighted average maturity of 14 years as of December 31, 2004.

 

Scheduled Maturities of Borrowing Arrangements

 

As of December 31, 2004, our indebtedness has the following maturities (in thousands):

 

2005

   $ 4,793

2006

     215,752

2007

     40,884

2008

     2,019

2009

     206,440

Thereafter

     373,290
    

     $ 843,178
    

 

Derivatives and Hedging

 

In the normal course of business, we are exposed to the effect of interest rate changes. We limit these risks by following established risk management policies and procedures including the use of derivatives. For interest rate exposures, derivatives are used primarily to fix the rate on debt based on floating-rate indices and to manage the cost of borrowing obligations. We currently have an interest rate swap to manage interest rate risk (the “2003-2008 Swap”). We prohibit the use of derivative instruments for trading or speculative purposes. Further, we have a policy of only entering into contracts with major financial institutions based upon their credit ratings and other factors. When viewed in conjunction with the underlying and offsetting exposure that the derivative is designed to hedge, we do not anticipate any material adverse effect on its net income or financial position in the future from the use of derivatives.

 

In 1998, we entered into an $800.0 million notional amount interest rate swap (the “1998 Swap”) that was treated as a cash flow hedge. In 1999, we shortened the maturity of the 1998 Swap in exchange for a payment to us of $21.6 million, which was recorded as other comprehensive income. We began amortizing this deferred gain out of accumulated other comprehensive income in July 2003, the amended expiration date of the 1998 Swap, and will continue such amortization through December 2007, the original expiration date of the 1998 Swap. As a result of debt refinancing in 2002, we reduced the notional amount of the 1998 Swap in exchange for a payment to the counterparty from us of $12.8 million. This partial swap breakage cost and $7.4 million of the deferred gain were recognized as a net expense of $5.4 million in the Consolidated Statement of Income for the year ended December 31, 2002.

 

In 2001, we entered into the 2003-2008 Swap in the notional amount of $450.0 million to hedge floating-rate debt for the period between July 1, 2003 and June 30, 2008, under which we pay a fixed rate at 5.385% and receive LIBOR from the counterparty to the agreement. The 2003-2008 Swap is treated as a cash flow hedge. On December 11, 2003, we received unanticipated cash proceeds from the sale of various facilities to Kindred, thereby reducing our expected future variable rate debt balances. Accordingly, we entered into an agreement with the counterparty to break $120.0 million of the notional amount in exchange for a payment from us of approximately $8.6 million. This partial swap breakage cost and $3.4 million of the deferred gain were recognized as a net expense of $5.2 million in the Consolidated Statement of Income for the year ended December 31, 2003.

 

71


Table of Contents
Index to Financial Statements

VENTAS, INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

Amortization of the deferred gain in accumulated other comprehensive income was $2.3 million and $1.5 million for the years ended December 31, 2004 and 2003, respectively. As of December 31, 2004, the remaining deferred gain in accumulated other comprehensive income was $6.9 million.

 

Unrealized gains and losses on the 2003-2008 Swap are recorded as other comprehensive income. The amounts reclassified into interest expense due to the swaps for the years ended December 31, 2004, 2003 and 2002 were $13.3 million, $19.2 million and $24.7 million, respectively. Assuming no changes in interest rates, we estimate that approximately $7.7 million of the current balance recorded in accumulated other comprehensive income will be recognized as interest expense within the next twelve months consistent with historical reporting. For the years ended December 31, 2004, 2003 and 2002, $0.5 million, $0.3 million and $1.9 million, respectively, of the unrealized loss on the swaps previously reported in accumulated other comprehensive income was reclassified to interest expense to reflect the excess of the notional amount of the swaps over the anticipated variable rate debt balances in the future.

 

There are no collateral requirements under the 2003-2008 Swap. We are exposed to credit loss in the event of the non-performance by the counterparty to an interest rate swap agreement. However, we do not anticipate non-performance by the counterparty. The notional amount of the 2003-2008 Swap is $330.0 million and is scheduled to decline as follows:

 

Notional Amount


 

Date


$300,000,000

  June 30, 2006

  150,000,000

  June 30, 2007

               —  

  June 30, 2008

 

At December 31, 2004, the 2003-2008 Swap was reported at its fair value of $16.5 million in liabilities in the Consolidated Balance Sheet. The offsetting entry is reported as a deferred loss in accumulated other comprehensive income.

 

Note 8—Fair Values of Financial Instruments

 

As of December 31, 2004 and 2003, the carrying amounts and fair values of our financial instruments were as follows:

 

     2004

    2003

 
     Carrying
Amount


    Fair Value

    Carrying
Amount


    Fair Value

 
     (in thousands)  

Cash and cash equivalents

   $ 3,365     $ 3,365     $ 82,104     $ 82,104  

Real estate loan receivable

     13,031       13,031       16,455       16,455  

Notes receivable from employees

     3,216       3,147       3,772       3,817  

Interest rate swap agreement

     (16,550 )     (16,550 )     (27,868 )     (27,868 )

Revolving credit facilities

     (39,000 )     (39,000 )     (59,100 )     (59,100 )

Senior Notes payable

     (491,038 )     (544,700 )     (366,038 )     (405,563 )

CMBS Loan

     (212,612 )     (212,612 )     (215,424 )     (215,424 )

Mortgages

     (100,528 )     (100,528 )     —         —    

 

Fair value estimates are subjective in nature and depend on a number of important assumptions, including estimates of future cash flows, risks, discount rates and relevant comparable market information associated with each financial instrument. The use of different market assumptions and estimation methodologies may have a material effect on the reported estimated fair value amounts. Accordingly, the estimates presented above are not necessarily indicative of the amounts we would realize in a current market exchange.

 

72


Table of Contents
Index to Financial Statements

VENTAS, INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

Note 9—Stockholders’ Equity and Stock Options

 

We have five plans under which options to purchase common stock have been, or may be, granted to officers, employees and non-employee directors, one plan under which executive officers may receive common stock in lieu of compensation and two plans under which certain directors may receive common stock in lieu of director fees (the following are collectively referred to as the “Plans”): (1) the 1987 Incentive Compensation Program (Employee Plan); (2) the 2000 Incentive Compensation Plan (Employee Plan); (3) the 1987 Stock Option Plan for Non-Employee Directors; (4) the 2004 Stock Plan for Directors; (5) the TheraTx, Incorporated 1996 Stock Option/Stock Issuance Plan; (6) the Executive Deferred Stock Compensation Plan; (7) the Common Stock Purchase Plan for Directors (the “Directors Stock Purchase Plan”); and (8) the Nonemployee Director Deferred Stock Compensation Plan.

 

Under the Plans (other than the Executive Deferred Stock Compensation Plan, Directors Stock Purchase Plan and Nonemployee Director Deferred Stock Compensation Plan), options are exercisable at the market price on the date of grant, expire ten years from the date of grant, and vest over varying periods ranging from one to four years. We have also granted options and restricted stock to certain officers, employees and non-employee directors outside of the Plans. The options and shares of restricted stock that have been granted outside the Plans vest over varying periods and the options are exercisable at the market price on the date of grant and expire ten years from the date of grant. As of December 31, 2004, options for 1,579,769 shares had been granted to eligible participants and remained outstanding (including options granted prior to our spin off of Kindred in 1998 and held by Kindred employees) under the Plans. As of December 31, 2004, options for 38,000 shares had been granted outside of the Plans to certain employees and non-employee directors and remained outstanding. We granted 68,271, 157,934, and 200,634 shares of restricted stock for the years ended December 31, 2004, 2003 and 2002, respectively. The market value of the restricted shares on the date of the award has been recorded as unearned compensation on restricted stock, with the unamortized balance shown as a separate component of stockholders’ equity. Unearned compensation is amortized to expense over the vesting period, with charges to operations of approximately $1.2 million in 2004, $1.3 million in 2003 and $1.9 million in 2002.

 

New option and restricted stock grants and stock issuances may only be made under the 2000 Incentive Compensation Plan (Employee Plan), the Executive Deferred Stock Compensation Plan, the 2004 Stock Plan for Directors, the Directors Stock Purchase Plan and the Nonemployee Director Deferred Stock Compensation Plan. Under the terms of the 2000 Incentive Compensation Plan (Employee Plan), 5,620,000 shares are reserved for grants to be issued to employees. Under the terms of the Executive Deferred Stock Compensation Plan, 500,000 shares are reserved for issuance to our executive officers in lieu of the payment of all or a portion of their salary, at their option. Under the terms of the 2004 Stock Plan for Directors, 200,000 shares are reserved for grants or issuance to the chairman of the board and non-employee directors. Under the terms of the Directors Stock Purchase Plan, 200,000 shares are reserved for issuance to the chairman of the board and non-employee directors in lieu of the payment of all or a portion of their retainer and meeting fees, at their option. Under the terms of the Nonemployee Deferred Stock Compensation Plan, 500,000 shares are reserved for issuance to nonemployee directors in lieu of the payment of all or a portion of their retainer and meeting fees, at their option. As of December 31, 2004, the number of shares available for future grants or issuance under the 2000 Incentive Compensation Plan (Employee Plan), the Executive Deferred Stock Compensation Plan, the 2004 Stock Plan for Directors, the Directors Stock Purchase Plan and the Nonemployee Director Deferred Stock Compensation Plan were 1,243,970, 500,000, 217,250, 164,278 and 497,486, respectively. No additional grants are permitted under the 1987 Incentive Compensation Program, the 1987 Stock Option Plan for Non-Employee Directors or the TheraTx, Incorporated 1996 Stock Option/Stock Issuance Plan. As a result, the shares reserved under these three Plans equal the options outstanding under such Plans. As of December 31, 2004, we had reserved 211,244 shares for issuance under these Plans.

 

73


Table of Contents
Index to Financial Statements

VENTAS, INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

The following is a summary of stock option activity in 2004, 2003 and 2002:

 

A. 2004 Activity

 

Activity


   Shares

    Range of Exercise
Prices


  

Weighted Average

Exercise Price


Outstanding at beginning of year

   2,565,618     $ 3.3125–$24.4701    $ 13.0621

Options granted

   336,423       21.6000–  25.1700      23.3192

Options exercised

   (1,229,705 )     3.6250–  24.4701      14.3216

Options canceled

   (54,567 )     3.6250–  23.0000      14.4420
    

            

Outstanding at end of year

   1,617,769       3.3125–  25.1700      14.1778
    

            

Exercisable at end of year

   1,282,761     $ 3.3125–$23.9037    $ 12.7607
    

            

 

B. 2003 Activity

 

Activity


   Shares

    Range of Exercise
Prices


  

Weighted Average

Exercise Price


Outstanding at beginning of year

   4,185,453     $ 0.1231–$26.0476    $ 13.6476

Options granted

   326,398       11.2000–  15.1800      11.5055

Options exercised

   (1,742,693 )     4.0000–  19.1606      13.0043

Options canceled

   (203,540 )     5.8913–  26.0476      16.1346
    

            

Outstanding at end of year

   2,565,618       3.3125–  24.4701      13.0621
    

            

Exercisable at end of year

   2,240,136     $ 3.3125–$24.4701    $ 13.2802
    

            

 

C. 2002 Activity

 

Activity


   Shares

    Range of Exercise
Prices


  

Weighted Average

Exercise Price


Outstanding at beginning of year

   4,834,219     $ 0.1231–$26.0476    $ 12.0116

Options granted

   379,390       11.8600–  13.4100      11.9621

Options exercised

   (774,770 )     3.3125–  10.8125      4.5710

Options canceled

   (253,386 )     0.1970–  19.8531      13.5480
    

            

Outstanding at end of year

   4,185,453       3.3125–  26.0476      13.3002
    

            

Exercisable at end of year

   3,798,409     $ 3.3125–$26.0476    $ 13.6476
    

            

 

A summary of stock options outstanding at December 31, 2004 follows:

 

Range of Exercise Prices


  

Outstanding

as of

December 31,

2004


  

Weighted

Average

Remaining

Contractual
Life

(years)


  

Weighted

Average

Exercise Price


  

Exercisable

as of

December 31,

2004


  

Weighted

Average

Exercise Price


$ 3.3125 to $ 8.0000

   294,415    6.0    $ 6.5744    294,415    $ 6.5744

$ 8.0001 to $13.7400

   706,163    6.9      11.9161    600,012      11.9814

$13.7401 to $18.6200

   200,883    2.3      16.1829    200,665      16.1840

$18.6201 to $25.1700

   416,308    7.6      22.4237    187,669      21.2971
    
              
      
     1,617,769    6.3    $ 14.1778    1,282,761    $ 12.7607
    
              
      

 

74


Table of Contents
Index to Financial Statements

VENTAS, INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

In 1995, FASB issued SFAS No. 123. This standard prescribes a fair value based method of accounting for employee stock options or similar equity instruments and requires certain pro forma disclosures. For purposes of the pro forma disclosures required under SFAS No. 123, the estimated fair value of the options is amortized to expense over the option’s vesting period. The estimated fair value of options granted for the years ended December 31, 2004, 2003 and 2002 was approximately $824,700, $235,500, and $337,100, respectively.

 

The following table illustrates the effect on net income and earnings per share if we had applied the fair value recognition provisions of SFAS No. 123, to all stock-based employee compensation.

 

    2004

    2003

    2002

 
    (in thousands)  

Net income, as reported

  $ 120,900     $ 162,753     $ 65,706  

Add: Stock based employee compensation expense included in reported net income

    1,207       1,320       1,853  

Deduct: Total stock-based employee compensation expense determined under fair value based method for all awards, net of related tax effects

    (2,110 )     (1,631 )     (2,422 )
   


 


 


Pro forma net income

  $ 119,997     $ 162,442     $ 65,137  
   


 


 


Earnings per share:

                       

Basic— as reported

  $ 1.45     $ 2.05     $ 0.95  

Basic—pro forma

  $ 1.44     $ 2.05     $ 0.94  

Diluted—as reported

  $ 1.43     $ 2.03     $ 0.93  

Diluted—pro forma

  $ 1.42     $ 2.03     $ 0.93  

 

In determining the estimated fair value of our stock options as of the date of grant, we used the Black-Scholes option pricing model with the following assumptions:

 

    2004

    2003

    2002

 

Risk-free interest rate

    4.5 %     4.0 %     4.1 %

Dividend yield

    7.4 %     9.0 %     9.0 %

Volatility factors of the expected market price for our common stock

  17.5 %   25.4 %   27.6 %

Weighted average expected life of options

  10 years     9 years     9 years  

 

The Black-Scholes option pricing model was developed for use in estimating the fair value of traded options which have no vesting restrictions and are fully transferable. In addition, option valuation models require the input of highly subjective assumptions, including the expected stock price volatility. Because our employee stock options have characteristics significantly different from those of traded options, and because changes in the subjective input assumptions can materially affect the fair value estimate, in our opinion, the existing models do not necessarily provide a reliable single measure of the fair value of our employee stock options.

 

75


Table of Contents
Index to Financial Statements

VENTAS, INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

Note 10—Income Taxes

 

We have elected to be taxed as a REIT under the Internal Revenue Code commencing with the year that ended December 31, 1999. We intend to continue to operate in such a manner as to enable it to qualify as a REIT. Our actual qualification and taxation as a REIT depends upon our ability to meet, on a continuing basis, distribution levels, stock ownership, and the various qualification tests. During the years ended December 31, 2004, 2003 and 2002, our tax treatment of distributions was as follows:

 

    2004

    2003

  2002

Tax treatment of distributions:

                   

Ordinary income

  $ 1.1164     $ 0.8025   $ 0.9500

Long-term capital gain

    0.1241       —       —  

Unrecaptured section 1250 gain

    0.0020       —       —  
   


 

 

Distribution reported for 1099-DIV purposes

    1.2425       0.8025     0.9500

Add: Dividend declared in current year and taxable in following year

    0.3250       0.2675     —  

Less: Dividend declared in prior year and taxable in current year

    (0.2675 )     —       —  
   


 

 

Distributions declared per common share outstanding

  $ 1.3000     $ 1.0700   $ 0.9500
   


 

 

 

No net provision for income taxes has been recorded in the Consolidated Financial Statements for the years ended December 31, 2004 and 2003 due to our belief that we qualified as a REIT and the distribution of more than 100% of our 2004 and 2003 taxable income as a dividend. In the third quarter of 2002, we filed our 2001 federal tax return on which we elected to apply certain 2002 dividend payments in excess of our 2002 taxable net income. As a result, we recorded a $2.2 million tax benefit for 2002.

 

The 2002 benefit for income taxes consists of the following (in thousands):

 

     2002

 

Current tax expense:

        

Federal

   $ (1,952 )

State

     (248 )
    


     $ (2,200 )
    


 

We believe we have met the annual distribution requirement by payment of at least 90% of our estimated taxable income for 2004, 2003 and 2002.

 

Net taxable income for federal income tax purposes results from net income for financial reporting purposes adjusted for the differences between the financial reporting and tax bases of assets and liabilities, including depreciation, prepaid rent, impairment losses on real estate, the United States Settlement liability, and the interest rate swap agreement. The net difference between tax bases of our asset and liabilities for federal income tax purposes was $91.9 and $119.2 million more than the book bases of those assets and liabilities for financial reporting for the years ended December 31, 2004 and 2003, respectively.

 

We made no income tax payments for the years ended December 31, 2004, 2003 and 2002.

 

As a former C corporation for federal income tax purposes, we potentially remain subject to corporate level taxes for any asset dispositions for the period January 1, 1999 through December 31, 2008 (“built-in gains tax”). The amount of income potentially subject to this special corporate level tax is generally equal to (a) the excess of

 

76


Table of Contents
Index to Financial Statements

VENTAS, INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

the fair value of the asset as of December 31, 1998 over its adjusted tax basis as of December 31, 1998, or (b) the actual amount of gain, whichever of (a) and (b) is lower. Some but not all future gains could be offset by available net operating losses. The deferred income tax liability of $30.4 million at December 31, 2004 and 2003 reflects a previously established liability to be utilized for any built-in gains tax incurred on assets that are disposed of prior to January 1, 2009.

 

In connection with the Kindred plan of reorganization, we entered into an agreement with Kindred to deposit into a third-party escrow account certain income tax refunds received by either Kindred or us. This agreement also amended and supplemented the agreement under which Kindred has indemnified us for certain tax liabilities relating to May 1, 1998. Under the terms of this agreement any excess Escrow Funds remaining after no further claims may be made by governmental authorities with respect to Subject Taxes or Subject Refunds (because of the expiration of statutes of limitation or otherwise) will be distributed equally to Kindred and us. At December 31, 2004, approximately $0.2 million of disputed Subject Refunds and accrued interest, representing 50% of the Escrow Funds, is recognized in restricted cash and other liabilities on our Consolidated Balance Sheet.

 

On April 1, 2003, the Internal Revenue Service (“IRS”) notified us that it had completed its review of our federal income tax returns for the 1997 and 1998 tax periods. The Joint Committee on Taxation affirmed the IRS Revenue Agent’s report concluding that we (1) do not owe any additional taxes for those periods, (2) are entitled to retain the approximately $26.0 million federal tax refund we received in 2000 for those periods (the “Original Federal Refund Amount”), and (3) are entitled to receive an additional refund of $1.2 million for those periods (the “Additional Federal Refund Amount”). In addition, as a result of the completion of the audit, we will retain substantially all of our favorable tax attributes such as net operating loss carryforwards and capital loss carryforwards.

 

As a result of the Joint Committee on Taxation’s findings, on April 3, 2003, we and Kindred agreed to disburse $13.5 million to each company from a previously established escrow account (the “Tax Refund Escrow”). The Tax Refund Escrow held the Original Federal Refund Amount and certain other tax refunds (collectively, the “Tax Refund Escrow Funds”) related to periods ending in years prior to or including the date of the 1998 spin off. As a result of the Additional Federal Refund Amount and other state and local refunds, in October 2003 and September 2004 Ventas and Kindred agreed to disburse $1.0 million and $0.8 million, respectively, to each company from the Tax Refund Escrow. As of December 31, 2004, our share of the amounts currently held in the Tax Refund Escrow was approximately $0.2 million.

 

In 2003, we reported an increase of approximately $20.2 million to our operating results, reflecting the reversal of a previously recorded contingent liability. A portion of this contingent liability included our share of the Tax Refund Escrow Funds reported in Other Liabilities—Disputed Federal, State and Local Tax Refunds on the Consolidated Balance Sheet. The other portion of this contingent liability was previously recorded in accounts payable and other accrued liabilities on the Consolidated Balance Sheet to take into account the uncertainties surrounding the outcome of the IRS audit for our 1997 and 1998 tax periods as well as other federal, state, local, franchise and miscellaneous tax items. As in certain prior periods, the IRS is currently reviewing our federal income tax return for the year ended December 31, 2001. As of December 31, 2004 and 2003, the total contingent liability was $1.8 million and $1.2 million, respectively.

 

We have a net operating loss carryforward of $10.2 million at December 31, 2004. This amount can be used to offset future taxable income (and/or taxable income for prior years if audits of any prior year’s return determine that amounts are owed), if any, remaining after the dividends paid deduction. We will be entitled to utilize NOLs and tax credit carryforwards only to the extent that REIT taxable income exceeds our deduction for dividends paid. The NOL carryforwards begin to expire in 2018. The availability of the carryforwards are subject to the results of the ongoing IRS examination for the prior tax years.

 

77


Table of Contents
Index to Financial Statements

VENTAS, INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

As a result of the uncertainties relating to the ultimate utilization of favorable tax attributes described above, no net deferred tax benefit has been ascribed to net operating loss carryforwards as of December 31, 2004 and 2003. The IRS may challenge our entitlement to these tax attributes during its review of the tax returns for the previous tax years. We believe we are entitled to these tax attributes, but there can be no assurance as to the outcome of these matters.

 

Note 11—Commitments and Contingencies

 

Agreement of Indemnity—Third-Party Leases

 

In connection with our spin off of Kindred in 1998 (the “1998 Spin Off”), we assigned our former third-party lease obligations (i.e., leases under which an unrelated third party is the landlord) as a tenant or as a guarantor of tenant obligations to Kindred (the “Third-Party Leases”). Under the terms of an indemnity agreement relating to the Third-Party Leases, Kindred agreed to indemnify and hold us harmless from and against all claims against us arising out of the Third-Party Leases assigned by us to Kindred. Either prior to or following the 1998 Spin Off, the tenant’s rights under a subset of the Third-Party Leases were assigned or sublet to third parties unrelated to Kindred. If Kindred or such third-party subtenants are unable to or do not satisfy the obligations under any Third-Party Lease, the lessors may claim that we remain liable under the Third-Party Leases. We believe we may have valid legal defenses to any such claim. However, there can be no assurance we would prevail against a claim brought by a lessor under a Third-Party Lease. In the event that a lessor should prevail in a claim against us, we may be entitled to receive revenues from those properties that would mitigate the costs incurred in connection with the satisfaction of such obligations. The Third-Party Leases relating to nursing facilities, hospitals, offices and warehouses have remaining terms (excluding renewal periods) of one to 10 years. The Third-Party Leases relating to ground leases have remaining terms from one to 80 years. Under Kindred’s plan of reorganization, Kindred assumed and agreed to fulfill its obligations under the indemnity agreement relating to the Third-Party Leases. There can be no assurance that Kindred will have sufficient assets, income and access to financing to enable it to satisfy, or that it will continue to honor, its obligations under the indemnity agreement relating to the Third-Party Leases. Under Kindred’s plan of reorganization, Kindred has agreed not to renew or extend any Third-Party Lease unless it first obtains a release of us from liability under such Third-Party Lease.

 

The total aggregate remaining minimum rental payments under the Third-Party Leases are as follows:

 

    

Skilled Nursing

Facilities


   Hospitals

   Land

  

Subleased

Third Party

Leases


   Other

   Total

     (in thousands)

2005

   $ 614    $ 1,925    $ 466    $ 1,117    $ 265    $ 4,387

2006

     235      1,025      468      1,117      88      2,933

2007

     —        1,025      461      1,117      —        2,603

2008

     —        1,025      399      1,117      —        2,541

2009

     —        —        392      1,117      —        1,509

Thereafter

     —        —        10,496      1,489      —        11,985
    

  

  

  

  

  

     $ 849    $ 5,000    $ 12,682    $ 7,074    $ 353    $ 25,958
    

  

  

  

  

  

 

Agreement of Indemnity—Third-Party Guarantees

 

In connection with the 1998 Spin Off, we assigned our former third-party guaranty agreements to Kindred (the “Third-Party Guarantees”). Under the terms of an indemnity agreement relating to the Third-Party Guarantees, Kindred agreed to indemnify and hold us harmless from and against all claims against us arising out

 

78


Table of Contents
Index to Financial Statements

VENTAS, INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

of the Third-Party Guarantees. Under Kindred’s plan of reorganization, Kindred assumed and agreed to fulfill its obligations under the indemnity agreement relating to the Third-Party Guarantees. There can be no assurance that Kindred will have sufficient assets, income and access to financing to enable it to satisfy, or that it will continue to honor, its obligations incurred in connection with the indemnity agreement relating to the Third-Party Guarantees. If Kindred is unable to or does not satisfy the obligations under any Third-Party Guarantee, then we may be liable for the payment and performance of the obligations under any such agreement. However, we believe we may have valid legal defenses to any such claim under a Third-Party Guarantee. As of December 31, 2004, we believe that we had no material exposure under the Third-Party Guarantees.

 

Assumption of Certain Operating Liabilities and Litigation

 

In connection with the 1998 Spin Off, Kindred agreed in various agreements (the “Spin Agreements”) to, among other things, assume and to indemnify us for any and all liabilities that may arise out of the ownership or operation of the healthcare operations either before or after the date of the 1998 Spin Off. The indemnification provided by Kindred also covers losses, including costs and expenses, which may arise from any future claims asserted against us based on these healthcare operations. In addition, at the time of the 1998 Spin Off, Kindred agreed to assume the defense, on our behalf, of any claims that were pending at the time of the 1998 Spin Off, and which arose out of the ownership or operation of the healthcare operations. Kindred also agreed to defend, on our behalf, any claims asserted after the 1998 Spin Off which arise out of the ownership and operation of the healthcare operations. Under Kindred’s plan of reorganization, Kindred assumed and agreed to perform its obligations under these indemnifications. There can be no assurance that Kindred will have sufficient assets, income and access to financing to enable it to satisfy, or that Kindred will continue to honor, its obligations incurred in connection with the 1998 Spin Off. If Kindred does not satisfy or otherwise honor the obligations under these arrangements, then we may be liable for the payment and performance of such obligations and may have to assume the defense of such claims.

 

Kindred Common Stock

 

On April 20, 2001, we received 1,498,500 shares of Kindred common stock, representing not more than 9.99% of the issued and outstanding common stock of Kindred as of that date. Based on applicable laws, regulations, advice from experts, an appraisal, the trading performance of Kindred common stock at the time and other appropriate facts and circumstances, the illiquidity and lack of registration of the Kindred common stock when received and our lack of significant influence over Kindred, we determined the value of the Kindred common stock to be $18.2 million on the date of issuance. The Kindred common stock was issued to us as additional future rent in consideration of our agreement to charge the base rent as provided in the Kindred Master Leases.

 

During the year ended December 31, 2002, we disposed of a total of 159,500 shares of Kindred common stock and recognized a gain of $5.0 million. During the year ended December 31, 2003, we disposed of the remaining 920,814 shares of Kindred common stock and recognized a gain of $9.0 million. As of December 31, 2004 and 2003, we did not own any Kindred common stock.

 

Settlement of United States Claims

 

Kindred and we were the subject of investigations by the United States Department of Justice regarding our prior healthcare operations, including matters arising from lawsuits filed under the qui tam, or whistleblower, provision of the Federal Civil False Claims Act, which allows private citizens to bring a suit in the name of the United States. See “Note 13—Litigation.” Kindred’s plan of reorganization contains a comprehensive settlement of all of these claims by the United States Department of Justice (the “United States Settlement”).

 

79


Table of Contents
Index to Financial Statements

VENTAS, INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

Under the United States Settlement, we were required to pay $103.6 million to the United States, of which $34.0 million was paid on April 20, 2001. The balance of $69.6 million bore interest at 6% per annum and was payable in equal quarterly installments over a five-year term commencing on June 30, 2001 and ending in 2006. We also paid approximately $0.4 million to legal counsel for the relators in the qui tam actions. In the fourth quarter of 2000, we recorded the full amount of the obligation under the United States Settlement for $96.5 million based on an imputed interest rate of 10.75%. On June 30, 2003, we incurred a $2.7 million non-cash expense relating to the early repayment of the United States Settlement that is reflected as interest on United States Settlement on our Consolidated Statement of Income for the year ended December 31, 2003. The $2.7 million interest expense reflects the difference between the total amount paid by us in final repayment of the United States Settlement and the amount reflected on our Consolidated Balance Sheet on the date of final repayment. There was no prepayment penalty or other cash expense on account of such early prepayment.

 

Note 12—Earnings Per Share

 

The following table shows the amounts used in computing basic and diluted earnings per share:

 

     Years Ended December 31,

           2004      

         2003      

         2002      

     (in thousands except per share amounts)

Numerator for basic and diluted earnings per share:

                    

Income before discontinued operations

   $ 100,173    $ 96,135    $ 36,949

Discontinued operations

     20,727      66,618      28,757
    

  

  

Net income

   $ 120,900    $ 162,753    $ 65,706
    

  

  

Denominator:

                    

Denominator for basic earnings per share—weighted average shares

     83,491      79,340      69,336

Effect of dilutive securities:

                    

Stock options

     825      715      883

Time vesting restricted stock awards

     36      39      71
    

  

  

Dilutive potential common stock

     861      754      954
    

  

  

Denominator for diluted earnings per share—adjusted weighted average

     84,352      80,094      70,290
    

  

  

Basic earnings per share

                    

Income before discontinued operations

   $ 1.20    $ 1.21    $ 0.53

Discontinued operations

     0.25      0.84      0.42
    

  

  

Net income

   $ 1.45    $ 2.05    $ 0.95
    

  

  

Diluted earnings per share

                    

Income before discontinued operations

   $ 1.19    $ 1.20    $ 0.53

Discontinued operations

     0.24      0.83      0.40
    

  

  

Net income

   $ 1.43    $ 2.03    $ 0.93
    

  

  

 

There were no anti-dilutive options outstanding for the year ended December 31, 2004. Options to purchase 1.1 million shares of common stock at exercise prices ranging from $15.69 to $24.47 were outstanding at December 31, 2003, but were not included in the computation of diluted earnings per share because the options’ exercise price was greater than the average market price of the common shares for the year ended December 31, 2003 and, therefore, the effect would be anti-dilutive. Options to purchase 2.8 million shares of common stock at

 

80


Table of Contents
Index to Financial Statements

VENTAS, INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

exercise prices ranging from $13.13 to $26.05 were outstanding at December 31, 2002, but were not included in the computation of diluted earnings per share because the options’ exercise price was greater than the average market price of the common shares for the year ended December 31, 2002 and, therefore, the effect would be anti-dilutive.

 

Note 13—Litigation

 

Legal Proceedings Presently Defended and Indemnified by Kindred Under the Spin Agreements

 

The following litigation and other matters arose from our operations prior to the time of the 1998 Spin Off or relate to assets or liabilities transferred to Kindred in connection with the 1998 Spin Off. Under the Spin Agreements, Kindred agreed to assume the defense, on our behalf, of any claims that (i) were pending at the time of the 1998 Spin Off and which arose out of the ownership or operation of the healthcare operations or any of the assets or liabilities transferred to Kindred in connection with the 1998 Spin Off, or (ii) were asserted after the 1998 Spin Off and which arose out of the ownership and operation of the healthcare operations or any of the assets or liabilities transferred to Kindred in connection with the 1998 Spin Off, and to indemnify us for any fees, costs, expenses and liabilities arising out of such operations (the “Indemnification”). Kindred is presently defending us in the matters described below, among others. Under Kindred’s plan of reorganization, Kindred assumed and agreed to abide by the Indemnification and to defend us in these and other matters as required under the Spin Agreements. However, there can be no assurance that Kindred will continue to defend us in such matters or that Kindred will have sufficient assets, income and access to financing to enable it to satisfy such obligations or its obligations incurred in connection with the 1998 Spin Off. In addition, many of the following descriptions are based primarily on information included in Kindred’s public filings and information provided to us by Kindred. There can be no assurance that Kindred has included in its public filings and provided us complete and accurate information in all instances.

 

A stockholder derivative suit entitled Thomas G. White on behalf of Ventas, Inc. v. W. Bruce Lunsford, et al ., Case No. 98 C103669 was filed in June 1998 in the Jefferson County, Kentucky, Circuit Court. The complaint alleges, among other things, that certain former officers and directors damaged our company by engaging in breaches of fiduciary duty, insider trading, fraud and securities fraud and damaging our reputation. The suit seeks unspecified damages, interest, punitive damages, reasonable attorneys’ fees, other costs, and any extraordinary equitable and/or injunctive relief permitted by law or equity to assure the plaintiff has an effective remedy. We believe the allegations in the complaint are without merit. On October 4, 2002, Kindred filed with the Court a motion to dismiss this action as to all defendants, including us, for lack of prosecution by the plaintiffs. On October 14, 2002, the Court granted Kindred’s motion to dismiss with prejudice. On October 17, 2002, the plaintiffs filed with the Court a motion to vacate that order of dismissal in order to allow further briefing. In response to the plaintiffs’ October 17, 2002 motion to vacate the order of dismissal, on August 13, 2003, the Court issued an order declining to dismiss the suit. In September 2003, Kindred filed a motion to dismiss this action as to all defendants, including us, based on plaintiff’s failure to make demand for remedy upon the appropriate Board of Directors. On March 18, 2004, the presiding judge recused himself and this action was reassigned. In July 2004, the Court ruled that it would consider the motion to dismiss this action based upon plaintiffs’ failure to make demand for remedy upon the appropriate Board of Directors. The briefing is now complete on this motion to dismiss but the Court has not yet ruled. Kindred has indicated that it intends to continue to defend this action vigorously on our behalf. We are unable at this time to estimate the possible loss or range of loss for this action and, therefore, no provision for liability, if any, resulting from this litigation has been made in the Consolidated Financial Statements as of December 31, 2004.

 

Kindred is a party to certain legal actions and regulatory investigations arising in the normal course of its business. We are a party to certain legal actions and regulatory investigations that arise from the normal course of

 

81


Table of Contents
Index to Financial Statements

VENTAS, INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

our prior healthcare operations, which legal actions and regulatory investigations are being defended by Kindred under the Indemnification. Neither we nor Kindred are able to predict the ultimate outcome of pending litigation and regulatory investigations. In addition, there can be no assurance that the Centers for Medicare and Medicaid Services or other regulatory agencies will not initiate additional investigations related to Kindred’s business or our prior healthcare business in the future, nor can there be any assurance that the resolution of any litigation or investigations, either individually or in the aggregate, would not have a material adverse effect on Kindred’s liquidity, financial position or results of operations, which in turn could have a material adverse effect on us.

 

Other Litigation

 

We are a plaintiff in an action seeking a declaratory judgment and damages entitled Ventas Realty, Limited Partnership et al. v. Black Diamond CLO 1998-1 Ltd., et al., Case No. 99C107076, filed November 22, 1999 in the Circuit Court of Jefferson County, Kentucky. Two of the three defendants in that action, Black Diamond International Funding, Ltd. and BDC Finance, LLC (collectively “Black Diamond”), have asserted counterclaims against us under theories of breach of contract, tortious interference with contract and abuse of process. We dispute the material allegations contained in Black Diamond’s counterclaims and we intend to continue to pursue its claims and defend the counterclaims vigorously. We are unable at this time to estimate the possible loss or range of loss for the counterclaims in this action, and therefore, no provision for liability, if any, resulting from this litigation has been made in our Consolidated Financial Statements as of December 31, 2004.

 

We are the plaintiff in an action entitled Ventas, Inc. v. Sullivan & Cromwell, Case No. 02-5232 filed by us on June 27, 2002 in the Superior Court of the District of Columbia. The complaint asserts claims of legal malpractice and breach of fiduciary duty by Sullivan & Cromwell in connection with its legal representation of us in the 1998 Spin Off. The Court set a January 23, 2006 trial date for this action. Although we intend to pursue our claims in this action vigorously, there can be no assurances that we will prevail on any of the claims in this action, or, if we do prevail on one or more of the claims, the amount of the recovery that may be awarded to us for such claims.

 

We are party to various other lawsuits arising in the normal course of our business. It is the opinion of management that, except as set forth in this Note 13, the disposition of these lawsuits will not, individually or in the aggregate, have a material adverse effect on us. If management’s assessment of our liability with respect to these actions is incorrect, such lawsuits could have a material adverse effect on us.

 

No provision for liability, if any, resulting from the aforementioned litigation has been made in our Consolidated Financial Statements as of December 31, 2004.

 

Note 14—Capital Stock

 

The authorized capital stock at December 31, 2004, 2003 and 2002 consisted of 180,000,000 shares of common stock, par value of $0.25 per share, and 10,000,000 shares of preferred stock, of which 300,000 shares have been designated Series A Participating Preferred Stock.

 

On June 19, 2002, we filed a universal shelf registration statement on Form S-3 with the Commission relating to $750.0 million of common stock, preferred stock, debt securities, depository shares and warrants. The registration statement became effective on July 8, 2002. As of December 31, 2004, $599.1 million of securities remained available for offering under the shelf registration statement.

 

On March 15, 2004, we completed the sale of 2,000,000 shares of our common stock in an underwritten public offering under our universal shelf registration statement. We received $51.1 million in net proceeds from the sale, which we used to repay indebtedness under the revolving credit facility and for general corporate purposes, including the funding of acquisitions.

 

82


Table of Contents
Index to Financial Statements

VENTAS, INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

During the fourth quarter ended December 31, 2002, we completed the sale of 9,000,000 shares of our common stock with Tenet Healthcare Corporation (“Tenet”). In the offering, Tenet sold all 8,301,067 shares of our common stock that it held. Our net proceeds from the sale were $93.6 million, which we used to repay outstanding indebtedness including the indebtedness incurred to invest in transactions with THI.

 

Excess Share Provision

 

In order to preserve our ability to maintain REIT status, our certificate of incorporation provides that if a person acquires beneficial ownership of greater than 9% of the outstanding stock, the shares that are beneficially owned in excess of such 9% limit are deemed to be excess shares. These shares are automatically deemed transferred to a trust for the benefit of a charitable institution or other qualifying organization selected by our Board of Directors. The trust is entitled to all dividends with respect to the shares and the trustee may exercise all voting power over the shares.

 

We have the right to buy the excess shares for a purchase price equal to the lesser of (1) the price per share in the transaction that created the excess shares, or (2) the market price on the date we buy the shares. We have the right to defer payment of the purchase price for the excess shares for up to five years. If we do not purchase the excess shares, the trustee of the trust is required to transfer the excess shares at the direction of the Board of Directors. The owner of the excess shares is entitled to receive the lesser of the proceeds from the sale of the excess shares or the original purchase price for such excess shares; any additional amounts are payable to the beneficiary of the trust.

 

The Board of Directors is empowered to grant waivers from the excess share provisions of our Certificate of Incorporation. On June 24, 2003 we granted a waiver (the “C&S Waiver”) from the 9% ownership limitation provisions of Article XII of our Certificate of Incorporation to Cohen & Steers Capital Management, Inc. (“C&S”). Under the C&S Waiver, C&S may beneficially own, in the aggregate, up to 14.0% in number of shares or value of our common stock.

 

Distribution Reinvestment and Stock Purchase Plan

 

We have a Distribution Reinvestment and Stock Purchase Plan. Under the plan’s terms, existing stockholders may purchase shares of common stock by reinvesting all or a portion of the cash distribution on their shares of our common stock. In addition, existing stockholders, as well as new investors, may purchase shares of common stock by making optional cash payments. Beginning in March 2005, we are offering a 1% discount on the purchase price of our stock to shareholders who reinvest their dividends and/or make optional cash purchases of common stock through the plan. In 2004, we offered a 2% discount on the purchase price of our stock to shareholders that participated in the plan. The availability of a market discount is at our discretion. The granting of a discount for one month or quarter, as applicable, will not insure the availability of a discount or the same discount in future months or quarters, respectively. Each month or quarter, as applicable, we may lower or eliminate the discount without prior notice. We may also, without prior notice, change our determination as to whether common shares will be purchased by the plan administrator directly from us or in the open market.

 

Note 15—Related Party Transactions

 

At December 31, 2004 and 2003, we had receivables of approximately $3.2 million and $3.8 million, respectively, due from certain current and former executive officers. The loans include interest provisions (with a 4.9% average rate) and were to finance the income taxes payable by the executive officers resulting from: (i) the 1998 Spin Off and (ii) vesting of restricted shares. The loans are payable over a period of 10 years. Interest on a

 

83


Table of Contents
Index to Financial Statements

VENTAS, INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

note relating to the 1998 Spin Off in the principal amount of $1.5 million at December 31, 2004 (the “1998 Spin Off Note”), is paid on a quarterly basis. The payee of the 1998 Spin Off Note resigned as an employee and director of Ventas on January 30, 2003. In the event of a change in control, as defined in our 1997 Incentive Compensation Plan, accrued interest on and the principal balance of the 1998 Spin Off Note is forgiven. Interest on the note relating to taxes paid for the vested portion of Restricted Shares (the “Restricted Share Note”) is payable annually out of and only to the extent of dividends from the vested restricted shares. In the event of a change in control (as defined in the relevant employment agreement) or upon termination of the officer without cause (as defined in the relevant employment agreement), the principal balance of the Restricted Share Note is forgiven. The Restricted Share Note is secured by a pledge of all of the restricted shares to which the Restricted Share Note relates and the Restricted Share Note is otherwise non-recourse. The 1998 Spin Off Note is not secured.

 

On October 15, 1998, we acquired eight personal care facilities and related facilities for approximately $7.1 million from Tangram Rehabilitation Network, Inc. (“Tangram”). Tangram is a wholly owned subsidiary of Res-Care, Inc. (“Res-Care”) of which a director of Ventas is the Chairman, President and Chief Executive Officer. We lease the Tangram facilities to Tangram pursuant to a master lease agreement which is guaranteed by Res-Care. For the years ended December 31, 2004, 2003 and 2002, Tangram has paid us approximately $834,000, $816,000 and $799,000 respectively, in base rent payments.

 

Note 16—Quarterly Financial Information (Unaudited)

 

Summarized unaudited consolidated quarterly information for the years ended December 31, 2004 and 2003 is provided below.

 

     Year Ended December 31, 2004

     First
Quarter


   Second
Quarter


   Third
Quarter


   Fourth
Quarter


     (in thousands, except per share amounts)

Revenues (1)

   $ 53,943    $ 59,425    $ 61,262    $ 62,226

Income before discontinued operations (1)

     23,091      25,464      25,100      26,518

Discontinued operations (1)

     184      190      197      20,156

Net income

     23,275      25,654      25,297      46,674

Earnings per share:

                           

Basic:

                           

Income before discontinued operations

   $ 0.28    $ 0.30    $ 0.30    $ 0.32

Discontinued operations

     0.00      0.01      0.00      0.24
    

  

  

  

Net income

   $ 0.28    $ 0.31    $ 0.30    $ 0.56
    

  

  

  

Diluted:

                           

Income before discontinued operations

   $ 0.28    $ 0.30    $ 0.30    $ 0.31

Discontinued operations

     0.00      0.00      0.00      0.24
    

  

  

  

Net income

   $ 0.28    $ 0.30    $ 0.30    $ 0.55
    

  

  

  

Dividends declared per share

   $ 0.3250    $ 0.3250    $ 0.3250    $ 0.3250

 

84


Table of Contents
Index to Financial Statements

VENTAS, INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 


(1) The amounts presented for the three months ended March 31, 2004, June 30, 2004 and September 30, 2004 are not equal to the same amounts previously reported in our quarterly reports on Form 10-Q for each period as a result of discontinued operations consisting of properties sold in fourth quarter 2004. The following is a reconciliation to the amounts previously reported in the Form 10-Q:

 

     For the three months ended

 
    

March 31,

2004


    June 30,
2004


    September 30,
2004


 
     (in thousands, except per share amounts)  

Revenues, previously reported in Form 10-Q

   $ 54,277     $ 59,767     $ 61,608  

Revenues, previously reported in Form 10-Q, subsequently reclassified to discontinued operations

     (334 )     (342 )     (346 )
    


 


 


Total revenues disclosed in Form 10-K

   $ 53,943     $ 59,425     $ 61,262  
    


 


 


Income before discontinued operations, previously reported in Form 10-Q

   $ 23,275     $ 25,654     $ 25,297  

Income before discontinued operations, previously reported in Form 10-Q, subsequently reclassified to discontinued operations

     (184 )     (190 )     (197 )
    


 


 


Income before discontinued operations disclosed in Form 10-K

   $ 23,091     $ 25,464     $ 25,100  
    


 


 


Discontinued operations, previously reported in Form 10-Q

   $ —       $ —       $ —    

Discontinued operations from properties sold subsequent to the respective reporting period

     184       190       197  
    


 


 


Discontinued operations disclosed in Form 10-K

   $ 184     $ 190     $ 197  
    


 


 


 

     Year Ended December 31, 2003

 
     First
Quarter


    Second
Quarter


    Third
Quarter


    Fourth
Quarter


 
     (in thousands, except per share amounts)  

Revenues (5)

   $ 46,718     $ 47,724     $ 50,067     $ 50,210  

Income before discontinued operations (5)

     35,806 (1)     14,998 (2)     30,217 (3)     15,114 (4)

Discontinued operations (5)

     1,482       1,131       1,995       62,010  

Net income

     37,288 (1)     16,129 (2)     32,212 (3)     77,124 (4)

Earnings per share:

                                

Basic:

                                

Income before discontinued operations

   $ 0.45 (1)   $ 0.19 (2)   $ 0.38 (3)   $ 0.19 (4)

Discontinued operations

     0.02       0.01       0.03       0.78  
    


 


 


 


Net income

   $ 0.47 (1)   $ 0.20 (2)   $ 0.41 (3)   $ 0.97 (4)
    


 


 


 


Diluted:

                                

Income before discontinued operations

   $ 0.45 (1)   $ 0.19 (2)   $ 0.38 (3)   $ 0.18 (4)

Discontinued operations

     0.02       0.01       0.02       0.78  
    


 


 


 


Net income

   $ 0.47 (1)   $ 0.20 (2)   $ 0.40 (3)   $ 0.96 (4)
    


 


 


 


Dividends declared per share

   $ 0.2675     $ 0.2675     $ 0.2675     $ 0.2675  

(1) Includes $20.2 million reversal of contingent liability.
(2) Includes $0.9 million gain from the sale of Kindred common stock and $3.8 million of interest expense on United States settlement.

 

85


Table of Contents
Index to Financial Statements

VENTAS, INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

(3) Includes $8.1 million gain from the sale of Kindred common stock.
(4) Includes $5.2 million loss on swap breakage.
(5) The amounts presented for the three months ended March 31, 2003, June 30, 2003 and September 30, 2003 are not equal to the same amounts previously reported in our quarterly reports on Form 10-Q for each period as a result of discontinued operations consisting of properties sold in fourth quarter 2004. The following is a reconciliation to the amounts previously reported in the Form 10-Q:

 

     For the three months ended

 
    

March 31,

2003


    June 30,
2003


    September 30,
2003


 
     (in thousands, except per share amounts)  

Revenues, previously reported in Form 10-Q

   $ 47,003     $ 48,016     $ 50,401  

Revenues, previously reported in Form 10-Q, subsequently reclassified to discontinued operations

     (285 )     (292 )     (334 )
    


 


 


Total revenues disclosed in Form 10-K

   $ 46,718     $ 47,724     $ 50,067  
    


 


 


Income before discontinued operations, previously reported in Form 10-Q

   $ 35,934     $ 15,129     $ 30,392  

Income before discontinued operations, previously reported in Form 10-Q, subsequently reclassified to discontinued operations

     (128 )     (131 )     (175 )
    


 


 


Income before discontinued operations disclosed in Form 10-K

   $ 35,806     $ 14,998     $ 30,217  
    


 


 


Discontinued operations, previously reported in Form 10-Q

   $ 1,354     $ 1,000     $ 1,820  

Discontinued operations from properties sold subsequent to the respective reporting period

     128       131       175  
    


 


 


Discontinued operations disclosed in Form 10-K

   $ 1,482     $ 1,131     $ 1,995  
    


 


 


 

Note 17—Condensed Consolidating Information

 

We and certain of our direct and indirect wholly owned subsidiaries (the “Wholly Owned Subsidiary Guarantors”) have fully and unconditionally guaranteed, on a joint and several basis, the obligation to pay principal and interest with respect to the Senior Notes of the Issuers. ETOP, which is a greater than 99% owned indirect subsidiary, and certain of its wholly owned subsidiaries (the “ETOP Subsidiary Guarantors” and collectively, with the Wholly Owned Subsidiary Guarantors, the “Guarantors”), have also provided a guarantee, on a joint and several basis, of the Senior Notes. We have other subsidiaries (“Non-Guarantor Subsidiaries”) that are not included among the Guarantors, and such subsidiaries are not obligated with respect to the Senior Notes. Contractual and legal restrictions, including those contained in the agreements governing the CMBS Transaction, and instruments governing certain Non-Guarantor Subsidiaries’ outstanding indebtedness, may under certain circumstances restrict our ability to obtain cash from our Non-Guarantor Subsidiaries for the purpose of meeting our debt service obligations, including our guarantee of payment of principal and interest on the Senior Notes. Additionally, as of December 31, 2004, approximately $113.5 million of the net assets of Ventas Realty were mortgaged to secure our revolving credit facility. Certain of our real estate assets are also subject to mortgages. The following summarizes our condensed consolidating information as of December 31, 2004 and 2003 and for each of the three years in the period ended December 31, 2004:

 

86


Table of Contents
Index to Financial Statements

VENTAS, INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

CONDENSED CONSOLIDATING BALANCE SHEET

As of December 31, 2004

 

    Ventas, Inc.

 

ETOP

and ETOP

Subsidiary

Guarantors


 

Wholly

Owned

Subsidiary

Guarantors


 

Issuers

(a)


   

Non-

Guarantor

Subsidiaries


   

Consolidated

Elimination


    Consolidated

    (In thousands)

Assets

                                               

Total net real estate investments

  $ 12,806   $ 58,339   $ —     $ 772,883     $ 227,104     $ —       $ 1,071,132

Cash and cash equivalents

    48     37     3     1,846       1,431       —         3,365

Escrow deposits and restricted cash

    237     138     —       12,812       12,523       —         25,710

Deferred financing costs, net

    —       —       —       10,938       2,612       —         13,550

Notes receivable from employees

    1,716     —       —       1,500       —         —         3,216

Equity in affiliates

    391,817     80,447     114,867     —         15       (587,146 )     —  

Other

    —       298     —       8,555       1,109       —         9,962
   

 

 

 


 


 


 

Total assets

  $ 406,624   $ 139,259   $ 114,870   $ 808,534     $ 244,794     $ (587,146 )   $ 1,126,935
   

 

 

 


 


 


 

Liabilities and stockholders’ equity (deficit)

                                               

Liabilities:

                                               

Senior Notes payable and other debt

  $ —     $ 436   $ —     $ 530,037     $ 312,705     $ —       $ 843,178

Intercompany

    —       3,622     —       (7,802 )     4,180       —         —  

Deferred revenue

    71     —       —       10,489       2,327       —         12,887

Interest rate swap agreements

    —       —       —       16,550       —         —         16,550

Accrued dividend

    27,498     —       —       —         —         —         27,498

Accrued interest

    —       3     —       7,435       1,305       —         8,743

Accounts payable and other accrued liabilities

    2,030     175     —       19,895       4,968       393       27,461

Deferred income taxes

    30,394     —       —       —         —         —         30,394
   

 

 

 


 


 


 

Total liabilities

    59,993     4,236     —       576,604       325,485       393       966,711

Total stockholders’ equity (deficit)

    346,631     135,023     114,870     231,930       (80,691 )     (587,539 )     160,224
   

 

 

 


 


 


 

Total liabilities and stockholders’ equity (deficit)

  $ 406,624   $ 139,259   $ 114,870   $ 808,534     $ 244,794     $ (587,146 )   $ 1,126,935
   

 

 

 


 


 


 


(a) Ventas Capital is a wholly owned direct subsidiary of Ventas Realty that was formed to facilitate the offering of the Senior Notes and has no assets or operations.

 

87


Table of Contents
Index to Financial Statements

VENTAS, INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

CONDENSED CONSOLIDATING BALANCE SHEET

As of December 31, 2003

 

    Ventas,
Inc.


 

Wholly

Owned

Subsidiary

Guarantors


 

Issuers

(a)


 

Non-

Guarantor

Subsidiaries


   

Consolidated

Elimination


    Consolidated

    (In thousands)

Assets

                                       

Total net real estate investments

  $ 13,500   $ —     $ 583,207   $ 101,038     $ —       $ 697,745

Cash and cash equivalents

    47     —       82,051     6       —         82,104

Escrow deposits and restricted cash

    742     —       1,791     5,042       —         7,575

Deferred financing costs, net

    —       —       9,519     3,946       —         13,465

Notes receivable from employees

    1,716     —       2,056     —         —         3,772

Equity in affiliates

    112,573     2,205     —       —         (114,778 )     —  

Other

    315     —       7,270     604       —         8,189
   

 

 

 


 


 

Total assets

  $ 128,893   $ 2,205   $ 685,894   $ 110,636     $ (114,778 )   $ 812,850
   

 

 

 


 


 

Liabilities and stockholders’ equity (deficit)

                                       

Liabilities:

                                       

Senior Notes payable and other debt

  $ —     $ —     $ 425,138   $ 215,424     $ —       $ 640,562

Deferred revenue

    97     —       12,458     2,753       —         15,308

Interest rate swap agreements

    —       —       27,868     —         —         27,868

Accrued dividend

    21,614     —       —       —         —         21,614

Accrued interest

    —       —       5,466     355       —         5,821

Accounts payable and other accrued liabilities

    2,179     —       12,789     —         —         14,968

Deferred income taxes

    30,394     —       —       —         —         30,394
   

 

 

 


 


 

Total liabilities

    54,284     —       483,719     218,532       —         756,535

Total stockholders’ equity (deficit)

    74,609     2,205     202,175     (107,896 )     (114,778 )     56,315
   

 

 

 


 


 

Total liabilities and stockholders’ equity (deficit)

  $ 128,893   $ 2,205   $ 685,894   $ 110,636     $ (114,778 )   $ 812,850
   

 

 

 


 


 


(a) Ventas Capital is a wholly owned direct subsidiary of Ventas Realty that was formed to facilitate the offering of the Senior Notes and has no assets or operations.

 

88


Table of Contents
Index to Financial Statements

VENTAS, INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

CONDENSED CONSOLIDATING STATEMENT OF INCOME

For the year ended December 31, 2004

 

    Ventas, Inc.

 

ETOP

and ETOP

Subsidiary

Guarantors


   

Wholly

Owned

Subsidiary

Guarantors


 

Issuers

(a)


   

Non-

Guarantor

Subsidiaries


 

Consolidated

Elimination


    Consolidated

    (In thousands)

Revenues:

                                               

Rental income

  $ 2,271   $ 5,198     $ —     $ 177,745     $ 47,697   $ —       $ 232,911

Interest income from loan receivable

    —       —         —       2,958       —       —         2,958

Equity earnings in affiliates

    119,661     (426 )     3,218     —         —       (122,453 )     —  

Interest and other income

    161     11       —       703       112     —         987
   

 


 

 


 

 


 

Total revenues

    122,093     4,783       3,218     181,406       47,809     (122,453 )     236,856

Expenses:

                                               

Property-level expense

    —       —         —       142       1,195     —         1,337

General, administrative and professional fees

    487     516       17     12,484       3,413     —         16,917

Amortization of restricted stock grants

    12     27       —       928       240     —         1,207

Depreciation

    694     1,960       —       37,214       9,167     —         49,035

Interest

    —       139       —       52,125       14,553     —         66,817

Loss on extinguishment of debt

    —       —         —       1,370       —       —         1,370

Intercompany interest

    —       (110 )     —       (409 )     519     —         —  
   

 


 

 


 

 


 

Total expenses

    1,193     2,532       17     103,854       29,087     —         136,683
   

 


 

 


 

 


 

Income (loss) before discontinued operations

    120,900     2,251       3,201     77,552       18,722     (122,453 )     100,173

Discontinued operations

    —       —         —       20,727       —       —         20,727
   

 


 

 


 

 


 

Net income (loss)

  $ 120,900   $ 2,251     $ 3,201   $ 98,279     $ 18,722   $ (122,453 )   $ 120,900
   

 


 

 


 

 


 


(a) Ventas Capital is a wholly owned direct subsidiary of Ventas Realty that was formed to facilitate the offering of the Senior Notes and has no assets or operations.

 

89


Table of Contents
Index to Financial Statements

VENTAS, INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

CONDENSED CONSOLIDATING STATEMENT OF INCOME

For the year ended December 31, 2003

 

     Ventas, Inc.

   

Wholly

Owned

Subsidiary

Guarantors


  

Issuers

(a)


  

Non-

Guarantor

Subsidiaries


  

Consolidated

Elimination


    Consolidated

 
     (In thousands)  

Revenues:

                                             

Rental income

   $ 2,112     $ —      $ 154,926    $ 32,949    $ —       $ 189,987  

Interest income from loan receivable

     —         —        3,036      —        —         3,036  

Equity earnings in affiliates

     145,945       1,224      —        —        (147,169 )     —    

Interest and other income

     341       —        1,342      13      —         1,696  
    


 

  

  

  


 


Total revenues

     148,398       1,224      159,304      32,962      (147,169 )     194,719  

Expenses:

                                             

General, administrative and professional fees

     159       —        12,482      2,517      —         15,158  

Reversal of contingent liability

     (20,164 )     —        —        —        —         (20,164 )

Amortization of restricted stock grants

     13       —        1,049      212      —         1,274  

Depreciation

     694       —        33,487      5,319      —         39,500  

Net loss on swap breakage

     —         —        5,168      —        —         5,168  

Interest

     —         —        53,376      8,284      —         61,660  

Loss on extinguishment of debt

     —         —        —        84      —         84  

Interest on United States Settlement

     4,943       —        —        —        —         4,943  
    


 

  

  

  


 


Total expenses

     (14,355 )     —        105,562      16,416      —         107,623  
    


 

  

  

  


 


Operating income (loss)

     162,753       1,224      53,742      16,546      (147,169 )     87,096  

Gain on sale of Kindred common stock

     —         —        9,039      —        —         9,039  
    


 

  

  

  


 


Income (loss) before discontinued operations

     162,753       1,224      62,781      16,546      (147,169 )     96,135  

Discontinued operations

     —         —        59,713      6,905      —         66,618  
    


 

  

  

  


 


Net income (loss)

   $ 162,753     $ 1,224    $ 122,494    $ 23,451    $ (147,169 )   $ 162,753  
    


 

  

  

  


 



(a) Ventas Capital is a wholly owned direct subsidiary of Ventas Realty that was formed to facilitate the offering of the Senior Notes and has no assets or operations.

 

90


Table of Contents
Index to Financial Statements

VENTAS, INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

CONDENSED CONSOLIDATING STATEMENT OF INCOME

For the year ended December 31, 2002

 

    Ventas,
Inc.


   

Wholly

Owned

Subsidiary

Guarantors


 

Issuers

(a)


 

Non-

Guarantor

Subsidiaries


 

Consolidated

Elimination


    Consolidated

 
    (In thousands)  

Revenues:

                                         

Rental income

  $ 1,959     $ —     $ 141,011   $ 31,852   $ —       $ 174,822  

Interest income on real estate loan

    —         —       995     —       —         995  

Equity earnings in affiliates

    67,572       536     —       —       (68,108 )     —    

Interest and other income

    283       —       822     73     —         1,178  
   


 

 

 

 


 


Total revenues

    69,814       536     142,828     31,925     (68,108 )     176,995  

Expenses:

                                         

General, administrative and professional fees

    134       —       10,585     2,194     —         12,913  

Amortization of restricted stock grants

    19       —       1,519     315     —         1,853  

Depreciation

    694       —       32,206     5,329     —         38,229  

Net loss on swap breakage

    —               5,407     —       —         5,407  

Interest

    —         —       62,057     10,327     —         72,384  

Interest on United States Settlement

    5,461       —       —       —               5,461  

Loss on extinguishment of debt

    —         —       11,077     —       —         11,077  
   


 

 

 

 


 


Total expenses

    6,308       —       122,851     18,165     —         147,324  
   


 

 

 

 


 


Operating income

    63,506       536     19,977     13,760     (68,108 )     29,671  

Gain on sale of Kindred common stock

    —         —       5,014     —       —         5,014  
   


 

 

 

 


 


Income (loss) before benefit for income taxes, gain on disposal of real estate and discontinued operations

    63,506       536     24,991     13,760     (68,108 )     34,685  

Provision (benefit) for income taxes

    (2,200 )     —       —       —       —         (2,200 )
   


 

 

 

 


 


Income (loss) before gain on disposal of real estate assets and discontinued operations

    65,706       536     24,991     13,760     (68,108 )     36,885  

Net gain on real estate disposals

    —         —       64     —       —         64  
   


 

 

 

 


 


Income (loss) before discontinued operations

    65,706       536     25,055     13,760     (68,108 )     36,949  

Discontinued operations

    —         —       28,565     192     —         28,757  
   


 

 

 

 


 


Net income (loss)

  $ 65,706     $ 536   $ 53,620   $ 13,952   $ (68,108 )   $ 65,706  
   


 

 

 

 


 



(a) Ventas Capital is a wholly owned direct subsidiary of Ventas Realty that was formed to facilitate the offering of the Senior Notes and has no assets or operations.

 

91


Table of Contents
Index to Financial Statements

VENTAS, INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

For the year ended December 31, 2004

 

    Ventas,
Inc.


   

ETOP

and ETOP

Subsidiary

Guarantors


   

Wholly

Owned

Subsidiary

Guarantors


   

Issuers

(a)


   

Non-

Guarantor

Subsidiaries


   

Consolidated

Elimination


  Consolidated

 
    (In thousands)  

Net cash provided by (used in) operating activities

  $ 2,578     $ 4,260     $ (19 )   $ 112,982     $ 30,157     $ —     $ 149,958  
   


 


 


 


 


 

 


Net cash provided by (used in) investing activities

    (121,141 )     27,152       14       (205,589 )     869       —       (298,695 )
   


 


 


 


 


 

 


Cash flows from financing activities:

                                                     

Net change in borrowings under revolving credit facility

    —         —         —         39,000       —           —       39,000  

Issuance of Senior Notes

    —         —         —         125,000       —         —       125,000  

Repayment of debt

    —         (3,509 )     —         (59,100 )     (4,402 )     —       (67,011 )

Payment of deferred financing costs

    —         —         —         (5,350 )     —         —       (5,350 )

Cash distributions from affiliates

    140,205       (35,366 )     8       (79,648 )     (25,199 )     —       —    

Intercompany note issuance

    —         7,500       —         (7,500 )     —         —       —    

Issuance of common stock

    64,206       —         —         —         —         —       64,206  

Proceeds from stock option exercises

    17,676       —         —         —         —         —       17,676  

Cash dividends to stockholders

    (103,523 )     —         —         —         —         —       (103,523 )
   


 


 


 


 


 

 


Net cash provided by (used in) financing activities

    118,564       (31,375 )     8       12,402       (29,601 )     —       69,998  
   


 


 


 


 


 

 


Net increase (decrease) in cash and cash equivalents

    1       37       3       (80,205 )     1,425       —       (78,739 )

Cash and cash equivalents at beginning of period

    47       —         —         82,051       6       —       82,104  
   


 


 


 


 


 

 


Cash and cash equivalents at end of period

  $ 48     $ 37     $ 3     $ 1,846     $ 1,431     $ —     $ 3,365  
   


 


 


 


 


 

 



(a) Ventas Capital is a wholly owned direct subsidiary of Ventas Realty that was formed to facilitate the offering of the Senior Notes and has no assets or operations.

 

92


Table of Contents
Index to Financial Statements

VENTAS, INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

For the year ended December 31, 2003

 

    Ventas, Inc.

   

Wholly

Owned

Subsidiary

Guarantors


   

Issuers

(a)


   

Non-

Guarantor

Subsidiaries


   

Consolidated

Elimination


    Consolidated

 
    (In thousands)  

Net cash provided by (used in) operating activities

  $ 158,508     $ 1,224     $ 99,971     $ 24,832     $ (147,169 )   $ 137,366  
   


 


 


 


 


 


Net cash provided by (used in) investing activities

    (52 )     —         152,297       7,456       —         159,701  
   


 


 


 


 


 


Cash flows from financing activities:

                                               

Net change in borrowings under revolving credit facility

    —         —         (59,900 )     —         —         (59,900 )

Purchase of Senior Notes

    —         —         (37,366 )     —         —         (37,366 )

Repayment of debt

    —         —         —         (7,247 )     —         (7,247 )

Payment of swap breakage fee

    —         —         (8,575 )     —         —         (8,575 )

Payment on United States Settlement

    (46,647 )     —         —         —         —         (46,647 )

Payment of deferred financing costs

    —         —         (40 )     —         —         (40 )

Cash distributions from affiliates

    (54,167 )     (1,224 )     (66,742 )     (25,036 )     147,169       —    

Issuance of common stock

    22,604       —         —         —         —         22,604  

Cash dividends to stockholders

    (80,247 )     —         —         —         —         (80,247 )
   


 


 


 


 


 


Net cash provided by (used in) financing activities

    (158,457 )     (1,224 )     (172,623 )     (32,283 )     147,169       (217,418 )
   


 


 


 


 


 


Net increase (decrease) in cash and cash equivalents

    (1 )     —         79,645       5       —         79,649  

Cash and cash equivalents at beginning of period

    48       —         2,406       1       —         2,455  
   


 


 


 


 


 


Cash and cash equivalents at end of period

  $ 47     $ —       $ 82,051     $ 6     $ —       $ 82,104  
   


 


 


 


 


 



(a) Ventas Capital is a wholly owned direct subsidiary of Ventas Realty that was formed to facilitate the offering of the Senior Notes and has no assets or operations.

 

93


Table of Contents
Index to Financial Statements

VENTAS, INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

For the year ended December 31, 2002

 

    Ventas, Inc.

   

Wholly

Owned

Subsidiary

Guarantors


   

Issuers

(a)


   

Non-

Guarantor

Subsidiaries


   

Consolidated

Elimination


    Consolidated

 
    (In thousands)  

Net cash provided by (used in) operating activities

  $ 65,841     $ 536     $ 95,145     $ 22,971     $ (68,108 )   $ 116,385  
   


 


 


 


 


 


Net cash provided by (used in) investing activities

    (871 )     —         (33,269 )     —         —         (34,140 )
   


 


 


 


 


 


Cash flows from financing activities:

                                               

Net change in borrowings under revolving credit facility

    —         —         (101,301 )     —         —         (101,301 )

Proceeds from debt

    —         —         620,300       —         —         620,300  

Repayment of debt

    —         —         (16,261 )     (2,329 )     —         (18,590 )

Repayment of debt through refinancing

    —         —         (607,106 )     —         —         (607,106 )

Payment on swap breakage fee

    —         —         (12,837 )     —         —         (12,837 )

Payment on United States Settlement

    (10,755 )     —         —         —         —         (10,755 )

Payment of deferred financing costs

    —         —         (15,127 )     —         —         (15,127 )

Cash distributions from affiliates

    (102,848 )     (536 )     55,917       (20,641 )     68,108       —    

Issuance of common stock

    93,560       —         —         —         —         93,560  

Proceeds from stock option exercises

    3,595       —         —         —         —         3,595  

Cash dividends to stockholders

    (50,125 )     —         —         —         —         (50,125 )
   


 


 


 


 


 


Net cash provided by (used in) financing activities

    (66,573 )     (536 )     (76,415 )     (22,970 )     68,108       (98,386 )
   


 


 


 


 


 


Net increase (decrease) in cash and cash equivalents

    (1,603 )     —         (14,539 )     1       —         (16,141 )

Cash and cash equivalents at beginning of period

    1,651       —         16,945       —         —         18,596  
   


 


 


 


 


 


Cash and cash equivalents at end of period

  $ 48     $ —       $ 2,406     $ 1     $ —       $ 2,455  
   


 


 


 


 


 



(a) Ventas Capital is a wholly owned direct subsidiary of Ventas Realty that was formed to facilitate the offering of the Senior Notes and has no assets or operations.

 

94


Table of Contents
Index to Financial Statements

VENTAS, INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

Note 18—ETOP Condensed Consolidating Information

 

ETOP, which is a greater than 99% owned indirect subsidiary of Ventas, Inc., and the ETOP Subsidiary Guarantors have provided full and unconditional guarantees, on a joint and several basis with us and certain of our direct and indirect wholly owned subsidiaries, of the obligation to pay principal and interest with respect to the Senior Notes. See “Note 17—Condensed Consolidating Information.” Certain of ETOP’s other direct and indirect wholly owned subsidiaries (the “ETOP Non-Guarantor Subsidiaries”) that have not provided the Guarantee of the Senior Notes are therefore not directly obligated with respect to the Senior Notes.

 

Contractual and legal restrictions, including those contained in the instruments governing certain of the ETOP Non-Guarantor Subsidiaries’ outstanding indebtedness, may under certain circumstances restrict ETOP’s (and therefore our) ability to obtain cash from the ETOP Non-Guarantor Subsidiaries for the purpose of satisfying the debt service obligations of ETOP and Ventas including ETOP’s and our guarantee of payment of principal and interest on the Senior Notes. See “Note 7—Borrowing Arrangements.” Certain of the ETOP Subsidiary Guarantors’ properties are subject to mortgages.

 

For comparative purposes, the ETOP Condensed Consolidating Financial Statements for the periods prior to the ElderTrust merger are presented as “Predecessor Company” financial statements and are not included as part of our Condensed Consolidating Financial Statements for those periods.

 

95


Table of Contents
Index to Financial Statements

VENTAS, INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

CONDENSED CONSOLIDATING BALANCE SHEET

As of December 31, 2004

 

    

ETOP and

ETOP

Subsidiary
Guarantors


    ETOP
Non-Guarantor
Subsidiaries


  

Consolidated

Elimination


    Consolidated

     (In thousands)

Assets

                             

Total net real estate investments

   $ 58,339     $ 97,404    $ —       $ 155,743

Cash and cash equivalents

     37       1,173      —         1,210

Restricted cash

     138       6,567      —         6,705

Equity in affiliates

     80,447       15      (80,462 )     —  

Other assets

     298       592      —         890
    


 

  


 

Total assets

   $ 139,259     $ 105,751    $ (80,462 )   $ 164,548
    


 

  


 

Liabilities and partners’ equity (deficit)

                             

Liabilities:

                             

Notes payable and other debt

   $ 436     $ 77,297    $ —       $ 77,733

Intercompany

     (4,180 )     4,180      —         —  

Note payable to affiliate

     7,802       —        —         7,802

Accrued interest

     3       700      —         703

Accounts payable and other accrued liabilities

     175       3,148      —         3,323
    


 

  


 

Total liabilities

     4,236       85,325      —         89,561

Total partners’ equity (deficit)

     135,023       20,426      (80,462 )     74,987
    


 

  


 

Total liabilities and partners’ equity (deficit)

   $ 139,259     $ 105,751    $ (80,462 )   $ 164,548
    


 

  


 

 

96


Table of Contents
Index to Financial Statements

VENTAS, INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

PREDECESSOR COMPANY CONDENSED CONSOLIDATING BALANCE SHEET

As of December 31, 2003

(unaudited)

 

    

ETOP and

ETOP

Subsidiary
Guarantors


   

ETOP

Non-Guarantor
Subsidiaries


   

Consolidated

Elimination


    Consolidated

 
     (In thousands)  

Assets

                                

Total net real estate investments

   $ 59,193     $ 91,456     $ —       $ 150,649  

Property held for sale

     4,971       —         —         4,971  

Cash and cash equivalents

     24,848       821       —         25,669  

Restricted cash

     673       4,774       —         5,447  

Accounts receivable from affiliated entities

     9,801       (6,263 )     —         3,538  

Equity in affiliates

     52,481       5       (52,486 )     —    

Other assets

     963       1,161       —         2,124  
    


 


 


 


Total assets

   $ 152,930     $ 91,954     $ (52,486 )   $ 192,398  
    


 


 


 


Liabilities and partners’ equity (deficit)

                                

Liabilities:

                                

Notes payable and other debt and lease obligations

   $ 3,964     $ 80,481     $ —       $ 84,445  

Liabilities associated with assets held for sale

     2,597       —         —         2,597  

Accounts payable and other accrued liabilities

     9,060       6,167       —         15,227  
    


 


 


 


Total liabilities

     15,621       86,648       —         102,269  

Minority interest

     (24 )     —         —         (24 )

Total partners’ equity (deficit)

     137,333       5,306       (52,486 )     90,153  
    


 


 


 


Total liabilities and partners’ equity (deficit)

   $ 152,930     $ 91,954     $ (52,486 )   $ 192,398  
    


 


 


 


 

97


Table of Contents
Index to Financial Statements

VENTAS, INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

CONDENSED CONSOLIDATING STATEMENT OF INCOME

For the period from February 5, 2004 through December 31, 2004

 

     ETOP and
ETOP
Subsidiary
Guarantors


   

ETOP

Non-Guarantor
Subsidiaries


   

Consolidated

Elimination


   Consolidated

     (In thousands)

Revenues:

                             

Rental income

   $ 5,198     $ 10,559     $ —      $ 15,757

Interest and other income

     11       104       —        115

Equity earnings in affiliates

     (426 )     —         426      —  
    


 


 

  

Total revenues

     4,783       10,663       426      15,872

Expenses:

                             

Property-level expense

     —         1,161       —        1,161

General, administrative and professional fees

     516       769       —        1,285

Amortization of restricted stock grants

     27       48       —        75

Depreciation

     1,960       3,066       —        5,026

Interest

     139       5,526       —        5,665

Intercompany interest

     (110 )     519       —        409
    


 


 

  

Total expenses

     2,532       11,089       —        13,621
    


 


 

  

Net income (loss)

   $ 2,251     $ (426 )   $   426    $ 2,251
    


 


 

  

 

98


Table of Contents
Index to Financial Statements

VENTAS, INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

PREDECESSOR COMPANY CONDENSED CONSOLIDATING STATEMENT OF INCOME

For the period from January 1, 2004 through February 4, 2004

 

     ETOP and
ETOP
Subsidiary
Guarantors


   ETOP
Non-Guarantor
Subsidiaries


  

Consolidated

Elimination


    Consolidated

     (In thousands)

Revenues:

                            

Rental income

   $ 507    $ 1,005    $ —       $ 1,512

Interest and other income

     113      10      (63 )     60

Equity earnings in affiliates

     66      —        (66 )     —  
    

  

  


 

Total revenues

     686      1,015      (129 )     1,572

Expenses:

                            

Property-level expense

     —        101      —         101

General and administrative

     182      18      —         200

Depreciation

     192      295      —         487

Interest

     40      509      —         549

Intercompany interest

     37      26      (63 )     —  

Loss on sale of fixed assets

     10      —        —         10

Loss on extinguishment of debt

     8      —        —         8
    

  

  


 

Total expenses

     469      949      (63 )     1,355
    

  

  


 

Income (loss) before discontinued operations

     217      66      (66 )     217

Discontinued operations

     414      —        —         414
    

  

  


 

Net income (loss)

   $ 631    $ 66    $ (66 )   $ 631
    

  

  


 

 

99


Table of Contents
Index to Financial Statements

VENTAS, INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

PREDECESSOR COMPANY CONDENSED CONSOLIDATING STATEMENT OF INCOME

For the year ended December 31, 2003

(unaudited)

 

     ETOP and
ETOP
Subsidiary
Guarantors


   

ETOP

Non-Guarantor
Subsidiaries


   Consolidated
Elimination


    Consolidated

 
     (In thousands)  

Revenues:

                               

Rental income

   $ 6,385     $ 12,335    $ —       $ 18,720  

Interest and other income

     198       108      —         306  

Intercompany interest income

     4,816       —        (4,816 )     —    

Equity earnings in affiliates

     481       —        (481 )     —    
    


 

  


 


Total revenues

     11,880       12,443      (5,297 )     19,026  

Expenses:

                               

Property-level expense

     —         1,229      —         1,229  

General and administrative

     2,358       275      —         2,633  

Severance expense

     1,270       —        —         1,270  

Depreciation

     2,345       3,493      —         5,838  

Interest

     2,043       5,976      —         8,019  

Intercompany interest

     669       989      (1,658 )     —    

Gain on extinguishment of debt

     (1,039 )     —        —         (1,039 )
    


 

  


 


Total expenses

     7,646       11,962      (1,658 )     17,950  
    


 

  


 


Income (loss) before discontinued operations

     4,234       481      (3,639 )     1,076  

Discontinued operations

     133       —        3,241       3,374  
    


 

  


 


Net income (loss)

   $ 4,367     $ 481    $ (398 )   $ 4,450  
    


 

  


 


 

100


Table of Contents
Index to Financial Statements

VENTAS, INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

PREDECESSOR COMPANY CONDENSED CONSOLIDATING STATEMENT OF INCOME

For the year ended December 31, 2002

(unaudited)

 

     ETOP and
ETOP
Subsidiary
Guarantors


    ETOP
Non-Guarantor
Subsidiaries


   Consolidated
Elimination


    Consolidated

 
     (In thousands)  

Revenues:

                               

Rental income

   $ 6,646     $ 9,584    $ —       $ 16,230  

Interest and other income

     1,241       51      —         1,292  

Intercompany interest income

     2,020       —        (2,020 )     —    

Equity earnings in affiliates

     447       —        (447 )     —    
    


 

  


 


Total revenues

     10,354       9,635      (2,467 )     17,522  

Expenses:

                               

Property-level expense

     128       1,161      —         1,289  

General and administrative

     2,098       210      —         2,308  

Depreciation

     2,372       2,679      —         5,051  

Interest

     2,974       4,800      —         7,774  

Intercompany interest

     —         338      (338 )     —    
    


 

  


 


Total expenses

     7,572       9,188      (338 )     16,422  
    


 

  


 


Operating income

     2,782       447      (2,129 )     1,100  

Equity in losses of unconsolidated entities

     (21 )     —        —         (21 )
    


 

  


 


Income (loss) before discontinued operations

     2,761       447      (2,129 )     1,079  

Discontinued operations

     (2,948 )     —        2,612       (336 )
    


 

  


 


Net income (loss)

   $ (187 )   $ 447    $ 483     $ 743  
    


 

  


 


 

101


Table of Contents
Index to Financial Statements

VENTAS, INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

For the period from February 5, 2004 through December 31, 2004

 

     ETOP and
ETOP
Subsidiary
Guarantors


   

ETOP

Non-Guarantor
Subsidiaries


   

Consolidated

Elimination


   Consolidated

 
     (In thousands)  

Net cash provided by operating activities

   $ 4,260     $ 3,108     $   —      $ 7,368  
    


 


 

  


Net cash used in investing activities

     —         (83 )     —        (83 )
    


 


 

  


Cash flows from financing activities:

                               

Repayment of debt

     (3,509 )     (1,169 )     —        (4,678 )

Issuance of note payable

     7,500       —         —        7,500  

Partner distribution

     (35,366 )     (1,551 )     —        (36,917 )
    


 


 

  


Net cash used in financing activities

     (31,375 )     (2,720 )     —        (34,095 )
    


 


 

  


Net increase (decrease) in cash and cash equivalents

     (27,115 )     305       —        (26,810 )

Cash and cash equivalents at beginning of period

     27,152       868       —        28,020  
    


 


 

  


Cash and cash equivalents at end of period

   $ 37     $ 1,173     $ —      $ 1,210  
    


 


 

  


 

102


Table of Contents
Index to Financial Statements

VENTAS, INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

PREDECESSOR COMPANY CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

For the period from January 1, 2004 through February 4, 2004

 

     ETOP and
ETOP
Subsidiary
Guarantors


    ETOP
Non-Guarantor
Subsidiaries


   

Consolidated

Elimination


   Consolidated

 
     (In thousands)  

Net cash provided by operating activities

   $ 820     $ 260     $   —      $ 1,080  
    


 


 

  


Net cash provided by investing activities

     2,806       —         —        2,806  
    


 


 

  


Cash flows from financing activities:

                               

Cash distribution to unitholders

     (1,293 )     —         —        (1,293 )

Payments on mortgages payable

     (30 )     (212 )     —        (242 )
    


 


 

  


Net cash used in financing activities

     (1,323 )     (212 )     —        (1,535 )
    


 


 

  


Net increase (decrease) in cash and cash equivalents

     2,303       48       —        2,351  

Cash and cash equivalents at beginning of period

     24,848       821       —        25,669  
    


 


 

  


Cash and cash equivalents at end of period

   $ 27,151     $ 869     $ —      $ 28,020  
    


 


 

  


 

103


Table of Contents
Index to Financial Statements

VENTAS, INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

PREDECESSOR COMPANY CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

For the year ended December 31, 2003

(unaudited)

 

    

ETOP

and ETOP
Subsidiary
Guarantors


   

ETOP

Non-Guarantor
Subsidiaries


   

Consolidated

Elimination


   Consolidated

 
     (In thousands)  

Net cash provided by operating activities

   $ 23,429     $ 2,617     $   —      $ 26,046  
    


 


 

  


Net cash provided by (used in) investing activities

     34,258       (293 )     —        33,965  
    


 


 

  


Cash flows from financing activities:

                               

Issuance of partnership units

     (112 )     —         —        (112 )

Distributions to unitholders

     (3,855 )     —         —        (3,855 )

Payments on mortgages payable

     (36,533 )     (1,154 )     —        (37,687 )
    


 


 

  


Net cash used in financing activities

     (40,500 )     (1,154 )     —        (41,654 )
    


 


 

  


Net increase (decrease) in cash and cash equivalents

     17,187       1,170       —        18,357  

Cash and cash equivalents at beginning of period

     6,906       473       —        7,379  
    


 


 

  


Cash and cash equivalents at end of period

   $ 24,093     $ 1,643     $ —      $ 25,736  
    


 


 

  


 

104


Table of Contents
Index to Financial Statements

VENTAS, INC.

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 

PREDECESSOR COMPANY CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

For the year ended December 31, 2002

(unaudited)

 

    

ETOP

and ETOP
Subsidiary
Guarantors


    ETOP
Non-Guarantor
Subsidiaries


   

Consolidated

Elimination


   Consolidated

 
     (In thousands)  

Net cash provided by operating activities

   $ 5,044     $ 3,701     $   —      $ 8,745  
    


 


 

  


Net cash provided by (used in) investing activities

     922       (340 )     —        582  
    


 


 

  


Cash flows from financing activities:

                               

Proceeds from (payments on) mortgages payable

     (10,739 )     4,034       —        (6,705 )
    


 


 

  


Net cash provided by (used in) financing activities

     (10,739 )     4,034       —        (6,705 )
    


 


 

  


Net increase (decrease) in cash and cash equivalents

     (4,773 )     7,395       —        2,622  

Cash and cash equivalents at beginning of period

     2,016       640       —        2,656  
    


 


 

  


Cash and cash equivalents at end of period

   $ (2,757 )   $ 8,035     $ —      $ 5,278  
    


 


 

  


 

105


Table of Contents
Index to Financial Statements

VENTAS, INC.

 

SCHEDULE III

REAL ESTATE AND ACCUMULATED DEPRECIATION

December 31, 2004

(Dollars in Thousands)

 

Facility name


  Location

 

Initial Cost to

Company


  Cost
Capitalized
Subsequent
to
Acquisition


 

Gross Amount
Carried at Close

of Period


  Accumulated
Depreciation


  Date of
Construction


  Date
Acquired


  Life on
Which
Depreciation
in Income
Statement is
Computed


  City

  State

  Land

 

Buildings
and
Improve-

ments


    Land

 

Buildings
and
Improve-

ments


       

KINDRED SKILLED NURSING FACILITIES

                                                       

Rehab. & Healthc. Ctr. of Huntsville

  Huntsville   AL   $ 534   $ 4,216   $ —     $ 534   $ 4,216   $ 2,294   1968   1991   25 years

Rehab. & Healthc. Ctr. of Birmingham

  Birmingham   AL     —       1,921     —       —       1,921     1,385   1971   1992   20 years

Rehab. & Healthcare Ctr. of Mobile

  Mobile   AL     5     2,981     —       5     2,981     1,352   1967   1992   29 years

Valley Healthcare & Rehab. Center

  Tucson   AZ     383     1,954     —       383     1,954     963   1964   1993   28 years

Sonoran Rehab & Care Center

  Phoenix   AZ     781     2,755     —       781     2,755     1,206   1962   1992   29 years

Desert Life Rehab & Care Center

  Tucson   AZ     611     5,117     —       611     5,117     3,026   1979   1982   37 years

Villa Campana Health Center

  Tucson   AZ     533     2,201     —       533     2,201     833   1983   1993   35 years

Kachina Point Health Care & Rehab.

  Sedona   AZ     364     4,179     —       364     4,179     2,081   1983   1984   45 years

Nob Hill Healthcare Center

  San Francisco   CA     1,902     7,531     —       1,902     7,531     3,370   1967   1993   28 years

Canyonwood Nursing & Rehab. Ctr.

  Redding   CA     401     3,784     —       401     3,784     1,338   1989   1989   45 years

Californian Care Center

  Bakersfield   CA     1,439     5,609     —       1,439     5,609     1,844   1988   1992   40 years

Magnolia Gardens Care Center

  Burlingame   CA     1,832     3,186     —       1,832     3,186     1,412   1955   1993   28.5 years

Lawton Healthcare Center

  San Francisco   CA     943     514     —       943     514     314   1962   1996   20 years

Valley Gardens HC & Rehab.

  Stockton   CA     516     3,405     —       516     3,405     1,320   1988   1988   29 years

Alta Vista Healthcare Center

  Riverside   CA     376     1,669     —       376     1,669     838   1966   1992   29 years

Maywood Acres Healthcare Center

  Oxnard   CA     465     2,363     —       465     2,363     1,065   1964   1993   29 years

La Veta Healthcare Center

  Orange   CA     47     1,459     —       47     1,459     672   1964   1992   28 years

Bay View Nursing & Rehab. Center

  Alameda   CA     1,462     5,981     —       1,462     5,981     2,686   1967   1993   45 years

Village Square Nsg. & Rehab. Ctr.

  San Marcos   CA     766     3,507     —       766     3,507     997   1989   1993   42 years

Cherry Hills Health Care Center

  Englewood   CO     241     2,180     —       241     2,180     1,079   1960   1995   30 years

Aurora Care Center

  Aurora   CO     197     2,328     —       197     2,328     1,006   1962   1995   30 years

Castle Garden Care Center

  Northglenn   CO     501     8,294     —       501     8,294     3,440   1971   1993   29 years

Brighton Care Center

  Brighton   CO     282     3,377     —       282     3,377     1,453   1969   1992   30 years

Andrew House Healthcare

  New Britain   CT     247     1,963     —       247     1,963     814   1967   1992   29 years

Camelot Nursing & Rehab. Center

  New London   CT     202     2,363     —       202     2,363     983   1969   1994   28 years

Windsor Rehab. & Healthcare Center

  Windsor   CT     368     2,520     —       368     2,520     1,177   1965   1994   30 years

Nutmeg Pavilion Healthcare

  New London   CT     401     2,777     —       401     2,777     1,322   1968   1992   29 years

Parkway Pavilion Healthcare

  Enfield   CT     337     3,607     —       337     3,607     1,684   1968   1994   28 years

Courtland Gardens Health Ctr., Inc.

  Stamford   CT     1,126     9,399     —       1,126     9,399     1,948   1956   1990   45 years

Savannah Rehab. & Nursing Center

  Savannah   GA     213     2,772     —       213     2,772     1,217   1968   1993   28.5 years

 

106


Table of Contents
Index to Financial Statements

VENTAS, INC.

 

SCHEDULE III

REAL ESTATE AND ACCUMULATED DEPRECIATION

December 31, 2004

(Dollars in Thousands)

 

Facility name


  Location

 

Initial Cost to

Company


  Cost
Capitalized
Subsequent
to
Acquisition


 

Gross Amount
Carried at Close

of Period


  Accumulated
Depreciation


  Date of
Construction


  Date
Acquired


  Life on
Which
Depreciation
in Income
Statement is
Computed


  City

  State

  Land

 

Buildings
and
Improve-

ments


    Land

 

Buildings
and
Improve-

ments


       

Specialty Care of Marietta

  Marietta   GA   241   2,782   —     241   2,782   1,330   1968   1993   28.5 years

Savannah Specialty Care Center

  Savannah   GA   157   2,219   —     157   2,219   1,130   1972   1991   26 years

Lafayette Nsg. & Rehab. Ctr.

  Fayetteville   GA   598   6,623   —     598   6,623   2,726   1989   1995   20 years

Tucker Nursing Center

  Tucker   GA   512   8,153   —     512   8,153   1,652   1972   1997   45 years

Hillcrest Rehab. Care Center

  Boise   ID   256   3,593   —     256   3,593   857   1977   1998   45 years

Cascade Care Center

  Caldwell   ID   312   2,050   —     312   2,050   541   1974   1998   45 years

Emmett Rehabilitation and Healthcare

  Emmett   ID   185   1,670   —     185   1,670   1,317   1960   1984   28 years

Lewiston Rehabilitation and Care Ctr.

  Lewiston   ID   133   3,982   —     133   3,982   1,993   1964   1984   29 years

Nampa Care Center

  Nampa   ID   252   2,810   —     252   2,810   2,212   1950   1983   25 years

Weiser Rehabilitation and Care Ctr.

  Weiser   ID   157   1,760   —     157   1,760   1,536   1963   1983   25 years

Moscow Care Center

  Moscow   ID   261   2,571   —     261   2,571   1,477   1955   1990   25 years

Mountain Valley Care and Rehab.

  Kellogg   ID   68   1,281   —     68   1,281   1,048   1971   1984   25 years

Rolling Hills Health Care Center

  New Albany   IN   81   1,894   —     81   1,894   878   1984   1993   25 years

Royal Oaks Healthcare & Rehab Ctr.

  Terre Haute   IN   418   5,779   —     418   5,779   1,296   1995   1995   45 years

Southwood Health & Rehab Center

  Terre Haute   IN   90   2,868   —     90   2,868   1,270   1988   1993   25 years

Kindred Corydon

  Corydon   IN   125   6,068   —     125   6,068   902   N/A   1998   45 years

Valley View Health Care Center

  Elkhart   IN   87   2,665   —     87   2,665   1,216   1985   1993   25 years

Wildwood Healthcare Center

  Indianapolis   IN   134   4,983   —     134   4,983   2,195   1988   1993   25 years

Meadowvale Health & Rehab. Ctr.

  Bluffton   IN   7   787   —     7   787   277   1962   1995   22 years

Columbia Healthcare Facility

  Evansville   IN   416   6,317   —     416   6,317   2,332   1983   1993   35 years

Bremen Health Care Center

  Bremen   IN   109   3,354   —     109   3,354   1,220   1982   1996   45 years

Windsor Estates Health & Rehab Ctr

  Kokomo   IN   256   6,625   —     256   6,625   2,207   1962   1995   35 years

Muncie Health Care & Rehab.

  Muncie   IN   108   4,202   —     108   4,202   1,775   1980   1993   25 years

Parkwood Health Care Center

  Lebanon   IN   121   4,512   —     121   4,512   1,942   1977   1993   25 years

Wedgewood Healthcare Center

  Clarksville   IN   119   5,115   —     119   5,115   1,630   1985   1995   35 years

Westview Nursing & Rehab. Center

  Bedford   IN   255   4,207   —     255   4,207   1,728   1970   1993   29 years

Columbus Health & Rehab. Center

  Columbus   IN   345   6,817   —     345   6,817   3,609   1966   1991   25 years

Rosewood Health Care Center

  Bowling Green   KY   248   5,371   —     248   5,371   2,554   1970   1990   30 years

Oakview Nursing & Rehab. Ctr.

  Calvert City   KY   124   2,882   —     124   2,882   1,368   1967   1990   30 years

Cedars of Lebanon Nursing Center

  Lebanon   KY   40   1,253   —     40   1,253   594   1930   1990   30 years

Winchester Centre for Health/Rehab.

  Winchester   KY   137   6,120   —     137   6,120   2,879   1967   1990   30 years

 

107


Table of Contents
Index to Financial Statements

VENTAS, INC.

 

SCHEDULE III

REAL ESTATE AND ACCUMULATED DEPRECIATION

December 31, 2004

(Dollars in Thousands)

 

Facility name


  Location

 

Initial Cost to

Company


  Cost
Capitalized
Subsequent
to
Acquisition


 

Gross Amount
Carried at Close

of Period


  Accumulated
Depreciation


  Date of
Construction


  Date
Acquired


  Life on
Which
Depreciation
in Income
Statement is
Computed


  City

  State

  Land

 

Buildings
and
Improve-

ments


    Land

 

Buildings
and
Improve-

ments


       

Riverside Manor Health Care

  Calhoun   KY   103   2,119   —     103   2,119   1,018   1963   1990   30 years

Maple Manor Healthcare Center

  Greenville   KY   59   3,187   —     59   3,187   1,526   1968   1990   30 years

Danville Centre for Health & Rehab.

  Danville   KY   322   3,538   —     322   3,538   1,361   1962   1995   30 years

Northfield Centre for Health & Rehab.

  Louisville   KY   285   1,555   —     285   1,555   834   1969   1985   30 years

Hillcrest Health Care Center

  Owensboro   KY   544   2,619   —     544   2,619   2,456   1963   1982   22 years

Woodland Terrace Health Care Fac.

  Elizabethtown   KY   216   1,795   —     216   1,795   1,622   1969   1982   26 years

Harrodsburg Health Care Center

  Harrodsburg   KY   137   1,830   —     137   1,830   1,094   1974   1985   35 years

Laurel Ridge Rehab. & Nursing Ctr.

  Jamaica Plain   MA   194   1,617   —     194   1,617   872   1968   1989   30 years

Blue Hills Alzheimer’s Care Center

  Stoughton   MA   511   1,026   —     511   1,026   1,015   1965   1982   28 years

Brigham Manor Nursing & Rehab Ctr

  Newburyport   MA   126   1,708   —     126   1,708   1,065   1806   1982   27 years

Presentation Nursing & Rehab. Ctr.

  Brighton   MA   184   1,220   —     184   1,220   1,009   1968   1982   28 years

Country Manor Rehab. & Nsg. Center

  Newburyport   MA   199   3,004   —     199   3,004   1,841   1968   1982   27 years

Crawford Skilled Nsg. & Rehab. Ctr.

  Fall River   MA   127   1,109   —     127   1,109   850   1968   1982   29 years

Hallmark Nursing & Rehab. Ctr.

  New Bedford   MA   202   2,694   —     202   2,694   1,717   1968   1982   26 years

Sachem Nursing & Rehab. Ctr.

  East Bridgewater   MA   529   1,238   —     529   1,238   1,166   1968   1982   27 years

Hammersmith House Nsg. Care Ctr.

  Saugus   MA   112   1,919   —     112   1,919   1,127   1965   1982   28 years

Oakwood Rehab. & Nursing Center

  Webster   MA   102   1,154   —     102   1,154   876   1967   1982   31 years

Timberlyn Heights Nsg. & Alz. Ctr.

  Great Barrington   MA   120   1,305   —     120   1,305   963   1968   1982   29 years

Brittany Healthcare Center

  Natick   MA   249   1,328   —     249   1,328   953   1996   1982   31 years

Bolton Manor Nursing Home

  Marlborough   MA   222   2,431   —     222   2,431   1,521   1973   1984   34.5 years

Hillcrest Nursing Home

  Fitchburg   MA   175   1,461   —     175   1,461   1,226   1957   1984   25 years

Country Gardens Sk. Nsg. & Rehab.

  Swansea   MA   415   2,675   —     415   2,675   1,621   1969   1984   27 years

Quincy Rehab. & Nursing Center

  Quincy   MA   216   2,911   —     216   2,911   2,115   1965   1984   24 years

Newton and Wellesley Alzheimer Ctr.

  Wellesley   MA   297   3,250   —     297   3,250   1,841   1971   1984   30 years

Den-Mar Rehab. & Nursing Center

  Rockport   MA   23   1,560   —     23   1,560   1,026   1963   1985   30 years

Eagle Pond Rehab. & Living Center

  South Dennis   MA   296   6,896   —     296   6,896   2,544   1985   1987   50 years

Blueberry Hill Healthcare

  Beverly   MA   129   4,290   —     129   4,290   2,393   1965   1968   40 years

Colony House Nsg. & Rehab. Ctr.

  Abington   MA   132   999   —     132   999   879   1965   1969   40 years

Embassy House Sk. Nsg. & Rehab.

  Brockton   MA   166   1,004   —     166   1,004   810   1968   1969   40 years

Franklin Sk. Nsg. & Rehab. Center

  Franklin   MA   156   757   —     156   757   667   1967   1969   40 years

Great Barrington Rehab. & Nsg. Ctr.

  Great Barrington   MA   60   1,142   —     60   1,142   954   1967   1969   40 years

River Terrace

  Lancaster   MA   268   957   —     268   957   894   1969   1969   40 years

 

108


Table of Contents
Index to Financial Statements

VENTAS, INC.

 

SCHEDULE III

REAL ESTATE AND ACCUMULATED DEPRECIATION

December 31, 2004

(Dollars in Thousands)

 

Facility name


  Location

 

Initial Cost to

Company


  Cost
Capitalized
Subsequent
to
Acquisition


 

Gross Amount
Carried at Close

of Period


  Accumulated
Depreciation


  Date of
Construction


  Date
Acquired


  Life on
Which
Depreciation
in Income
Statement is
Computed


  City

  State

  Land

 

Buildings
and
Improve-

ments


    Land

 

Buildings
and
Improve-

ments


       

Walden Rehab. & Nursing Center

  Concord   MA   181   1,347   —     181   1,347   1,173   1969   1968   40 years

Harrington House Nsg. & Rehab. Ctr.

  Walpole   MA   4   4,444   —     4   4,444   1,380   1991   1991   45 years

Augusta Rehabilitation Center

  Augusta   ME   152   1,074   —     152   1,074   710   1968   1985   30 years

Eastside Rehab. and Living Center

  Bangor   ME   316   1,349   —     316   1,349   789   1967   1985   30 years

Winship Green Nursing Center

  Bath   ME   110   1,455   —     110   1,455   830   1974   1985   35 years

Brewer Rehabilitation & Living Center

  Brewer   ME   228   2,737   —     228   2,737   1,424   1974   1985   33 years

Kennebunk Nursing Center

  Kennebunk   ME   99   1,898   —     99   1,898   983   1977   1985   35 years

Norway Rehabilitation & Living Center

  Norway   ME   133   1,658   —     133   1,658   881   1972   1985   39 years

Shore Village Rehab. & Nursing Ctr.

  Rockland   ME   100   1,051   —     100   1,051   681   1968   1985   30 years

Westgate Manor

  Bangor   ME   287   2,718   —     287   2,718   1,526   1969   1985   31 years

Brentwood Rehab. & Nsg. Center

  Yarmouth   ME   181   2,789   —     181   2,789   1,504   1945   1985   45 years

Fieldcrest Manor Nursing Home

  Waldoboro   ME   101   1,020   —     101   1,020   685   1963   1985   32 years

Park Place Health Care Center

  Great Falls   MT   600   6,311   —     600   6,311   2,768   1963   1993   28 years

Parkview Acres Care & Rehab Ctr.

  Dillon   MT   207   2,578   —     207   2,578   1,136   1965   1993   29 years

Pettigrew Rehab. & Healthcare Ctr.

  Durham   NC   101   2,889   —     101   2,889   1,332   1969   1993   28 years

LaSalle Healthcare Center

  Durham   NC   140   3,238   —     140   3,238   1,353   1969   1993   29 years

Sunnybrook & HC Rehab. Spec.

  Raleigh   NC   187   3,409   —     187   3,409   1,816   1971   1991   25 years

Blue Ridge Rehab. & Healthcare Ctr.

  Asheville   NC   250   3,819   —     250   3,819   1,580   1977   1991   32 years

Raleigh Rehab. & Healthcare Center

  Raleigh   NC   316   5,470   —     316   5,470   2,906   1969   1991   25 years

Rose Manor Health Care Center

  Durham   NC   201   3,527   —     201   3,527   1,801   1972   1991   26 years

Cypress Pointe Rehab & HC Center

  Winmington   NC   233   3,710   —     233   3,710   1,760   1966   1993   28.5 years

Winston-Salem Rehab & HC Center

  Winston-Salem   NC   305   5,142   —     305   5,142   2,711   1968   1991   25 years

Silas Creek Manor

  Winston-Salem   NC   211   1,893   —     211   1,893   842   1966   1993   28.5 years

Lincoln Nursing Center

  Lincoln   NC   39   3,309   —     39   3,309   1,761   1976   1986   35 years

Guardian Care of Roanoke Rapids

  Roanoke Rapids   NC   339   4,132   —     339   4,132   2,142   1967   1991   25 years

Guardian Care of Henderson

  Henderson   NC   206   1,997   —     206   1,997   883   1957   1993   29 years

Rehab. & Nursing Center of Monroe

  Monroe   NC   185   2,654   —     185   2,654   1,311   1963   1993   28 years

Guardian Care of Kinston

  Kinston   NC   186   3,038   —     186   3,038   1,306   1961   1993   29 years

Guardian Care of Zebulon

  Zebulon   NC   179   1,933   —     179   1,933   853   1973   1993   29 years

Guardian Care of Rocky Mount.

  Rocky Mount   NC   240   1,733   —     240   1,733   942   1975   1997   25 years

Rehab. & Health Center of Gastonia

  Gastonia   NC   158   2,359   —     158   2,359   1,111   1968   1992   29 years

Guardian Care of Elizabeth City

  Elizabeth City   NC   71   561   —     71   561   627   1977   1982   20 years

 

109


Table of Contents
Index to Financial Statements

VENTAS, INC.

 

SCHEDULE III

REAL ESTATE AND ACCUMULATED DEPRECIATION

December 31, 2004

(Dollars in Thousands)

 

Facility name


  Location

 

Initial Cost to

Company


  Cost
Capitalized
Subsequent
to
Acquisition


 

Gross Amount
Carried at Close

of Period


  Accumulated
Depreciation


  Date of
Construction


  Date
Acquired


  Life on
Which
Depreciation
in Income
Statement is
Computed


  City

  State

  Land

 

Buildings
and
Improve-

ments


    Land

 

Buildings
and
Improve-

ments


       

Chapel Hill Rehab. & Healthcare Ctr.

  Chapel Hill   NC   347   3,029   —     347   3,029   1,432   1984   1993   28 years

Homestead Health Care & Rehab Ctr

  Lincoln   NE   277   1,528   1,178   277   2,706   1,936   1961   1994   45 years

Dover Rehab. & Living Center

  Dover   NH   355   3,797   —     355   3,797   2,222   1969   1990   25 years

Greenbriar Terrace Healthcare

  Nashua   NH   776   6,011   —     776   6,011   3,230   1963   1990   25 years

Hanover Terrace Healthcare

  Hanover   NH   326   1,825   —     326   1,825   792   1969   1993   29 years

Las Vegas Healthcare & Rehab. Ctr.

  Las Vegas   NV   454   1,018   —     454   1,018   350   1940   1992   30 years

Torrey Pines Care Center

  Las Vegas   NV   256   1,324   —     256   1,324   622   1971   1992   29 years

Franklin Woods Health Care Center

  Columbus   OH   190   4,712   —     190   4,712   1,637   1986   1992   38 years

Chillicothe Nursing & Rehab. Center

  Chillecothe   OH   128   3,481   —     128   3,481   1,918   1976   1985   34 years

Pickerington Nursing & Rehab. Ctr.

  Pickerington   OH   312   4,382   —     312   4,382   1,515   1984   1992   37 years

Logan Health Care Center

  Logan   OH   169   3,750   —     169   3,750   1,665   1979   1991   30 years

Winchester Place Nsg. & Rehab. Ctr.

  Canal Winchestr.   OH   454   7,149   —     454   7,149   3,724   1974   1993   28 years

Minerva Park Nursing & Rehab. Ctr.

  Columbus   OH   210   3,684   —     210   3,684   871   1973   1997   45 years

West Lafayette Rehab & Nsg Ctr

  West Lafayette   OH   185   3,278   —     185   3,278   1,014   1972   1996   45 years

Cambridge Health & Rehab. Center

  Cambridge   OH   108   2,642   —     108   2,642   1,221   1975   1993   25 years

Coshocton Health & Rehab. Center

  Coshocton   OH   203   1,979   —     203   1,979   911   1974   1993   25 years

Bridgepark Ctr. for Rehab. & Nsg. Sv.

  Akron   OH   341   5,491   —     341   5,491   2,502   1970   1993   28 years

Lebanon Country Manor

  Lebanon   OH   105   3,617   —     105   3,617   1,585   1984   1986   43 years

Sunnyside Care Center

  Salem   OR   1,519   2,688   —     1,519   2,688   1,136   1981   1991   30 years

Medford Rehab. & Healthcare Center

  Medford   OR   362   4,610   —     362   4,610   2,038   N/A   1991   34 years

Wyomissing Nsg. & Rehab. Ctr.

  Reading   PA   61   5,095   —     61   5,095   1,052   1966   1993   45 years

Health Havens Nursing & Rehab. Ctr.

  E. Providence   RI   174   2,643   —     174   2,643   563   1962   1990   45 years

Oak Hill Nursing & Rehab. Ctr.

  Pawtucket   RI   91   6,724   —     91   6,724   1,404   1966   1990   45 years

Madison Healthcare & Rehab Ctr.

  Madison   TN   168   1,445   —     168   1,445   672   1968   1992   29 years

Cordova Rehab. & Nursing Center

  Cordova   TN   322   8,830   —     322   8,830   4,230   1979   1986   39 years

Primacy Healthcare & Rehab Ctr.

  Memphis   TN   1,222   8,344   —     1,222   8,344   3,196   1980   1990   37 years

Masters Health Care Center

  Algood   TN   524   4,370   —     524   4,370   2,069   1981   1987   38 years

Wasatch Care Center

  Ogden   UT   374   596   —     374   596   479   1964   1990   25 years

Crosslands Rehab. & Health Care Ctr

  Sandy   UT   334   4,300   —     334   4,300   1,387   1987   1992   40 years

St. George Care and Rehab. Center

  St. George   UT   420   4,465   —     420   4,465   1,933   1976   1993   29 years

Federal Heights Rehab. & Nsg. Ctr.

  Salt Lake City   UT   201   2,322   —     201   2,322   1,052   1962   1992   29 years

Wasatch Valley Rehabilitation

  Salt Lake City   UT   389   3,545   —     389   3,545   1,513   1962   1995   29 years

 

110


Table of Contents
Index to Financial Statements

VENTAS, INC.

 

SCHEDULE III

REAL ESTATE AND ACCUMULATED DEPRECIATION

December 31, 2004

(Dollars in Thousands)

 

Facility name


  Location

 

Initial Cost to

Company


  Cost
Capitalized
Subsequent
to
Acquisition


 

Gross Amount
Carried at Close

of Period


  Accumulated
Depreciation


  Date of
Construction


  Date
Acquired


  Life on
Which
Depreciation
in Income
Statement is
Computed


  City

  State

  Land

 

Buildings
and
Improve-

ments


    Land

 

Buildings
and
Improve-

ments


       

Nansemond Pointe Rehab. & HC Ctr.

  Suffolk   VA   534   6,990   —     534   6,990   2,918   1963   1991   32 years

Harbour Pointe Med. & Rehab. Ctr

  Norfolk   VA   427   4,441   —     427   4,441   1,991   1969   1993   28 years

River Pointe Rehab. & Healthc. Ctr.

  Virginia Beach   VA   770   4,440   —     770   4,440   2,462   1953   1991   25 years

Bay Pointe Medical & Rehab. Centre

  Virginia Beach   VA   805   2,886   —     425   2,886   1,235   1971   1993   29 years

Birchwood Terrace Healthcare

  Burlington   VT   15   4,656   —     15   4,656   2,591   1965   1990   27 years

Arden Rehabilitation & Healthcare Ctr

  Seattle   WA   1,111   4,013   —     1,111   4,013   1,755   1950   1993   28.5 years

Northwest Continuum Care Center

  Longview   WA   145   2,563   —     145   2,563   1,160   1955   1992   29 years

Bellingham Health Care & Rehab Svc

  Bellingham   WA   442   3,823   —     442   3,823   1,680   1972   1993   28.5 years

Rainier Vista Care Center

  Puyallup   WA   520   4,780   —     520   4,780   1,599   1986   1991   40 years

Lakewood Healthcare Center

  Lakewood   WA   504   3,511   —     504   3,511   1,231   1989   1989   45 years

Vancouver Healthcare & Rehab. Center

  Vancouver   WA   449   2,964   —     449   2,964   1,373   1970   1993   28 years

Heritage Health & Rehab. Center

  Vancouver   WA   76   835   —     76   835   351   1955   1992   29 years

Edmonds Rehab. & Healthcare Ctr.

  Edmonds   WA   355   3,032   —     355   3,032   1,590   1961   1991   25 years

Queen Anne Healthcare

  Seattle   WA   570   2,750   —     570   2,750   1,266   1970   1993   29 years

San Luis Medical & Rehab Center

  Greenbay   WI   259   5,299   —     259   5,299   2,439   N/A   1996   25 years

Eastview Medical & Rehab. Center

  Antigo   WI   200   4,047   —     200   4,047   2,096   1962   1991   28 years

Colonial Manor Medical & Rehab Ctr.

  Wausau   WI   169   3,370   —     169   3,370   1,472   1964   1995   30 years

Colony Oaks Care Center

  Appleton   WI   353   3,571   —     353   3,571   1,715   1967   1993   29 years

North Ridge Med. & Rehab. Center

  Manitowoc   WI   206   3,785   —     206   3,785   1,716   1964   1992   29 years

Vallhaven Care Center

  Neenah   WI   337   5,125   —     337   5,125   2,370   1966   1993   28 years

Kennedy Park Medical & Rehab. Ctr.

  Schofield   WI   301   3,596   —     301   3,596   2,785   1966   1982   29 years

Mt. Carmel Medical & Rehab. Ctr.

  Burlington   WI   274   7,205   —     274   7,205   2,894   1971   1991   30 years

Mt. Carmel Medical & Rehab. Ctr.

  Milwaukee   WI   2,678   25,867   —     2,678   25,867   12,479   1958   1991   30 years

Sheridan Medical Complex

  Kenosha   WI   282   4,910   —     282   4,910   2,588   1964   1991   25 years

Woodstock Health & Rehab. Center

  Kenosha   WI   562   7,424   —     562   7,424   4,073   1970   1991   25 years

Mountain Towers Healthcare & Rehab

  Cheyenne   WY   342   3,814   —     342   3,814   1,585   1964   1992   29 years

South Central Wyoming HC. & Rehab

  Rawlins   WY   151   1,738   —     151   1,738   755   1955   1993   29 years

Wind River Healthcare & Rehab. Ctr

  Riverton   WY   179   1,559   —     179   1,559   672   1967   1992   29 years

Sage View Care Center

  Rock Springs   WY   287   2,392   —     287   2,392   1,059   1964   1993   30 years
           
 
 
 
 
 
           

TOTAL KINDRED NURSING FACILITIES

          61,609   638,825   1,178   61,229   640,003   295,944            

 

111


Table of Contents
Index to Financial Statements

VENTAS, INC.

 

SCHEDULE III

REAL ESTATE AND ACCUMULATED DEPRECIATION

December 31, 2004

(Dollars in Thousands)

 

Facility name


  Location

 

Initial Cost to

Company


  Cost
Capitalized
Subsequent
to
Acquisition


 

Gross Amount
Carried at Close

of Period


  Accumulated
Depreciation


  Date of
Construction


  Date
Acquired


  Life on
Which
Depreciation
in Income
Statement is
Computed


  City

  State

  Land

 

Buildings
and
Improve-

ments


    Land

 

Buildings
and
Improve-

ments


       

NON-KINDRED SKILLED NURSING FACILITIES

                                           

Millenium Health & Rehab. Ctr. at South River

  Edgewater   MD   580   7,120   —     580   7,120   617   1980   2002   25 years

Regency Nursing and Rehabilitation

  Forestville   MD   640   10,560   —     640   10,560   1,144   1966   2002   25 years

St. Agnes Nursing and Rehabilitation

  Ellicott City   MD   830   11,370   —     830   11,370   985   1985   2002   25 years

Woodside Convalescent Center

  Rochester   MN   639   3,440   56   639   3,496   2,825   N/A   1982   28 years

Lopatcong Center

  Phillipsburg   NJ   1,490   12,336   —     1,490   12,336   447   1982   2004   30 years

Chardon Quality Care Center

  Chardon   OH   210   6,614   —     210   6,614   573   1987   2002   25 years

Greenbriar Quality Care

  Boardman   OH   380   8,958   —     380   8,958   776   1991   2002   25 years

Regency Manor

  Columbus   OH   607   16,424   —     607   16,424   400   1883   2004   35 years

Burlington House

  Cincinnati   OH   918   5,087   —     918   5,087   121   1989   2004   35 years

Marietta Convalescent Center

  Marietta   OH   158   3,266   75   158   3,341   1,466   N/A   1993   25 years

Wayne Center

  Wayne   PA   662   6,872   —     662   6,872   241   1875   2004   30 years

Belvedere Nursing & Rehab

  Chester   PA   822   7,202   —     822   7,202   259   1899   2004   30 years

Chapel Manor

  Philadelphia   PA   1,596   13,982   —     1,596   13,982   502   1948   2004   30 years

Pennsburg Manor

  Pennsburg   PA   1,091   7,871   —     1,091   7,871   295   1982   2004   30 years
           
 
 
 
 
 
           

TOTAL NON-KINDRED SKILLED NURSING FACILITIES

          10,623   121,102   131   10,623   121,233   10,651            
           
 
 
 
 
 
           

TOTAL FOR SKILLED NURSING FACILITIES

          72,232   759,927   1,309   71,852   761,236   306,595            

KINDRED HOSPITALS

                                           

Kindred Hospital—Phoenix

  Phoenix   AZ   226   3,359   —     226   3,359   1,611   N/A   1992   30 years

Kindred Hospital—Tucson

  Tuscon   AZ   130   3,091   —     130   3,091   1,821   N/A   1994   25 years

Kindred Hospital—Ontario

  Ontario   CA   523   2,988   —     523   2,988   1,559   N/A   1994   25 years

Kindred Hospital—San Leandro

  San Leandro   CA   2,735   5,870   —     2,735   5,870   4,757   N/A   1993   25 years

Kindred Hospital—Orange County

  Westminster   CA   728   7,384   —     728   7,384   4,473   N/A   1993   20 years

THC—Orange County

  Orange County   CA   3,144   2,611   —     3,144   2,611   558   1990   1995   40 years

Kindred Hospital—San Diego

  San Diego   CA   670   11,764   —     670   11,764   5,852   N/A   1994   25 years

Kindred Hospital—Denver

  Denver   CO   896   6,367   —     896   6,367   3,915   N/A   1994   20 years

Kindred Hospital—Coral Gables

  Coral Gables   FL   1,071   5,348   —     1,071   5,348   3,074   N/A   1992   30 years

 

112


Table of Contents
Index to Financial Statements

VENTAS, INC.

 

SCHEDULE III

REAL ESTATE AND ACCUMULATED DEPRECIATION

December 31, 2004

(Dollars in Thousands)

 

Facility name


  Location

 

Initial Cost to

Company


  Cost
Capitalized
Subsequent
to
Acquisition


 

Gross Amount
Carried at Close

of Period


  Accumulated
Depreciation


  Date of
Construction


  Date
Acquired


  Life on
Which
Depreciation
in Income
Statement is
Computed


  City

  State

  Land

 

Buildings
and
Improve-

ments


    Land

 

Buildings
and
Improve-

ments


       

Kindred Hospital—St. Petersburg

  St. Petersburg   FL   1,418   17,525   7   1,418   17,532   7,422   1968   1997   40 years

Kindred Hospital—Ft. Lauderdale

  Ft. Lauderdale   FL   1,758   14,080   —     1,758   14,080   7,822   N/A   1989   30 years

Kindred Hospital—North Florida

  Green Cove Spr.   FL   145   4,613   —     145   4,613   2,263   N/A   1994   20 years

Kindred Hospital—Central Tampa

  Tampa   FL   2,732   7,676   —     2,732   7,676   2,266   1970   1993   40 years

Kindred Hospital—Hollywood

  Hollywood   FL   605   5,229   —     605   5,229   2,367   1937   1995   20 years

Kindred Hospital—Sycamore

  Sycamore   IL   77   8,549   —     77   8,549   3,969   N/A   1993   20 years

Kindred Hospital—Chicago North

  Chicago   IL   1,583   19,980   —     1,583   19,980   9,635   N/A   1995   25 years

Kindred Hospital—Lake Shore

  Chicago   IL   1,513   9,525   —     1,513   9,525   7,256   1995   1976   20 years

Kindred Hospital—Northlake

  Northlake   IL   850   6,498   —     850   6,498   3,404   N/A   1991   30 years

Kindred Hospital—Indianapolis

  Indianapolis   IN   985   3,801   —     985   3,801   2,078   N/A   1993   30 years

Kindred Hospital—Louisville

  Louisville   KY   3,041   12,330   —     3,041   12,279   6,406   N/A   1995   20 years

Kindred Hospital—New Orleans

  New Orleans   LA   648   4,971   —     648   4,971   2,855   1968   1978   20 years

Kindred Hosp—Boston Northshore

  Peabody   MA   543   7,568   —     543   7,568   2,367   1974   1993   40 years

Kindred Hospital—Boston

  Boston   MA   1,551   9,796   —     1,551   9,796   6,058   N/A   1994   25 years

Kindred Hospital—Detroit

  Detroit   MI   355   3,544   —     355   3,544   2,288   N/A   1991   20 years

Kindred Hospital—Kansas City

  Kansas City   MO   277   2,914   —     277   2,914   1,656   N/A   1992   30 years

Kindred Hospital—St. Louis

  St. Louis   MO   1,126   2,087   —     1,126   2,087   1,264   N/A   1991   40 years

Kindred Hospital—Greensboro

  Greensboro   NC   1,010   7,586   —     1,010   7,586   4,195   N/A   1994   20 years

Kindred Hospital—Albuquerque

  Albuquerque   NM   11   4,253   —     11   4,253   1,163   1985   1993   40 years

THC—Las Vegas Hospital

  Las Vegas   NV   1,110   2,177   —     1,110   2,177   578   1980   1994   40 years

Kindred Hospital—Oklahoma City

  Oklahoma City   OK   293   5,607   —     293   5,607   2,495   N/A   1993   30 years

Kindred Hospital—Philadelphia

  Philadelphia   PA   135   5,223   —     135   5,223   1,564   N/A   1995   35 years

Kindred Hospital—Pittsburgh

  Oakdale   PA   662   12,854   —     662   12,854   4,503   N/A   1996   40 years

Kindred Hospital—Chattanooga

  Chattanooga   TN   757   4,415   —     757   4,415   2,492   N/A   1993   22 years

Kindred Hospital—San Antonio

  San Antonio   TX   249   11,413   —     249   11,413   4,699   N/A   1993   30 years

Kindred Hospital—Ft. Worth Southwest

  Ft. Worth   TX   2,342   7,458   —     2,342   7,458   4,752   1987   1986   20 years

Kindred Hospital—Houston Northwest

  Houston   TX   1,699   6,788   —     1,699   6,788   2,364   1986   1985   40 years

Kindred Hospital—Mansfield

  Mansfield   TX   267   2,462   —     267   2,462   1,173   N/A   1990   40 years

Kindred Hospital—Ft. Worth West

  Ft. Worth   TX   648   10,608   —     648   10,608   4,789   N/A   1994   34 years

Kindred Hospital—Houston

  Houston   TX   33   7,062   —     33   7,062   3,584   N/A   1994   20 years
           
 
 
 
 
 
           

TOTAL FOR KINDRED HOSPITALS

          38,546   277,374   7   38,546   277,330   137,347            

 

113


Table of Contents
Index to Financial Statements

VENTAS, INC.

 

SCHEDULE III

REAL ESTATE AND ACCUMULATED DEPRECIATION

December 31, 2004

(Dollars in Thousands)

 

Facility name


  Location

 

Initial Cost to

Company


  Cost
Capitalized
Subsequent
to
Acquisition


 

Gross Amount
Carried at Close

of Period


  Accumulated
Depreciation


  Date of
Construction


  Date
Acquired


  Life on
Which
Depreciation
in Income
Statement is
Computed


  City

  State

  Land

 

Buildings
and
Improve-

ments


    Land

 

Buildings
and
Improve-

ments


       

NON-KINDRED HOSPITALS

                                           

Greenbriar Hospital

  Boardman   OH   90   3,332   —     90   3,332   289   1991   2002   25 years
           
 
 
 
 
 
           

TOTAL FOR NON-KINDRED HOSPITALS

          90   3,332   —     90   3,332   289            
           
 
 
 
 
 
           

TOTAL FOR HOSPITALS

          38,636   280,706   7   38,636   280,662   137,636            

SENIOR HOUSING FACILITIES

                                           

Summerville at South Windsor

  South Windsor   CT   2,187   12,713   —     2,187   12,713   162   1999   2004   35 years

The Grand Court Ft. Myers

  Ft. Myers   FL   1,065   9,586   —     1,065   9,586   286   1988   2004   35 years

The Grand Court Tavares

  Tavares   FL   431   3,881   —     431   3,881   133   1985   2004   35 years

The Grand Court Belleville

  Belleville   IL   370   3,333   —     370   3,333   92   1984   2004   35 years

Seasons at Glenview

  Northbrook   IL   1,988   39,762   —     1,988   39,762   816   1999   2004   35 years

The Grand Court Overland Park

  Overland Park   KS   2,297   20,676   —     2,297   20,676   486   1988   2004   35 years

Heritage Woods

  Agawarn   MA   1,249   4,625   —     1,249   4,625   200   1997   2004   30 years

Heritage at North Andover

  North Andover   MA   1,194   12,544   —     1,194   12,544   402   1994   2004   30 years

Heritage at Vernon Court

  Newton   MA   1,793   9,678   —     1,793   9,678   307   1930   2004   30 years

Heritage at Cleveland Circle

  Brookline   MA   1,468   11,418   —     1,468   11,418   360   1995   2004   30 years

Cabot Park Village

  Newtonville   MA   1,772   14,854   —     1,772   14,854   492   1996   2004   30 years

The Village at Farm Pond

  Framingham   MA   5,165   33,335   —     5,165   33,335   82   1999   2004   35 years

The Grand Court Adrian

  Adrian   MI   601   5,411   —     601   5,411   176   1988   2004   35 years

The Grand Court Farmington Hills

  Farmington Hills   MI   847   7,619   —     847   7,619   189   1989   2004   35 years

The Grand Court Kansas City I

  Kansas City   MO   1,250   11,249   —     1,250   11,249   298   1989   2004   35 years

The Grand Court Albuquerque

  Albuquerque   NM   1,382   12,440   —     1,382   12,440   392   1991   2004   35 years

The Grand Court Las Vegas

  Las Vegas   NV   679   6,107   —     679   6,107   172   1987   2004   35 years

The Commons at Greenbriar

  Boardman   OH   210   2,106   —     210   2,106   183   1987   2002   25 years

The Grand Court Dayton

  Dayton   OH   636   5,721   —     636   5,721   211   1987   2004   35 years

The Grand Court Findlay

  Findlay   OH   385   3,464   —     385   3,464   105   1984   2004   35 years

The Grand Court Springfield

  Springfield   OH   250   2,250   —     250   2,250   77   1986   2004   35 years

Summerville at Mentor

  Mentor   OH   559   11,341   —     559   11,341   145   1999   2004   35 years

Berkshire Commons

  Reading   PA   470   4,301   —     470   4,301   163   1997   2004   30 years

Lehigh

  Macungie   PA   420   4,406   —     420   4,406   162   1997   2004   30 years

Sanatoga Court

  Pottstown   PA   360   3,233   —     360   3,233   123   1997   2004   30 years

 

114


Table of Contents
Index to Financial Statements

VENTAS, INC.

 

SCHEDULE III

REAL ESTATE AND ACCUMULATED DEPRECIATION

December 31, 2004

(Dollars in Thousands)

 

Facility name


  Location

 

Initial Cost to

Company


  Cost
Capitalized
Subsequent
to
Acquisition


 

Gross Amount
Carried at Close

of Period


  Accumulated
Depreciation


  Date of
Construction


  Date
Acquired


  Life on
Which
Depreciation
in Income
Statement is
Computed


  City

  State

  Land

 

Buildings
and
Improve-

ments


    Land

 

Buildings
and
Improve-

ments


       

Highgate at Paoli Pointe

  Paoli   PA     1,151     9,079     —       1,151     9,079     308   1997   2004   30 years

Mifflin Court

  Shillington   PA     689     4,265     —       689     4,265     90   1997   2004   35 years

Woodbridge

  Kimberton   PA     970     4,469     —       970     4,469     170   1996   2004   30 years

The Grand Court Lubbock

  Lubbock   TX     720     6,479     —       720     6,479     160   1984   2004   35 years

The Grand Court Bristol

  Bristol   VA     648     5,835     —       648     5,835     185   1985   2004   35 years
           

 

 

 

 

 

           

TOTAL FOR SENIOR HOUSING FACILITIES

            33,206     286,180     —       33,206     286,180     7,127            

PERSONAL CARE FACILITIES

                                                       

ResCare—Tangram—8 sites

  San Marcos   TX     616     6,512     4     616     6,521     2,036   N/A   1998   20 years
           

 

 

 

 

 

           

TOTAL FOR PERSONAL CARE FACILITIES

            616     6,512     4     616     6,521     2,036            

MEDICAL OFFICE BUILDINGS

                                                       

JFK Medical Plaza

  Lake Worth   FL     453     1,711     —       453     1,711     20   1999   2004   35 years

Palms West Building 6

  Loxahatchee   FL     964     2,679     —       964     2,679     32   2000   2004   35 years

Regency Medical Office Park Phase II

  Melbourne   FL     769     3,810     —       769     3,810     27   1998   2004   35 years

Regency Medical Office Park Phase I

  Melbourne   FL     590     3,156     —       590     3,156     23   1995   2004   35 years

Lacey Branch Office Building

  Forked River   NJ     63     621     —       63     621     22   1996   2004   30 years

Professional Office Building I

  Upland   PA     —       6,243     40     —       6,283     215   1978   2004   30 years

DCMH Medical Office Building

  Drexel Hill   PA     —       10,379     46     —       10,425     358   1984   2004   30 years

Abilene Medical Commons I

  Abilene   TX     178     1,600     —       178     1,600     19   2000   2004   35 years
           

 

 

 

 

 

           

TOTAL FOR MEDICAL OFFICE BUILDINGS

            3,017     30,199     86     3,017     30,285     716            
           

 

 

 

 

 

           

TOTAL FOR ALL PROPERTIES

          $ 147,707   $ 1,363,524   $ 1,406   $ 147,327   $ 1,364,884   $ 454,110            
           

 

 

 

 

 

           

 

115


Table of Contents
Index to Financial Statements

VENTAS, INC.

 

SCHEDULE III

REAL ESTATE AND ACCUMULATED DEPRECIATION

December 31, 2004

(Dollars in Thousands)

 

     For the years ended December 31,

 
     2004

    2003

    2002

 

Reconciliation of real estate:

                        

Carrying cost:

                        

Balance at beginning of period

   $ 1,090,181     $ 1,221,406     $ 1,175,838  

Additions during period:

                        

Acquisitions

     427,332       —         53,000  

Dispositions:

                        

Sale of facilities

     (5,302 )     (127,844 )     (7,432 )

Assets reclassified as held for sale

     —         (3,381 )        
    


 


 


Balance end of period

   $ 1,512,211     $ 1,090,181     $ 1,221,406  
    


 


 


Accumulated depreciation:

                        

Balance at beginning of period

   $ 408,891     $ 409,132     $ 369,502  

Additions during period:

                        

Depreciation expense

     48,849       41,659       41,891  

Dispositions:

                        

Sale of facilities

     (3,630 )     (40,461 )     (2,261 )

Assets reclassified as held for sale

     —         (1,439 )        
    


 


 


Balance end of period

   $ 454,110     $ 408,891     $ 409,132  
    


 


 


 

116


Table of Contents
Index to Financial Statements

ITEM 9.     Changes in and Disagreements With Accountants on Accounting and Financial Disclosure

 

Not applicable.

 

ITEM 9A.     Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

We have established disclosure controls and procedures to ensure that material information relating to us is timely communicated to the officers who certify our financial reports and to other members of our management and Board of Directors.

 

Based upon their evaluation as of December 31, 2004, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) are effective to ensure that information required to be disclosed by us in our Exchange Act filings is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms.

 

Internal Control Over Financial Reporting

 

The information set forth under “Management Report on Internal Control over Financial Reporting” and “Report of Independent Registered Public Accounting Firm on Internal Control over Financial Reporting” included in Part II, Item 8 of this Annual Report on Form 10-K is incorporated by reference into this Item 9A.

 

During the fourth quarter of 2004, there were no changes in our internal control over financial reporting or in other factors that have materially affected, or are reasonably likely to materially affect, those controls.

 

ITEM 9B.     Other Information

 

Not applicable.

 

117


Table of Contents
Index to Financial Statements

PART III

 

ITEM 10.     Directors and Executive Officers of the Registrant

 

The information required by this Item 10 is incorporated by reference to our definitive Proxy Statement for the 2005 Annual Meeting of Stockholders, which will be filed by us with the Commission not later than April 30, 2005.

 

ITEM 11.     Executive Compensation

 

The information required by this Item 11 is incorporated by reference to our definitive Proxy Statement for the 2005 Annual Meeting of Stockholders, which will be filed by us with the Commission not later than April 30, 2005.

 

ITEM 12.     Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

 

The information required by this Item 12 is incorporated by reference to our definitive Proxy Statement for the 2005 Annual Meeting of Stockholders, which will be filed by us with the Commission not later than April 30, 2005.

 

ITEM 13.     Certain Relationships and Related Transactions

 

The information required by this Item 12 is incorporated by reference to our definitive Proxy Statement for the 2005 Annual Meeting of Stockholders, which will be filed by us with the Commission not later than April 30, 2005.

 

ITEM 14.     Principal Accountant Fees and Services

 

The information required by this Item 14 is incorporated by reference to our definitive Proxy Statement for the 2005 Annual Meeting of Stockholders, which will be filed by us with the Commission not later than April 30, 2005.

 

118


Table of Contents
Index to Financial Statements

PART IV

 

ITEM 15.     Exhibits, Financial Statement Schedules and Reports on Form 8-K

 

Financial Statements and Financial Statement Schedules

 

The following documents have been included in Part II, Item 8 of this Annual Report on Form 10-K:

 

Report of Independent Registered Public Accounting Firm

Consolidated Balance Sheets as of December 31, 2004 and 2003

Consolidated Statements of Income for the years ended December 31, 2004, 2003 and 2002

Consolidated Statements of Stockholders’ Equity (Deficit) for the years ended December 31, 2004, 2003 and 2002

Consolidated Statements of Cash Flows for the years ended December 31, 2004, 2003 and 2002

Notes to Consolidated Financial Statements

Consolidated Financial Statement Schedule

Schedule III—Real Estate and Accumulated Depreciation

 

All other schedules have been omitted because they are inapplicable, not required or the information is included elsewhere in the Consolidated Financial Statements or notes thereto.

 

Exhibits

 

Exhibit

Number


  

Description of Document


  

Location of Document


2.1

   Agreement and Plan of Merger dated as of November 19, 2003 among Ventas, Inc., Ventas Sub, LLC and ElderTrust.    Incorporated by reference to Exhibit 2.1 to our Current Report on Form 8-K filed on November 21, 2003.

3.1.1

   Certificate of Incorporation of Ventas, Inc., as amended.    Incorporated by reference to Exhibit 3 to our Quarterly Report on Form 10-Q for the quarter ended September 30, 1995.

3.1.2

   Certificate of Amendment to Certificate of Incorporation of Ventas, Inc.    Incorporated by reference to Exhibit 3.1 to our Quarterly Report on Form 10-Q for the quarter ended June 30, 1998.

3.2

   Third Amended and Restated Bylaws of Ventas, Inc.    Incorporated by reference to Exhibit 3.2 to our Annual Report on Form 10-K for the year ended December 31, 1997.

4.1

   Specimen common stock certificate.    Incorporated by reference to Exhibit 4.1 to our Annual Report on Form 10-K for the year ended December 31, 1998.

4.2

   Letter Agreement dated June 24, 2003 between Ventas, Inc. and Cohen & Steers Capital Management, Inc. (relating to a limited waiver of the provisions of Article XII of the Certificate of Incorporation of Ventas, Inc.)    Incorporated by reference to Exhibit 4.2 to our Quarterly Report on Form 10-Q for the quarter ended June 30, 2003.

4.3.1

   Ventas, Inc. Distribution Reinvestment and Stock Purchase Plan.    Incorporated by reference to our Registration Statement on Form S-3, as amended, File No. 333-65642.

 

119


Table of Contents
Index to Financial Statements

Exhibit

Number


  

Description of Document


  

Location of Document


4.3.2

   Amendment to Ventas, Inc. Distribution Reinvestment and Stock Purchase Plan.    Incorporated by reference to our Prospectus Supplement dated December 8, 2003 to the Prospectus dated January 23, 2002, filed pursuant to Rule 424(b)(5) and part of our Registration Statement on Form S-3, as amended, File No. 333-65642.

4.4.1

   Indenture dated as of April 17, 2002 among Ventas Realty, Ventas Capital, the Guarantors named therein and U.S. Bank National Association, as Trustee, relating to the 8  3 / 4 % Senior Notes due 2009.    Incorporated by reference to Exhibit 99.1 to our Current Report on Form 8-K filed on April 24, 2002.

4.4.2

   Supplemental Indenture dated as of October 11, 2002 among Ventas Healthcare Properties, Inc., as a Guaranteeing Subsidiary, Ventas Realty and Ventas Capital, as Issuers, Ventas, Inc. and Ventas LP Realty, L.L.C., as Guarantors, and U.S. Bank National Association, as Trustee.    Incorporated by reference to Exhibit 99.1 to our Current Report on Form 8-K filed on October 16, 2002.

4.4.3

   Supplemental Indenture dated as of November 25, 2002 among Ventas TRS, as a Guaranteeing Subsidiary, Ventas Realty and Ventas Capital, as Issuers, Ventas, Inc., Ventas LP Realty, L.L.C. and Ventas Healthcare Properties, Inc., as Guarantors, and U.S. Bank National Association, as Trustee.    Incorporated by reference to Exhibit 99.1 to our Current Report on Form 8-K filed on November 26, 2002.

4.4.4

   Supplemental Indenture dated as of February 20, 2004 among the newly-acquired Restricted Subsidiaries listed in Annex A thereto, as Guaranteeing Subsidiaries, Ventas Realty and Ventas Capital, as Issuers, Ventas, Inc., Ventas LP Realty, L.L.C., Ventas Healthcare Properties, Inc. and Ventas TRS, as Guarantors, and U.S. Bank National Association, as Trustee.    Incorporated by reference to Exhibit 4.5.4 to our Annual Report on Form 10-K for the year ended December 31, 2003.

4.4.5

   Supplemental Indenture dated as of December 15, 2004 among Ventas Framingham, LLC and Ventas Management, LLC, as Guaranteeing Subsidiaries, Ventas Realty and Ventas Capital, as Issuers, the other Guarantors named therein and U.S. Bank National Association, as Trustee.    Filed herewith.

4.5.1

   Indenture dated as of April 17, 2002 among Ventas Realty, Ventas Capital, the Guarantors named therein and U.S. Bank National Association, as Trustee, relating to the 9% Senior Notes due 2012.    Incorporated by reference to Exhibit 99.2 to our Current Report on Form 8-K filed on April 24, 2002.

4.5.2

   Supplemental Indenture dated as of October 11, 2002 among Ventas Healthcare Properties, Inc., as a Guaranteeing Subsidiary, Ventas Realty and Ventas Capital, as Issuers, Ventas, Inc. and Ventas LP Realty, L.L.C., as Guarantors, and U.S. Bank National Association, as Trustee.    Incorporated by reference to Exhibit 99.2 to our Current Report on Form 8-K filed on October 16, 2002.

 

120


Table of Contents
Index to Financial Statements

Exhibit

Number


  

Description of Document


  

Location of Document


4.5.3

   Supplemental Indenture dated as of November 25, 2002 among Ventas TRS, as a Guaranteeing Subsidiary, Ventas Realty and Ventas Capital, as Issuers, Ventas, Inc., Ventas LP Realty, L.L.C. and Ventas Healthcare Properties, Inc., as Guarantors, and U.S. Bank National Association, as Trustee.    Incorporated by reference to Exhibit 99.2 to our Current Report on Form 8-K filed on November 26, 2002.

4.5.4

   Supplemental Indenture dated as of February 20, 2004 among the newly-acquired Restricted Subsidiaries listed in Annex A thereto, as Guaranteeing Subsidiaries, Ventas Realty and Ventas Capital, as Issuers, Ventas, Inc., Ventas LP Realty, L.L.C., Ventas Healthcare Properties, Inc. and Ventas TRS, as Guarantors, and U.S. Bank National Association, as Trustee.    Incorporated by reference to Exhibit 4.6.4 to our Annual Report on Form 10-K for the year ended December 31, 2003.

4.5.5

   Supplemental Indenture dated as of December 15, 2004 among Ventas Framingham, LLC and Ventas Management, LLC, as Guaranteeing Subsidiaries, Ventas Realty and Ventas Capital, as Issuers, the other Guarantors named therein and U.S. Bank National Association, as Trustee.    Filed herewith.

4.6.1

   Indenture dated as of October 15, 2004 among Ventas Realty and Ventas Capital, as Issuers, the Guarantors named therein and U.S. Bank National Association, as Trustee, relating to the 6  5 / 8 % Senior Notes due 2014.    Incorporated by reference to Exhibit 4.1 to our Current Report on Form 8-K filed on October 15, 2004.

4.6.2

   Supplemental Indenture dated as of December 15, 2004 among Ventas Framingham, LLC and Ventas Management, LLC, as Guaranteeing Subsidiaries, Ventas Realty and Ventas Capital, as Issuers, the other Guarantors named therein and U.S. Bank National Association, as Trustee.    Incorporated by reference to Exhibit 4.1.2 to Amendment No. 1 to our Registration Statement on Form S-4, File No. 333-120642, filed on December 21, 2004.

4.7

   Registration Rights Agreement dated as of September 30, 1999 between Ventas, Inc. and Debra A. Cafaro.    Incorporated by reference to Exhibit 4.15 to Amendment No. 2 to our Registration Statement on Form S-3, File No. 333-101598, filed on December 16, 2002.

4.8

   Registration Rights Agreement dated as of October 15, 2004 among Ventas Realty and Ventas Capital, as Issuers, Ventas, Inc. and Ventas LP Realty, L.L.C., as Guarantors, and the Initial Purchasers named therein.    Incorporated by reference to Exhibit 4.2 to our Current Report on Form 8-K filed on October 15, 2004.

4.9.1

   Loan and Security Agreement dated as of December 12, 2001 between Ventas Finance, as Borrower, and Merrill Lynch Mortgage Lending, Inc., as Lender.    Incorporated by reference to Exhibit 4.1 to our Current Report on Form 8-K filed on January 2, 2002.

4.9.2

   Form of Assignment of Leases and Rents dated as of December 12, 2001 by Ventas Finance, as Assignor, to Merrill Lynch Mortgage Lending, Inc., as Assignee.    Incorporated by reference to Exhibit 4.2 to our Current Report on Form 8-K filed on January 2, 2002.

4.9.3

   Form of Deed of Trust, Assignment of Leases and Rents, Security Agreement and Fixture Filing dated as of December 12, 2001 by Ventas Finance, as Trustor, to First American Title Insurance Company, as Trustee, for the benefit of Merrill Lynch Mortgage Lending, Inc., as Beneficiary.    Incorporated by reference to Exhibit 4.3 to our Current Report on Form 8-K filed on January 2, 2002.

 

121


Table of Contents
Index to Financial Statements

Exhibit

Number


  

Description of Document


  

Location of Document


4.9.4

   Form of Mortgage, Assignment of Leases and Rents, Security Agreement and Fixture Filing dated as of December 12, 2001 by Ventas Finance, as Mortgagor, to Merrill Lynch Mortgage Lending, Inc., as Mortgagee.    Incorporated by reference to Exhibit 4.4 to our Current Report on Form 8-K filed on January 2, 2002.

4.9.5

   Letter Agreement dated December 12, 2001 among Merrill Lynch Mortgage Lending, Inc., Ventas, Inc. and Ventas Finance (regarding the use of certain insurance proceeds received in connection with a casualty to a collateral property under the Loan and Security Agreement).    Incorporated by reference to Exhibit 4.5 to our Current Report on Form 8-K filed on January 2, 2002.

4.9.6

   Letter Agreement dated as of December 12, 2001 among Merrill Lynch Mortgage Lending, Inc., JP Morgan Chase Bank, as Senior Collateral Agent and Junior Collateral Agent under various credit agreements with Kindred Healthcare, Inc., and Ventas Finance, as Landlord (concerning various notice requirements regarding the collateral property under the Loan and Security Agreement).    Incorporated by reference to Exhibit 4.6 to our Current Report on Form 8-K filed on January 2, 2002.

4.9.7

   Letter Agreement dated as of December 12, 2001 among Merrill Lynch Mortgage Lending, Inc., Ventas Realty and Ventas Finance (concerning various rent reset rights under the Kindred Master Lease Agreements).    Incorporated by reference to Exhibit 4.7 to our Current Report on Form 8-K filed on January 2, 2002.

4.9.8

   Collateral Assignment of Interest Rate Protection Agreement dated as of December 12, 2001 by Ventas Finance, as Assignor, to Merrill Lynch Mortgage Lending, Inc., as Assignee.    Incorporated by reference to Exhibit 4.8 to our Current Report on Form 8-K filed on January 2, 2002.

4.9.9

   Mortgage Loan Purchase Agreement dated as of December 12, 2001 between Ventas Specialty I, LLC, as Purchaser, and Merrill Lynch Mortgage Lending, Inc., as Seller.    Incorporated by reference to Exhibit 4.9 to our Current Report on Form 8-K filed on January 2, 2002.

4.9.10

   Promissory Note dated as of December 12, 2001 from Ventas Finance, as Borrower, to Merrill Lynch Mortgage Lending, Inc., as Lender.    Incorporated by reference to Exhibit 4.10 to our Current Report on Form 8-K filed on January 2, 2002.

4.9.11

   Form of Subordination, Non-Disturbance and Attornment Agreement dated as of December 12, 2001 among Kindred, as Tenant, Ventas Finance, as Landlord, and Merrill Lynch Mortgage Lending, Inc., as Lender.    Incorporated by reference to Exhibit 4.11 to our Current Report on Form 8-K filed on January 2, 2002.

4.9.12

   Cash Management Agreement dated as of December 12, 2001 among Ventas Finance, as Borrower, Merrill Lynch Mortgage Lending, Inc., as Lender, and First Union National Bank, as Agent.    Incorporated by reference to Exhibit 4.12 to our Current Report on Form 8-K filed on January 2, 2002.

4.9.13

   Trust and Servicing Agreement dated as of December 12, 2001 among Ventas Specialty I, LLC, as Depositor, First Union National Bank, as Servicer and Special Servicer, LaSalle Bank National Association, as Trustee and Tax Administrator, and ABN Amro Bank N.V., as Fiscal Agent.    Incorporated by reference to Exhibit 4.13 to our Current Report on Form 8-K filed on January 2, 2002.

 

122


Table of Contents
Index to Financial Statements

Exhibit

Number


  

Description of Document


  

Location of Document


  4.9.14

   Environmental Indemnity Agreement dated as of December 12, 2001 among Ventas Finance, as Borrower, Ventas, Inc., as Guarantor, and Merrill Lynch Mortgage Lending, Inc., as Lender.    Incorporated by reference to Exhibit 4.14 to our Current Report on Form 8-K filed on January 2, 2002.

  4.9.15

   Exceptions to Non-Recourse Guaranty dated as of December 12, 2001 by Ventas, Inc., as Guarantor, for the benefit of Merrill Lynch Mortgage Lending, Inc., as Lender.    Incorporated by reference to Exhibit 4.15 to our Current Report on Form 8-K filed on January 2, 2002.

  4.9.16

   Certificate Purchase Agreement dated as of December 4, 2001 among Ventas Specialty I, LLC, Ventas, Inc., Merrill Lynch Pierce, Fenner & Smith Incorporated and Morgan Stanley & Co. Incorporated.    Incorporated by reference to Exhibit 4.16 to our Current Report on Form 8-K filed on January 2, 2002.

  4.9.17

   Schedule of Agreements Substantially Identical in all Material Respects to the agreements incorporated by reference as Exhibits 4.9.2, 4.9.3, 4.9.4 and 4.9.11 to this Annual Report on Form 10-K, pursuant to Instruction 2 to Item 601 of Regulation S-K.    Incorporated by reference to Exhibit 4.2.17 to our Annual Report on Form 10-K for the year ended December 31, 2001.

10.1.1

   Agreement and Plan of Reorganization dated as of April 30, 1998 between Ventas, Inc. and Kindred, Inc.    Incorporated by reference to Exhibit 10.4.1 to our Annual Report on Form 10-K for the year ended December 31, 2001.

10.1.2

   Distribution Agreement dated as of April 30, 1998 between Kindred, Inc. and Ventas, Inc.    Incorporated by reference to Exhibit 10.4.2 to our Annual Report on Form 10-K for the year ended December 31, 2001.

10.1.3.1

   Tax Allocation Agreement dated as of April 30, 1998 between Ventas, Inc. and Kindred, Inc.    Incorporated by reference to Exhibit 10.9 to our Quarterly Report on Form 10-Q for the quarter ended June 30, 1998.

10.1.3.2

   Tax Refund Escrow Agreement and First Amendment of the Tax Allocation Agreement dated as of April 20, 2001 between Kindred, Inc., on behalf of itself and each of its subsidiaries, and Ventas, Inc., on behalf of itself and each of Ventas Realty and Ventas LP Realty, L.L.C.    Incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K/A filed on April 24, 2001.

10.1.3.3

   Cash Escrow Agreement dated as of April 20, 2001 among Kindred, Inc., Ventas, Inc. and State Street Bank and Trust Company.    Incorporated by reference to Exhibit 10.4.3.3 to our Annual Report on Form 10-K for the year ended December 31, 2001.

10.1.4

   Agreement of Indemnity—Third Party Leases dated April 30, 1998 between Kindred, Inc. and its subsidiaries and Ventas, Inc.    Incorporated by reference to Exhibit 10.11 to Quarterly Report on Form 10-Q for the quarter ended June 30, 1998.

10.1.5

   Agreement of Indemnity—Third Party Contracts dated April 30, 1998 between Kindred, Inc. and its subsidiaries and Ventas, Inc.    Incorporated by reference to Exhibit 10.12 to the Quarterly Report on Form 10-Q for the quarter ended June 30, 1998.

10.2.1.1

   Amended and Restated Master Lease Agreement No. 1 dated as of April 20, 2001 for lease executed by Ventas Realty, as Lessor, and Kindred, Inc. and Kindred Operating, Inc., as Tenant.    Incorporated by reference to Exhibit 10.2 to our Current Report on Form 8-K/A filed on April 24, 2001.

 

123


Table of Contents
Index to Financial Statements

Exhibit

Number


  

Description of Document


  

Location of Document


10.2.1.2

   Schedule of Agreements Substantially Identical in All Material Respects to the agreement incorporated by reference as Exhibit 10.2.1 to this Annual Report on Form 10-K, pursuant to Instruction 2 to Item 601 of Regulation S-K.    Incorporated by reference to Exhibit 10.3 to our Current Report on Form 8-K/A filed on April 24, 2001.

10.2.1.3

   Termination of Memorandum of Lease dated as of June 21, 2002 among Kindred Healthcare, Inc., Kindred Operating, Inc. and Ventas Realty (relating to Northern Virginia Community Hospital, Arlington, Virginia).    Incorporated by reference to Exhibit 10.7 to our Quarterly Report on Form 10-Q for the quarter ended June 30, 2002.

10.2.2.1

   Lease Severance and Amendment Agreement dated as of December 12, 2001 among Kindred Healthcare, Inc., as Tenant, Kindred Operating, Inc., as Operator and Tenant, and Ventas Realty, as Lessor.    Incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K filed on January 2, 2002.

10.2.2.2

   Master Lease Agreement dated as of December 12, 2001 among Ventas Realty, as Lessor, and Kindred Healthcare, Inc. and Kindred Operating, Inc., as Tenants.    Incorporated by reference to Exhibit 10.2 to our Current Report on Form 8-K filed on January 2, 2002.

10.2.3.1

   Agreement for Sale of Real Estate and Master Lease Amendments dated May 14, 2003 between Ventas Realty and Kindred Healthcare, Inc. and Kindred Operating, Inc.    Incorporated by reference to Exhibit 10.2.1 to our Quarterly Report on Form 10-Q for the quarter ended June 30, 2003.

10.2.3.2

   Master Lease No. 1 Partial Lease Termination Agreement dated as of June 30, 2003 among Kindred Healthcare, Inc., Kindred Operating, Inc. and Ventas Realty.    Incorporated by reference to Exhibit 10.2.2 to our Quarterly Report on Form 10-Q for the quarter ended June 30, 2003.

10.2.3.3

   Master Lease No. 2 Partial Lease Termination Agreement dated as of June 30, 2003 among Kindred Healthcare, Inc., Kindred Operating, Inc. and Ventas Realty.    Incorporated by reference to Exhibit 10.2.3 to our Quarterly Report on Form 10-Q for the quarter ended June 30, 2003.

10.2.3.4

   Master Lease No. 3 Partial Lease Termination Agreement dated as of June 30, 2003 among Kindred Healthcare, Inc., Kindred Operating, Inc. and Ventas Realty.    Incorporated by reference to Exhibit 10.2.4 to our Quarterly Report on Form 10-Q for the quarter ended June 30, 2003.

10.2.3.5

   Master Lease No. 4 Partial Lease Termination Agreement dated as of June 30, 2003 among Kindred Healthcare, Inc., Kindred Operating, Inc. and Ventas Realty.    Incorporated by reference to Exhibit 10.2.5 to our Quarterly Report on Form 10-Q for the quarter ended June 30, 2003.

10.2.4.1

   Master Lease No. 1 Amendment Agreement dated as of June 30, 2003 among Kindred Healthcare, Inc., Kindred Operating, Inc. and Ventas Realty.    Incorporated by reference to Exhibit 10.3.1 to our Quarterly Report on Form 10-Q for the quarter ended June 30, 2003.

10.2.4.2

   Master Lease No. 2 Amendment Agreement dated as of June 30, 2003 among Kindred Healthcare, Inc., Kindred Operating, Inc. and Ventas Realty.    Incorporated by reference to Exhibit 10.3.2 to our Quarterly Report on Form 10-Q for the quarter ended June 30, 2003.

10.2.4.3

   Master Lease No. 3 Amendment Agreement dated as of June 30, 2003 among Kindred Healthcare, Inc., Kindred Operating, Inc. and Ventas Realty.    Incorporated by reference to Exhibit 10.3.3 to our Quarterly Report on Form 10-Q for the quarter ended June 30, 2003.

 

124


Table of Contents
Index to Financial Statements

Exhibit

Number


  

Description of Document


  

Location of Document


10.2.4.4

   Master Lease No. 4 Amendment Agreement dated as of June 30, 2003 among Kindred Healthcare, Inc., Kindred Operating, Inc. and Ventas Realty.    Incorporated by reference to Exhibit 10.3.4 to our Quarterly Report on Form 10-Q for the quarter ended June 30, 2003.

10.2.4.5

   CMBS Master Lease Amendment Agreement dated as of June 30, 2003 among Kindred Healthcare, Inc., Kindred Operating, Inc. and Ventas Realty.    Incorporated by reference to Exhibit 10.3.5 to our Quarterly Report on Form 10-Q for the quarter ended June 30, 2003.

10.2.5

   Agreement for Sale of Real Estate and Master Lease Amendments dated November 5, 2003 between Ventas Realty and Kindred Healthcare, Inc. and Kindred Operating, Inc.    Incorporated by reference to Exhibit 99.1 to our Current Report on Form 8-K filed on November 10, 2003.

10.2.6.1

   Master Lease Agreement No. 1A dated as of September 8, 2004 between Ventas Realty and Kindred Healthcare, Inc. and Kindred Operating, Inc.    Incorporated by reference to Exhibit 10.6 to our Current Report on Form 8-K filed on September 13, 2004.

10.2.6.2

   Lease Severance and Amendment Agreement dated as of September 8, 2004 between Ventas Realty and Kindred Healthcare, Inc. and Kindred Operating, Inc.    Incorporated by reference to Exhibit 10.7 to our Current Report on Form 8-K filed on September 13, 2004.

10.2.7.1

   Master Lease No. 1 Partial Lease Termination Agreement (IN-4620) dated as of December 22, 2004 among Kindred Healthcare, Inc., Kindred Healthcare Operating, Inc. and Ventas Realty.    Filed herewith.

10.2.7.2

   Master Lease No. 1 Partial Lease Termination Agreement (CA-4693) dated as of December 22, 2004 among Kindred Healthcare, Inc., Kindred Healthcare Operating, Inc. and Ventas Realty.    Filed herewith.

10.3.1

   Third Amended and Restated Credit, Security and Guaranty Agreement dated as of September 8, 2004 among Ventas Realty, as borrower, Ventas, Inc. and certain subsidiaries of Ventas, Inc. identified therein, as guarantors, the lenders identified therein, Bank of America, N.A., as Administrative Agent and Issuing Bank for the Letters of Credit thereunder, Merrill Lynch & Co., Merrill Lynch Pierce Fenner & Smith Incorporated and UBS Securities LLC, as Co-Syndication Agents, and Calyon New York Branch, JPMorgan Chase Bank and Citicorp North America, Inc., as Co-Documentation Agents.    Incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K filed on September 13, 2004.

10.3.2.1

   Amended and Restated Mortgage, Security Agreement and Assignment of Rents dated as of April 17, 2002 by Ventas Realty, as Mortgagor, to Bank of America, N.A., Administrative Agent, as Mortgagee.    Incorporated by reference to Exhibit 99.4 to our Current Report on Form 8-K filed on April 24, 2002.

10.3.2.2

   Amended and Restated Deed of Trust and Security Agreement dated as of April 17, 2002 by Ventas Realty, as Grantor, to Ronda C. Bundy, as Trustee, for the benefit of Bank of America, N.A., Administrative Agent, as Beneficiary.    Incorporated by reference to Exhibit 99.5 to our Current Report on Form 8-K filed on April 24, 2002.

 

125


Table of Contents
Index to Financial Statements

Exhibit

Number


  

Description of Document


  

Location of Document


10.3.2.3

   Assignment of Leases and Rents dated as of April 17, 2002 by Ventas Realty, Assignor, to Bank of America, N.A., Administrative Agent, Assignee.    Incorporated by reference to Exhibit 99.6 to our Current Report on Form 8-K filed on April 24, 2002.

10.3.2.4

   Schedule of Agreements Substantially Identical in All Material Respects to the agreements incorporated by reference as Exhibits 10.3.2.1, 10.3.2.2 and 10.3.2.3 to this Annual Report on Form 10-K, pursuant to Instruction 2 to Item 601 of Regulation S-K.    Incorporated by reference to Exhibit 99.7 to our Current Report on Form 8-K filed on April 24, 2002.

10.3.3.1

   First Amendment to Amended and Restated Open-End Mortgage, Assignment of Rents and Security Agreement dated as of September 8, 2004 between Ventas Realty, as Mortgagor, and Bank of America, N.A., in its capacity as Administrative Agent, as Mortgagee.    Incorporated by reference to Exhibit 10.2 to our Current Report on Form 8-K filed on September 13, 2004.

10.3.3.2

   First Amendment to Amended and Restated Deed of Trust, Assignment of Rents and Leases and Security Agreement dated as of September 8, 2004 between Ventas Realty, as Grantor, and Bank of America, N.A., in its capacity as Administrative Agent, as Beneficiary.    Incorporated by reference to Exhibit 10.3 to our Current Report on Form 8-K filed on September 13, 2004.

10.3.3.3

   First Amendment to Amended and Restated Assignment of Leases and Rents dated as of September 8, 2004 between Ventas Realty, as Assignor, and Bank of America, N.A., in its capacity as Administrative Agent, as Assignee.    Incorporated by reference to Exhibit 10.4 to our Current Report on Form 8-K filed on September 13, 2004.

10.3.3.4

   Schedule of Agreements Substantially Identical in All Material Respects to the agreements incorporated by reference as Exhibits 10.3.3.1, 10.3.3.2 and 10.3.3.3 to this Annual Report on Form 10-K, pursuant to Instruction 2 to Item 601 of Regulation S-K.    Incorporated by reference to Exhibit 10.5 to our Current Report on Form 8-K filed on September 13, 2004.

10.4.1

   ISDA Master Agreement dated September 28, 2001 between Bank of America, N.A. and Ventas Realty.    Incorporated by reference to Exhibit 10.25.1 to our Annual Report on Form 10-K for the year ended December 31, 2001.

10.4.2

   Letter Agreement dated October 25, 2001 between Bank of America, N.A. and Ventas Realty.    Incorporated by reference to Exhibit 10.25.2 to our Annual Report on Form 10-K for the year ended December 31, 2001.

10.5.1

   ISDA Master Agreement dated as of December 11, 2001 between Banc of America Financial Products, Inc. and Ventas Finance.    Incorporated by reference to Exhibit 10.24.1 to our Annual Report on Form 10-K for the year ended December 31, 2001.

10.5.2

   Letter Agreement dated December 11, 2001 between Ventas Finance and Banc of America Financial Products, Inc.    Incorporated by reference to Exhibit 10.24.2 to our Annual Report on Form 10-K for the year ended December 31, 2001.

10.5.3

   Letter Agreement dated December 11, 2001 between Bank of America, N.A. and Ventas Realty.    Incorporated by reference to Exhibit 10.24.3 to our Annual Report on Form 10-K for the year ended December 31, 2001.

 

126


Table of Contents
Index to Financial Statements

Exhibit

Number


  

Description of Document


  

Location of Document


10.6.1.1

   Purchase and Sale Agreement dated as of November 1, 2002 between Ventas Realty, as Buyer, and Trans Healthcare of Ohio, Inc., as Seller.    Incorporated by reference to Exhibit 10.1.1 to our Current Report on Form 8-K filed on November 18, 2002.

10.6.1.2

   First Amendment to Purchase Agreement dated as of April 28, 2003 between Ventas Realty and Trans Healthcare, Inc. and the subsidiaries of Trans Healthcare, Inc. named therein.    Incorporated by reference to Exhibit 10.4.1 to our Quarterly Report on Form 10-Q for the quarter ended June 30, 2003.

10.6.2.1

   Master Lease Agreement dated as of November 1, 2002 between Ventas Realty, as Landlord, and the Tenants named therein.    Incorporated by reference to Exhibit 10.1.2 to our Current Report on Form 8-K filed on November 18, 2002.

10.6.2.2

   First Amendment to Master Lease Agreement dated as of April 28, 2003 between Ventas Realty and THI of Ohio at Chardon, LLC, THI of Ohio at Greenbriar North, LLC, Trans Healthcare of Ohio, Inc., THI of Ohio ALFS at the Commons, LLC, THI of Maryland at South River, LLC, Millennium Health and Rehabilitation Center of Forestville, LLC and Millennium Health and Rehabilitation Center of Ellicott City, LLC.    Incorporated by reference to Exhibit 10.4.3 to our Quarterly Report on Form 10-Q for the quarter ended June 30, 2003.

10.6.2.3

   Second Amendment to Master Lease Agreement dated as of September 30, 2003 between Ventas Realty and THI of Ohio at Chardon, LLC, THI of Ohio at Greenbriar North, LLC, Trans Healthcare of Ohio, Inc., THI of Ohio ALFS at the Commons, LLC, THI of Maryland at South River, LLC, Millennium Health and Rehabilitation Center of Forestville, LLC and Millennium Health and Rehabilitation Center of Ellicott City, LLC.    Incorporated by reference to Exhibit 10.1.3 to our Quarterly Report on Form 10-Q for the quarter ended September 30, 2003.

10.6.3.1

   Loan Agreement dated as of November 1, 2002 among Ventas Realty, as Lender, and the Borrowers named therein.    Incorporated by reference to Exhibit 10.2.1 to our Current Report on Form 8-K filed on November 18, 2002.

10.6.3.2

   Resizing and First Amendment to Loan Documents dated as of December 27, 2002 among Ventas TRS, as Lender, the Mortgage Borrowers named therein and Trans Healthcare, Inc. and the Subsidiary Guarantors named therein.    Incorporated by reference to Exhibit 10.5.2.2 to our Annual Report on Form 10-K for the year ended December 31, 2002.

10.6.3.3

   Promissory Note dated as of November 1, 2002 from certain Borrowers named therein to Ventas Realty, as Lender.    Incorporated by reference to Exhibit 10.2.2 to our Current Report on Form 8-K filed on November 18, 2002.

10.6.3.4

   Guaranty of Recourse Obligations dated as of November 1, 2002 by the Guarantors named therein for the benefit of Ventas Realty, as Lender.    Incorporated by reference to Exhibit 10.2.3 to our Current Report on Form 8-K filed on November 18, 2002.

10.6.3.5

   Assignment of Leases, Rents and Contracts dated as of November 1, 2002 by the Borrowers named therein to Ventas Realty, as Lender.    Incorporated by reference to Exhibit 10.2.4 to our Current Report on Form 8-K filed on November 18, 2002.

 

127


Table of Contents
Index to Financial Statements

Exhibit

Number


  

Description of Document


  

Location of Document


10.6.3.6

   Open-End Fee and Leasehold Mortgage and Security Agreement dated as of November 1, 2002 by the Borrowers named therein for the benefit of Ventas Realty, as Lender.    Incorporated by reference to Exhibit 10.2.5 to our Current Report on Form 8-K filed on November 18, 2002.

10.6.3.7

   Deed of Trust and Security Agreement dated as of November 1, 2002 by the Borrowers named therein to Brian Lobuts, as Trustee for the benefit of Ventas Realty, as Lender.    Incorporated by reference to Exhibit 10.2.6 to our Current Report on Form 8-K filed on November 18, 2002.

10.6.3.8

   Schedule of Agreements Substantially Identical in All Material Respects to the agreements incorporated by reference as Exhibits 10.6.3.5, 10.6.3.6 and 10.6.3.7 to this Annual Report on Form 10-K, pursuant to Instruction 2 to Item 601 of Regulation S-K.    Incorporated by reference to Exhibit 10.2.7 to our Current Report on Form 8-K filed on November 18, 2002.

10.6.4.1

   Mezzanine Loan Agreement dated as of November 1, 2002 among Ventas Realty, as Lender, and the Borrowers named therein.    Incorporated by reference to Exhibit 10.3.1 to our Current Report on Form 8-K filed on November 18, 2002.

10.6.4.2

   Resizing and First Amendment to Loan Documents dated as of December 27, 2002 among Ventas Realty, as Mezzanine Lender, the Mezzanine Borrowers named therein and Trans Healthcare, Inc. and the Subsidiary Guarantors named therein, as Guarantors.    Incorporated by reference to Exhibit 10.5.3.2 to our Annual Report on Form 10-K for the year ended December 31, 2002.

10.6.4.3

   Second Amendment to Mezzanine Loan Agreement dated as of September 30, 2003 between Ventas Realty and Trans Healthcare, Inc. and the subsidiaries of Trans Healthcare, Inc. named therein.    Incorporated by reference to Exhibit 10.1.1 to our Quarterly Report on Form 10-Q for the quarter ended September 30, 2003.

10.6.4.4

   Promissory Note dated as of November 1, 2002 from the Mezzanine Borrowers named therein to Ventas Realty, as Mezzanine Lender.    Incorporated by reference to Exhibit 10.3.2 to our Current Report on Form 8-K filed on November 18, 2002.

10.6.4.5

   Guaranty dated as of November 1, 2002 by Trans Healthcare, Inc. and subsidiaries named therein, as Guarantors, in favor of Ventas Realty, as Lender.    Incorporated by reference to Exhibit 10.3.3 to our Current Report on Form 8-K filed on November 18, 2002.

10.6.4.6

   First Amendment to Guaranty dated as of April 28, 2003 between Ventas Realty and Trans Healthcare of Ohio, Inc.    Incorporated by reference to Exhibit 10.1.2 to our Quarterly Report on Form 10-Q for the quarter ended June 30, 2003.

10.6.4.7

   Second Amendment to Guaranty dated as of September 30, 2003 between Ventas Realty and Trans Healthcare of Ohio, Inc.    Incorporated by reference to Exhibit 10.4.2 to our Quarterly Report on Form 10-Q for the quarter ended September 30, 2003.

10.6.4.8

   Guarantor Pledge and Security Agreement dated as of November 1, 2002 by Trans Healthcare, Inc. and subsidiaries named therein, as Guarantors, in favor of Ventas Realty, as Lenders.    Incorporated by reference to Exhibit 10.3.4 to our Current Report on Form 8-K filed on November 18, 2002.

10.6.4.9

   Mezzanine Pledge and Security Agreement dated as of November 1, 2002 by THI of Ohio SNFS, LLC, THI of Maryland SNFS I, LLC and THI of Maryland SNFS II, LLC, as Pledgors, in favor of Ventas Realty, as Secured Party.    Incorporated by reference to Exhibit 10.3.5 to our Current Report on Form 8-K filed on November 18, 2002.

 

128


Table of Contents
Index to Financial Statements

Exhibit

Number


  

Description of Document


  

Location of Document


10.6.5.1

   Purchase and Sale Agreement dated December 27, 2002 between Ventas TRS and General Electric Capital Corporation.    Incorporated by reference to Exhibit 10.5.4.1 to our Annual Report on Form 10-K for the year ended December 31, 2002.

10.6.5.2

   General Assignment dated as of December 27, 2002 by Ventas TRS to General Electric Capital Corporation.    Incorporated by reference to Exhibit 10.5.4.2 to our Annual Report on Form 10-K for the year ended December 31, 2002.

10.6.5.3

   Intercreditor Agreement dated as of December 27, 2002 between General Electric Capital Corporation, as Senior Lender, and Ventas Realty, as Mezzanine Lender.    Incorporated by reference to Exhibit 10.5.4.3 to our Annual Report on Form 10-K for the year ended December 31, 2002.

10.7

   Waiver Agreement dated as of August 13, 2001 among Ventas Realty, Kindred Healthcare, Inc. and Kindred Operating, Inc.    Incorporated by reference to Exhibit 10.3 to our Quarterly Report on Form 10-Q for the quarter ended September 30, 2001.

10.8

   First Amended and Restated Agreement of Limited Partnership dated as of January 31, 2000, executed and delivered by the Company and Ventas LP Realty, L.L.C.    Incorporated by reference to Exhibit 10.20 to our Current Report on Form 8-K filed on February 8, 2000.

10.9

   Form of Assignment and Assumption of Lease Agreement dated on or prior to January 31, 1990 between Hillhaven and certain subsidiaries, on the one hand, and Tenet and certain subsidiaries, on the other hand, together with the related Guaranty by Hillhaven.    Incorporated by reference to Exhibit 10.37 to our Annual Report on Form 10-K for the year ended December 31, 1995.

10.10

   Amended and Restated Guarantee Reimbursement Agreement dated as of April 28, 1998 among Kindred, Inc., Kindred Operating, Inc. and Tenet Healthcare Corporation, Inc.    Incorporated by reference to Exhibit 10.20 to our Annual Report on Form 10-K for the year ended December 31, 1999.

10.11.1*

   1987 Stock Option Plan for Non-Employee Directors.    Incorporated by reference to Exhibit 10.10 to our Registration Statement on Form S-1, as amended, File No. 033-30212.

10.11.2*

   Amendment to the 1987 Stock Option Plan for Non-Employee Directors dated April 30, 1998.    Incorporated by reference to Exhibit 10.14 to our Quarterly Report on Form 10-Q for the quarter ended June 30, 1998.

10.12*

   TheraTx, Incorporated 1996 Stock Option/Stock Issuance Plan.    Incorporated by reference to Exhibit 99.1 to the Registration Statement on Form S-8 of TheraTx, File No. 333-15171.

10.13.1*

   1987 Incentive Compensation Program.    Incorporated by reference to Exhibit 10.9 to our Registration Statement on Form S-1, as amended, File No. 033-30212.

10.13.2*

   Amendment to the 1987 Incentive Compensation Program dated May 15, 1991.    Incorporated by reference to Exhibit 4.4 to our Registration Statement on Form S-8, as amended, File No. 033-40949.

10.13.3*

   Amendment to the 1987 Incentive Compensation Program dated May 18, 1994.    Incorporated by reference to Exhibit 10.13 to our Annual Report on Form 10-K for the year ended December 31, 1994.

 

129


Table of Contents
Index to Financial Statements

Exhibit

Number


  

Description of Document


  

Location of Document


10.13.4*

   Amendment to the 1987 Incentive Compensation Program dated February 15, 1995.    Incorporated by reference to Exhibit 10.14 to our Annual Report on Form 10-K for the year ended December 31, 1994.

10.13.5*

   Amendment to the 1987 Incentive Compensation Program dated September 27, 1995.    Incorporated by reference to Exhibit 10.17 to our Annual Report on Form 10-K for the year ended December 31, 1995.

10.13.6*

   Amendment to the 1987 Incentive Compensation Program effective May 15, 1996.    Incorporated by reference to Exhibit 10.19 to our Annual Report on Form 10-K for the year ended December 31, 1996.

10.13.7*

   Amendment to the 1987 Incentive Compensation Program dated April 30, 1998.    Incorporated by reference to Exhibit 10.13 to our Quarterly Report on Form 10-Q for the quarter ended June 30, 1998.

10.13.8*

   Amendment to the 1987 Incentive Compensation Program dated as of December 31, 1998.    Incorporated by reference to Exhibit 10.30 to our Annual Report on Form 10-K for the year ended December 31, 1998.

10.14.1*

   Ventas, Inc. 2000 Incentive Compensation Plan, as amended.    Filed herewith.

10.14.2*

   Form of Stock Option Agreement—2000 Incentive Compensation Plan.    Incorporated by reference to Exhibit 10.8 to our Quarterly Report on Form 10-Q for the quarter ended September 30, 2004.

10.14.3*

   Form of Restricted Stock Agreement—2000 Incentive Compensation Plan.    Incorporated by reference to Exhibit 10.9 to our Quarterly Report on Form 10-Q for the quarter ended September 30, 2004.

10.14.4*

   Form of Restricted Stock Unit Agreement—2000 Incentive Compensation Plan.    Incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K filed on January 24, 2005.

10.15*

   Ventas, Inc. Common Stock Purchase Plan for Directors.    Incorporated by reference to Exhibit 10.1 to our Quarterly Report on Form 10-Q for the quarter ended June 30, 2001.

10.16.1*

   Ventas, Inc. 2004 Stock Plan for Directors, as amended.    Filed herewith.

10.16.2*

   Form of Stock Option Agreement—2004 Stock Plan for Directors.    Incorporated by reference to Exhibit 10.10 to our Quarterly Report on Form 10-Q for the quarter ended September 30, 2004.

10.16.3 *

   Form of Restricted Stock Agreement—2004 Stock Plan for Directors.    Incorporated by reference to Exhibit 10.11 to our Quarterly Report on Form 10-Q for the quarter ended September 30, 2004.

10.17*

   Form of Indemnification Agreement for directors of TheraTx, Incorporated.    Incorporated by reference to Exhibit 10.13 to the Registration Statement on Form S-1 of TheraTx, File No. 033-78784.

10.18*

   Directors and Officers Insurance and Company Reimbursement Policies.    Incorporated by reference to Exhibit 10.1 to our Annual Report on Form 10-K for the year ended December 31, 1995.

10.19*

   Employment Agreement dated March 5, 1999 between Ventas, Inc. and Debra A. Cafaro.    Incorporated by reference to Exhibit 10.1 to our Quarterly Report on Form 10-Q for the quarter ended March 31, 1999.

 

130


Table of Contents
Index to Financial Statements

Exhibit

Number


  

Description of Document


  

Location of Document


10.20.1*

   Employment Agreement dated as of July 31, 1998 between Ventas, Inc. and T. Richard Riney.    Incorporated by reference to Exhibit 10.15.2.1 to our Annual Report on Form 10-K for the year ended December 31, 2002.

10.20.2*

   Amendment to Employment Agreement dated as of September 30, 1999 between Ventas, Inc. and T. Richard Riney.    Incorporated by reference to Exhibit 10.15.2.2 to our Annual Report on Form 10-K for the year ended December 31, 2002.

10.20.3*

   Change-in-Control Severance Agreement dated as of May 1, 1998 between Ventas, Inc. and T. Richard Riney.    Incorporated by reference to Exhibit 10.15.2.3 to our Annual Report on Form 10-K for the year ended December 31, 2002.

10.20.4*

   Amendment to Change-in-Control Severance Agreement dated as of September 30, 1999 between Ventas, Inc. and T. Richard Riney.    Incorporated by reference to Exhibit 10.15.2.4 to our Annual Report on Form 10-K for the year ended December 31, 2002.

10.21*

   Amended and Restated Employment Agreement dated as of December 31, 2004 between Ventas, Inc. and Richard A. Schweinhart.    Incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K filed on January 6, 2005.

10.22*

   Employment Agreement dated as of September 18, 2002 between Ventas, Inc. and Raymond J. Lewis.    Incorporated by reference to Exhibit 10.3 to our Quarterly Report on Form 10-Q for the quarter ended September 30, 2002.

10.23*

   Employment Agreement dated as of July 19, 2004 between Ventas, Inc. and K. Travis George.    Incorporated by reference to Exhibit 10.1 to our Quarterly Report on Form 10-Q for the quarter ended June 30, 2004.

10.24.1*

   Employment Agreement dated May 6, 2000 between Ventas, Inc. and Brian K. Wood.    Incorporated by reference to Exhibit 10.1 to our Quarterly Report on Form 10-Q for the quarter ended June 30, 2000.

10.24.2*

   First Amendment to Employment Agreement dated as of January 2, 2002 between Brian K. Wood and Ventas, Inc.    Incorporated by reference to Exhibit 10.27 to our Annual Report on Form 10-K for the year ended December 31, 2001.

10.25.1*

   Resignation and Release Agreement dated January 28, 2003 between Ventas, Inc. and W. Bruce Lundsford.    Incorporated by reference to Exhibit 10.17.1 to our Annual Report on Form 10-K for the year ended December 31, 2002.

10.25.2*

   Promissory Note entered into as of June 15, 1998 between Ventas Realty and W. Bruce Lundsford.    Incorporated by reference to Exhibit 10.17.2 to our Annual Report on Form 10-K for the year ended December 31, 2002.

10.25.3*

   Amendment to Promissory Note entered into as of December 31, 1998 between Ventas Realty and W. Bruce Lundsford.    Incorporated by reference to Exhibit 10.4 to our Annual Report on Form 10-K for the year ended December 31, 1998.

10.26.1*

   Ventas Executive Deferred Stock Compensation Plan.    Incorporated by reference to Exhibit 4.2 to our Registration Statement on Form S-8, File No. 333-118944.

 

131


Table of Contents
Index to Financial Statements

Exhibit

Number


  

Description of Document


  

Location of Document


10.26.2*

   Deferral Election Form under the Ventas Executive Deferred Stock Compensation Plan.    Incorporated by reference to Exhibit 4.4 to our Registration Statement on Form S-8, File No. 333-118944.

10.27.1*

   Ventas Nonemployee Director Deferred Stock Compensation Plan.    Incorporated by reference to Exhibit 4.1 to our Registration Statement on Form S-8, File No. 333-118944.

10.27.2*

   Deferral Election Form under the Ventas Nonemployee Director Deferred Stock Compensation Plan.    Incorporated by reference to Exhibit 4.3 to our Registration Statement on Form S-8, File No. 333-118944.

12

   Statement regarding computation of Ratios of Earnings to Fixed Charges.    Filed herewith.

21

   Subsidiaries of Ventas, Inc.    Filed herewith.

23

   Consent of Ernst & Young LLP.    Filed herewith.

31.1

   Certification of Debra A. Cafaro, Chairman, President and Chief Executive Officer, pursuant to Rule 13a-14(a) under the Exchange Act.    Filed herewith.

31.2

   Certification of Richard A. Schweinhart, Senior Vice President and Chief Financial Officer, pursuant to Rule 13a-14(a) under the Exchange Act.    Filed herewith.

32.1

   Certification of Debra A. Cafaro, Chairman, President and Chief Executive Officer, pursuant to Rule 13a-14(b) under the Exchange Act and 18 U.S.C. 1350.    Filed herewith.

32.2

   Certification of Richard A. Schweinhart, Senior Vice President and Chief Financial Officer, pursuant to Rule 13a-14(b) under the Exchange Act and 18 U.S.C. 1350.    Filed herewith.

* Management contract or compensatory plan or arrangement required to be filed as an exhibit pursuant to Item 15(c) of Form 10-K.

 

Reports on Form 8-K

 

On October 12, 2004, we filed a Current Report on Form 8-K dated October 8, 2004 reporting, under items 8.01 and 9.01, our intention to offer, in a private placement, up to $125 million aggregate principal amount of senior notes due 2014 of Ventas Realty and Ventas Capital and the pricing of that offering.

 

On October 15, 2004, we filed a Current Report on Form 8-K dated October 15, 2004 reporting, under items 1.01, 2.03 and 9.01, the issuance and sale of $125 million aggregate principal amount of 6  5 / 8 % Senior Notes due 2014 of Ventas Realty and Ventas Capital through a private placement to qualified institutional buyers pursuant to Rule 144A and in offshore transactions pursuant to Regulation S under the Securities Act of 1933, as amended.

 

On October 28, 2004, we furnished a Current Report on Form 8-K dated October 27, 2004 reporting, under items 2.02 and 9.01, our results of operations and financial condition as of and for the quarter and nine months ended September 30, 2004 (including our Condensed Consolidated Balance Sheets as of September 30, 2004, June 30, 2004, March 31, 2004 and December 31, 2003, our Condensed Consolidated Statements of Income for the three and nine months ended September 30, 2004 and 2003 and our Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2004 and 2003).

 

132


Table of Contents
Index to Financial Statements

On November 24, 2004, we furnished a Current Report on Form 8-K dated November 22, 2004 reporting, under item 7.01, the adoption by certain of our executive officers of non-discretionary, written trading plans that comply with Rule 10b5-1 under the Exchange Act to monetize a portion of their equity-based compensation.

 

On December 6, 2004, we filed a Current Report on Form 8-K dated December 3, 2004 reporting, under items 8.01 and 9.01, the declaration by our Board of Directors of a regular quarterly dividend of $0.325 per share (making it the fourth quarterly installment of our 2004 annual dividend), payable in cash on January 13, 2005 to stockholders of record on January 3, 2005.

 

On December 23, 2004, we furnished a Current Report on Form 8-K dated December 23, 2004 reporting, under items 7.01 and 9.01, the disposition of two of our hospitals to Kindred for a purchase price of $21.1 million.

 

In addition, we have filed or furnished three Current Reports on Form 8-K since December 31, 2004:

 

On January 6, 2005, we filed a Current Report on Form 8-K dated December 31, 2004 reporting, under items 1.01 and 9.01, our entry into an Amended and Restated Employment Agreement with Richard A. Schweinhart, our Senior Vice President and Chief Financial Officer.

 

On January 24, 2005, we filed a Current Report on Form 8-K dated January 18, 2005 reporting, under items 1.01 and 9.01, the determination by the Executive Compensation Committee of our Board of Directors of 2005 performance measures and potential bonus amounts under our annual cash incentive bonus program and the 2005 long-term incentive compensation structure for executive officers.

 

On March 1, 2005, we filed a Current Report on Form 8-K dated February 28, 2005 reporting, under items 2.02 and 9.01, our results of operations and financial condition as of and for the quarter and year ended December 31, 2004 (including our Condensed Consolidated Balance Sheets as of December 31, 2004, September 30, 2004, June 30, 2004, March 31, 2004 and December 31, 2003, our Condensed Consolidated Statements of Income for the years ended December 31, 2004 and 2003 and our Condensed Consolidated Statements of Cash Flows for the years ended December 31, 2004 and 2003) and, under item 8.01, the declaration by our Board of Directors of a regular quarterly dividend of $0.36 per share, payable in cash on April 5, 2005 to stockholders of record on March 24, 2005.

 

133


Table of Contents
Index to Financial Statements

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Date:    March 1, 2005

 

V ENTAS , I NC .

By:

 

/s/    D EBRA A. C AFARO        


   

Debra A. Cafaro

Chairman, President and Chief Executive Officer

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

 

Signature


  

Title


 

Date


/s/    D EBRA A. C AFARO        


Debra A. Cafaro

  

Chairman, President and Chief Executive Officer

(Principal Executive Officer)

  March 1, 2005

/s/    R ICHARD A. S CHWEINHART        


Richard A. Schweinhart

  

Senior Vice President and Chief Financial Officer

(Principal Financial Officer)

  March 1, 2005

/s/    K. T RAVIS G EORGE        


K. Travis George

  

Controller

(Principal Accounting Officer)

  March 1, 2005

/s/    D OUGLAS C ROCKER II        


Douglas Crocker II

  

Director

  March 1, 2005

/s/    R ONALD G. G EARY        


Ronald G. Geary

  

Director

  March 1, 2005

/s/    J AY M. G ELLERT        


Jay M. Gellert

  

Director

  March 1, 2005

/s/    C HRISTOPHER T. H ANNON        


Christopher T. Hannon

  

Director

  March 1, 2005

/s/    S HELI Z. R OSENBERG        


Sheli Z. Rosenberg

  

Director

  March 1, 2005

/s/    T HOMAS C. T HEOBALD        


Thomas C. Theobald

  

Director

  March 1, 2005

 

134


Table of Contents
Index to Financial Statements

EXHIBIT INDEX

 

Exhibit

Number


  

Description of Document


  

Location of Document


2.1    Agreement and Plan of Merger dated as of November 19, 2003 among Ventas, Inc., Ventas Sub, LLC and ElderTrust.    Incorporated by reference to Exhibit 2.1 to our Current Report on Form 8-K filed on November 21, 2003.
3.1.1    Certificate of Incorporation of Ventas, Inc., as amended.    Incorporated by reference to Exhibit 3 to our Quarterly Report on Form 10-Q for the quarter ended September 30, 1995.
3.1.2    Certificate of Amendment to Certificate of Incorporation of Ventas, Inc.    Incorporated by reference to Exhibit 3.1 to our Quarterly Report on Form 10-Q for the quarter ended June 30, 1998.
3.2    Third Amended and Restated Bylaws of Ventas, Inc.    Incorporated by reference to Exhibit 3.2 to our Annual Report on Form 10-K for the year ended December 31, 1997.
4.1    Specimen common stock certificate.    Incorporated by reference to Exhibit 4.1 to our Annual Report on Form 10-K for the year ended December 31, 1998.
4.2    Letter Agreement dated June 24, 2003 between Ventas, Inc. and Cohen & Steers Capital Management, Inc. (relating to a limited waiver of the provisions of Article XII of the Certificate of Incorporation of Ventas, Inc.)    Incorporated by reference to Exhibit 4.2 to our Quarterly Report on Form 10-Q for the quarter ended June 30, 2003.
4.3.1    Ventas, Inc. Distribution Reinvestment and Stock Purchase Plan.    Incorporated by reference to our Registration Statement on Form S-3, as amended, File No. 333-65642.
4.3.2    Amendment to Ventas, Inc. Distribution Reinvestment and Stock Purchase Plan.    Incorporated by reference to our Prospectus Supplement dated December 8, 2003 to the Prospectus dated January 23, 2002, filed pursuant to Rule 424(b)(5) and part of our Registration Statement on Form S-3, as amended, File No. 333-65642.
4.4.1    Indenture dated as of April 17, 2002 among Ventas Realty, Ventas Capital, the Guarantors named therein and U.S. Bank National Association, as Trustee, relating to the 8  3 / 4 % Senior Notes due 2009.    Incorporated by reference to Exhibit 99.1 to our Current Report on Form 8-K filed on April 24, 2002.
4.4.2    Supplemental Indenture dated as of October 11, 2002 among Ventas Healthcare Properties, Inc., as a Guaranteeing Subsidiary, Ventas Realty and Ventas Capital, as Issuers, Ventas, Inc. and Ventas LP Realty, L.L.C., as Guarantors, and U.S. Bank National Association, as Trustee.    Incorporated by reference to Exhibit 99.1 to our Current Report on Form 8-K filed on October 16, 2002.
4.4.3    Supplemental Indenture dated as of November 25, 2002 among Ventas TRS, as a Guaranteeing Subsidiary, Ventas Realty and Ventas Capital, as Issuers, Ventas, Inc., Ventas LP Realty, L.L.C. and Ventas Healthcare Properties, Inc., as Guarantors, and U.S. Bank National Association, as Trustee.    Incorporated by reference to Exhibit 99.1 to our Current Report on Form 8-K filed on November 26, 2002.

 


Table of Contents
Index to Financial Statements

Exhibit

Number


  

Description of Document


  

Location of Document


4.4.4    Supplemental Indenture dated as of February 20, 2004 among the newly-acquired Restricted Subsidiaries listed in Annex A thereto, as Guaranteeing Subsidiaries, Ventas Realty and Ventas Capital, as Issuers, Ventas, Inc., Ventas LP Realty, L.L.C., Ventas Healthcare Properties, Inc. and Ventas TRS, as Guarantors, and U.S. Bank National Association, as Trustee.    Incorporated by reference to Exhibit 4.5.4 to our Annual Report on Form 10-K for the year ended December 31, 2003.
4.4.5    Supplemental Indenture dated as of December 15, 2004 among Ventas Framingham, LLC and Ventas Management, LLC, as Guaranteeing Subsidiaries, Ventas Realty and Ventas Capital, as Issuers, the other Guarantors named therein and U.S. Bank National Association, as Trustee.    Filed herewith.
4.5.1    Indenture dated as of April 17, 2002 among Ventas Realty, Ventas Capital, the Guarantors named therein and U.S. Bank National Association, as Trustee, relating to the 9% Senior Notes due 2012.    Incorporated by reference to Exhibit 99.2 to our Current Report on Form 8-K filed on April 24, 2002.
4.5.2    Supplemental Indenture dated as of October 11, 2002 among Ventas Healthcare Properties, Inc., as a Guaranteeing Subsidiary, Ventas Realty and Ventas Capital, as Issuers, Ventas, Inc. and Ventas LP Realty, L.L.C., as Guarantors, and U.S. Bank National Association, as Trustee.    Incorporated by reference to Exhibit 99.2 to our Current Report on Form 8-K filed on October 16, 2002.
4.5.3    Supplemental Indenture dated as of November 25, 2002 among Ventas TRS, as a Guaranteeing Subsidiary, Ventas Realty and Ventas Capital, as Issuers, Ventas, Inc., Ventas LP Realty, L.L.C. and Ventas Healthcare Properties, Inc., as Guarantors, and U.S. Bank National Association, as Trustee.    Incorporated by reference to Exhibit 99.2 to our Current Report on Form 8-K filed on November 26, 2002.
4.5.4    Supplemental Indenture dated as of February 20, 2004 among the newly-acquired Restricted Subsidiaries listed in Annex A thereto, as Guaranteeing Subsidiaries, Ventas Realty and Ventas Capital, as Issuers, Ventas, Inc., Ventas LP Realty, L.L.C., Ventas Healthcare Properties, Inc. and Ventas TRS, as Guarantors, and U.S. Bank National Association, as Trustee.    Incorporated by reference to Exhibit 4.6.4 to our Annual Report on Form 10-K for the year ended December 31, 2003.
4.5.5    Supplemental Indenture dated as of December 15, 2004 among Ventas Framingham, LLC and Ventas Management, LLC, as Guaranteeing Subsidiaries, Ventas Realty and Ventas Capital, as Issuers, the other Guarantors named therein and U.S. Bank National Association, as Trustee.    Filed herewith.
4.6.1    Indenture dated as of October 15, 2004 among Ventas Realty and Ventas Capital, as Issuers, the Guarantors named therein and U.S. Bank National Association, as Trustee, relating to the 6  5 / 8 % Senior Notes due 2014.    Incorporated by reference to Exhibit 4.1 to our Current Report on Form 8-K filed on October 15, 2004.

 


Table of Contents
Index to Financial Statements

Exhibit

Number


  

Description of Document


  

Location of Document


4.6.2    Supplemental Indenture dated as of December 15, 2004 among Ventas Framingham, LLC and Ventas Management, LLC, as Guaranteeing Subsidiaries, Ventas Realty and Ventas Capital, as Issuers, the other Guarantors named therein and U.S. Bank National Association, as Trustee.    Incorporated by reference to Exhibit 4.1.2 to Amendment No. 1 to our Registration Statement on Form S-4, File No. 333-120642, filed on December 21, 2004.
4.7    Registration Rights Agreement dated as of September 30, 1999 between Ventas, Inc. and Debra A. Cafaro.    Incorporated by reference to Exhibit 4.15 to Amendment No. 2 to our Registration Statement on Form S-3, File No. 333-101598, filed on December 16, 2002.
4.8    Registration Rights Agreement dated as of October 15, 2004 among Ventas Realty and Ventas Capital, as Issuers, Ventas, Inc. and Ventas LP Realty, L.L.C., as Guarantors, and the Initial Purchasers named therein.    Incorporated by reference to Exhibit 4.2 to our Current Report on Form 8-K filed on October 15, 2004.
4.9.1    Loan and Security Agreement dated as of December 12, 2001 between Ventas Finance, as Borrower, and Merrill Lynch Mortgage Lending, Inc., as Lender.    Incorporated by reference to Exhibit 4.1 to our Current Report on Form 8-K filed on January 2, 2002.
4.9.2    Form of Assignment of Leases and Rents dated as of December 12, 2001 by Ventas Finance, as Assignor, to Merrill Lynch Mortgage Lending, Inc., as Assignee.    Incorporated by reference to Exhibit 4.2 to our Current Report on Form 8-K filed on January 2, 2002.
4.9.3    Form of Deed of Trust, Assignment of Leases and Rents, Security Agreement and Fixture Filing dated as of December 12, 2001 by Ventas Finance, as Trustor, to First American Title Insurance Company, as Trustee, for the benefit of Merrill Lynch Mortgage Lending, Inc., as Beneficiary.    Incorporated by reference to Exhibit 4.3 to our Current Report on Form 8-K filed on January 2, 2002.
4.9.4    Form of Mortgage, Assignment of Leases and Rents, Security Agreement and Fixture Filing dated as of December 12, 2001 by Ventas Finance, as Mortgagor, to Merrill Lynch Mortgage Lending, Inc., as Mortgagee.    Incorporated by reference to Exhibit 4.4 to our Current Report on Form 8-K filed on January 2, 2002.
4.9.5    Letter Agreement dated December 12, 2001 among Merrill Lynch Mortgage Lending, Inc., Ventas, Inc. and Ventas Finance (regarding the use of certain insurance proceeds received in connection with a casualty to a collateral property under the Loan and Security Agreement).    Incorporated by reference to Exhibit 4.5 to our Current Report on Form 8-K filed on January 2, 2002.
4.9.6    Letter Agreement dated as of December 12, 2001 among Merrill Lynch Mortgage Lending, Inc., JP Morgan Chase Bank, as Senior Collateral Agent and Junior Collateral Agent under various credit agreements with Kindred Healthcare, Inc., and Ventas Finance, as Landlord (concerning various notice requirements regarding the collateral property under the Loan and Security Agreement).    Incorporated by reference to Exhibit 4.6 to our Current Report on Form 8-K filed on January 2, 2002.

 


Table of Contents
Index to Financial Statements

Exhibit

Number


  

Description of Document


  

Location of Document


4.9.7    Letter Agreement dated as of December 12, 2001 among Merrill Lynch Mortgage Lending, Inc., Ventas Realty and Ventas Finance (concerning various rent reset rights under the Kindred Master Lease Agreements).    Incorporated by reference to Exhibit 4.7 to our Current Report on Form 8-K filed on January 2, 2002.
4.9.8    Collateral Assignment of Interest Rate Protection Agreement dated as of December 12, 2001 by Ventas Finance, as Assignor, to Merrill Lynch Mortgage Lending, Inc., as Assignee.    Incorporated by reference to Exhibit 4.8 to our Current Report on Form 8-K filed on January 2, 2002.
4.9.9    Mortgage Loan Purchase Agreement dated as of December 12, 2001 between Ventas Specialty I, LLC, as Purchaser, and Merrill Lynch Mortgage Lending, Inc., as Seller.    Incorporated by reference to Exhibit 4.9 to our Current Report on Form 8-K filed on January 2, 2002.
4.9.10    Promissory Note dated as of December 12, 2001 from Ventas Finance, as Borrower, to Merrill Lynch Mortgage Lending, Inc., as Lender.    Incorporated by reference to Exhibit 4.10 to our Current Report on Form 8-K filed on January 2, 2002.
4.9.11    Form of Subordination, Non-Disturbance and Attornment Agreement dated as of December 12, 2001 among Kindred, as Tenant, Ventas Finance, as Landlord, and Merrill Lynch Mortgage Lending, Inc., as Lender.    Incorporated by reference to Exhibit 4.11 to our Current Report on Form 8-K filed on January 2, 2002.
4.9.12    Cash Management Agreement dated as of December 12, 2001 among Ventas Finance, as Borrower, Merrill Lynch Mortgage Lending, Inc., as Lender, and First Union National Bank, as Agent.    Incorporated by reference to Exhibit 4.12 to our Current Report on Form 8-K filed on January 2, 2002.
4.9.13    Trust and Servicing Agreement dated as of December 12, 2001 among Ventas Specialty I, LLC, as Depositor, First Union National Bank, as Servicer and Special Servicer, LaSalle Bank National Association, as Trustee and Tax Administrator, and ABN Amro Bank N.V., as Fiscal Agent.    Incorporated by reference to Exhibit 4.13 to our Current Report on Form 8-K filed on January 2, 2002.
4.9.14    Environmental Indemnity Agreement dated as of December 12, 2001 among Ventas Finance, as Borrower, Ventas, Inc., as Guarantor, and Merrill Lynch Mortgage Lending, Inc., as Lender.    Incorporated by reference to Exhibit 4.14 to our Current Report on Form 8-K filed on January 2, 2002.
4.9.15    Exceptions to Non-Recourse Guaranty dated as of December 12, 2001 by Ventas, Inc., as Guarantor, for the benefit of Merrill Lynch Mortgage Lending, Inc., as Lender.    Incorporated by reference to Exhibit 4.15 to our Current Report on Form 8-K filed on January 2, 2002.
4.9.16    Certificate Purchase Agreement dated as of December 4, 2001 among Ventas Specialty I, LLC, Ventas, Inc., Merrill Lynch Pierce, Fenner & Smith Incorporated and Morgan Stanley & Co. Incorporated.    Incorporated by reference to Exhibit 4.16 to our Current Report on Form 8-K filed on January 2, 2002.
4.9.17    Schedule of Agreements Substantially Identical in all Material Respects to the agreements incorporated by reference as Exhibits 4.9.2, 4.9.3, 4.9.4 and 4.9.11 to this Annual Report on Form 10-K, pursuant to Instruction 2 to Item 601 of Regulation S-K.    Incorporated by reference to Exhibit 4.2.17 to our Annual Report on Form 10-K for the year ended December 31, 2001.

 


Table of Contents
Index to Financial Statements

Exhibit

Number


  

Description of Document


  

Location of Document


10.1.1    Agreement and Plan of Reorganization dated as of April 30, 1998 between Ventas, Inc. and Kindred, Inc.    Incorporated by reference to Exhibit 10.4.1 to our Annual Report on Form 10-K for the year ended December 31, 2001.
10.1.2    Distribution Agreement dated as of April 30, 1998 between Kindred, Inc. and Ventas, Inc.    Incorporated by reference to Exhibit 10.4.2 to our Annual Report on Form 10-K for the year ended December 31, 2001.
10.1.3.1    Tax Allocation Agreement dated as of April 30, 1998 between Ventas, Inc. and Kindred, Inc.    Incorporated by reference to Exhibit 10.9 to our Quarterly Report on Form 10-Q for the quarter ended June 30, 1998.
10.1.3.2    Tax Refund Escrow Agreement and First Amendment of the Tax Allocation Agreement dated as of April 20, 2001 between Kindred, Inc., on behalf of itself and each of its subsidiaries, and Ventas, Inc., on behalf of itself and each of Ventas Realty and Ventas LP Realty, L.L.C.    Incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K/A filed on April 24, 2001.
10.1.3.3    Cash Escrow Agreement dated as of April 20, 2001 among Kindred, Inc., Ventas, Inc. and State Street Bank and Trust Company.    Incorporated by reference to Exhibit 10.4.3.3 to our Annual Report on Form 10-K for the year ended December 31, 2001.
10.1.4    Agreement of Indemnity—Third Party Leases dated April 30, 1998 between Kindred, Inc. and its subsidiaries and Ventas, Inc.    Incorporated by reference to Exhibit 10.11 to Quarterly Report on Form 10-Q for the quarter ended June 30, 1998.
10.1.5    Agreement of Indemnity—Third Party Contracts dated April 30, 1998 between Kindred, Inc. and its subsidiaries and Ventas, Inc.    Incorporated by reference to Exhibit 10.12 to the Quarterly Report on Form 10-Q for the quarter ended June 30, 1998.
10.2.1.1    Amended and Restated Master Lease Agreement No. 1 dated as of April 20, 2001 for lease executed by Ventas Realty, as Lessor, and Kindred, Inc. and Kindred Operating, Inc., as Tenant.    Incorporated by reference to Exhibit 10.2 to our Current Report on Form 8-K/A filed on April 24, 2001.
10.2.1.2    Schedule of Agreements Substantially Identical in All Material Respects to the agreement incorporated by reference as Exhibit 10.2.1 to this Annual Report on Form 10-K, pursuant to Instruction 2 to Item 601 of Regulation S-K.    Incorporated by reference to Exhibit 10.3 to our Current Report on Form 8-K/A filed on April 24, 2001.
10.2.1.3    Termination of Memorandum of Lease dated as of June 21, 2002 among Kindred Healthcare, Inc., Kindred Operating, Inc. and Ventas Realty (relating to Northern Virginia Community Hospital, Arlington, Virginia).    Incorporated by reference to Exhibit 10.7 to our Quarterly Report on Form 10-Q for the quarter ended June 30, 2002.
10.2.2.1    Lease Severance and Amendment Agreement dated as of December 12, 2001 among Kindred Healthcare, Inc., as Tenant, Kindred Operating, Inc., as Operator and Tenant, and Ventas Realty, as Lessor.    Incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K filed on January 2, 2002.
10.2.2.2    Master Lease Agreement dated as of December 12, 2001 among Ventas Realty, as Lessor, and Kindred Healthcare, Inc. and Kindred Operating, Inc., as Tenants.    Incorporated by reference to Exhibit 10.2 to our Current Report on Form 8-K filed on January 2, 2002.

 


Table of Contents
Index to Financial Statements

Exhibit

Number


  

Description of Document


  

Location of Document


10.2.3.1    Agreement for Sale of Real Estate and Master Lease Amendments dated May 14, 2003 between Ventas Realty and Kindred Healthcare, Inc. and Kindred Operating, Inc.    Incorporated by reference to Exhibit 10.2.1 to our Quarterly Report on Form 10-Q for the quarter ended June 30, 2003.
10.2.3.2    Master Lease No. 1 Partial Lease Termination Agreement dated as of June 30, 2003 among Kindred Healthcare, Inc., Kindred Operating, Inc. and Ventas Realty.    Incorporated by reference to Exhibit 10.2.2 to our Quarterly Report on Form 10-Q for the quarter ended June 30, 2003.
10.2.3.3    Master Lease No. 2 Partial Lease Termination Agreement dated as of June 30, 2003 among Kindred Healthcare, Inc., Kindred Operating, Inc. and Ventas Realty.    Incorporated by reference to Exhibit 10.2.3 to our Quarterly Report on Form 10-Q for the quarter ended June 30, 2003.
10.2.3.4    Master Lease No. 3 Partial Lease Termination Agreement dated as of June 30, 2003 among Kindred Healthcare, Inc., Kindred Operating, Inc. and Ventas Realty.    Incorporated by reference to Exhibit 10.2.4 to our Quarterly Report on Form 10-Q for the quarter ended June 30, 2003.
10.2.3.5    Master Lease No. 4 Partial Lease Termination Agreement dated as of June 30, 2003 among Kindred Healthcare, Inc., Kindred Operating, Inc. and Ventas Realty.    Incorporated by reference to Exhibit 10.2.5 to our Quarterly Report on Form 10-Q for the quarter ended June 30, 2003.
10.2.4.1    Master Lease No. 1 Amendment Agreement dated as of June 30, 2003 among Kindred Healthcare, Inc., Kindred Operating, Inc. and Ventas Realty.    Incorporated by reference to Exhibit 10.3.1 to our Quarterly Report on Form 10-Q for the quarter ended June 30, 2003.
10.2.4.2    Master Lease No. 2 Amendment Agreement dated as of June 30, 2003 among Kindred Healthcare, Inc., Kindred Operating, Inc. and Ventas Realty.    Incorporated by reference to Exhibit 10.3.2 to our Quarterly Report on Form 10-Q for the quarter ended June 30, 2003.
10.2.4.3    Master Lease No. 3 Amendment Agreement dated as of June 30, 2003 among Kindred Healthcare, Inc., Kindred Operating, Inc. and Ventas Realty.    Incorporated by reference to Exhibit 10.3.3 to our Quarterly Report on Form 10-Q for the quarter ended June 30, 2003.
10.2.4.4    Master Lease No. 4 Amendment Agreement dated as of June 30, 2003 among Kindred Healthcare, Inc., Kindred Operating, Inc. and Ventas Realty.    Incorporated by reference to Exhibit 10.3.4 to our Quarterly Report on Form 10-Q for the quarter ended June 30, 2003.
10.2.4.5    CMBS Master Lease Amendment Agreement dated as of June 30, 2003 among Kindred Healthcare, Inc., Kindred Operating, Inc. and Ventas Realty.    Incorporated by reference to Exhibit 10.3.5 to our Quarterly Report on Form 10-Q for the quarter ended June 30, 2003.
10.2.5    Agreement for Sale of Real Estate and Master Lease Amendments dated November 5, 2003 between Ventas Realty and Kindred Healthcare, Inc. and Kindred Operating, Inc.    Incorporated by reference to Exhibit 99.1 to our Current Report on Form 8-K filed on November 10, 2003.
10.2.6.1    Master Lease Agreement No. 1A dated as of September 8, 2004 between Ventas Realty and Kindred Healthcare, Inc. and Kindred Operating, Inc.    Incorporated by reference to Exhibit 10.6 to our Current Report on Form 8-K filed on September 13, 2004.
10.2.6.2    Lease Severance and Amendment Agreement dated as of September 8, 2004 between Ventas Realty and Kindred Healthcare, Inc. and Kindred Operating, Inc.    Incorporated by reference to Exhibit 10.7 to our Current Report on Form 8-K filed on September 13, 2004.

 


Table of Contents
Index to Financial Statements

Exhibit

Number


  

Description of Document


  

Location of Document


10.2.7.1    Master Lease No. 1 Partial Lease Termination Agreement (IN-4620) dated as of December 22, 2004 among Kindred Healthcare, Inc., Kindred Healthcare Operating, Inc. and Ventas Realty.    Filed herewith.
10.2.7.2    Master Lease No. 1 Partial Lease Termination Agreement (CA-4693) dated as of December 22, 2004 among Kindred Healthcare, Inc., Kindred Healthcare Operating, Inc. and Ventas Realty.    Filed herewith.
10.3.1    Third Amended and Restated Credit, Security and Guaranty Agreement dated as of September 8, 2004 among Ventas Realty, as borrower, Ventas, Inc. and certain subsidiaries of Ventas, Inc. identified therein, as guarantors, the lenders identified therein, Bank of America, N.A., as Administrative Agent and Issuing Bank for the Letters of Credit thereunder, Merrill Lynch & Co., Merrill Lynch Pierce Fenner & Smith Incorporated and UBS Securities LLC, as Co-Syndication Agents, and Calyon New York Branch, JPMorgan Chase Bank and Citicorp North America, Inc., as Co-Documentation Agents.    Incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K filed on September 13, 2004.
10.3.2.1    Amended and Restated Mortgage, Security Agreement and Assignment of Rents dated as of April 17, 2002 by Ventas Realty, as Mortgagor, to Bank of America, N.A., Administrative Agent, as Mortgagee.    Incorporated by reference to Exhibit 99.4 to our Current Report on Form 8-K filed on April 24, 2002.
10.3.2.2    Amended and Restated Deed of Trust and Security Agreement dated as of April 17, 2002 by Ventas Realty, as Grantor, to Ronda C. Bundy, as Trustee, for the benefit of Bank of America, N.A., Administrative Agent, as Beneficiary.    Incorporated by reference to Exhibit 99.5 to our Current Report on Form 8-K filed on April 24, 2002.
10.3.2.3    Assignment of Leases and Rents dated as of April 17, 2002 by Ventas Realty, Assignor, to Bank of America, N.A., Administrative Agent, Assignee.    Incorporated by reference to Exhibit 99.6 to our Current Report on Form 8-K filed on April 24, 2002.
10.3.2.4    Schedule of Agreements Substantially Identical in All Material Respects to the agreements incorporated by reference as Exhibits 10.3.2.1, 10.3.2.2 and 10.3.2.3 to this Annual Report on Form 10-K, pursuant to Instruction 2 to Item 601 of Regulation S-K.    Incorporated by reference to Exhibit 99.7 to our Current Report on Form 8-K filed on April 24, 2002.
10.3.3.1    First Amendment to Amended and Restated Open-End Mortgage, Assignment of Rents and Security Agreement dated as of September 8, 2004 between Ventas Realty, as Mortgagor, and Bank of America, N.A., in its capacity as Administrative Agent, as Mortgagee.    Incorporated by reference to Exhibit 10.2 to our Current Report on Form 8-K filed on September 13, 2004.
10.3.3.2    First Amendment to Amended and Restated Deed of Trust, Assignment of Rents and Leases and Security Agreement dated as of September 8, 2004 between Ventas Realty, as Grantor, and Bank of America, N.A., in its capacity as Administrative Agent, as Beneficiary.    Incorporated by reference to Exhibit 10.3 to our Current Report on Form 8-K filed on September 13, 2004.

 


Table of Contents
Index to Financial Statements

Exhibit

Number


  

Description of Document


  

Location of Document


10.3.3.3    First Amendment to Amended and Restated Assignment of Leases and Rents dated as of September 8, 2004 between Ventas Realty, as Assignor, and Bank of America, N.A., in its capacity as Administrative Agent, as Assignee.    Incorporated by reference to Exhibit 10.4 to our Current Report on Form 8-K filed on September 13, 2004.
10.3.3.4    Schedule of Agreements Substantially Identical in All Material Respects to the agreements incorporated by reference as Exhibits 10.3.3.1, 10.3.3.2 and 10.3.3.3 to this Annual Report on Form 10-K, pursuant to Instruction 2 to Item 601 of Regulation S-K.    Incorporated by reference to Exhibit 10.5 to our Current Report on Form 8-K filed on September 13, 2004.
10.4.1    ISDA Master Agreement dated September 28, 2001 between Bank of America, N.A. and Ventas Realty.    Incorporated by reference to Exhibit 10.25.1 to our Annual Report on Form 10-K for the year ended December 31, 2001.
10.4.2    Letter Agreement dated October 25, 2001 between Bank of America, N.A. and Ventas Realty.    Incorporated by reference to Exhibit 10.25.2 to our Annual Report on Form 10-K for the year ended December 31, 2001.
10.5.1    ISDA Master Agreement dated as of December 11, 2001 between Banc of America Financial Products, Inc. and Ventas Finance.    Incorporated by reference to Exhibit 10.24.1 to our Annual Report on Form 10-K for the year ended December 31, 2001.
10.5.2    Letter Agreement dated December 11, 2001 between Ventas Finance and Banc of America Financial Products, Inc.    Incorporated by reference to Exhibit 10.24.2 to our Annual Report on Form 10-K for the year ended December 31, 2001.
10.5.3    Letter Agreement dated December 11, 2001 between Bank of America, N.A. and Ventas Realty.    Incorporated by reference to Exhibit 10.24.3 to our Annual Report on Form 10-K for the year ended December 31, 2001.
10.6.1.1    Purchase and Sale Agreement dated as of November 1, 2002 between Ventas Realty, as Buyer, and Trans Healthcare of Ohio, Inc., as Seller.    Incorporated by reference to Exhibit 10.1.1 to our Current Report on Form 8-K filed on November 18, 2002.
10.6.1.2    First Amendment to Purchase Agreement dated as of April 28, 2003 between Ventas Realty and Trans Healthcare, Inc. and the subsidiaries of Trans Healthcare, Inc. named therein.    Incorporated by reference to Exhibit 10.4.1 to our Quarterly Report on Form 10-Q for the quarter ended June 30, 2003.
10.6.2.1    Master Lease Agreement dated as of November 1, 2002 between Ventas Realty, as Landlord, and the Tenants named therein.    Incorporated by reference to Exhibit 10.1.2 to our Current Report on Form 8-K filed on November 18, 2002.
10.6.2.2    First Amendment to Master Lease Agreement dated as of April 28, 2003 between Ventas Realty and THI of Ohio at Chardon, LLC, THI of Ohio at Greenbriar North, LLC, Trans Healthcare of Ohio, Inc., THI of Ohio ALFS at the Commons, LLC, THI of Maryland at South River, LLC, Millennium Health and Rehabilitation Center of Forestville, LLC and Millennium Health and Rehabilitation Center of Ellicott City, LLC.    Incorporated by reference to Exhibit 10.4.3 to our Quarterly Report on Form 10-Q for the quarter ended June 30, 2003.

 


Table of Contents
Index to Financial Statements

Exhibit

Number


  

Description of Document


  

Location of Document


10.6.2.3    Second Amendment to Master Lease Agreement dated as of September 30, 2003 between Ventas Realty and THI of Ohio at Chardon, LLC, THI of Ohio at Greenbriar North, LLC, Trans Healthcare of Ohio, Inc., THI of Ohio ALFS at the Commons, LLC, THI of Maryland at South River, LLC, Millennium Health and Rehabilitation Center of Forestville, LLC and Millennium Health and Rehabilitation Center of Ellicott City, LLC.    Incorporated by reference to Exhibit 10.1.3 to our Quarterly Report on Form 10-Q for the quarter ended September 30, 2003.
10.6.3.1    Loan Agreement dated as of November 1, 2002 among Ventas Realty, as Lender, and the Borrowers named therein.    Incorporated by reference to Exhibit 10.2.1 to our Current Report on Form 8-K filed on November 18, 2002.
10.6.3.2    Resizing and First Amendment to Loan Documents dated as of December 27, 2002 among Ventas TRS, as Lender, the Mortgage Borrowers named therein and Trans Healthcare, Inc. and the Subsidiary Guarantors named therein.    Incorporated by reference to Exhibit 10.5.2.2 to our Annual Report on Form 10-K for the year ended December 31, 2002.
10.6.3.3    Promissory Note dated as of November 1, 2002 from certain Borrowers named therein to Ventas Realty, as Lender.    Incorporated by reference to Exhibit 10.2.2 to our Current Report on Form 8-K filed on November 18, 2002.
10.6.3.4    Guaranty of Recourse Obligations dated as of November 1, 2002 by the Guarantors named therein for the benefit of Ventas Realty, as Lender.    Incorporated by reference to Exhibit 10.2.3 to our Current Report on Form 8-K filed on November 18, 2002.
10.6.3.5    Assignment of Leases, Rents and Contracts dated as of November 1, 2002 by the Borrowers named therein to Ventas Realty, as Lender.    Incorporated by reference to Exhibit 10.2.4 to our Current Report on Form 8-K filed on November 18, 2002.
10.6.3.6    Open-End Fee and Leasehold Mortgage and Security Agreement dated as of November 1, 2002 by the Borrowers named therein for the benefit of Ventas Realty, as Lender.    Incorporated by reference to Exhibit 10.2.5 to our Current Report on Form 8-K filed on November 18, 2002.
10.6.3.7    Deed of Trust and Security Agreement dated as of November 1, 2002 by the Borrowers named therein to Brian Lobuts, as Trustee for the benefit of Ventas Realty, as Lender.    Incorporated by reference to Exhibit 10.2.6 to our Current Report on Form 8-K filed on November 18, 2002.
10.6.3.8    Schedule of Agreements Substantially Identical in All Material Respects to the agreements incorporated by reference as Exhibits 10.6.3.5, 10.6.3.6 and 10.6.3.7 to this Annual Report on Form 10-K, pursuant to Instruction 2 to Item 601 of Regulation S-K.    Incorporated by reference to Exhibit 10.2.7 to our Current Report on Form 8-K filed on November 18, 2002.
10.6.4.1    Mezzanine Loan Agreement dated as of November 1, 2002 among Ventas Realty, as Lender, and the Borrowers named therein.    Incorporated by reference to Exhibit 10.3.1 to our Current Report on Form 8-K filed on November 18, 2002.
10.6.4.2    Resizing and First Amendment to Loan Documents dated as of December 27, 2002 among Ventas Realty, as Mezzanine Lender, the Mezzanine Borrowers named therein and Trans Healthcare, Inc. and the Subsidiary Guarantors named therein, as Guarantors.    Incorporated by reference to Exhibit 10.5.3.2 to our Annual Report on Form 10-K for the year ended December 31, 2002.

 


Table of Contents
Index to Financial Statements

Exhibit

Number


  

Description of Document


  

Location of Document


10.6.4.3    Second Amendment to Mezzanine Loan Agreement dated as of September 30, 2003 between Ventas Realty and Trans Healthcare, Inc. and the subsidiaries of Trans Healthcare, Inc. named therein.    Incorporated by reference to Exhibit 10.1.1 to our Quarterly Report on Form 10-Q for the quarter ended September 30, 2003.
10.6.4.4    Promissory Note dated as of November 1, 2002 from the Mezzanine Borrowers named therein to Ventas Realty, as Mezzanine Lender.    Incorporated by reference to Exhibit 10.3.2 to our Current Report on Form 8-K filed on November 18, 2002.
10.6.4.5    Guaranty dated as of November 1, 2002 by Trans Healthcare, Inc. and subsidiaries named therein, as Guarantors, in favor of Ventas Realty, as Lender.    Incorporated by reference to Exhibit 10.3.3 to our Current Report on Form 8-K filed on November 18, 2002.
10.6.4.6    First Amendment to Guaranty dated as of April 28, 2003 between Ventas Realty and Trans Healthcare of Ohio, Inc.    Incorporated by reference to Exhibit 10.1.2 to our Quarterly Report on Form 10-Q for the quarter ended June 30, 2003.
10.6.4.7    Second Amendment to Guaranty dated as of September 30, 2003 between Ventas Realty and Trans Healthcare of Ohio, Inc.    Incorporated by reference to Exhibit 10.4.2 to our Quarterly Report on Form 10-Q for the quarter ended September 30, 2003.
10.6.4.8    Guarantor Pledge and Security Agreement dated as of November 1, 2002 by Trans Healthcare, Inc. and subsidiaries named therein, as Guarantors, in favor of Ventas Realty, as Lenders.    Incorporated by reference to Exhibit 10.3.4 to our Current Report on Form 8-K filed on November 18, 2002.
10.6.4.9    Mezzanine Pledge and Security Agreement dated as of November 1, 2002 by THI of Ohio SNFS, LLC, THI of Maryland SNFS I, LLC and THI of Maryland SNFS II, LLC, as Pledgors, in favor of Ventas Realty, as Secured Party.    Incorporated by reference to Exhibit 10.3.5 to our Current Report on Form 8-K filed on November 18, 2002.
10.6.5.1    Purchase and Sale Agreement dated December 27, 2002 between Ventas TRS and General Electric Capital Corporation.    Incorporated by reference to Exhibit 10.5.4.1 to our Annual Report on Form 10-K for the year ended December 31, 2002.
10.6.5.2    General Assignment dated as of December 27, 2002 by Ventas TRS to General Electric Capital Corporation.    Incorporated by reference to Exhibit 10.5.4.2 to our Annual Report on Form 10-K for the year ended December 31, 2002.
10.6.5.3    Intercreditor Agreement dated as of December 27, 2002 between General Electric Capital Corporation, as Senior Lender, and Ventas Realty, as Mezzanine Lender.    Incorporated by reference to Exhibit 10.5.4.3 to our Annual Report on Form 10-K for the year ended December 31, 2002.
10.7    Waiver Agreement dated as of August 13, 2001 among Ventas Realty, Kindred Healthcare, Inc. and Kindred Operating, Inc.    Incorporated by reference to Exhibit 10.3 to our Quarterly Report on Form 10-Q for the quarter ended September 30, 2001.
10.8    First Amended and Restated Agreement of Limited Partnership dated as of January 31, 2000, executed and delivered by the Company and Ventas LP Realty, L.L.C.    Incorporated by reference to Exhibit 10.20 to our Current Report on Form 8-K filed on February 8, 2000.

 


Table of Contents
Index to Financial Statements

Exhibit

Number


    

Description of Document


  

Location of Document


10.9      Form of Assignment and Assumption of Lease Agreement dated on or prior to January 31, 1990 between Hillhaven and certain subsidiaries, on the one hand, and Tenet and certain subsidiaries, on the other hand, together with the related Guaranty by Hillhaven.    Incorporated by reference to Exhibit 10.37 to our Annual Report on Form 10-K for the year ended December 31, 1995.
10.10      Amended and Restated Guarantee Reimbursement Agreement dated as of April 28, 1998 among Kindred, Inc., Kindred Operating, Inc. and Tenet Healthcare Corporation, Inc.    Incorporated by reference to Exhibit 10.20 to our Annual Report on Form 10-K for the year ended December 31, 1999.
10.11.1 *    1987 Stock Option Plan for Non-Employee Directors.    Incorporated by reference to Exhibit 10.10 to our Registration Statement on Form S-1, as amended, File No. 033-30212.
10.11.2 *    Amendment to the 1987 Stock Option Plan for Non-Employee Directors dated April 30, 1998.    Incorporated by reference to Exhibit 10.14 to our Quarterly Report on Form 10-Q for the quarter ended June 30, 1998.
10.12*      TheraTx, Incorporated 1996 Stock Option/Stock Issuance Plan.    Incorporated by reference to Exhibit 99.1 to the Registration Statement on Form S-8 of TheraTx, File No. 333-15171.
10.13.1 *    1987 Incentive Compensation Program.    Incorporated by reference to Exhibit 10.9 to our Registration Statement on Form S-1, as amended, File No. 033-30212.
10.13.2 *    Amendment to the 1987 Incentive Compensation Program dated May 15, 1991.    Incorporated by reference to Exhibit 4.4 to our Registration Statement on Form S-8, as amended, File No. 033-40949.
10.13.3 *    Amendment to the 1987 Incentive Compensation Program dated May 18, 1994.    Incorporated by reference to Exhibit 10.13 to our Annual Report on Form 10-K for the year ended December 31, 1994.
10.13.4 *    Amendment to the 1987 Incentive Compensation Program dated February 15, 1995.    Incorporated by reference to Exhibit 10.14 to our Annual Report on Form 10-K for the year ended December 31, 1994.
10.13.5 *    Amendment to the 1987 Incentive Compensation Program dated September 27, 1995.    Incorporated by reference to Exhibit 10.17 to our Annual Report on Form 10-K for the year ended December 31, 1995.
10.13.6 *    Amendment to the 1987 Incentive Compensation Program effective May 15, 1996.    Incorporated by reference to Exhibit 10.19 to our Annual Report on Form 10-K for the year ended December 31, 1996.
10.13.7 *    Amendment to the 1987 Incentive Compensation Program dated April 30, 1998.    Incorporated by reference to Exhibit 10.13 to our Quarterly Report on Form 10-Q for the quarter ended June 30, 1998.
10.13.8 *    Amendment to the 1987 Incentive Compensation Program dated as of December 31, 1998.    Incorporated by reference to Exhibit 10.30 to our Annual Report on Form 10-K for the year ended December 31, 1998.
10.14.1 *    Ventas, Inc. 2000 Incentive Compensation Plan, as amended.    Filed herewith.

 


Table of Contents
Index to Financial Statements

Exhibit

Number


  

Description of Document


  

Location of Document


10.14.2*    Form of Stock Option Agreement—2000 Incentive Compensation Plan.    Incorporated by reference to Exhibit 10.8 to our Quarterly Report on Form 10-Q for the quarter ended September 30, 2004.
10.14.3*    Form of Restricted Stock Agreement—2000 Incentive Compensation Plan.    Incorporated by reference to Exhibit 10.9 to our Quarterly Report on Form 10-Q for the quarter ended September 30, 2004.
10.14.4*    Form of Restricted Stock Unit Agreement—2000 Incentive Compensation Plan.    Incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K filed on January 24, 2005.
10.15*    Ventas, Inc. Common Stock Purchase Plan for Directors.    Incorporated by reference to Exhibit 10.1 to our Quarterly Report on Form 10-Q for the quarter ended June 30, 2001.
10.16.1*    Ventas, Inc. 2004 Stock Plan for Directors, as amended.    Filed herewith.
10.16.2*    Form of Stock Option Agreement—2004 Stock Plan for Directors.    Incorporated by reference to Exhibit 10.10 to our Quarterly Report on Form 10-Q for the quarter ended September 30, 2004.
10.16.3*    Form of Restricted Stock Agreement—2004 Stock Plan for Directors.    Incorporated by reference to Exhibit 10.11 to our Quarterly Report on Form 10-Q for the quarter ended September 30, 2004.
10.17*    Form of Indemnification Agreement for directors of TheraTx, Incorporated.    Incorporated by reference to Exhibit 10.13 to the Registration Statement on Form S-1 of TheraTx, File No. 033-78784.
10.18*    Directors and Officers Insurance and Company Reimbursement Policies.    Incorporated by reference to Exhibit 10.1 to our Annual Report on Form 10-K for the year ended December 31, 1995.
10.19*    Employment Agreement dated March 5, 1999 between Ventas, Inc. and Debra A. Cafaro.    Incorporated by reference to Exhibit 10.1 to our Quarterly Report on Form 10-Q for the quarter ended March 31, 1999.
10.20.1*    Employment Agreement dated as of July 31, 1998 between Ventas, Inc. and T. Richard Riney.    Incorporated by reference to Exhibit 10.15.2.1 to our Annual Report on Form 10-K for the year ended December 31, 2002.
10.20.2*    Amendment to Employment Agreement dated as of September 30, 1999 between Ventas, Inc. and T. Richard Riney.    Incorporated by reference to Exhibit 10.15.2.2 to our Annual Report on Form 10-K for the year ended December 31, 2002.
10.20.3*    Change-in-Control Severance Agreement dated as of May 1, 1998 between Ventas, Inc. and T. Richard Riney.    Incorporated by reference to Exhibit 10.15.2.3 to our Annual Report on Form 10-K for the year ended December 31, 2002.
10.20.4*    Amendment to Change-in-Control Severance Agreement dated as of September 30, 1999 between Ventas, Inc. and T. Richard Riney.    Incorporated by reference to Exhibit 10.15.2.4 to our Annual Report on Form 10-K for the year ended December 31, 2002.

 


Table of Contents
Index to Financial Statements

Exhibit

Number


  

Description of Document


  

Location of Document


10.21*    Amended and Restated Employment Agreement dated as of December 31, 2004 between Ventas, Inc. and Richard A. Schweinhart.    Incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K filed on January 6, 2005.
10.22*    Employment Agreement dated as of September 18, 2002 between Ventas, Inc. and Raymond J. Lewis.    Incorporated by reference to Exhibit 10.3 to our Quarterly Report on Form 10-Q for the quarter ended September 30, 2002.
10.23*    Employment Agreement dated as of July 19, 2004 between Ventas, Inc. and K. Travis George.    Incorporated by reference to Exhibit 10.1 to our Quarterly Report on Form 10-Q for the quarter ended June 30, 2004.
10.24.1*    Employment Agreement dated May 6, 2000 between Ventas, Inc. and Brian K. Wood.    Incorporated by reference to Exhibit 10.1 to our Quarterly Report on Form 10-Q for the quarter ended June 30, 2000.
10.24.2*    First Amendment to Employment Agreement dated as of January 2, 2002 between Brian K. Wood and Ventas, Inc.    Incorporated by reference to Exhibit 10.27 to our Annual Report on Form 10-K for the year ended December 31, 2001.
10.25.1*    Resignation and Release Agreement dated January 28, 2003 between Ventas, Inc. and W. Bruce Lundsford.    Incorporated by reference to Exhibit 10.17.1 to our Annual Report on Form 10-K for the year ended December 31, 2002.
10.25.2*    Promissory Note entered into as of June 15, 1998 between Ventas Realty and W. Bruce Lundsford.    Incorporated by reference to Exhibit 10.17.2 to our Annual Report on Form 10-K for the year ended December 31, 2002.
10.25.3*    Amendment to Promissory Note entered into as of December 31, 1998 between Ventas Realty and W. Bruce Lundsford.    Incorporated by reference to Exhibit 10.4 to our Annual Report on Form 10-K for the year ended December 31, 1998.
10.26.1*    Ventas Executive Deferred Stock Compensation Plan.    Incorporated by reference to Exhibit 4.2 to our Registration Statement on Form S-8, File No. 333-118944.
10.26.2*    Deferral Election Form under the Ventas Executive Deferred Stock Compensation Plan.    Incorporated by reference to Exhibit 4.4 to our Registration Statement on Form S-8, File No. 333-118944.
10.27.1*    Ventas Nonemployee Director Deferred Stock Compensation Plan.    Incorporated by reference to Exhibit 4.1 to our Registration Statement on Form S-8, File No. 333-118944.
10.27.2*    Deferral Election Form under the Ventas Nonemployee Director Deferred Stock Compensation Plan.    Incorporated by reference to Exhibit 4.3 to our Registration Statement on Form S-8, File No. 333-118944.
12    Statement regarding computation of Ratios of Earnings to Fixed Charges.    Filed herewith.
21    Subsidiaries of Ventas, Inc.    Filed herewith.
23    Consent of Ernst & Young LLP.    Filed herewith.

 


Table of Contents
Index to Financial Statements

Exhibit

Number


  

Description of Document


  

Location of Document


31.1    Certification of Debra A. Cafaro, Chairman, President and Chief Executive Officer, pursuant to Rule 13a-14(a) under the Exchange Act.    Filed herewith.
31.2    Certification of Richard A. Schweinhart, Senior Vice President and Chief Financial Officer, pursuant to Rule 13a-14(a) under the Exchange Act.    Filed herewith.
32.1    Certification of Debra A. Cafaro, Chairman, President and Chief Executive Officer, pursuant to Rule 13a-14(b) under the Exchange Act and 18 U.S.C. 1350.    Filed herewith.
32.2    Certification of Richard A. Schweinhart, Senior Vice President and Chief Financial Officer, pursuant to Rule 13a-14(b) under the Exchange Act and 18 U.S.C. 1350.    Filed herewith.

* Management contract or compensatory plan or arrangement required to be filed as an exhibit pursuant to Item 15(c) of Form 10-K.

EXHIBIT 4.4.5

 

SUPPLEMENTAL INDENTURE

 

S UPPLEMENTAL I NDENTURE (this “ Supplemental Indenture ”), dated as of December 15, 2004, by and among Ventas Framingham, LLC, a Delaware limited liability company, and Ventas Management, LLC, a Delaware limited liability company (each, a “ Guaranteeing Subsidiary ” and collectively, the “ Guaranteeing Subsidiaries ”), Ventas Realty, Limited Partnership, a Delaware limited partnership, and Ventas Capital Corporation, a Delaware corporation (collectively, the “ Issuers ”), the other Guarantors (as defined in the Indenture referred to herein) and U.S. Bank National Association, as trustee under the Indenture referred to herein (the “ Trustee ”).

 

W I T N E S S E T H

 

WHEREAS, the Issuers have heretofore executed and delivered to the Trustee an Indenture dated as of April 17, 2002, as supplemented by the Supplemental Indenture dated as of October 11, 2002, the Supplemental Indenture dated as of November 25, 2002, the Supplemental Indenture dated as of February 20, 2004 and the Supplemental Indenture dated as of June 1, 2004 (as so supplemented, the “ Indenture ”), providing for the issuance of 8  3 / 4 % Senior Notes due 2009 (the “ Notes ”);

 

WHEREAS, the Indenture provides that under certain circumstances each Guaranteeing Subsidiary shall execute and deliver to the Trustee a supplemental indenture pursuant to which the Guaranteeing Subsidiary shall unconditionally guarantee all of the Issuers’ Obligations (as defined in the Indenture) under the Notes and the Indenture on the terms and conditions set forth herein (a “ Note Guarantee ”); and

 

WHEREAS, pursuant to Section 9.01 of the Indenture, the Trustee is authorized to execute and deliver this Supplemental Indenture.

 

NOW THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby acknowledged, each Guaranteeing Subsidiary and the Trustee mutually covenant and agree for the equal and ratable benefit of the Holders of the Notes as follows:

 

1. C APITALIZED T ERMS . Capitalized terms used herein without definition shall have the meanings assigned to them in the Indenture.

 

2. A GREEMENT TO G UARANTEE . Each Guaranteeing Subsidiary hereby agrees as follows:

 

(a) Subject to Article 10 of the Indenture, such Guaranteeing Subsidiary hereby, jointly and severally with all other Guarantors, unconditionally guarantees to each Holder of a Note authenticated and delivered by the Trustee and to the Trustee and its successors and assigns, irrespective of the validity and enforceability of the Indenture, the Notes or the obligations of the Issuers thereunder, that:

 

(i) the principal of, and premium and Liquidated Damages, if any, and interest on the Notes will be promptly paid in full when due, whether at maturity,

 

1


by acceleration, redemption or otherwise, and interest on the overdue principal of and interest on the Notes, if any, if lawful, and all other obligations of the Issuers to the Holders or the Trustee hereunder or thereunder will be promptly paid in full or performed, all in accordance with the terms hereof and thereof; and

 

(ii) in case of any extension of time of payment or renewal of any Notes or any of such other obligations, that same will be promptly paid in full when due or performed in accordance with the terms of the extension or renewal, whether at stated maturity, by acceleration or otherwise.

 

Failing payment when due of any amount so guaranteed or any performance so guaranteed for whatever reason, the Guarantors shall be jointly and severally obligated to pay the same immediately.

 

(b) The obligations hereunder shall be unconditional, irrespective of the validity, regularity or enforceability of the Notes or the Indenture, the absence of any action to enforce the same, any waiver or consent by any Holder of the Notes with respect to any provisions hereof or thereof, the recovery of any judgment against the Issuers, any action to enforce the same or any other circumstance which might otherwise constitute a legal or equitable discharge or defense of a Guarantor, other than payment in full of all obligations under the Notes.

 

(c) The following is hereby waived: diligence, presentment, demand of payment, filing of claims with a court in the event of insolvency or bankruptcy of the Issuers, any right to require a proceeding first against the Issuers, protest, notice and all demands whatsoever.

 

(d) This Note Guarantee shall not be discharged except by complete performance of the obligations contained in the Notes and the Indenture, and such Guaranteeing Subsidiary hereby accepts all obligations of a Guarantor under the Indenture.

 

(e) If any Holder or the Trustee is required by any court or otherwise to return to the Issuers, the Guarantors or any custodian, trustee, liquidator or other similar official acting in relation to either the Issuers or the Guarantors, any amount paid by either to the Trustee or such Holder, this Note Guarantee, to the extent theretofore discharged, shall be reinstated in full force and effect.

 

(f) Such Guaranteeing Subsidiary shall not be entitled to any right of subrogation in relation to the Holders in respect of any obligations guaranteed hereby until payment in full of all obligations guaranteed hereby.

 

(g) As between the Guarantors, on the one hand, and the Holders and the Trustee, on the other hand, (1) the maturity of the obligations guaranteed hereby may be accelerated as provided in Article 6 of the Indenture for the purposes of this Note Guarantee, notwithstanding any stay, injunction or other prohibition preventing such acceleration in respect of the obligations guaranteed hereby, and (2) in the event of any

 

2


declaration of acceleration of such obligations as provided in Article 6 of the Indenture, such obligations (whether or not due and payable) shall forthwith become due and payable by the Guarantors for the purpose of this Note Guarantee.

 

(h) The Guarantors shall have the right to seek contribution from any non-paying Guarantor so long as the exercise of such right does not impair the rights of the Holders under the Note Guarantees.

 

(i) In accordance with Section 10.02 of the Indenture, after giving effect to any maximum amount and all other contingent and fixed liabilities that are relevant under any applicable Bankruptcy Law or fraudulent conveyance law, and after giving effect to any collections from, rights to receive contribution from or payments made by or on behalf of any other Guarantor in respect of the obligations of such other Guarantor under Article 10 of the Indenture, this Note Guarantee shall be limited to the maximum amount permissible such that the obligations of such Guaranteeing Subsidiary under this Note Guarantee will not constitute a fraudulent transfer or conveyance.

 

3. E XECUTION AND D ELIVERY . Each Guaranteeing Subsidiary agrees that this Note Guarantee shall remain in full force and effect notwithstanding any failure to endorse on each Note a notation of such Note Guarantee.

 

4. G UARANTEEING S UBSIDIARIES M AY C ONSOLIDATE , E TC . ON C ERTAIN T ERMS .

 

(a) No Guaranteeing Subsidiary may sell or otherwise dispose of all or substantially all of its assets to, or consolidate with or merge with or into (whether or not such Guaranteeing Subsidiary is the surviving Person) another Person, other than the Issuers or another Guarantor unless:

 

(i) immediately after giving effect to that transaction, no Default or Event of Default exists; and

 

(ii) subject to Section 10.05 of the Indenture, the Person acquiring the property in any such sale or disposition or the Person formed by or surviving any such consolidation or merger assumes all of the obligations of that Guaranteeing Subsidiary under the Indenture, this Note Guarantee and the Registration Rights Agreement pursuant to a supplemental indenture in form and substance reasonably satisfactory to the Trustee.

 

(b) In case of any such consolidation, merger, sale or conveyance and upon the assumption by the successor Person, by supplemental indenture, executed and delivered to the Trustee and satisfactory in form to the Trustee, of this Note Guarantee endorsed upon the Notes and the due and punctual performance of all of the covenants and conditions of the Indenture to be performed by the Guaranteeing Subsidiary, such successor Person shall succeed to and be substituted for the Guaranteeing Subsidiary with the same effect as if it had been named herein as a Guaranteeing Subsidiary. Such successor Person thereupon may cause to be signed any or all of the Note Guarantees to

 

3


be endorsed upon all of the Notes issuable under the Indenture which theretofore shall not have been signed by the Issuers and delivered to the Trustee. All the Note Guarantees so issued shall in all respects have the same legal rank and benefit under the Indenture as the Note Guarantees theretofore and thereafter issued in accordance with the terms of the Indenture as though all of such Note Guarantees had been issued at the date of the execution hereof.

 

(c) Except as set forth in Articles 4 and 5 and Section 10.05 of the Indenture, and notwithstanding clauses (a) and (b) above, nothing contained in the Indenture or in any of the Notes shall prevent any consolidation or merger of a Guaranteeing Subsidiary with or into the Issuers or another Guarantor, or shall prevent any sale or conveyance of the property of a Guaranteeing Subsidiary as an entirety or substantially as an entirety to the Issuers or another Guarantor.

 

5. R ELEASES .

 

(a) The Note Guarantee of a Guaranteeing Subsidiary shall be released, and any Person acquiring assets (including by way of merger or consolidation) or Capital Stock of a Guaranteeing Subsidiary under those circumstances specified in the Indenture shall not be required to assume the obligations of such Guaranteeing Subsidiary, in each case in accordance with the provisions of Section 10.05 of the Indenture. Upon delivery by the Issuers to the Trustee of an Officers’ Certificate and an Opinion of Counsel stating that the provisions of Section 10.05 of the Indenture have been complied with, the Trustee shall execute any documents reasonably required in order to evidence the release of any Guaranteeing Subsidiary from its obligations under this Note Guarantee.

 

(b) Any Guaranteeing Subsidiary not released from its obligations under this Note Guarantee shall remain liable for the full amount of principal of and interest on the Notes and for the other obligations of any Guarantor under the Indenture as provided in Article 10 of the Indenture.

 

6. N O R ECOURSE A GAINST O THERS . No past, present or future director, officer, employee, incorporator, stockholder or agent of any Guaranteeing Subsidiary, as such, shall have any liability for any obligations of the Issuers or any Guaranteeing Subsidiary under the Notes, this Note Guarantee, the Indenture or this Supplemental Indenture or for any claim based on, in respect of, or by reason of, such obligations or their creation. Each Holder of the Notes by accepting a Note waives and releases all such liability. The waiver and release are part of the consideration for issuance of the Notes. Such waiver may not be effective to waive liabilities under the federal securities laws and it is the view of the Commission that such a waiver is against public policy.

 

7. NEW YORK LAW TO GOVERN. THE INTERNAL LAW OF THE STATE OF NEW YORK SHALL GOVERN AND BE USED TO CONSTRUE THIS SUPPLEMENTAL INDENTURE AND NOTE GUARANTEE WITHOUT GIVING EFFECT TO APPLICABLE PRINCIPLES OF CONFLICTS OF LAW TO THE EXTENT THAT THE APPLICATION OF THE LAWS OF ANOTHER JURISDICTION WOULD BE REQUIRED THEREBY.

 

4


8. C OUNTERPARTS . The parties may sign any number of copies of this Supplemental Indenture. Each signed copy shall be an original, but all of them together represent the same agreement.

 

9. E FFECT OF H EADINGS . The Section headings herein are for convenience only and shall not affect the construction hereof.

 

10. T HE T RUSTEE . The Trustee shall not be responsible in any manner whatsoever for or in respect of the validity or sufficiency of this Supplemental Indenture or for or in respect of the recitals contained herein, all of which recitals are made solely by the Guaranteeing Subsidiaries and the Issuers.

 

5


IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly executed and attested, all as of the date first above written.

 

GUARANTEEING SUBSIDIARIES:

V ENTAS F RAMINGHAM , LLC

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Executive Vice President, General

   

Counsel and Secretary

V ENTAS M ANAGEMENT , LLC

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Executive Vice President, General

   

Counsel and Secretary

ISSUERS:

V ENTAS R EALTY , L IMITED P ARTNERSHIP

By:

 

V ENTAS , I NC ., its General Partner

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Executive Vice President,

   

General Counsel and

   

Corporate Secretary

V ENTAS C APITAL C ORPORATION

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Executive Vice President,

   

General Counsel and Corporate

   

Secretary

 

6


EXISTING GUARANTORS:

V ENTAS , I NC .

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Executive Vice President,

   

General Counsel and Corporate

   

Secretary

V ENTAS LP R EALTY , L.L.C.

By:

 

V ENTAS , I NC ., its Sole Member

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Executive Vice President,

   

General Counsel and

   

Corporate Secretary

V ENTAS H EALTHCARE P ROPERTIES , I NC .

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Executive Vice President,

   

General Counsel and Corporate

   

Secretary

V ENTAS T RS , LLC

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Executive Vice President

E LDER T RUST

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Secretary

 

7


E LDER T RUST O PERATING L IMITED P ARTNERSHIP

By:

 

E LDER T RUST , its General Partner

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Secretary

ET C APITAL C ORP .

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Secretary

ET S UB -B ERKSHIRE L IMITED P ARTNERSHIP

By:

 

ET B ERKSHIRE , LLC, its General Partner

By:

 

E LDER T RUST O PERATING L IMITED

   

P ARTNERSHIP ,

its Sole Member

By:

 

E LDER T RUST , its General Partner

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Secretary

ET B ERKSHIRE , LLC

By:

 

E LDER T RUST O PERATING L IMITED

   

P ARTNERSHIP ,

its Sole Member

By:

 

E LDER T RUST , its General Partner

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Secretary

 

8


C ABOT ALF, L.L.C.

By:

 

E LDER T RUST O PERATING L IMITED

   

P ARTNERSHIP , its Sole Member

By:

 

E LDER T RUST , its General Partner

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Secretary

C LEVELAND ALF, L.L.C.

By:

 

E LDER T RUST O PERATING L IMITED

   

P ARTNERSHIP ,

its Sole Member

By:

 

E LDER T RUST , its General Partner

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Secretary

ET S UB - HERITAGE W OODS , L.L.C.

By:

 

E LDER T RUST O PERATING L IMITED

   

P ARTNERSHIP ,

its Sole Member

By:

 

E LDER T RUST , its General Partner

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Secretary

ET S UB -H IGHGATE , L.P.

By:

 

ET GENPAR, L.L.C.,

its General Partner

By:

 

E LDER T RUST O PERATING L IMITED

   

P ARTNERSHIP ,

its Sole Member

By:

 

E LDER T RUST , its General Partner

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Secretary

 

9


ET G ENPAR , L.L.C.

By:

 

E LDER T RUST O PERATING L IMITED

   

P ARTNERSHIP ,

its Sole Member

By:

 

E LDER T RUST , its General Partner

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Secretary

ET S UB -L ACEY I, L.L.C.

By:

 

E LDER T RUST O PERATING L IMITED

   

P ARTNERSHIP ,

its Sole Member

By:

 

E LDERTRUST , its General Partner

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Secretary

ET S UB -L EHIGH L IMITED P ARTNERSHIP

By:

 

ET L EHIGH , LLC,

its General Partner

By:

 

E LDER T RUST O PERATING L IMITED

   

P ARTNERSHIP ,

its Sole Member

By:

 

E LDER T RUST , its General Partner

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Secretary

ET L EHIGH , LLC

By:

 

E LDER T RUST O PERATING L IMITED

   

P ARTNERSHIP ,

its Sole Member

By:

 

E LDER T RUST , its General Partner

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Secretary

 

10


ET S UB -L OPATCONG , L.L.C.

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Secretary

ET S UB -P ENNSBURG M ANOR L IMITED P ARTNERSHIP , L.L.P.

By:

 

ET P ENNSBURG F INANCE , L.L.C., its

General Partner

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Secretary

ET P ENNSBURG F INANCE , L.L.C.

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Secretary

ET S UB -P HILLIPSBURG I, L.L.C.

By:

 

E LDER T RUST O PERATING L IMITED

   

P ARTNERSHIP ,

its Sole Member

By:

 

E LDER T RUST , its General Partner

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Secretary

ET S UB -P LEASANT V IEW , L.L.C.

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Secretary

 

11


ET S UB -R ITTENHOUSE L IMITED P ARTNERSHIP , L.L.P.

By:

 

GENPAR, L.L.C., its General Partner

By:

 

E LDER T RUST O PERATING L IMITED

   

P ARTNERSHIP ,

its Sole Member

By:

 

E LDER T RUST , its General Partner

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Secretary

ET S UB -R IVERVIEW R IDGE L IMITED P ARTNERSHIP , L.L.P.

By:

 

ET GENPAR, L.L.C., its General Partner

By:

 

E LDER T RUST O PERATING L IMITED

   

P ARTNERSHIP ,

its Sole Member

By:

 

E LDER T RUST , its General Partner

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Secretary

ET S UB -S ANATOGA L IMITED P ARTNERSHIP

By:

 

ET S ANATOGA , LLC, its General Partner

By:

 

E LDER T RUST O PERATING L IMITED

   

P ARTNERSHIP ,

its Sole Member

By:

 

E LDER T RUST , its General Partner

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Secretary

 

12


ET S ANATOGA , LLC

By:

 

E LDER T RUST O PERATING L IMITED

   

P ARTNERSHIP ,

its Sole Member

By:

 

E LDER T RUST , its General Partner

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Secretary

ET S UB -SMOB, L.L.C.

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Secretary

V ERNON ALF, L.L.C.

By:

 

E LDER T RUST O PERATING L IMITED

   

P ARTNERSHIP ,

its Sole Member

By:

 

E LDER T RUST , its General Partner

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Secretary

ET S UB -W ILLOWBROOK L IMITED P ARTNERSHIP , L.L.P.

By:

 

GENPAR, L.L.C., its General Partner

By:

 

E LDER T RUST O PERATING L IMITED

   

P ARTNERSHIP ,

its Sole Member

By:

 

E LDERTRUST , its General Partner

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Secretary

 

13


ET S UB -W AYNE I L IMITED P ARTNERSHIP , L.L.P.

By:

 

ET W AYNE F INANCE , L.L.C., its

General Partner

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Secretary

ET W AYNE F INANCE , L.L.C.

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Secretary

ET W AYNE F INANCE , I NC .

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Chairman, Executive Vice

   

President and Secretary

 

14


TRUSTEE:

U.S. B ANK N ATIONAL A SSOCIATION

By:

 

/s/ Robert T. Jones


Name:

 

Robert T. Jones

Title:

 

Vice President & Trust Officer

 

15

EXHIBIT 4.5.5

 

SUPPLEMENTAL INDENTURE

 

S UPPLEMENTAL I NDENTURE (this “ Supplemental Indenture ”), dated as of December 15, 2004, by and among Ventas Framingham, LLC, a Delaware limited liability company, and Ventas Management, LLC, a Delaware limited liability company (each, a “ Guaranteeing Subsidiary ” and collectively, the “ Guaranteeing Subsidiaries ”), Ventas Realty, Limited Partnership, a Delaware limited partnership, and Ventas Capital Corporation, a Delaware corporation (collectively, the “ Issuers ”), the other Guarantors (as defined in the Indenture referred to herein) and U.S. Bank National Association, as trustee under the Indenture referred to herein (the “ Trustee ”).

 

W I T N E S S E T H

 

WHEREAS, the Issuers have heretofore executed and delivered to the Trustee an Indenture dated as of April 17, 2002, as supplemented by the Supplemental Indenture dated as of October 11, 2002, the Supplemental Indenture dated as of November 25, 2002, the Supplemental Indenture dated as of February 20, 2004 and the Supplemental Indenture dated as of June 1, 2004 (as so supplemented, the “ Indenture ”), providing for the issuance of 9% Senior Notes due 2012 (the “ Notes ”);

 

WHEREAS, the Indenture provides that under certain circumstances each Guaranteeing Subsidiary shall execute and deliver to the Trustee a supplemental indenture pursuant to which the Guaranteeing Subsidiary shall unconditionally guarantee all of the Issuers’ Obligations (as defined in the Indenture) under the Notes and the Indenture on the terms and conditions set forth herein (a “ Note Guarantee ”); and

 

WHEREAS, pursuant to Section 9.01 of the Indenture, the Trustee is authorized to execute and deliver this Supplemental Indenture.

 

NOW THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby acknowledged, each Guaranteeing Subsidiary and the Trustee mutually covenant and agree for the equal and ratable benefit of the Holders of the Notes as follows:

 

1. C APITALIZED T ERMS . Capitalized terms used herein without definition shall have the meanings assigned to them in the Indenture.

 

2. A GREEMENT TO G UARANTEE . Each Guaranteeing Subsidiary hereby agrees as follows:

 

(a) Subject to Article 10 of the Indenture, such Guaranteeing Subsidiary hereby, jointly and severally with all other Guarantors, unconditionally guarantees to each Holder of a Note authenticated and delivered by the Trustee and to the Trustee and its successors and assigns, irrespective of the validity and enforceability of the Indenture, the Notes or the obligations of the Issuers thereunder, that:

 

(i) the principal of, and premium and Liquidated Damages, if any, and interest on the Notes will be promptly paid in full when due, whether at maturity,


by acceleration, redemption or otherwise, and interest on the overdue principal of and interest on the Notes, if any, if lawful, and all other obligations of the Issuers to the Holders or the Trustee hereunder or thereunder will be promptly paid in full or performed, all in accordance with the terms hereof and thereof; and

 

(ii) in case of any extension of time of payment or renewal of any Notes or any of such other obligations, that same will be promptly paid in full when due or performed in accordance with the terms of the extension or renewal, whether at stated maturity, by acceleration or otherwise.

 

Failing payment when due of any amount so guaranteed or any performance so guaranteed for whatever reason, the Guarantors shall be jointly and severally obligated to pay the same immediately.

 

(b) The obligations hereunder shall be unconditional, irrespective of the validity, regularity or enforceability of the Notes or the Indenture, the absence of any action to enforce the same, any waiver or consent by any Holder of the Notes with respect to any provisions hereof or thereof, the recovery of any judgment against the Issuers, any action to enforce the same or any other circumstance which might otherwise constitute a legal or equitable discharge or defense of a Guarantor, other than payment in full of all obligations under the Notes.

 

(c) The following is hereby waived: diligence, presentment, demand of payment, filing of claims with a court in the event of insolvency or bankruptcy of the Issuers, any right to require a proceeding first against the Issuers, protest, notice and all demands whatsoever.

 

(d) This Note Guarantee shall not be discharged except by complete performance of the obligations contained in the Notes and the Indenture, and such Guaranteeing Subsidiary hereby accepts all obligations of a Guarantor under the Indenture.

 

(e) If any Holder or the Trustee is required by any court or otherwise to return to the Issuers, the Guarantors or any custodian, trustee, liquidator or other similar official acting in relation to either the Issuers or the Guarantors, any amount paid by either to the Trustee or such Holder, this Note Guarantee, to the extent theretofore discharged, shall be reinstated in full force and effect.

 

(f) Such Guaranteeing Subsidiary shall not be entitled to any right of subrogation in relation to the Holders in respect of any obligations guaranteed hereby until payment in full of all obligations guaranteed hereby.

 

(g) As between the Guarantors, on the one hand, and the Holders and the Trustee, on the other hand, (1) the maturity of the obligations guaranteed hereby may be accelerated as provided in Article 6 of the Indenture for the purposes of this Note Guarantee, notwithstanding any stay, injunction or other prohibition preventing such acceleration in respect of the obligations guaranteed hereby, and (2) in the event of any

 

2


declaration of acceleration of such obligations as provided in Article 6 of the Indenture, such obligations (whether or not due and payable) shall forthwith become due and payable by the Guarantors for the purpose of this Note Guarantee.

 

(h) The Guarantors shall have the right to seek contribution from any non-paying Guarantor so long as the exercise of such right does not impair the rights of the Holders under the Note Guarantees.

 

(i) In accordance with Section 10.02 of the Indenture, after giving effect to any maximum amount and all other contingent and fixed liabilities that are relevant under any applicable Bankruptcy Law or fraudulent conveyance law, and after giving effect to any collections from, rights to receive contribution from or payments made by or on behalf of any other Guarantor in respect of the obligations of such other Guarantor under Article 10 of the Indenture, this Note Guarantee shall be limited to the maximum amount permissible such that the obligations of such Guaranteeing Subsidiary under this Note Guarantee will not constitute a fraudulent transfer or conveyance.

 

3. E XECUTION AND D ELIVERY . Each Guaranteeing Subsidiary agrees that this Note Guarantee shall remain in full force and effect notwithstanding any failure to endorse on each Note a notation of such Note Guarantee.

 

4. G UARANTEEING S UBSIDIARIES M AY C ONSOLIDATE , E TC . ON C ERTAIN T ERMS .

 

(a) No Guaranteeing Subsidiary may sell or otherwise dispose of all or substantially all of its assets to, or consolidate with or merge with or into (whether or not such Guaranteeing Subsidiary is the surviving Person) another Person, other than the Issuers or another Guarantor unless:

 

(i) immediately after giving effect to that transaction, no Default or Event of Default exists; and

 

(ii) subject to Section 10.05 of the Indenture, the Person acquiring the property in any such sale or disposition or the Person formed by or surviving any such consolidation or merger assumes all of the obligations of that Guaranteeing Subsidiary under the Indenture, this Note Guarantee and the Registration Rights Agreement pursuant to a supplemental indenture in form and substance reasonably satisfactory to the Trustee.

 

(b) In case of any such consolidation, merger, sale or conveyance and upon the assumption by the successor Person, by supplemental indenture, executed and delivered to the Trustee and satisfactory in form to the Trustee, of this Note Guarantee endorsed upon the Notes and the due and punctual performance of all of the covenants and conditions of the Indenture to be performed by the Guaranteeing Subsidiary, such successor Person shall succeed to and be substituted for the Guaranteeing Subsidiary with the same effect as if it had been named herein as a Guaranteeing Subsidiary. Such successor Person thereupon may cause to be signed any or all of the Note Guarantees to

 

3


be endorsed upon all of the Notes issuable under the Indenture which theretofore shall not have been signed by the Issuers and delivered to the Trustee. All the Note Guarantees so issued shall in all respects have the same legal rank and benefit under the Indenture as the Note Guarantees theretofore and thereafter issued in accordance with the terms of the Indenture as though all of such Note Guarantees had been issued at the date of the execution hereof.

 

(c) Except as set forth in Articles 4 and 5 and Section 10.05 of the Indenture, and notwithstanding clauses (a) and (b) above, nothing contained in the Indenture or in any of the Notes shall prevent any consolidation or merger of a Guaranteeing Subsidiary with or into the Issuers or another Guarantor, or shall prevent any sale or conveyance of the property of a Guaranteeing Subsidiary as an entirety or substantially as an entirety to the Issuers or another Guarantor.

 

5. R ELEASES .

 

(a) The Note Guarantee of a Guaranteeing Subsidiary shall be released, and any Person acquiring assets (including by way of merger or consolidation) or Capital Stock of a Guaranteeing Subsidiary under those circumstances specified in the Indenture shall not be required to assume the obligations of such Guaranteeing Subsidiary, in each case in accordance with the provisions of Section 10.05 of the Indenture. Upon delivery by the Issuers to the Trustee of an Officers’ Certificate and an Opinion of Counsel stating that the provisions of Section 10.05 of the Indenture have been complied with, the Trustee shall execute any documents reasonably required in order to evidence the release of any Guaranteeing Subsidiary from its obligations under this Note Guarantee.

 

(b) Any Guaranteeing Subsidiary not released from its obligations under this Note Guarantee shall remain liable for the full amount of principal of and interest on the Notes and for the other obligations of any Guarantor under the Indenture as provided in Article 10 of the Indenture.

 

6. N O R ECOURSE A GAINST O THERS . No past, present or future director, officer, employee, incorporator, stockholder or agent of any Guaranteeing Subsidiary, as such, shall have any liability for any obligations of the Issuers or any Guaranteeing Subsidiary under the Notes, this Note Guarantee, the Indenture or this Supplemental Indenture or for any claim based on, in respect of, or by reason of, such obligations or their creation. Each Holder of the Notes by accepting a Note waives and releases all such liability. The waiver and release are part of the consideration for issuance of the Notes. Such waiver may not be effective to waive liabilities under the federal securities laws and it is the view of the Commission that such a waiver is against public policy.

 

7. NEW YORK LAW TO GOVERN. THE INTERNAL LAW OF THE STATE OF NEW YORK SHALL GOVERN AND BE USED TO CONSTRUE THIS SUPPLEMENTAL INDENTURE AND NOTE GUARANTEE WITHOUT GIVING EFFECT TO APPLICABLE PRINCIPLES OF CONFLICTS OF LAW TO THE EXTENT THAT THE APPLICATION OF THE LAWS OF ANOTHER JURISDICTION WOULD BE REQUIRED THEREBY.

 

4


8. C OUNTERPARTS . The parties may sign any number of copies of this Supplemental Indenture. Each signed copy shall be an original, but all of them together represent the same agreement.

 

9. E FFECT OF H EADINGS . The Section headings herein are for convenience only and shall not affect the construction hereof.

 

10. T HE T RUSTEE . The Trustee shall not be responsible in any manner whatsoever for or in respect of the validity or sufficiency of this Supplemental Indenture or for or in respect of the recitals contained herein, all of which recitals are made solely by the Guaranteeing Subsidiaries and the Issuers.

 

5


IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly executed and attested, all as of the date first above written.

 

GUARANTEEING SUBSIDIARIES:

V ENTAS F RAMINGHAM , LLC

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Executive Vice President, General

   

Counsel and Secretary

V ENTAS M ANAGEMENT , LLC

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Executive Vice President, General

   

Counsel and Secretary

ISSUERS:

V ENTAS R EALTY , L IMITED P ARTNERSHIP

By:

 

V ENTAS , I NC ., its General Partner

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Executive Vice President,

   

General Counsel and

   

Corporate Secretary

V ENTAS C APITAL C ORPORATION

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Executive Vice President,

   

General Counsel and Corporate

   

Secretary

 

6


EXISTING GUARANTORS:

V ENTAS , I NC .

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Executive Vice President,

   

General Counsel and Corporate

   

Secretary

V ENTAS LP R EALTY , L.L.C.

By:

 

V ENTAS , I NC ., its Sole Member

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Executive Vice President,

   

General Counsel and

   

Corporate Secretary

V ENTAS H EALTHCARE P ROPERTIES , I NC .

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Executive Vice President,

   

General Counsel and Corporate

   

Secretary

V ENTAS TRS, LLC

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Executive Vice President

E LDER T RUST

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Secretary

 

7


E LDER T RUST O PERATING L IMITED P ARTNERSHIP

By:

 

E LDER T RUST , its General Partner

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Secretary

ET C APITAL C ORP .

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Secretary

ET S UB -B ERKSHIRE L IMITED P ARTNERSHIP

By:

 

ET B ERKSHIRE , LLC, its General Partner

By:

 

E LDER T RUST O PERATING L IMITED

   

P ARTNERSHIP ,

its Sole Member

By:

 

E LDER T RUST , its General Partner

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Secretary

ET B ERKSHIRE , LLC

By:

 

E LDER T RUST O PERATING L IMITED

   

P ARTNERSHIP ,

its Sole Member

By:

 

E LDER T RUST , its General Partner

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Secretary

 

8


C ABOT ALF, L.L.C.

By:

 

E LDER T RUST O PERATING L IMITED

   

P ARTNERSHIP ,

its Sole Member

By:

 

E LDER T RUST , its General Partner

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Secretary

C LEVELAND ALF, L.L.C.

By:

 

E LDERTRUST O PERATING L IMITED

   

P ARTNERSHIP ,

its Sole Member

By:

 

E LDER T RUST , its General Partner

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Secretary

ET S UB -H ERITAGE W OODS , L.L.C.

By:

 

E LDER T RUST O PERATING L IMITED

   

P ARTNERSHIP ,

its Sole Member

By:

 

E LDER T RUST , its General Partner

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Secretary

ET S UB -H IGHGATE , L.P.

By:

 

ET GENPAR, L.L.C., its General Partner

By:

 

E LDER T RUST O PERATING L IMITED

   

P ARTNERSHIP ,

its Sole Member

By:

 

E LDER T RUST , its General Partner

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Secretary

 

9


ET GENPAR, L.L.C.

By:

 

E LDER T RUST O PERATING L IMITED

   

P ARTNERSHIP ,

its Sole Member

By:

 

E LDER T RUST , its General Partner

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Secretary

ET S UB -L ACEY I, L.L.C.

By:

 

E LDER T RUST O PERATING L IMITED

   

P ARTNERSHIP ,

its Sole Member

By:

 

E LDER T RUST , its General Partner

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Secretary

ET S UB -L EHIGH L IMITED P ARTNERSHIP

By:

 

ET L EHIGH , LLC, its General Partner

By:

 

E LDER T RUST O PERATING L IMITED

   

P ARTNERSHIP ,

its Sole Member

By:

 

E LDER T RUST , its General Partner

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Secretary

ET L EHIGH , LLC

By:

 

E LDER T RUST O PERATING L IMITED

   

P ARTNERSHIP ,

its Sole Member

By:

 

E LDER T RUST , its General Partner

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Secretary

 

10


ET S UB -L OPATCONG , L.L.C.

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Secretary

ET S UB -P ENNSBURG M ANOR L IMITED P ARTNERSHIP ,

L.L.P.

By:

 

ET P ENNSBURG F INANCE , L.L.C., its

General Partner

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Secretary

ET P ENNSBURG F INANCE , L.L.C.

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Secretary

ET S UB -P HILLIPSBURG I, L.L.C.

By:

 

E LDER T RUST O PERATING L IMITED

   

P ARTNERSHIP ,

its Sole Member

By:

 

E LDER T RUST , its General Partner

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Secretary

ET S UB -P LEASANT V IEW , L.L.C.

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Secretary

 

11


ET S UB -R ITTENHOUSE L IMITED P ARTNERSHIP , L.L.P.

By:

 

GENPAR, L.L.C., its General Partner

By:

 

E LDER T RUST O PERATING L IMITED

   

P ARTNERSHIP ,

its Sole Member

By:

 

E LDER T RUST , its General Partner

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Secretary

ET S UB -R IVERVIEW R IDGE L IMITED P ARTNERSHIP , L.L.P.

By:

 

ET GENPAR, L.L.C., its General Partner

By:

 

E LDER T RUST O PERATING L IMITED

   

P ARTNERSHIP ,

its Sole Member

By:

 

E LDER T RUST , its General Partner

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Secretary

ET S UB -S ANATOGA L IMITED P ARTNERSHIP

By:

 

ET S ANATOGA , LLC, its General Partner

By:

 

E LDER T RUST O PERATING L IMITED

   

P ARTNERSHIP ,

its Sole Member

By:

 

E LDER T RUST , its General Partner

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Secretary

 

12


ET S ANATOGA , LLC

By:

 

E LDER T RUST O PERATING L IMITED

   

P ARTNERSHIP ,

its Sole Member

By:

 

E LDER T RUST , its General Partner

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Secretary

ET S UB -SMOB, L.L.C.

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Secretary

V ERNON ALF, L.L.C.

By:

 

E LDERTRUST O PERATING L IMITED

   

P ARTNERSHIP ,

its Sole Member

By:

 

E LDER T RUST , its General Partner

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Secretary

ET S UB -W ILLOWBROOK L IMITED P ARTNERSHIP , L.L.P.

By:

 

GENPAR, L.L.C., its General Partner

By:

 

E LDER T RUST O PERATING L IMITED

   

P ARTNERSHIP ,

its Sole Member

By:

 

E LDER T RUST , its General Partner

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Secretary

 

13


ET S UB -W AYNE I L IMITED P ARTNERSHIP , L.L.P.

By:

 

ET W AYNE F INANCE , L.L.C., its General Partner

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Secretary

ET W AYNE F INANCE , L.L.C.

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Secretary

ET W AYNE F INANCE , I NC .

By:

 

/s/ T. Richard Riney


Name:

 

T. Richard Riney

Title:

 

Chairman, Executive Vice President and Secretary

 

 

14


TRUSTEE:

U.S. B ANK N ATIONAL A SSOCIATION

By:

 

/s/ Robert T. Jones


Name:

 

Robert T. Jones

Title:

 

Vice President & Trust Officer

 

15

Exhibit 10.2.7.1

 


 

MASTER LEASE NO. 1 PARTIAL LEASE TERMINATION AGREEMENT (IN-4620)

 

BY AND AMONG

 

KINDRED HEALTHCARE, INC.

(f/k/a Vencor, Inc.),

 

KINDRED HEALTHCARE OPERATING, INC.

(f/k/a Vencor Operating, Inc.),

 

AND

 

VENTAS REALTY, LIMITED PARTNERSHIP

 



MASTER LEASE NO. 1 PARTIAL LEASE TERMINATION AGREEMENT (IN-4620)

 

THIS MASTER LEASE NO. 1 PARTIAL LEASE TERMINATION AGREEMENT (IN-4620) (hereinafter this “ Agreement ”) is dated as of the 22nd day of December, 2004, and is by and among VENTAS REALTY, LIMITED PARTNERSHIP , a Delaware limited partnership (together with its successors and assigns, “ Lessor ”), having an office at 10350 Ormsby Park Place, Suite 300, Louisville, Kentucky 40223, and KINDRED HEALTHCARE, INC. , a Delaware corporation (f/k/a Vencor, Inc.) (“ Kindred ”), and KINDRED HEALTHCARE OPERATING, INC ., a Delaware corporation (f/k/a Vencor Operating, Inc.) (“ Operator ”; Operator, jointly and severally with Kindred and permitted successors and assignees of Operator and Kindred, “ Tenant ”), both having an office at 680 South 4 th Avenue, Louisville, Kentucky 40202.

 

RECITALS

 

A. Lessor and Tenant entered into a certain Amended and Restated Master Lease Agreement No. 1 dated as of April 20, 2001 (as the same may have been or may hereafter be amended, amended and restated, supplemented, modified, severed, renewed, extended or replaced, the “ Lease ”), demising to Tenant certain properties.

 

B. Lessor and Tenant entered into an Agreement for Sale of Real Estate and Master Lease Amendment (IN-4620) dated as of the date hereof (the “ Sale/Amendment Agreement ”).

 

C. Pursuant to the Sale/Amendment Agreement, Lessor and Tenant desire to terminate the Lease as it applies to certain of the Leased Properties demised pursuant to the Lease, on the terms set forth in this Agreement.

 

NOW, THEREFORE, in consideration of the premises and other good and valuable consideration, the parties hereby agree as follows:

 

1. Capitalized Terms . All capitalized terms used herein and not defined herein shall have the meaning ascribed thereto in the Lease.

 

2. Partial Lease Termination . Effective as of the date hereof, the Lease shall terminate with respect to the Leased Property described on Exhibit A attached to and made a part of this Agreement in accordance with the terms of Section 40.16 of the Lease, and Tenant shall remain obligated to perform all of its indemnification obligations and other liabilities and obligations under the Lease that survive such termination in accordance with the terms of such Section 40.16 , Section 24.1 of the Lease and any other applicable provisions of the Lease.

 

3. Termination Fee . Simultaneously with Lessor’s and Tenant’s entry into this Agreement, Tenant shall pay to Lessor, by wire transfer of immediately available funds to such wire transfer account(s) as Lessor may specify in writing, the sum of One Hundred Thousand and No/100 Dollars ($100,000.00) in consideration of Lessor’s agreement to terminate the Lease as it applies to the Leased Property referenced in Paragraph 2 above.


4. No Other Amendments . Except as provided in this Agreement, the Lease remains in full force and effect without modification.

 

5. Successors and Assigns . This Agreement and the covenants and agreements herein contained shall be binding upon and inure to the benefit of Lessor and Tenant and their respective heirs, devisees, successors and assigns.

 

6. Integrated Agreement; Modifications; Waivers . This Agreement constitutes the entire agreement between the parties hereto with respect to the subject matter hereof and supersedes any and all prior representations, understandings and agreements, whether written or oral. Each of the parties hereto acknowledges that it has not relied upon, in entering into this Agreement, any representation, warranty, promise or condition not specifically set forth in this Agreement. No supplement, modification or waiver of any provision of this Agreement shall be binding unless executed in writing by the party to be bound thereby. No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a waiver of any other provision hereof (whether or not similar), nor shall such waiver constitute a continuing waiver unless otherwise expressly provided.

 

7. Headings and Captions . The headings and captions of the paragraphs of this Agreement are for convenience of reference only and shall not affect the meaning or interpretation of this Agreement or any provision hereof.

 

8. Gender and Number . As used in this Agreement, the neuter shall include the feminine and masculine, the singular shall include the plural, and the plural shall include the singular, except where expressly provided to the contrary.

 

9. Severability . In the event that any paragraph, section, sentence, clause or phrase contained in this Agreement becomes or is held by any court of competent jurisdiction to be illegal, null or void or against public policy, the remaining paragraphs, sections, sentences, clauses or phrases contained in this Agreement shall not be affected thereby.

 

10. Counterparts . This Agreement and any amendment to this Agreement may be signed in any number of counterparts, each of which shall be an original, with the same effect as if the signatures thereto were upon the same instrument.

 

[Signature Page Follows]

 

2


IN WITNESS WHEREOF, the parties hereto have executed these presents the day and year first above written.

 

TENANT:

KINDRED HEALTHCARE, INC.,

a Delaware corporation formerly known as

Vencor, Inc.

By:

 

/s/ Joseph L. Landenwich


Name:

 

Joseph L. Landenwich

Its:

 

Senior Vice President of Corporate Legal

Affairs and Corporate Secretary

TENANT:

KINDRED HEALTHCARE OPERATING, INC.,

a Delaware corporation formerly known

as Vencor Operating, Inc.

By:

 

/s/ Joseph L. Landenwich


Name:

 

Joseph L. Landenwich

Its:

 

Senior Vice President of Corporate Legal

Affairs and Corporate Secretary

LESSOR:

VENTAS REALTY, LIMITED PARTNERSHIP,

a Delaware limited partnership

By:

 

Ventas, Inc., a Delaware corporation,

its general partner

By:

 

/s/ T. Richard Riney


   

T. Richard Riney, Executive Vice

President, General Counsel and

Secretary


Acknowledgments

 

STATE OF KENTUCKY

              )
                )

COUNTY OF JEFFERSON

              )

 

This 21st day of December, 2004, personally came before me Deborah L. Stemmle, a Notary Public in and for said County and State, Joseph L. Landenwich, who being by me duly sworn, says that he is the Senior Vice President of Corporate Legal Affairs and Corporate Secretary of KINDRED HEALTHCARE, INC., a Delaware corporation, and that the seal affixed to the foregoing instrument in writing is the corporate seal of said corporation, and that said writing was signed and sealed by him on behalf of such corporation by its authority duly given. And the said Joseph L. Landenwich acknowledged the said writing to be the act and deed of said corporation.

 

WITNESS my hand and notarial stamp/seal this 21st day of December, 2004.

 

/s/ Deborah L. Stemmle


Notary Public

 

My Commission Expires:

 

Notary Public, State at Large, KY

My commission expires May 22, 2005

[Notarial Stamp/Seal]

 

STATE OF KENTUCKY

              )
                )

COUNTY OF JEFFERSON

              )

 

This 21st day of December, 2004, personally came before me Deborah L. Stemmle, a Notary Public in and for said County and State, Joseph L. Landenwich, who being by me duly sworn, says that he is the Senior Vice President of Corporate Legal Affairs and Corporate Secretary of KINDRED HEALTHCARE OPERATING, INC., a Delaware corporation, and that the seal affixed to the foregoing instrument in writing is the corporate seal of said corporation, and that said writing was signed and sealed by him on behalf of such corporation by its authority duly given. And the said Joseph L. Landenwich acknowledged the said writing to be the act and deed of said corporation.

 

WITNESS my hand and notarial stamp/seal this 21st day of December, 2004.

 

/s/ Deborah L. Stemmle


Notary Public

 

My Commission Expires:

Notary Public, State at Large, KY

My commission expires May 22, 2005

[Notarial Stamp/Seal]


STATE OF KENTUCKY

              )
                )

COUNTY OF JEFFERSON

              )

 

This 20th day of December, 2004, personally came before me Barbara F. Thompson, a Notary Public in and for said County and State, T. Richard Riney, who being by me duly sworn, says that he is the Executive Vice President, General Counsel and Secretary of VENTAS, INC., a Delaware corporation, in its capacity as the general partner of VENTAS REALTY, LIMITED PARTNERSHIP, a Delaware limited partnership, and that the seal affixed to the foregoing instrument in writing is the corporate seal of said corporation, and that said writing was signed and sealed by him on behalf of such corporation by its authority duly given, in its aforesaid general partner capacity on behalf of the aforesaid limited partnership. And the said Executive Vice President, General Counsel and Secretary acknowledged the said writing to be the act and deed of said corporation, acting in such general partner capacity.

 

WITNESS my hand and notarial stamp/seal this 20th day of December, 2004.

 

/s/ Barbara F. Thompson


Notary Public

 

My Commission Expires:

December 9, 2006

[Notarial Stamp/Seal]


CONSENT

 

The undersigned hereby consents to the terms of the foregoing instrument.

 

JPMORGAN CHASE BANK (formerly THE CHASE MANHATTAN BANK, successor by merger to MORGAN GUARANTY TRUST COMPANY OF NEW YORK), as administrative agent and Collateral Agent under that certain $300,000,000 Amended and Restated Credit Agreement, dated as of June 28, 2004

 

By:

 

/s/ Dawn Lee Lum


Name:

 

Dawn L. Lee Lum

Title:

 

Vice President

 

STATE OF NEW YORK

              )
                )

COUNTY OF NEW YORK

              )

 

This 20th day of December, 2004, personally came before me Edeline C. Adderley, a Notary Public in and for said County and State, Dawn L. Lee Lum, who being by me duly sworn, says that she is the Vice President of JPMORGAN CHASE BANK, a national banking association, and that the seal affixed to the foregoing instrument in writing is the corporate seal of said corporation, and that said writing was signed and sealed by her on behalf of such corporation by its authority duly given. And the said Vice President acknowledged the said writing to be the act and deed of said corporation.

 

WITNESS my hand and notarial stamp/seal this 20th day of December, 2004.

 

/s/ Edeline C. Adderley


Notary Public

 

My Commission Expires:

September 3, 2006

[Notarial Stamp/Seal]


Exhibit A

 

Terminated Leased Properties

 

Master Lease No. 1


    

1.      LaGrange Community Hospital

   - IN-4620

Exhibit 10.2.7.2

 


MASTER LEASE NO. 1 PARTIAL LEASE TERMINATION AGREEMENT (CA-4693)

 

BY AND AMONG

 

KINDRED HEALTHCARE, INC.

(f/k/a Vencor, Inc.),

 

KINDRED HEALTHCARE OPERATING, INC.

(f/k/a Vencor Operating, Inc.),

 

AND

 

VENTAS REALTY, LIMITED PARTNERSHIP

 



MASTER LEASE NO. 1 PARTIAL LEASE TERMINATION AGREEMENT (CA-4693)

 

THIS MASTER LEASE NO. 1 PARTIAL LEASE TERMINATION AGREEMENT (CA-4693) (hereinafter this “ Agreement ”) is dated as of the 22nd day of December, 2004, and is by and among VENTAS REALTY, LIMITED PARTNERSHIP , a Delaware limited partnership (together with its successors and assigns, “ Lessor ”), having an office at 10350 Ormsby Park Place, Suite 300, Louisville, Kentucky 40223, and KINDRED HEALTHCARE, INC. , a Delaware corporation (f/k/a Vencor, Inc.) (“ Kindred ”), and KINDRED HEALTHCARE OPERATING, INC ., a Delaware corporation (f/k/a Vencor Operating, Inc.) (“ Operator ”; Operator, jointly and severally with Kindred and permitted successors and assignees of Operator and Kindred, “ Tenant ”), both having an office at 680 South 4 th Avenue, Louisville, Kentucky 40202.

 

RECITALS

 

A. Lessor and Tenant entered into a certain Amended and Restated Master Lease Agreement No. 1 dated as of April 20, 2001 (as the same may have been or may hereafter be amended, amended and restated, supplemented, modified, severed, renewed, extended or replaced, the “ Lease ”), demising to Tenant certain properties.

 

B. Lessor and Tenant entered into an Agreement for Sale of Real Estate and Master Lease Amendment (CA-4693) dated as of the date hereof (the “ Sale/Amendment Agreement ”).

 

C. Pursuant to the Sale/Amendment Agreement, Lessor and Tenant desire to terminate the Lease as it applies to certain of the Leased Properties demised pursuant to the Lease, on the terms set forth in this Agreement.

 

NOW, THEREFORE, in consideration of the premises and other good and valuable consideration, the parties hereby agree as follows:

 

1. Capitalized Terms . All capitalized terms used herein and not defined herein shall have the meaning ascribed thereto in the Lease.

 

2. Partial Lease Termination . Effective as of the date hereof, the Lease shall terminate with respect to the Leased Property described on Exhibit A attached to and made a part of this Agreement in accordance with the terms of Section 40.16 of the Lease, and Tenant shall remain obligated to perform all of its indemnification obligations and other liabilities and obligations under the Lease that survive such termination in accordance with the terms of such Section 40.16 , Section 24.1 of the Lease and any other applicable provisions of the Lease.

 

3. Termination Fee . Simultaneously with Lessor’s and Tenant’s entry into this Agreement, Tenant shall pay to Lessor, by wire transfer of immediately available funds to such wire transfer account(s) as Lessor may specify in writing, the sum of Four Hundred Thousand and No/100 Dollars ($400,000.00) in consideration of Lessor’s agreement to terminate the Lease as it applies to the Leased Property referenced in Paragraph 2 above.


4. No Other Amendments . Except as provided in this Agreement, the Lease remains in full force and effect without modification.

 

5. Successors and Assigns . This Agreement and the covenants and agreements herein contained shall be binding upon and inure to the benefit of Lessor and Tenant and their respective heirs, devisees, successors and assigns.

 

6. Integrated Agreement; Modifications; Waivers . This Agreement constitutes the entire agreement between the parties hereto with respect to the subject matter hereof and supersedes any and all prior representations, understandings and agreements, whether written or oral. Each of the parties hereto acknowledges that it has not relied upon, in entering into this Agreement, any representation, warranty, promise or condition not specifically set forth in this Agreement. No supplement, modification or waiver of any provision of this Agreement shall be binding unless executed in writing by the party to be bound thereby. No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a waiver of any other provision hereof (whether or not similar), nor shall such waiver constitute a continuing waiver unless otherwise expressly provided.

 

7. Headings and Captions . The headings and captions of the paragraphs of this Agreement are for convenience of reference only and shall not affect the meaning or interpretation of this Agreement or any provision hereof.

 

8. Gender and Number . As used in this Agreement, the neuter shall include the feminine and masculine, the singular shall include the plural, and the plural shall include the singular, except where expressly provided to the contrary.

 

9. Severability . In the event that any paragraph, section, sentence, clause or phrase contained in this Agreement becomes or is held by any court of competent jurisdiction to be illegal, null or void or against public policy, the remaining paragraphs, sections, sentences, clauses or phrases contained in this Agreement shall not be affected thereby.

 

10. Counterparts . This Agreement and any amendment to this Agreement may be signed in any number of counterparts, each of which shall be an original, with the same effect as if the signatures thereto were upon the same instrument.

 

[Signature Page Follows]

 

2


IN WITNESS WHEREOF, the parties hereto have executed these presents the day and year first above written.

 

TENANT:

KINDRED HEALTHCARE, INC.,

a Delaware corporation formerly known as

Vencor, Inc.

By:

 

/s/ Joseph L. Landenwich


Name:

 

Joseph L. Landenwich

Its:

 

Senior Vice President of Corporate Legal

Affairs and Corporate Secretary

TENANT:

KINDRED HEALTHCARE OPERATING, INC.,

a Delaware corporation formerly known

as Vencor Operating, Inc.

By:

 

/s/ Joseph L. Landenwich


Name:

 

Joseph L. Landenwich

Its:

 

Senior Vice President of Corporate Legal

Affairs and Corporate Secretary

LESSOR:

VENTAS REALTY, LIMITED PARTNERSHIP,

a Delaware limited partnership

By:

 

Ventas, Inc., a Delaware corporation, its

general partner

By:

 

/s/ T. Richard Riney


   

T. Richard Riney, Executive Vice

President, General Counsel and

Secretary


Acknowledgments

 

STATE OF KENTUCKY

              )
                )

COUNTY OF JEFFERSON

              )

 

This 21st day of December, 2004, personally came before me Deborah L. Stemmle, a Notary Public in and for said County and State, Joseph L. Landenwich, who being by me duly sworn, says that he is the Senior Vice President of Corporate Legal Affairs and Corporate Secretary of KINDRED HEALTHCARE, INC., a Delaware corporation, and that the seal affixed to the foregoing instrument in writing is the corporate seal of said corporation, and that said writing was signed and sealed by him on behalf of such corporation by its authority duly given. And the said Joseph L. Landenwich acknowledged the said writing to be the act and deed of said corporation.

 

WITNESS my hand and notarial stamp/seal this 21st day of December, 2004.

 

/s/ Deborah L. Stemmle


Notary Public

 

My Commission Expires:

 

Notary Public, State at Large, KY

My commission expires May 22, 2005

[Notarial Stamp/Seal]

 

STATE OF KENTUCKY

              )
                )

COUNTY OF JEFFERSON

              )

 

This 21st day of December, 2004, personally came before me Deborah L. Stemmle, a Notary Public in and for said County and State, Joseph L. Landenwich, who being by me duly sworn, says that he is the Senior Vice President of Corporate Legal Affairs and Corporate Secretary of KINDRED HEALTHCARE OPERATING, INC., a Delaware corporation, and that the seal affixed to the foregoing instrument in writing is the corporate seal of said corporation, and that said writing was signed and sealed by him on behalf of such corporation by its authority duly given. And the said Joseph L. Landenwich acknowledged the said writing to be the act and deed of said corporation.

 

WITNESS my hand and notarial stamp/seal this 21st day of December, 2004.

 

/s/ Deborah L. Stemmle


Notary Public

 

My Commission Expires:

Notary Public, State at Large, KY

My commission expires May 22, 2005

[Notarial Stamp/Seal]


STATE OF KENTUCKY

              )
                )

COUNTY OF JEFFERSON

              )

 

This 20th day of December, 2004, personally came before me Barbara F. Thompson, a Notary Public in and for said County and State, T. Richard Riney, who being by me duly sworn, says that he is the Executive Vice President, General Counsel and Secretary of VENTAS, INC., a Delaware corporation, in its capacity as the general partner of VENTAS REALTY, LIMITED PARTNERSHIP, a Delaware limited partnership, and that the seal affixed to the foregoing instrument in writing is the corporate seal of said corporation, and that said writing was signed and sealed by him on behalf of such corporation by its authority duly given, in its aforesaid general partner capacity on behalf of the aforesaid limited partnership. And the said Executive Vice President, General Counsel and Secretary acknowledged the said writing to be the act and deed of said corporation, acting in such general partner capacity.

 

WITNESS my hand and notarial stamp/seal this 20th day of December, 2004.

 

/s/ Barbara F. Thompson


Notary Public

 

My Commission Expires:

December 9, 2006

[Notarial Stamp/Seal]


CONSENT

 

The undersigned hereby consents to the terms of the foregoing instrument.

 

JPMORGAN CHASE BANK (formerly THE CHASE MANHATTAN BANK, successor by merger to MORGAN GUARANTY TRUST COMPANY OF NEW YORK), as administrative agent and Collateral Agent under that certain $300,000,000 Amended and Restated Credit Agreement, dated as of June 28, 2004

 

By:

 

/s/ Dawn Lee Lum


Name:

 

Dawn L. Lee Lum

Title:

 

Vice President

 

STATE OF NEW YORK

              )
                )

COUNTY OF NEW YORK

              )

 

This 20th day of December, 2004, personally came before me Edeline C. Adderley, a Notary Public in and for said County and State, Dawn L. Lee Lum, who being by me duly sworn, says that she is the Vice President of JPMORGAN CHASE BANK, a national banking association, and that the seal affixed to the foregoing instrument in writing is the corporate seal of said corporation, and that said writing was signed and sealed by her on behalf of such corporation by its authority duly given. And the said Vice President acknowledged the said writing to be the act and deed of said corporation.

 

WITNESS my hand and notarial stamp/seal this 20th day of December, 2004.

 

/s/ Edeline C. Adderley


Notary Public

 

My Commission Expires:

September 3, 2006


[Notarial Stamp/Seal]


Exhibit A

 

Terminated Leased Properties

 

Master Lease No. 1


    

1.      Menlo Park Surgical Hospital

  

- CA #4693

Exhibit 10.14.1

 

VENTAS, INC.

 

2000 INCENTIVE COMPENSATION PLAN

 

ARTICLE 1.

 

Purpose

 

This Ventas, Inc. 2000 Incentive Compensation Plan (“ Plan ”) is an amendment and restatement of the 1997 Incentive Compensation Plan. The purpose of this Plan is to advance the interest of Ventas, Inc., a Delaware corporation (“ Company ”), its subsidiaries and its stockholders by encouraging employees who will largely be responsible for the long-term success and development of the Company. The Plan is also intended to provide flexibility to the Company in attracting, retaining and motivating employees and promoting their efforts on behalf of the Company.

 

ARTICLE 2.

 

Definitions and Construction

 

2.1. Definitions . As used in the Plan, terms defined parenthetically immediately after their use shall have the respective meanings provided by such definitions, and the terms set forth below shall have the following meanings (in either case, such terms shall apply equally to both the singular and plural forms of the terms defined):

 

(a) “ Award ” shall mean, individually or collectively, a grant under the Plan of Options, Restricted Stock, Restricted Stock Units, SARs, Performance Units, stock awards and cash awards.

 

(b) “ Board ” shall mean the Board of Directors of the Company.

 

(c) “ Cause ” shall mean, unless otherwise defined in an agreement evidencing an Award, a felony conviction of a Participant or the failure of a Participant to contest prosecution for a felony, or a Participant’s willful misconduct or dishonesty, any of which is determined by the Committee to be directly and materially harmful to the business or reputation of the Company or its Subsidiaries.

 

(d) A “ Change in Control ” shall mean any of the following events:

 

(1) An acquisition (other than directly from the Company) of any voting securities of the Company (“ Voting Securities ”) by any Person immediately after which such Person has beneficial ownership (within the meaning of Rule 13d-3 promulgated under the Exchange Act) (“ Beneficial Ownership and/or Beneficially Owned ”) of 20% or more of the combined voting power of the Company’s then outstanding Voting Securities; provided, however, that in determining whether a Change in Control has occurred, Voting Securities which are acquired in a Non-Control Acquisition (as hereinafter defined) shall not constitute an acquisition which would cause a Change in Control. A Non-Control Acquisition shall mean an acquisition by (i) the Company or


any Subsidiary, (ii) an employee benefit plan (or a trust forming a part thereof) maintained by the Company or any Subsidiary, or (iii) any Person in connection with a Non-Control Transaction (as hereinafter defined);

 

(2) The individuals who, as of December 31, 1999, are members of the Board (“ Incumbent Board ”) cease for any reason to constitute at least a majority of the Board; provided, however, that if the election, or nomination for election by the Company’s stockholders, of any new director was approved by a vote of at least a majority of the Incumbent Board, such new director shall, for purposes of the Plan, be considered as a member of the Incumbent Board; provided, further, however, that no individual shall be considered a member of the Incumbent Board if such individual initially assumed office as a result of either an actual or threatened election contest (as described in Rule 14a-11 promulgated under the Exchange Act) (“ Election Contest ”) or other actual or threatened solicitation of proxies or consents by or on behalf of a Person other than the Board (“ Proxy Contest ”) including by reason of any agreement intended to avoid or settle any Election Contest or Proxy Contest; or

 

(3) Approval by stockholders of the Company of:

 

(A) A merger, consolidation or reorganization involving the Company, unless such is a Non-Control Transaction. For purposes of the Plan, the term “ Non-Control Transaction ” shall mean a merger, consolidation or reorganization of the Company in which:

 

(i) the stockholders of the Company, immediately before such merger, consolidation or reorganization, own, directly or indirectly immediately following such merger, consolidation or reorganization, at least a majority of the combined voting power of the voting securities of the corporation resulting from such merger or consolidation or reorganization (“ Surviving Corporation ”) over which any Person has Beneficial Ownership in substantially the same proportion as their ownership of the Voting Securities immediately before such merger, consolidation or reorganization;

 

(ii) the individuals who were members of the Incumbent Board immediately prior to the execution of the agreement providing for such merger, consolidation or reorganization constitute at least a majority of the members of the board of directors of the Surviving Corporation; and

 

(iii) no Person (other than the Company, any Subsidiary, any employee benefit plan (or any trust forming a part thereof) maintained by the Company, the Surviving Corporation, or any Person who, immediately prior to such merger, consolidation or reorganization had Beneficial Ownership of 20% or more of the then outstanding Voting Securities) has Beneficial Ownership of 20% or more of the combined voting power of the Surviving Corporation’s then outstanding voting securities;

 

-2-


(B) complete liquidation or dissolution of the Company; or

 

(C) An agreement for the sale or other disposition of all or substantially all of the assets of the Company to any Person (other than a transfer to a Subsidiary).

 

(4) Any other event that the Committee shall determine constitutes an effective Change in Control of the Company.

 

Notwithstanding the foregoing, a Change in Control shall not be deemed to occur solely because any Person (“ Subject Person ”) acquired Beneficial Ownership of more than the permitted amount of the outstanding Voting Securities as a result of the acquisition of Voting Securities by the Company which, by reducing the number of Voting Securities outstanding, increases the proportional number of shares Beneficially Owned by the Subject Person; provided, however, that if a Change in Control would occur (but for the operation of this sentence) as a result of the acquisition of Voting Securities by the Company, and after such share acquisition by the Company, the Subject Person becomes the Beneficial Owner of any additional Voting Securities which increases the percentage of the then outstanding Voting Securities Beneficially Owned by the Subject Person, then a Change in Control shall occur.

 

(e) “ Code ” shall mean the Internal Revenue Code of 1986, as amended from time to time, or any successor thereto.

 

(f) “ Committee ” shall mean the committee described in Section 3.1 or, as applicable, any other committee or any officer to whom the Board or the Committee has delegated authority in accordance with Section 3.1.

 

(g) “ Disability ” shall mean the total disability as determined by the Committee in accordance with standards and procedures similar to those under the Company’s long-term disability plan, or, if none, a physical or mental infirmity which the Committee determines impairs the Participant’s ability to perform substantially his or her duties for a period of 180 consecutive days.

 

(h) “ Employee ” shall mean an individual who is a full-time employee of the Company, a Subsidiary or a partnership or limited liability company in which the Company or its Subsidiaries own a majority interest.

 

(i) “ Exchange Act ” shall mean the Securities Exchange Act of 1934, as amended from time to time.

 

(j) “ Fair Market Value ” of the Shares shall mean, as of any applicable date, the closing sale price of the Shares on the New York Stock Exchange or any national or regional stock exchange on which the Shares are traded, or if no such reported sale of the Shares shall have occurred on such date, on the next preceding date on which there was such a reported sale. If there shall be any material alteration in the present system of reporting sale prices of the Shares, or if the Shares shall no longer be listed on the New York Stock Exchange or a national or regional stock exchange, the fair market value of the Shares as of a particular date shall be determined by such method as shall be determined by the Committee.

 

-3-


(k) “ ISOs ” shall have the meaning given such term in Section 6.1.

 

(l) “ Nonexecutive Employees ” shall mean Employees who are not executive officers of the Company.

 

(m) “ NQSOs ” shall have the meaning given such term in Section 6.1.

 

(n) “ Option ” shall mean an option to purchase Shares granted pursuant to Article 6.

 

(o) “ Option Agreement ” shall mean an agreement evidencing the grant of an Option as described in Section 6.2.

 

(p) “ Option Exercise Price ” shall mean the purchase price per Share subject to an Option, which shall not be less than the Fair Market Value of the Share on the date of grant (110% of Fair Market Value in the case of an ISO granted to a Ten Percent Shareholder).

 

(q) “ Participant ” shall mean any Employee selected by the Committee to receive an Award under the Plan.

 

(r) “ Performance Goals ” shall have the meaning given such term in Section 8.4.

 

(s) “ Performance Period ” shall have the meaning given such term in Section 8.3.

 

(t) “ Performance Unit ” shall mean the right to receive a payment from the Company upon the achievement of specified Performance Goals as set forth in a Performance Unit Agreement.

 

(u) “ Performance Unit Agreement ” shall mean an agreement evidencing a Performance Unit Award, as described in Section 8.2.

 

(v) “ Person ” shall have the meaning ascribed to such term in Section 3(a)(9) of the Exchange Act and as used in Sections 13(d) and 14(d) thereof, including a “group” as defined in Section 13(d).

 

(w) “ Plan ” shall mean this Ventas, Inc. 2000 Incentive Compensation Plan as the same may be amended from time to time.

 

(x) “ Restricted Award Agreement ” shall mean an agreement evidencing a Restricted Stock Award or Restricted Stock Unit Award, as described in Section 7.2.

 

(y) “ Restricted Stock ” shall mean Shares granted pursuant to Article 7 as to which the restrictions have not expired.

 

(z) “ Restricted Stock Unit ” shall mean an Award granted pursuant to Article 7 denominated in units of the Company’s common stock.

 

(aa) “ Restriction Period ” shall mean the period determined by the Committee during which the transfer of Shares is limited in some way or Shares or Restricted Stock Units are otherwise restricted or subject to forfeiture as provided in Article 7.

 

-4-


(bb) “ Retirement ” shall mean retirement by a Participant in accordance with the terms of the Company’s retirement or pension plans.

 

(cc) “ Shares ” shall mean the shares of the Company’s common stock, par value $.25 per share.

 

(dd) “ Subsidiary ” shall mean, with respect to any company, any corporation or other Person of which a majority of its voting power, equity securities, or equity interest is owned directly or indirectly by such company.

 

(ee) “ Ten Percent Shareholder ” shall mean an Employee who, at the time an ISO is granted, owns (within the meaning of Section 422(b)(6) of the Code) stock possessing more than 10% of the total combined voting power of all classes of stock of the Company.

 

2.2. Gender and Number . Except where otherwise indicated by the context, reference to the masculine gender shall include the feminine gender, the plural shall include the singular and the singular shall include the plural.

 

2.3. Severability . In the event any provision of the Plan shall be held illegal or invalid for any reason, the illegality or invalidity shall not affect the remaining parts of the Plan, and the Plan shall be construed and enforced as if the illegal or invalid provision had not been included.

 

ARTICLE 3.

 

Administration

 

3.1. The Committee . The Plan shall be administered by a Committee appointed by the Board consisting of one or more directors of the Company or the entire Board of the Company. To the extent deemed appropriate by the Board, members of the Committee shall be “outside directors” within the meaning of Section 162(m) of the Code (or any successor provision thereto).

 

Notwithstanding the foregoing, the Board may delegate responsibility for granting Awards and otherwise administering the Plan with respect to designated classes of Employees to one or more different committees consisting of one or more members of the Board, subject to such limitations as the Board deems appropriate. To the extent consistent with applicable law, the Board or the Committee may authorize one or more officers of the Company to grant Awards to designated classes of Employees, within limits specifically prescribed by the Board or the Committee. As of January 25, 2005, the Board has delegated the ability to grant Awards to Nonexecutive Employees to a Board committee comprised of the Chief Executive Officer. Consistent with this paragraph, the Board or Committee shall each year establish an annual allotment of Shares with respect to which such Board committee or Company officer authorized pursuant to this paragraph may grant Awards to Nonexecutive Employees. Unless another amount shall otherwise be determined by the Board or Committee by authorized action, an annual allotment of ten thousand (10,000) Shares is hereby established with respect to which such Board committee or Company officer is authorized pursuant to this paragraph to grant each year. Any Shares within such annual allotment with respect to which Awards are not granted with respect to such annual period shall be automatically added to the annual allotment available

 

-5-


pursuant to this paragraph in each succeeding year for Awards to Nonexecutive Employees until such Shares are used for Awards. If and to the extent an Award granted pursuant to this paragraph shall expire or terminate for any reason without having been exercised in full, or shall be forfeited, the Shares (including Restricted Stock) associated with such Awards shall again become available for Awards pursuant to this paragraph.

 

The Committee shall meet at such times and places as it determines and may meet through a telephone conference call. The members of the Committee shall be appointed from time to time by, and shall serve at the discretion of, the Board.

 

3.2. Authority of the Committee . Subject to the provisions of the Plan, the Committee shall have full authority to:

 

(a) select Participants to whom Awards are granted;

 

(b) determine the size, types and frequency of Awards granted under the Plan;

 

(c) determine the terms and conditions of Awards, including any restrictions or conditions to the Awards, which need not be identical, including, without limitation, the conditions under which Participants may defer the receipt of payment or delivery of Shares that would otherwise be due such Participants (including by virtue of the exercise of an Option or SAR, the lapse or waiver of restrictions with respect to Restricted Stock or Restricted Stock Units, or the satisfaction of any requirements or goals with respect to Performance Units or other Awards);

 

(d) accelerate the exercisability of any Award, for any reason;

 

(e) construe and interpret the Plan and any agreement or instrument entered into under the Plan; and

 

(f) establish, amend and rescind rules and regulations for the Plan’s administration.

 

The Committee shall make all other determinations which may be necessary or advisable for the administration of the Plan. The Committee may delegate its authority as identified hereunder; provided, however, that such delegation is permitted by law. The Committee (or the Board, in the absence of any such Committee) shall have the discretion to determine for purposes of the Plan whether any participant in the Plan (i) is or remains (or is not or does not remain) a full-time employee of the Company, and (ii) shall have incurred (or shall not have incurred) a termination of employment.

 

3.3. Decisions Binding . All determinations and decisions made by the Committee pursuant to the provisions of the Plan, and all related orders or resolutions of the Board, shall be final, conclusive and binding upon all persons, including the Company, its stockholders, Employees, Participants and their estates and beneficiaries.

 

3.4. Section 16 Compliance; Bifurcation of Plan . It is the intention of the Company that the Plan and the administration of the Plan comply in all respects with Section 16(b) of the Exchange Act and the rules and regulations promulgated thereunder to the extent deemed

 

-6-


appropriate by the Committee. If any Plan provision, or any aspect of the administration of the Plan, is found not to be in compliance with Section 16(b) of the Exchange Act, the provision or administration shall be deemed null and void to the extent deemed appropriate by the Committee, and the Plan shall be construed in favor of its meeting the requirements of Rule 16b-3 promulgated under the Exchange Act to the extent deemed appropriate by the Committee. Notwithstanding anything in the Plan to the contrary, the Board or the Committee, in its discretion, may bifurcate the Plan so as to restrict, limit or condition the use of any provision of the Plan to Participants who are subject to Section 16 of the Exchange Act without so restricting, limiting or conditioning the Plan with respect to other Participants.

 

ARTICLE 4.

 

Shares Available Under the Plan

 

4.1. Number of Shares . Subject to adjustment as provided in Section 4.2, the number of Shares reserved for issuance upon the exercise of Awards and the payment of benefits in connection with Awards is 5,620,000 Shares. Any Shares issued under the Plan may consist, in whole or in part, of authorized and unissued Shares or treasury Shares. If and to the extent an Award shall expire or terminate for any reason without having been exercised in full (including a cancellation and regrant of an Option), or shall be forfeited, the Shares (including Restricted Stock) associated with such Awards shall again become available for Awards under the Plan.

 

4.2. Adjustments in Authorized Shares and Outstanding Awards . In the event of a merger, reorganization, consolidation, recapitalization, reclassification, split-up, spin-off, separation, liquidation, stock dividend, stock split, reverse stock split, property dividend, share repurchase, share combination, share exchange, issuance of warrants, rights or debentures, or other change in the corporate structure of the Company affecting the Shares, the Committee may substitute or adjust the total number and class of Shares or other stock or securities which may be issued under the Plan, and the number, class and/or price of Shares subject to outstanding Awards, as it determines to be appropriate and equitable to prevent dilution or enlargement of the rights of Participants and to preserve, without exceeding, the value of any outstanding Awards; and further provided, that the number of Shares subject to any Award shall always be a whole number. In the case of ISOs, such adjustments shall be made in such a manner so as not to constitute a “modification” within the meaning of Section 424(h)(3) of the Code and only to the extent otherwise permitted by Sections 422 and 424 of the Code. The consummation of the transactions contemplated by the spinoff of Vencor Healthcare, Inc. and the distribution of shares of Vencor Healthcare, Inc. to the shareholders of the Company shall not result in a Participant’s termination of employment under the Plan until such Participant terminates employment from Vencor Healthcare, Inc.

 

ARTICLE 5.

 

Eligibility and Participation

 

All Employees are eligible to receive Awards under the Plan. In selecting Employees to receive Awards under the Plan, as well as in determining the number of Shares subject to, and the other terms and conditions applicable to, each Award, the Committee shall take into

 

-7-


consideration such factors as it deems relevant in promoting the purposes of the Plan, including the duties of the Employees, their present and potential contribution to the success of the Company and their anticipated number of years of active service as employees.

 

ARTICLE 6.

 

Stock Options

 

6.1. Grant of Options . Subject to the terms and provisions of the Plan, the Committee may grant Options to Participants at any time and from time to time, in the form of options which are intended to qualify as incentive stock options within the meaning of Section 422 of the Code (“ ISOs ”), Options which are not intended to so qualify (“ NQSOs ”) or a combination thereof. All ISOs must be granted within ten years from the date on which the Plan was adopted by the Board, and may only be granted to employees of the Company or any subsidiary corporation (within the meaning of Section 424(f)). The maximum number of Shares with respect to which Options may be granted to any Participant during any calendar year shall be 750,000, subject to adjustment as provided in Section 4.2.

 

6.2. Option Agreement . Each Option shall be evidenced by an Option Agreement that shall specify the Option Exercise Price, the duration of the Option, the number of Shares to which the Option relates and such other provisions as the Committee may determine or which are required by the Plan. The Option Agreement shall also specify whether the Option is intended to be an ISO or a NQSO and shall include such provisions applicable to the particular type of Option granted.

 

6.3. Duration of Options . Each Option shall expire at such time as is determined by the Committee at the time of grant; provided, however, that no Option shall be exercised later than the tenth anniversary of its grant (fifth anniversary in the case of an ISO granted to a Ten Percent Shareholder).

 

6.4. Exercise of Options . Options shall be exercisable at such times and be subject to such restrictions and conditions as the Committee shall approve at the time of grant, which need not be the same for each grant or for each Participant. The Committee may accelerate the exercisability of any Option. Options shall be exercised, in whole or in part, by delivery to the Company of a written notice of exercise, setting forth the number of Shares with respect to which the Option is to be exercised and accompanied by full payment of the Option Exercise Price and all applicable withholding taxes.

 

6.5. Payment of Option Exercise Price . The Option Exercise Price for Shares as to which an Option is exercised shall be paid to the Company in full at the time of exercise either (a) in cash in the form of currency or other cash equivalent acceptable to the Company, (b) by tendering Shares (by either actual delivery or by attestation) having a Fair Market Value (determined as of the close of the business day immediately preceding the day on which the Option is exercised) equal to the Option Exercise Price (provided such Shares have been held by the Participant for at least six months prior to their tender), (c) any other reasonable consideration that the Committee may deem appropriate or (d) by a combination of the forms of consideration described in (a), (b) and (c) of this Section 6.5. The Committee may permit the

 

-8-


cashless exercise of Options as described in Regulation T promulgated by the Federal Reserve Board, subject to applicable securities law restrictions and assuming the cashless exercise is completed in a transaction independent of the Company and appropriately structured to avoid any adverse accounting consequences to the Company, or by any other means which the Committee determines to be consistent with the Plan’s purpose and applicable law.

 

6.6. Vesting Upon Change in Control . Upon a Change in Control, any then outstanding Options held by Participants shall become fully vested and immediately exercisable.

 

6.7. Termination of Employment . The Committee determines the treatment of Options upon termination of employment of a Participant. Unless the Committee determines otherwise, the treatment of Options upon termination of employment of a Participant shall be as set forth in this Section 6.7. If the employment of a Participant is terminated for Cause, all then outstanding Options of such Participant, whether or not exercisable, shall terminate immediately. Unless the Committee determines otherwise, if the employment of a Participant is terminated for any reason other than for Cause, death, Disability or Retirement, to the extent then outstanding Options of such Participant are exercisable, such Options may be exercised by such Participant or such Participant’s personal representative at any time prior to the expiration date of the Options or within 90 days after the date of such termination of employment, whichever is earlier. In the event of the Retirement of a Participant, to the extent then outstanding Options of such Participant are exercisable, such Options may be exercised by the Participant (a) in the case of NQSOs, within two years after the date of Retirement and (b) in the case of ISOs, within 90 days after Retirement; provided, however, that no such Options may be exercised on a date subsequent to their expiration. In the event of the death or Disability of a Participant while employed by the Company or a Subsidiary, all then outstanding Options of such Participant shall become fully vested and immediately exercisable, and may be exercised at any time (a) in the case of NQSOs, within two years after the date of death or determination of Disability and (b) in the case of ISOs, within one year after the date of death or determination of Disability; provided, however, that no such Options may be exercised on a date subsequent to their expiration. In the event of the death of a Participant, the Option may be exercised by the person or persons to whom rights pass by will or by the laws of descent and distribution, or if appropriate, the legal representative of the deceased Participant’s estate. In the event of the Disability of a Participant, Options may be exercised by the Participant, or if such Participant is incapable of exercising the Options, by such Participant’s legal representative.

 

6.8. Transferable Options . The Committee may, in its discretion by appropriate provision in the Participant’s Option Agreement, authorize all or a portion of any NQSOs to be granted to a Participant be on terms which permit transfer by such Participant to (i) the spouse, children or grandchildren of the Participant (“ Immediate Family Members ”), (ii) a trust or trusts for the exclusive benefit of such Participant and/or his Immediate Family Members, or (iii) a partnership or limited liability company in which such Participant and/or his Immediate Family Members are the only partners or members, as applicable; provided that (a) there may be no consideration for any such transfer (other than interests in such partnership or limited liability company), (b) the Option Agreement must expressly provide for transferability in a manner consistent with the Section and (c) subsequent transfers of transferable NQSOs shall be prohibited except by will or the laws of descent and distribution. Following transfer, any such NQSOs shall continue to be subject to the same terms and conditions as were applicable

 

-9-


immediately prior to transfer, provided that for purposes of this Article 6 (excluding Section 6.7) the term “Participant” shall be deemed to refer to the transferee. The events of termination of employment as set forth in Section 6.7 shall continue to be applied with respect to the original Participant. Any transferred NQSOs shall be exercisable by the transferee only to the extent, and for the periods, specified in the Option Agreement.

 

6.9. Certificate Legend . For any Shares issued upon exercise of an ISO, the Company may legend such Shares as it deems appropriate.

 

6.10. Committee Determination of Option Terms . Notwithstanding anything to the contrary in Section 6.4 or Section 6.7, the Committee determines the period of time the Option is exercisable (provided that no Option shall be exercised later than the tenth anniversary of its grant) and to the extent that the Option Agreement provides for exercisability of the Option during a period when Section 6.4 or Section 6.7 would not otherwise permit exercise of the Option, the Option Agreement shall control as to such exercisability.

 

ARTICLE 7.

 

Restricted Stock and Restricted Stock Units

 

7.1. Grant of Restricted Stock . Subject to the terms and provisions of the Plan, the Committee may grant Restricted Stock or Restricted Stock Units, as elected by the Participant, to Participants at any time and from time to time and upon such terms and conditions as it may determine.

 

7.2. Restricted Award Agreement . Each grant of Restricted Stock or Restricted Stock Unit shall be evidenced by a Restricted Award Agreement which shall specify the Restriction Period, the number of shares of Restricted Stock or Restricted Stock Units granted, and payment date for Restricted Stock Units, as determined by the Participant, and such other provisions as the Committee may determine and which are required by the Plan.

 

7.3. Non-Transferability of Restricted Stock . Except as provided in this Article 7, shares of Restricted Stock and Restricted Stock Units may not be sold, transferred, pledged, assigned or otherwise alienated or hypothecated until the end of the applicable Restriction Period or later as specified in the Restricted Award Agreement, or upon earlier satisfaction of any other conditions determined at the time of grant specified in the Restricted Award Agreement.

 

7.4. Other Restrictions . The Committee may impose such other restrictions on any shares of Restricted Stock or any Restricted Stock Units as it may deem advisable, including, without limitation, restrictions based upon the achievement of Performance Goals, years of service and/or restrictions under applicable Federal or state securities laws. The Committee may provide that any share of Restricted Stock shall be held (together with a stock power executed in blank by the Participant) in custody by the Company until any or all restrictions thereon shall have lapsed.

 

7.5. Reacquisition of Restricted Stock and Forfeiture of Restricted Stock Units . Committee shall determine and set forth in a Participant’s Restricted Award Agreement such events upon which a Participant’s shares of Restricted Stock shall be reacquired by the Company

 

-10-


or Restricted Stock Units shall be forfeited, which may include, without limitation, the termination of a Participant’s employment during the Restriction Period or the nonachievement of Performance Goals. Any such forfeited shares of Restricted Stock held by a Participant which are to be reacquired by the Company shall be immediately returned to the Company by the Participant, and the Participant shall only receive the amount, if any, paid by the Participant for such Restricted Stock.

 

7.6. Certificate Legend . In addition to any legends placed on certificates pursuant to Section 7.4, each certificate representing shares of Restricted Stock shall bear the following legend:

 

“The sale or other transfer of the shares represented by this Certificate, whether voluntary, involuntary or by operation of law, is subject to certain restrictions on transfer as set forth in the Ventas, Inc. 2000 Incentive Compensation Plan, and in the related Restricted Stock Agreement. A copy of the Plan and such Restricted Stock Agreement may be obtained from the Secretary of Ventas, Inc.”

 

7.7. Lapse of Restrictions Generally . Except as otherwise provided in this Article 7, shares of Restricted Stock shall be delivered to the Participant and no longer subject to reacquisition after the last day of the Restriction Period and Restricted Stock Units shall be fully vested after the last day of the Restriction Period and shall be paid as set forth in the Restricted Award Agreement; provided, however, that if the restriction relates to the achievement of a Performance Goal, the Restriction Period shall not end until the Committee has certified in writing that the Performance Goal has been met. Once the shares of Restricted Stock are released from their restrictions, the Participant shall be entitled to have the legend required by Section 7.6 removed from the Participant’s share certificate, which certificate shall thereafter represent Shares free from any and all restrictions under the Plan.

 

7.8. Lapse of Restrictions Upon Change in Control . Upon a Change in Control, any restrictions and other conditions pertaining to then outstanding shares of Restricted Stock and Restricted Stock Units held by Participants, including, but not limited to, vesting requirements, shall lapse and such Restricted Stock shall thereafter be immediately free from any and all restrictions under the Plan and such Restricted Stock Units shall be paid as set forth in the Restricted Award Agreement.

 

7.9. Voting Rights; Dividends and Other Distributions . During the Restriction Period, Participants holding shares of Restricted Stock may exercise full voting rights, and shall be entitled to receive all dividends and other distributions paid, with respect to such Restricted Stock. If any dividends or distributions are paid in Shares, the Shares shall be subject to the same restrictions as the shares of Restricted Stock with respect to which they were paid.

 

On each dividend or other distribution date with respect to Shares, a cash dollar amount equal to the amount of cash dividends or the fair market value of property other than Shares that would have been paid or distributed on a number of Shares equal to the number of Restricted Stock Units held by Participants as of the close of business on the record date for such dividend or distribution shall be paid in cash to such Participants. If any dividend or distribution with

 

-11-


respect to Shares is payable in Shares, Participants shall be credited with an additional number of Restricted Stock Units equal to the product of the number of Restricted Stock Units held by such Participants on the record date for such dividend or distribution multiplied by the number of Shares (including fractions thereof) distributable as a dividend or distribution on a Share. Restricted Stock Units which are credited to Participants pursuant to the preceding sentence shall be subject to the same terms and conditions of the Plan, the Restricted Award Agreement and elections applicable with respect to such Restricted Stock Units with respect to which they relate.

 

7.10. Termination of Employment . Unless the Committee determines otherwise, if the employment of a Participant is terminated for any reason other than death or Disability prior to the expiration of the Restriction Period applicable to any shares of Restricted Stock then held by the Participant, such Shares shall thereupon be immediately reacquired by and returned to the Company, and the Participant shall only receive the amount, if any, paid by the Participant for such Restricted Stock. Unless the Committee determines otherwise, if the employment of a Participant is terminated for any reason other than death or Disability prior to the expiration of the Restriction Period applicable to any Restricted Stock Units, such Restricted Stock Units shall thereupon be immediately forfeited. Unless the Committee determines otherwise, if the employment of a Participant is terminated as a result of death or Disability prior to the expiration of the Restriction Period applicable to any Shares of Restricted Stock or Restricted Stock Units then held by the Participant, any restrictions and other conditions pertaining to such Shares or Restricted Stock Units then held by the Participant, including, but not limited to, vesting requirements, shall immediately lapse and such Shares of Restricted Stock shall thereafter be immediately transferable and nonforfeitable and such Restricted Stock Units shall be paid as set forth in the Restricted Award Agreement. Notwithstanding anything in the Plan to the contrary, except in the case of Restricted Stock or Restricted Stock Units for which a Performance Goal must be achieved, the Committee may determine, in its sole discretion, in the case of any termination of a Participant’s employment other than for Cause, that the restrictions on some or all of the Shares of Restricted Stock or on the Restricted Stock Units awarded to a Participant shall immediately lapse and such Shares of Restricted Stock shall thereafter be immediately transferable and nonforfeitable and such Restricted Stock Units shall be immediately vested and be paid as set forth in the Restricted Award Agreement.

 

ARTICLE 8.

 

Performance Units

 

8.1. Grant of Performance Units . The Committee may, from time to time and upon such terms and conditions as it may determine, grant Performance Units which will become payable to a Participant upon certification in writing by the Committee that the Performance Goals related thereto have been achieved. The maximum number of Performance Units which may be awarded to a Participant during any calendar year shall be 100,000 units, subject to adjustment as provided in Section 4.2. If the Performance Goals are achieved in full, and the Participant remains employed with the Company as of the end of the relevant Performance Period, the Participant will be allocated Shares equal to the number of Performance Units initially awarded to the Participant for the relevant Performance Period. Each award of Performance Units may provide for the allocation of fewer Performance Units in the event of partial fulfillment of Performance Goals.

 

-12-


8.2. Performance Unit Agreement . Each Performance Unit grant shall be evidenced by a Performance Unit Agreement that shall specify the Performance Goals, the Performance Period and the number of Performance Units to which it pertains.

 

8.3. Performance Period . The period of performance (“ Performance Period ”) with respect to each Performance Unit shall be such period of time, which shall not be less than six months, nor more than five years, as determined by the Committee, for the measurement of the extent to which Performance Goals are attained.

 

8.4. Performance Goals . The goals (“ Performance Goals ”) that are to be achieved with respect to each Performance Unit, (or Restricted Stock, Restricted Stock Unit, stock award or cash award subject to a requirement that Performance Goals be achieved), shall be those objectives established by the Committee as it deems appropriate, and which may be expressed in terms of (a) earnings per Share, (b) Share price, (c) pre-tax profit, (d) net earnings, (e) return on equity or assets, (f) revenues, (g) any combination of the foregoing, or (h) such other goals as the Committee may determine. Performance Goals may be in respect of the performance of the Company and its Subsidiaries (which may be on a consolidated basis), a Subsidiary, a division or other operating unit of the Company. Performance Goals may be absolute or relative and may be expressed in terms of a progression within a specified range. The Committee shall establish Performance Goals applicable to a particular fiscal year within 90 days of the commencement of such fiscal year, provided that the outcome of the Performance Goal is substantially uncertain at the time of its adoption. To the extent deemed appropriate by the Committee, the Performance Goals with respect to a Performance Period shall be established by the Committee in order to comply with Rule 16b-3 under the Exchange Act and Section 162(m) of the Code, as applicable. The Committee shall determine the target levels of performance that must be achieved with respect to each criteria that is identified in a Performance Goal in order for a Performance Goal to be treated as attained in whole or in part. In the event that the Performance Goals are based on more than one business criteria, the Committee may determine to make a grant of an Award upon attainment of the Performance Goal relating to any one or more of such criteria.

 

8.5. Termination of Employment . Unless the Committee determines otherwise, if the employment of a Participant shall terminate prior to the expiration of the Performance Period for any reason other than for death or Disability, the Performance Units then held by the Participant shall terminate. Unless the Committee determines otherwise, in the case of termination of employment by reason of death or Disability of a Participant prior to the expiration of the Performance Period, then all Performance Units which are potentially available under an outstanding Award and which have not been issued shall be fully vested in, paid and issued to Participant or, in the case of Participant’s death, shall be vested in, paid and issued to Participant’s estate, as of the date of the Participant’s death.

 

8.6. Payment Upon Change In Control . Upon a Change in Control, any and all outstanding Performance Units which are potentially available under any outstanding Award shall become fully vested and immediately payable.

 

8.7. Payment of Performance Units . Subject to such terms and conditions as the Committee may impose, and unless otherwise provided in the Performance Unit Agreement, Performance Units shall be payable within 90 days following the end of the Performance Period

 

-13-


during which the Participant attained at least the minimum acceptable level of achievement under the Performance Goals, or 90 days following a Change in Control, as applicable. The Committee, in its discretion, may determine at the time of payment required in connection with a Performance Unit whether such payment shall be made (a) solely in cash, (b) solely in Shares (valued at the Fair Market Value of the Shares on the date of payment) or (c) a combination of cash and Shares; provided, however, that if a Performance Unit becomes payable upon a Change in Control, the Performance Unit shall be paid solely in cash.

 

8.8. Designation of Beneficiary . Each Participant may, from time to time, name any beneficiary or beneficiaries (who may be named contingently or successively) to whom the right to receive payments under a Performance Unit is to be paid in case of the Participant’s death before receiving any or all such payment. Each such designation shall revoke all prior designations by the Participant, shall be in a form prescribed by the Company and shall be effective only when filed by the Participant in writing with the Committee during the Participant’s lifetime. In the absence of any such designation, benefits remaining unpaid at the Participant’s death shall be paid to the Participant’s estate.

 

8.9. No Rights as Stockholder . The award of Performance Units to a Participant shall not create any rights in such Participant as a stockholder of the Company, until the payment of any Shares associated with such Performance Units.

 

ARTICLE 9.

 

Stock Appreciation Rights

 

9.1. Grant of Stock Appreciation Rights . An SAR is a right to receive, without payment to the Company, a number of Shares, cash or any combination thereof, the amount of which is determined pursuant to the formula set forth in Section 9.5. An SAR may be granted (a) with respect to any Option granted under the Plan, either concurrently with the grant of such Option or at such later time as determined by the Committee (as to all or any portion of the Shares subject to the Option) or (b) alone, without reference to any Option.

 

9.2. Number of SARs . Each SAR granted to any Participant shall relate to such number of Shares as the Committee shall determine, subject to adjustment as provided in Section 4.2. If an SAR is granted in conjunction with an Option, the number of Shares to which the SAR pertains shall be reduced by the same number for which the holder of the Option exercises the related Option. The maximum number of SARs which may be granted to any Participant during any calendar year shall be 100,000, subject to adjustment as provided in Section 4.2.

 

9.3. Duration . Subject to early termination as herein provided, the term of each SAR shall be as determined by the Committee, but shall not exceed ten years from the date of grant. Unless otherwise provided by the Committee, each SAR shall become exercisable at such time or times, to such extent and upon such conditions as the Option, if any, to which it relates is exercisable. The Committee may, in its discretion, accelerate the exercisability of any SAR.

 

9.4. Exercise . A holder may exercise an SAR, in whole or in part, by giving written notice to the Company, specifying the number of SARs which such Participant wishes to

 

-14-


exercise. Upon receipt of such written notice, the Company shall deliver, within 90 days thereafter, to the exercising holder, certificates for the Shares or cash or both as determined by the Committee, to which the Participant is entitled pursuant to Section 9.5.

 

9.5. Payment .

 

(a) Number of Shares . Subject to the right of the Committee to deliver cash in lieu of Shares (which, as it pertains to officers and directors of the Company, shall comply with all requirements of the Exchange Act and regulations adopted thereunder), the number of Shares which shall be issuable upon the exercise of an SAR shall be determined by dividing (i) the number of Shares to which the SAR is exercised multiplied by the amount of the appreciation in such Shares (for this purpose, the “appreciation” shall be the amount by which the Fair Market Value of the Shares subject to the SAR on the date of exercise exceeds (x) in the case of an SAR related to an Option, the Option Exercise Price of the Shares under the Option or (y) in the case of an SAR granted alone without reference to a related Option, an amount that the Committee determined at the time of grant to be the Fair Market Value of a Share, subject to adjustment as provided in Section 4.2) by (ii) the Fair Market Value of a Share on the exercise date.

 

(b) Cash . In lieu of issuing Shares upon the exercise of an SAR, the Committee may elect, in its sole discretion, to pay the holder of the SAR cash equal to the Fair Market Value on the exercise date of any or all of the Shares which would otherwise be issuable. No fractional Shares shall be issued upon exercise of an SAR; instead, the holder of the SAR shall be entitled to receive a cash adjustment equal to the same fraction of the Fair Market Value of a Share on the exercise date or to purchase the portion necessary to make a whole Share at its Fair Market Value on the date of exercise.

 

9.6. SAR Agreement . Each SAR shall be evidenced by an SAR Agreement that shall further specify the terms and conditions of such Award. Any terms and conditions of the Award shall be consistent with the terms of the Plan.

 

ARTICLE 10.

 

Stock and Cash Awards

 

A stock award consists of the transfer by the Company to a Participant of Shares, without other payment therefor, as additional compensation for services to the Company. A cash award consists of a monetary payment made by the Company to a Participant as additional compensation for services to the Company. The Committee shall determine, in its sole discretion, the amount of any stock or cash award. Stock and cash awards may be subject to the terms and conditions, which may vary from time to time and among Participants, as the Committee deems appropriate. The maximum amount of a cash award which may be granted to a Participant during any calendar year under the Plan shall not be greater than $900,000. Payment of a stock or cash award will normally depend on meeting Performance Goals. Each award of stock or cash may provide for lesser payment in the event of partial fulfillment of Performance Goals.

 

-15-


ARTICLE 11.

 

Amendment, Modification and Termination

 

11.1. Effective Date . The Plan as amended and restated became effective as of February 24, 2000. The amendment and restatement of the Plan shall be rescinded and all Options, Shares of Restricted Stock, SARs, Performance Units and other Awards granted hereunder relying on the increase in the number of Shares set forth in Section 4.2 or the increase in the maximum cash award shall be null and void unless within 12 months from the date of the adoption of the Plan by the Board it shall have been approved by the holders of a majority of the outstanding Shares present or represented and entitled to vote on the Plan at a stockholders’ meeting.

 

11.2. Termination Date . The Plan shall terminate on the earliest to occur of (a) the tenth anniversary of the adoption of the 1997 Incentive Compensation Plan by the Board, (b) the date when all Shares available under the Plan shall have been acquired pursuant to the exercise of Awards and the payment of all benefits in connection with Performance Unit Awards has been made or (c) such other date as the Board may determine in accordance with Section 11.3.

 

11.3. Amendment, Modification and Termination . The Board may, at any time, amend, modify or terminate the Plan. Without the approval of the stockholders of the Company (as may be required by the Code, Section 16 of the Exchange Act and the rules promulgated thereunder, any national securities exchange or system on which the Shares are then listed or reported or a regulatory body having jurisdiction with respect hereto), however, no such amendment, modification or termination may:

 

(a) materially increase the benefits accruing to Participants under the Plan;

 

(b) increase the total amount of Shares which may be issued under the Plan, except as provided in Section 4.2; or

 

(c) materially modify the class of Employees eligible to participate in the Plan.

 

11.4. Awards Previously Granted . No amendment, modification or termination of the Plan shall in any manner adversely affect any outstanding Award without the written consent of the Participant holding such Award.

 

ARTICLE 12.

 

Non-Transferability

 

Except as expressly provided in the Plan, a Participant’s rights under the Plan may not be assigned, pledged or otherwise transferred other than by will or the laws of descent and distribution, except that upon a Participant’s death, the Participant’s rights to payment pursuant to a Performance Unit may be transferred to a beneficiary designated in accordance with Section 8.8. Except as expressly provided in the Plan, during a Participant’s lifetime, an Award may be exercised only by such Participant.

 

-16-


ARTICLE 13.

 

No Granting of Employment Rights

 

Neither the Plan, nor any action taken under the Plan, shall be construed as giving any Employee the right to become a Participant, nor shall an Award under the Plan be construed as giving a Participant any right with respect to continuance of employment by the Company. The Company expressly reserves the right to terminate, whether by dismissal, discharge or otherwise, a Participant’s employment at any time, with or without Cause, except as may otherwise be provided by any written agreement between the Company and the Participant.

 

ARTICLE 14.

 

Withholding

 

14.1. Tax Withholding . A Participant shall remit to the Company an amount sufficient to satisfy Federal, state and local taxes (including the Participant’s FICA and Medicare obligation) required by law to be withheld with respect to any grant, exercise or payment made under or as a result of the Plan.

 

14.2. Share Withholding . If the Company has a withholding obligation upon the issuance of Shares under the Plan, a Participant may, subject to the discretion of the Committee, elect to satisfy the withholding requirement, in whole or in part, by having the Company withhold Shares having a Fair Market Value on the date the withholding tax is to be determined equal only to the minimum amount required to be withheld under applicable law. Notwithstanding the foregoing, the Committee may, by the adoption of rules or otherwise, modify the provisions of this Section 14.2 or impose such other restrictions or limitations on such elections as may be necessary to ensure that such elections will be exempt transactions under Section 16(b) of the Exchange Act.

 

ARTICLE 15.

 

Indemnification

 

No member of the Board or the Committee, nor any officer or Employee acting on behalf of the Board or the Committee, shall be personally liable for any action, determination or interpretation taken or made with respect to the Plan, and all members of the Board, the Committee and each officer or Employee of the Company acting on their behalf shall, to the extent permitted by law, be fully indemnified and protected by the Company with respect to any such action, determination or interpretation.

 

ARTICLE 16.

 

Successors

 

All obligations of the Company with respect to Awards granted under the Plan shall be binding on any successor to the Company, whether the existence of such successor is a result of a direct or indirect purchase, merger, consolidation or otherwise, of all or substantially all of the business and/or assets of the Company.

 

-17-


ARTICLE 17.

 

Governing Law

 

To the extent not preempted by Federal law, the Plan, and all agreements under the Plan, shall be governed by, and construed in accordance with, the laws of the State of Delaware without regard to its conflict of laws rules. Furthermore, the Plan and all Option Agreements relating to ISOs shall be interpreted to the extent deemed appropriate by the Committee so as to qualify as incentive stock options under the Code.

 

-18-

Exhibit 10.16.1

 

VENTAS, INC.

 

2004 STOCK PLAN

FOR DIRECTORS

 

ARTICLE 1. PURPOSE

 

The Ventas, Inc. 2004 Stock Plan for Directors (“Plan”) is an amendment and restatement of the 2000 Stock Option Plan for Directors. The purpose of this Plan is to promote the interests of Ventas, Inc., its subsidiaries and stockholders, by allowing the Company to attract and retain highly qualified directors by permitting them to obtain or increase their proprietary interest in the Company.

 

ARTICLE 2. DEFINITIONS AND CONSTRUCTION

 

2.1 Definitions . As used in the Plan, terms defined parenthetically immediately after their use shall have the respective meanings provided by such definitions, and the terms set forth below shall have the following meanings (in either case, such terms shall apply equally to both the singular and plural forms of the terms defined):

 

(a) “Award” shall mean, individually or collectively, a grant under the Plan of Options, Restricted Stock, Restricted Stock Units or Other Stock-Based Awards.

 

(b) “Award Agreement” shall mean, individually or collectively, an Option Agreement, Restricted Award Agreement, or an agreement evidencing an Other Stock-Based Award.

 

(c) “Board” shall mean the Board of Directors of the Company.

 

(d) “Cause” shall mean, unless otherwise defined in an Award Agreement, a felony conviction of a Director or the failure of a Director to contest prosecution for a felony, or a Director’s willful misconduct or dishonesty, any of which is determined by the Committee to be directly and materially harmful to the business or reputation of the Company or its Subsidiaries.

 

(e) “Change in Control” shall mean any of the following events:

 

(1) An acquisition (other than directly from the Company) of any voting securities of the Company (“Voting Securities”) by any Person immediately after which such Person has beneficial ownership (within the meaning of Rule 13d-3 promulgated under the Exchange Act) (“Beneficial Ownership and/or Beneficially Owned”) of 20% or more of the combined voting power of the Company’s then outstanding Voting Securities; provided, however, that in determining whether a Change in Control has occurred, Voting Securities which are acquired in a Non-Control Acquisition (as hereinafter defined) shall not constitute an acquisition which would cause a Change in Control. A Non-Control Acquisition shall mean an acquisition by (i) the Company or any Subsidiary, (ii) an employee benefit plan (or a trust forming a part thereof) maintained by the Company or any Subsidiary, or (iii) any Person in connection with a Non-Control Transaction (as hereinafter defined);


(2) The individuals who, as of January 1, 2004, are members of the Board (“Incumbent Board”) cease for any reason to constitute at least a majority of the Board; provided, however, that if the election, or nomination for election by the Company’s stockholders, of any new director was approved by a vote of at least a majority of the Incumbent Board, such new director shall, for purposes of the Plan, be considered as a member of the Incumbent Board; provided, further, however, that no individual shall be considered a member of the Incumbent Board if such individual initially assumed office as a result of either an actual or threatened election contest (as described in the former Rule 14a-11 promulgated under the Exchange Act) (“Election Contest”) or other actual or threatened solicitation of proxies or consents by or on behalf of a Person other than the Board (“Proxy Contest”) including by reason of any agreement intended to avoid or settle any Election Contest or Proxy Contest; or

 

(3) Approval by stockholders of the Company of:

 

(A) A merger, consolidation or reorganization involving the Company, unless such is a Non-Control Transaction. For purposes of the Plan, the term “Non-Control Transaction” shall mean a merger, consolidation or reorganization of the Company in which:

 

(i) the stockholders of the Company, immediately before such merger, consolidation or reorganization, own, directly or indirectly immediately following such merger, consolidation or reorganization, at least a majority of the combined voting power of the voting securities of the corporation resulting from such merger or consolidation or reorganization (“Surviving Corporation”) over which any Person has Beneficial Ownership in substantially the same proportion as their ownership of the Voting Securities immediately before such merger, consolidation or reorganization;

 

(ii) the individuals who were members of the Incumbent Board immediately prior to the execution of the agreement providing for such merger, consolidation or reorganization constitute at least a majority of the members of the board of directors of the Surviving Corporation; and

 

(iii) no Person (other than the Company, any Subsidiary, any employee benefit plan (or any trust forming a part thereof) maintained by the Company, the Surviving Corporation, or any Person who, immediately prior to such merger, consolidation or reorganization had Beneficial Ownership of 20% or more of the then outstanding Voting Securities) has Beneficial Ownership of 20% or more of the combined voting power of the Surviving Corporation’s then outstanding voting securities;

 

(B) A complete liquidation or dissolution of the Company; or

 

-2-


(C) An agreement for the sale or other disposition of all or substantially all of the assets of the Company to any Person (other than a transfer to a Subsidiary).

 

(4) Any other event that the Committee shall determine constitutes an effective Change in Control of the Company.

 

Notwithstanding the foregoing, a Change in Control shall not be deemed to occur solely because any Person (“Subject Person”) acquired Beneficial Ownership of more than the permitted amount of the outstanding Voting Securities as a result of the acquisition of Voting Securities by the Company which, by reducing the number of Voting Securities outstanding, increases the proportional number of shares Beneficially Owned by the Subject Person; provided, however, that if a Change in Control would occur (but for the operation of this sentence) as a result of the acquisition of Voting Securities by the Company, and after such share acquisition by the Company, the Subject Person becomes the Beneficial Owner of any additional Voting Securities which increases the percentage of the then outstanding Voting Securities Beneficially Owned by the Subject Person, then a Change in Control shall occur.

 

(f) “Code” shall mean the Internal Revenue Code of 1986, as amended from time to time, and any successor thereto.

 

(g) “Committee” shall mean the Committee provided for in Section 7.1.

 

(h) “Company” shall mean Ventas, Inc., a Delaware corporation.

 

(i) “Director” shall mean a member of the Board who is not an employee of the Company or any Subsidiary.

 

(j) “Disability” shall mean the total disability as determined by the Committee in accordance with standards and procedures similar to those under the Company’s long-term disability plan, or, if none, a physical or mental infirmity which the Committee determines impairs the Participant’s ability to perform substantially his or her duties for a period of 180 consecutive days.

 

(k) “Exchange Act” shall mean the Securities Exchange Act of 1934, as amended from time to time.

 

(l) “Fair Market Value” of the Shares shall mean, as of any applicable date, the closing sale price of the Shares on the New York Stock Exchange or any national or regional stock exchange on which the Shares are traded, or if no such reported sale of the Shares shall have occurred on such date, on the next preceding date on which there was such a reported sale. If there shall be any material alteration in the present system of reporting sale prices of the Shares, or if the Shares shall no longer be listed on the New York Stock Exchange or a national or regional stock exchange, the fair market value of the Shares as of a particular date shall be determined by such method as shall be determined by the Committee.

 

(m) “Option” shall mean an option granted to an Optionee pursuant to the Plan.

 

-3-


(n) “Option Agreement” shall mean a written agreement between the Company and an Optionee evidencing the granting of an Option and containing terms and conditions concerning the exercise of the Option.

 

(o) “Optionee” shall mean a Director who has been granted an Option or the personal representative, heir or legatee of an Optionee who has the right to exercise the Option upon the death of the Optionee.

 

(p) “Other Stock-Based Award” shall mean any right granted under Article 6.

 

(q) “Person” shall have the meaning ascribed to such term in Section 3(a)(9) of the Exchange Act and as used in Sections 13(d) and 14 (d) thereof, including a “group” as defined in Section 13(d).

 

(r) “Plan” shall mean this Ventas, Inc. 2004 Stock Plan for Directors, as the same may be amended from time to time.

 

(s) “Restricted Award Agreement” shall mean an agreement evidencing a Restricted Stock Award or Restricted Stock Unit Award, as described in Section 5.3.

 

(t) “Restricted Stock” shall mean Shares granted pursuant to Article 5 as to which the restrictions have not expired.

 

(u) “Restricted Stock Unit” shall mean an Award granted pursuant to Article 5 denominated in units of the Company’s common stock.

 

(v) Restriction Period” shall mean the period set forth in Section 5.1 or determined by the Committee during which the transfer of Shares is limited in some way or Shares or Restricted Stock Units are otherwise restricted or subject to forfeiture as provided in Article 5.

 

(w) “Shares” shall mean the shares of the Company’s common stock, par value $.25 per share.

 

(x) “Subsidiary” shall mean, with respect to any company, any corporation or other Person of which a majority of its voting power, equity securities or equity interest is owned directly or indirectly by such company.

 

2.2 Gender and Number . Except where otherwise indicated by the context, reference to the masculine gender shall include the feminine gender, the plural shall include the singular and the singular shall include the plural.

 

2.3 Severability . In the event any provision of the Plan shall be held illegal or invalid for any reason, the illegality or invalidity shall not affect the remaining parts of the Plan, and the Plan shall be construed and enforced as if the illegal or invalid provision had not been included.

 

-4-


ARTICLE 3. SHARES SUBJECT TO THE PLAN

 

The stock to be offered under the Plan shall be Shares, which Shares may be unissued Shares or treasury Shares. Subject to the adjustments provided for in Article 8, the aggregate number of Shares to be delivered upon exercise of all Awards and the payment of benefits in connection with Awards granted under the Plan shall not exceed 400,000 Shares. If and to the extent an Award shall expire or terminate for any reason without having been exercised in full or shall be forfeited, the Shares (including Restricted Stock) associated with such Awards shall again become available for Awards under the Plan.

 

ARTICLE 4. TERMS AND CONDITIONS OF OPTIONS

 

4.1 Non-Discretionary Grants . On January 1 of each year during the term of the Plan, each Director (i) who is elected a director at the preceding annual meeting of shareholders or who has been appointed a director by the Board during the preceding year and (ii) who is acting as a director on January 1, shall receive a grant of an Option for 5,000 Shares. Such Options shall have the following terms and conditions:

 

(a) The exercise price of the Option shall be equal to 100% of the Fair Market Value of the Shares on the date the Option is granted.

 

(b) The term of the Option shall be ten years from the date of grant unless sooner terminated as provided herein.

 

(c) The Option shall be exercisable in two equal annual installments, with the first installment becoming exercisable on the date of grant of the Option and the second installment becoming exercisable on the first anniversary of the date of grant of the Option. Notwithstanding the provisions of this Section 4.1, upon a Change in Control or the retirement of the director, the Optionee shall have the right to exercise the Option in full as to all Shares subject to the Option.

 

4.2 Termination of Option.

 

(a) If the Optionee ceases to be a director of the Company for any reason other than death, Disability, retirement or removal for Cause, the Option shall terminate three months after the Optionee ceases to be a director of the Company (unless the Optionee dies during such period), or on the Option’s expiration date, if earlier, and shall be exercisable during such period after the Optionee ceases to be a director of the Company only with respect to the number of Shares which the Optionee was entitled to purchase on the day preceding the day on which the Optionee ceased to be a director.

 

(b) If the Optionee ceases to be a director of the Company because of removal for Cause, the Option shall terminate on the date of the Optionee’s removal.

 

(c) In the event of the Optionee’s death, Disability or retirement while a director of the Company, or the Optionee’s death within three months after the Optionee ceases to be a director (other than by reason of removal for Cause), the Option shall terminate upon the earlier to occur of (A) 12 months after the date of the Optionee’s death, Disability or retirement, or (B)

 

-5-


the Option’s expiration date. The Option shall be exercisable during such period after the Optionee’s death or Disability with respect to the number of Shares as to which the Option shall have been exercisable on the date preceding the Optionee’s death or Disability, as the case may be. In the event of the retirement of the director, the Option shall be fully exercisable during such period.

 

4.3 Restrictions on Transferability of Option . The Option shall not be transferable by the Optionee otherwise than by bequest or the laws of descent and distribution, and shall be exercisable during the Optionee’s lifetime only by the Optionee; provided, however, that the Optionee may, subject to any restrictions under Section 16(b) of the Exchange Act, transfer the Options to (i) the Optionee’s spouse or lineal descendants (“Immediate Family Members”), (ii) trusts for the exclusive benefit of such Optionee and/or his Immediate Family Members, or (iii) a partnership or limited liability company in which such Optionee and/or his Immediate Family Members are the only partners or members, as applicable; provided that (a) there may be no consideration for any such transfer (other than interests in such partnership or limited liability company) and (b) subsequent transfers of any transferred Option shall be prohibited other than by bequest or the laws of descent and distribution. Following transfer, any such Option shall continue to be subject to the same terms and conditions as were applicable immediately prior to transfer, provided that for purposes of the Plan (excluding Section 4.2) the term “Optionee” shall be deemed to refer to the transferee. Notwithstanding the above, the provisions of Section 4.2 concerning the termination of an Option shall continue to be applied with respect to the original Optionee. Any transferred Option shall be exercisable by the transferee only to the extent, and for the periods, specified in the Option Agreement.

 

4.4 Payment of Exercise Price . The exercise price shall be paid in cash at the time of exercise or by means of a “cashless exercise” through a third party, except that in lieu of all or part of the cash or third-party “cashless exercise”, the Optionee may tender to the Company Shares already owned by the Optionee having a Fair Market Value equal to the exercise price, less any cash paid. Any Company Shares tendered to the Company pursuant to this provision must have been held by the Optionee for at least six months prior to exercise. The Fair Market Value of such tendered Shares shall be determined as of the close of the business day immediately preceding the day on which the Option is exercised.

 

4.5 Discretionary Grants . Subject to the terms and provisions of the Plan, the Committee may grant Options in addition to the Options specified in Section 4.1 at any time and from time to time. The Committee shall determine the terms and conditions of Options granted pursuant to this Section 4.5 but in no event shall the exercise price of such Options be less than 100% of the Fair Market Value of Shares on the date the Option is granted.

 

4.6 Option Agreement . Each Option shall be evidenced by an Option Agreement which shall set forth the number of Shares for which the Option was granted, the provisions set forth in this Article 4 relating to the Option and such other terms and conditions consistent with the Plan.

 

-6-


ARTICLE 5. TERMS AND CONDITIONS OF RESTRICTED STOCK

 

5.1 Non-Discretionary Grants . Upon stockholder approval of the Plan and on January 1 of each succeeding year during the term of the Plan, each Director (i) who is elected a director at the preceding annual meeting of shareholders or who has been appointed a director by the Board during the preceding year and (ii) who is acting as a director on the date of such stockholder approval or on January 1 in any succeeding year during the term of the Plan, respectively, shall receive a grant of 1,750 shares of Restricted Stock or 1,750 Restricted Stock Units, as elected by the Director. On the initial election by the shareholders of a Director to the Board who is not and has not been a member of the Board, or if earlier, on the initial appointment by the Board of a Director, such Director shall receive a grant of 2,000 shares of Restricted Stock or 2,000 Restricted Stock Units, as elected by the Director. The restrictions on the transfer of shares of Restricted Stock granted pursuant to this Section 5.1 shall lapse with respect to one-half of the shares of Restricted Stock granted on the first anniversary of the date of such grant provided the recipient of the grant is a director of the Board at such time and with respect to the remaining one-half of the shares of Restricted Stock granted on the second anniversary of the date of such grant provided the recipient of the grant is a director of the Board at such time. One-half of the Restricted Stock Units granted pursuant to this Section 5.1 shall vest on the first anniversary of the date of such grant provided the recipient of the grant is a director of the Board at such time and the remaining one-half of the Restricted Stock Units shall vest on the second anniversary of the date of such grant provided the recipient of the grant is a director of the Board at such time. Notwithstanding the provisions of this Section 5.1, upon a Change in Control or the retirement of the Director, all restrictions pertaining to the then outstanding shares of Restricted Stock and Restricted Stock Units held by Directors shall lapse and such Shares of Restricted Stock shall thereafter be immediately free from any and all restrictions under the Plan and Restricted Stock Units shall be paid as set forth in the Restricted Award Agreement.

 

5.2 Discretionary Grants . Subject to the terms and provisions of the Plan, the Committee may grant shares of Restricted Stock or Restricted Stock Units, as elected by the Director, in addition to the Restricted Stock and Restricted Stock Units specified in Section 5.1 at any time and from time to time. The Committee shall generally determine the terms and conditions of Restricted Stock and Restricted Stock Units granted pursuant to this Section 5.2 but the Director shall determine the payment date for Restricted Stock Units.

 

5.3 Restricted Award Agreement . Each grant of Restricted Stock or Restricted Stock Units shall be evidenced by a Restricted Award Agreement which shall specify the Restriction Period, the number of shares of Restricted Stock or Restricted Stock Units granted, as elected by the Director, and such other provisions as the Committee may determine or which are required by the Plan.

 

5.4 Non-Transferability of Restricted Stock . Except as provided in this Article 5, shares of Restricted Stock and Restricted Stock Units may not be sold, transferred, pledged, assigned or otherwise alienated or hypothecated until the end of the applicable Restriction Period or later as specified in the Restricted Award Agreement, or upon earlier satisfaction of any other conditions determined at the time of grant specified in the Restricted Award Agreement.

 

-7-


5.5 Other Restrictions . The Committee may impose such other restrictions on any shares of Restricted Stock or Restricted Stock Units as it may deem advisable, including, without limitation, legends on certificates representing shares of Restricted Stock and restrictions under applicable Federal or state securities laws. The Committee may provide that any share of Restricted Stock shall be held (together with a stock power executed in blank by the Director) in custody by the Company until any or all restrictions thereon shall have lapsed.

 

5.6 Reacquisition of Restricted Stock . Any forfeited shares of Restricted Stock held by a Director or former Director which are to be reacquired by the Company shall be immediately returned to the Company by the Director or former Director, and the Director or former Director shall only receive the amount, if any, paid by the Director or former Director for such Restricted Stock.

 

5.7 Voting Rights; Dividends and Other Distributions . Unless determined otherwise by the Committee, during the Restriction Period, directors of the Board holding shares of Restricted Stock may exercise full voting rights, and shall be entitled to receive all dividends and other distributions paid, with respect to such Restricted Stock. If any dividends or distributions are paid in Shares, the Shares shall be subject to the same restrictions as the shares of Restricted Stock with respect to which they were paid.

 

On each dividend or other distribution date with respect to Shares, a cash dollar amount equal to the amount of cash dividends or the fair market value of property other than Shares that would have been paid or distributed on a number of Shares equal to the number of Restricted Stock Units held by Directors as of the close of business on the record date for such dividend or distribution shall be paid in cash to such Directors. If any dividend or distribution with respect to Shares is payable in Shares, Directors shall be credited with an additional number of Restricted Stock Units equal to the product of the number of Restricted Stock Units held by such Directors on the record date for such dividend or distribution multiplied by the number of Shares (including fractions thereof) distributable as a dividend or distribution on a Share. Restricted Stock Units which are credited to Directors pursuant to the preceding sentence shall be subject to the same terms and conditions of the Plan, the Restricted Award Agreement and elections applicable with respect to such Restricted Stock Units with respect to which they relate.

 

5.8 Termination of Directorship . If the recipient of Restricted Stock ceases to be a director of the Board for any reason other than retirement or Change in Control prior to the expiration of the Restriction Period applicable to any shares of Restricted Stock then held by the Director, such Shares shall thereupon be immediately forfeited by and returned to the Company, and the former Director shall only receive the amount, if any, paid by the former Director for such Restricted Stock. If the recipient of Restricted Stock Units ceases to be a director of the Board for any reason other than retirement or Change in Control prior to the expiration of the Restriction Period applicable to any Restricted Stock Units then held by the Director, such Restricted Stock Units shall thereupon be immediately forfeited.

 

ARTICLE 6. OTHER STOCK-BASED AWARDS

 

The Board may grant to Directors such other Awards (including, without limitation, restricted stock units, stock awards, stock appreciation rights and rights to dividends and

 

-8-


dividend equivalents) that are denominated or payable in, valued in whole or in part by reference to, or otherwise based on or related to, Shares (including, without limitation, securities convertible into Shares) as are deemed by the Committee to be consistent with the purposes of the Plan.

 

ARTICLE 7. ADMINISTRATION

 

7.1 The Committee . Portions of the Plan are designed to operate automatically and not require any significant administration. To the extent administration is required, the Plan shall be administered by a Committee appointed by the Board which shall include two or more directors of the Company or the entire Board. The Committee may permit a Director to defer receipt of payment or delivery of Shares that would otherwise be due to such Director by virtue of the exercise of an Option, the lapse or waiver of restrictions with respect to Restricted Stock or Restricted Stock Units or the satisfaction of any requirements or goals with respect to Other Stock-Based Awards. The Committee shall meet at such times and places as it determines and may meet through a telephone conference call. A majority of its members shall constitute a quorum, and the decision of the majority of those present at any meeting at which a quorum is present shall constitute the decision of the Committee. Any decision reduced to writing and signed by a majority of the members of the Committee shall be fully effective as if it had been made by a majority at a meeting duly held. All decisions, determinations and selections made by the Committee pursuant to the provisions of the Plan shall be final. To the extent permitted by law, the Committee may delegate its authority hereunder.

 

7.2 Section 16 Compliance . It is the intention of the Company that the Plan and the administration of the Plan comply in all respects with Section 16(b) of the Exchange Act and the rules and regulations promulgated thereunder to the extent deemed appropriate by the Committee. If any Plan provision, or any aspect of the administration of the Plan, is found not to be in compliance with Section 16(b) of the Exchange Act, the provision or administration shall be deemed null and void to the extent deemed appropriate by the Committee, and in all events the Plan shall be construed in favor of its meeting the requirements of Rule 16b-3 promulgated under the Exchange Act to the extent deemed appropriate by the Committee.

 

ARTICLE 8. ADJUSTMENTS UPON CHANGE IN CAPITALIZATION

 

Notwithstanding the limitations set forth in Article 3, in the event of a merger, reorganization, consolidation, recapitalization, reclassification, split-up, spin-off, separation, liquidation, stock dividend, stock split, reverse stock split, property dividend, share repurchase, share combination, share exchange, issuance of warrants, rights or debentures or other change in corporate structure of the Company affecting the Shares, the Committee shall make an appropriate and equitable adjustment in the maximum number of Shares available under the Plan or to any one individual and in the number, kind and exercise price of Shares subject to Awards granted under the Plan to prevent dilution or enlargement of the rights of Directors under the Plan and outstanding Awards.

 

-9-


ARTICLE 9. AMENDMENTS AND DISCONTINUANCE

 

9.1 In General . Except as provided in Section 9.2, the Board may discontinue, amend, modify or terminate the Plan at any time.

 

9.2 Exchange Compliance . To the extent required to meet the requirements of any national securities exchange or system on which the Shares are then listed or reported or a regulatory body having jurisdiction with respect thereto, without the approval of the stockholders of the Company, no amendment or modification may make a material revision to the Plan.

 

9.3 No Effect on Outstanding Awards . Any Award which is outstanding under the Plan at the time of the Plan’s amendment or termination shall remain in effect in accordance with its terms and conditions and those of the Plan as in effect when the Award was granted.

 

ARTICLE 10. MERGER, CONSOLIDATION, ETC.

 

10.1 Conversion on Certain Mergers . In the event the Company merges or consolidates with another corporation, or all or substantially all of the Company’s capital stock or assets are acquired by another corporation, and the surviving or acquiring corporation issues shares of its stock to the Company’s stockholders in connection with the merger, consolidation or acquisition, the surviving or acquiring corporation shall adopt the Plan. Following such adoption, the Optionee shall, at no additional cost (other than the exercise price), be entitled to receive upon the exercise of an Option, in lieu of the number of Shares to which such Option is then exercisable, the number and class of stock or other securities to which the Optionee would have been entitled pursuant to the terms of the merger, consolidation or acquisition if immediately prior thereto the Optionee had been the holder of record of a number of Shares equal to the number of Shares as to which the Option shall then be exercisable.

 

10.2 No Conversion on Other Mergers . In the event that the Company merges or consolidates with another corporation, or all or substantially all of the Company’s capital stock or assets are acquired by another corporation, and the surviving or acquiring corporation does not issue shares of its stock to the Company’s stockholders in connection with the merger, consolidation or acquisition, then, notwithstanding any other provision of the Plan to the contrary, no Option may be exercised after the effective date of the merger, consolidation or acquisition.

 

ARTICLE 11. EFFECTIVE DATE AND TERMINATION OF THE PLAN

 

11.1 Effective Date . The amendment and restatement of the Plan shall become effective January 1, 2004. All Awards granted hereunder which could not have been granted under the Plan prior to its amendment and restatement shall be null and void unless within 12 months from the date of the adoption of the amendment and restatement of the Plan by the Board it shall have been approved by the holders of a majority of the outstanding Shares present or represented and entitled to vote on the Plan at a stockholders’ meeting.

 

11.2 Termination Date . The Plan shall terminate on the earliest to occur of (i) the date when all of the Shares available under the Plan shall have been acquired through the exercise of Options granted under the Plan; (ii) 10 years after the date of adoption of the 1997 Stock Option Plan for Non-Employee Directors by the Board; or (iii) such earlier date as the Board may determine.

 

-10-


ARTICLE 12. NO RIGHT TO REELECTION

 

Neither the Plan, nor any action taken under the Plan, shall be construed as conferring upon a Director any right to continue as a director of the Company, to be renominated by the Board or reelected by the stockholders of the Company.

 

ARTICLE 13. INDEMNIFICATION

 

No member of the Board or the Committee, nor any officer or employee acting on behalf of the Board or the Committee, shall be personally liable for any action, determination or interpretation taken or made with respect to the Plan, and all members of the Board, the Committee and each officer or employee of the Company acting on their behalf shall, to the extent permitted by law, be fully indemnified and protected by the Company with respect to any such action, determination or interpretation.

 

ARTICLE 14. GOVERNING LAW

 

The provisions of the Plan shall be construed, administered and enforced according to the laws of the State of Delaware without regard to its conflict of laws rules.

 

-11-

EXHIBIT 12

 

STATEMENT REGARDING COMPUTATION OF RATIOS OF EARNINGS TO FIXED CHARGES

 

     2004

    2003

    2002

    2001

    2000

 

Income (loss) before gain on disposal of real estate assets, discontinued operations, provision for income taxes and extraordinary loss

   $ 100,173     $ 96,135     $ 34,685     $ 48,687     $ (70,136 )

Interest Expense

                                        

Notes payable and other debt

     66,349       61,364       70,534       79,595       86,803  

United States Settlement

     —         4,943       5,461       4,592       —    
    


 


 


 


 


Earnings

   $ 166,522     $ 162,442     $ 110,680     $ 132,874     $ 16,667  
    


 


 


 


 


Interest Expense

                                        

Notes payable and other debt

     66,349       61,364       70,534       79,595       86,803  

United States Settlement

     —         4,943       5,461       4,592       —    
    


 


 


 


 


Fixed Charges

   $ 66,349     $ 66,307     $ 75,995     $ 84,187     $ 86,803  
    


 


 


 


 


Ratio of Earnings to Fixed Charges (a)

     2.51 x     2.45 x     1.46 x     1.58 x     —    
    


 


 


 


 



(a) Earnings were insufficient to cover fixed charges by $69.7 million in 2000. Earnings in 2000 were reduced by $96.5 million for the United States Settlement.

EXHIBIT 21

 

SUBSIDIARIES OF VENTAS, INC.

AS OF FEBRUARY 28, 2005

 

Ventas Realty, Limited Partnership, a Delaware limited partnership

Ventas LP Realty, LLC., a Delaware limited liability company

Ventas Finance I, LLC, a Delaware limited liability company

Ventas Finance I, Inc., a Delaware corporation (“VFI Inc.”). VFI Inc. does business under the following names:

Ventas Finance I (KY), Inc.;

Ventas Finance I (UT), Inc.;

Ventas Finance I (WA), Inc,; and

Ventas Finance I (WI), Inc.

Ventas Specialty I, LLC, a Delaware limited liability company

Ventas Specialty I, Inc., a Delaware corporation

Ventas Capital Corporation, a Delaware corporation

Ventas Healthcare Properties, Inc., a Delaware corporation

Ventas TRS, LLC, a Delaware limited liability company

Ventas Framingham, LLC, a Delaware limited liability company

Ventas Management, LLC, a Delaware limited liability company

Ventas Fairwood, LLC, a Delaware limited liability company

Ventas Springfield/Findlay, LLC, a Delaware limited liability company

Ventas Belleville, LLC, a Delaware limited liability company

Ventas Farmington Hills, LLC, a Delaware limited liability company

Ventas Kansas City I, LLC, a Delaware limited liability company

Ventas Regency Medical Park I, LLC, a Delaware limited liability company

Ventas Bayshore Medical, LLC, a Delaware limited liability company

Ventas Whitehall Estates, LLC, a Delaware limited liability company

ElderTrust, a Maryland real estate investment trust

ElderTrust Operating Limited Partnership, a Delaware limited partnership

ET Capital Corp., a Delaware corporation

ET GENPAR, L.L.C., a Delaware limited liability company

ET Sub-Belvedere Limited Partnership, L.L.P., a Virginia limited liability partnership

ET Belvedere Finance, L.L.C., a Delaware limited liability company

ET Belvedere Finance, Inc., a Delaware corporation

ET Sub-Berkshire Limited Partnership, a Delaware limited partnership

ET Berkshire, LLC, a Delaware limited liability company

ET Sub-Cabot Park, L.L.C., a Delaware limited liability company

Cabot ALF, L.L.C., a Delaware limited liability company

ET Sub-Cleveland Circle, L.L.C. a Delaware limited liability company

Cleveland ALF, L.L.C., a Delaware limited liability company

ET Sub-DCMH Limited Partnership, L.L.P., a Virginia limited liability partnership

ET DCMH Finance, L.L.C., a Delaware limited liability company

ET DCMH Finance, Inc., a Delaware corporation

ET Sub-Heritage Andover, L.L.C., a Delaware limited liability company

ET Heritage Andover Finance, Inc., a Delaware corporation

ET Sub-Heritage Woods, L.L.C., a Delaware limited liability company

ET Sub-Highgate, L.P., a Pennsylvania limited partnership

ET Sub-Lacey I, L.L.C., a Delaware limited liability company

ET Sub-Lehigh Limited Partnership, a Delaware limited partnership

ET Lehigh, LLC, a Delaware limited liability company

ET Sub-Lopatcong, L.L.C., a Delaware limited liability company

ET Sub-Pennsburg Manor Limited Partnership, L.L.P., a Virginia limited liability partnership

ET Pennsburg Finance, L.L.C., a Delaware limited liability company

ET Sub-Phillipsburg I, L.L.C., a Delaware limited liability company

ET Sub-Pleasant View, L.L.C., a Delaware limited liability company

ET Sub-POB I Limited Partnership, L.L.P., a Virginia limited liability partnership

ET POBI Finance, L.L.C., a Delaware limited liability company


ET POBI Finance, Inc., a Delaware corporation

ET Sub-Rittenhouse Limited Partnership, L.L.P., a Virginia limited liability partnership

ET Sub-Riverview Ridge Limited Partnership, L.L.P., a Virginia limited liability partnership

ET Sub-Sanatoga Limited Partnership, a Delaware limited partnership

ET Sanatoga, LLC, a Delaware limited liability company

ET Sub-SMOB, L.L.C., a Delaware limited liability company

ET Sub-Vernon Court, L.L.C., a Delaware limited liability company

Vernon ALF, L.L.C., a Delaware limited liability company

ET Sub-Wayne I, Limited Partnership, L.L.P., a Virginia limited liability partnership

ET Wayne Finance, L.L.C., a Delaware limited liability company

ET Wayne Finance, Inc., a Delaware corporation

ET Sub-Willowbrook Limited Partnership, L.L.P., a Virginia limited liability partnership

ET Sub-Woodbridge, L.P., a Pennsylvania limited partnership

Exhibit 23

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the incorporation by reference in the Registration Statement (Form S-8 No. 333-02717) pertaining to the Vencor, Inc. 1987 Incentive Compensation Plan; the Registration Statement (Form S-8 No. 033-34191) pertaining to the Vencor, Inc. 1987 Stock Option Plan for Non-Employee Directors; the Registration Statement (Form S-8 No. 333-25519) pertaining to the TheraTx, Incorporated 1996 Stock Option/Stock Issuance Plan; the Registration Statement (Form S-8 No. 333-61552) pertaining to the Ventas, Inc. Common Stock Purchase Plan for Directors; the Registration Statement (Form S-3 No. 333-65642) pertaining to the Ventas, Inc. Distribution Reinvestment and Stock Purchase Plan; the Registration Statement (Form S-3 No. 333-90756) pertaining to securities of Ventas, Inc. and subsidiaries; the Registration Statement (Form S-8 No. 333-97251) pertaining to the Ventas, Inc. 2000 Incentive Compensation Plan; the Registration Statement (Form S-3 No. 333-107942) pertaining to securities of Ventas, Inc. and subsidiaries; the Registration Statement (Form S-8 No. 333-107951) pertaining to the 2000 Stock Option Plan for Directors; the Registration Statement (Form S-3 No. 333-101598) pertaining to securities of Ventas, Inc. and subsidiaries; the Registration Statement (Form S-3 No. 333-119261) pertaining to securities of Ventas, Inc. and subsidiaries; and the Registration Statement (Form S-8 No. 333-118944) pertaining to the Ventas Executive Deferred Stock Compensation Plan and Ventas Nonemployee Director Deferred Stock Compensation Plan, of our reports dated February 22, 2005 with respect to the consolidated financial statements and schedule of Ventas, Inc., Ventas, Inc. management’s assessment of the effectiveness of internal control over financial reporting, and the effectiveness of internal control over financial reporting of Ventas, Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2004.

 

/s/ Ernst & Young LLP

 

Chicago, Illinois

February 25, 2005

Exhibit 31.1

 

I, Debra A. Cafaro, Chairman, President and Chief Executive Officer of Ventas, Inc., certify that:

 

1. I have reviewed this Annual Report on Form 10-K of Ventas, Inc.

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  (c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  (d) Disclosed in this report, any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting, which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: March 1, 2005

 

/s/ Debra A. Cafaro


Debra A. Cafaro

Chairman, President and Chief Executive Officer

Exhibit 31.2

 

I, Richard A. Schweinhart, Senior Vice President and Chief Financial Officer of Ventas, Inc., certify that:

 

1. I have reviewed this Annual Report on Form 10-K of Ventas, Inc.

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  (c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  (d) Disclosed in this report, any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting, which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: March 1, 2005

 

/s/ Richard A. Schweinhart


Richard A. Schweinhart

Senior Vice President and Chief Financial Officer

Exhibit 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report on Form 10-K of Ventas, Inc. (the “Company”) for the period ended December 31, 2004 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Debra A. Cafaro, Chairman, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: March 1, 2005

 

/s/ Debra A. Cafaro


Debra A. Cafaro

Chairman, President and Chief Executive Officer

 

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

Exhibit 32.2

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report on Form 10-K of Ventas, Inc. (the “Company”) for the period ended December 31, 2004 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Richard A. Schweinhart, Senior Vice President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: March 1, 2005

 

/s/ Richard A. Schweinhart


Richard A. Schweinhart

Senior Vice President and Chief Financial Officer

 

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.